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Abstract 
Depression in young people is common, resulting in morbidity and mortality. 
Behavioural Activation (BA) is a cost-effective and efficacious treatment for reducing 
depressive symptoms in adults. There is little published research relating to BA as a 
treatment option for young people with depression. Thus, the aim was to explore 
the feasibility of conducting a trial of BA for depression in Child and Adolescent 
Mental Health Services (CAMHS). 
Stage I 
The initial stage of the study comprised a focused ethnography, conducted over a 
six-month period. The purpose was to explore the CAMHS study site, with a view to 
pre-empting (and addressing) any difficulties that may be encountered during a 
planned trial. Participant observation (158 hours), staff interviews (n= 6) and 
document collection (n= 17) were used to gather data. Data were coded using 
thematic analysis and the resulting themes were verified by a second coder. Insights 
into the individual, practical and organisational boundaries of the service guided 
implementation of Stage II. 
Stage II 
The second stage involved a randomised controlled feasibility trial with an 
embedded qualitative component. Participants were identified via a case note 
review or self/clinician referral from three CAMHS over seventeen months. Young 
people (aged 12 to 17 years) displaying symptoms of depression were offered a 
structured diagnostic interview to confirm depression status. Additional measures of 
mood, functioning and self-esteem were recorded. Twenty-two patients were 
randomised to BA or usual CAMHS care. Existing CAMHS staff were trained to deliver 
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the 8-week manualised BA intervention. Following treatment, participants in the BA 
arm, their parents and clinicians were offered semi-structured interviews to explore 
their experiences of receiving or administering BA. Verbatim interview transcripts 
were coded using thematic analysis. At three months post-baseline, the diagnostic 
interview and outcome measures were repeated. At six months post-baseline, a 
telephone interview repeated selected outcomes.  
Participant recruitment was successful but the trial suggests that the process 
used could be streamlined. Participants were 82% female, with a mean age of 15.7 
(SD, 1.2) years. Qualitative feedback from patients and their caregivers supported 
the acceptability of BA treatment. Families also identified barriers to participating in 
the intervention. Most staff found the intervention acceptable, but some raised 
concerns about the manualised treatment delivery. Retention at three months was 
68%, with higher loss to follow-up in the BA (4/11; 36%) vs. usual care (3/11; 27%). 
Although not powered to demonstrate statistical differences, preliminary 
quantitative data suggest BA treatment may result in improved outcomes compared 
to usual care, such as remission from depression. Fewer BA participants met 
depression criteria at three-month follow-up (3/7; 42.9%) than in usual care (7/8; 
87.5%). However, the assessor was not blinded to treatment allocation, fidelity was 
not assessed and the number of sessions was not controlled for, which increases 
uncertainty relating to the results.  
This research contributes valuable information about how a BA trial could be 
implemented in an adolescent mental health setting, and provides indications about 
the potential of the approach to treat depression in this context. However, 
outstanding questions relating to the feasibility of the intervention remain.  
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Introduction 
At the outset, I envisaged this PhD project would be a purely quantitative 
endeavour; a pilot Randomised Controlled Trial (RCT) that would evaluate 
Behavioural Activation (BA) as a treatment for young people with depression in Child 
and Adolescent Mental Health Services (CAMHS). This expectation was primarily 
based on learning about RCTs as the ‘gold standard’ of research, along with the 
ubiquity of RCT evidence in the clinical practice guidelines (Torgerson and Torgerson, 
2008, National Institute for Health and Clinical Excellence, 2005). However, once I 
initiated the background literature review it quickly became clear how little 
published research there was relating to BA for children and young people. There 
were many outstanding questions relating to the feasibility of a BA approach, 
particularly in a UK CAMHS context. Alongside this were the inherent differences 
across cultures and contexts in the definitions of the terms ‘child’, ‘adolescent’ and 
‘young person’. In relation to the potential use of BA in UK clinical practice, I 
appraised different research methods and methodologies and considered whether a 
purely qualitative approach would be a more suitable design to answer my research 
questions. As qualitative research is concerned with how the social world is 
interpreted, understood, experienced, produced or constituted (Mason, 2002), it 
seemed to be well suited to answering questions relating to the acceptability and 
feasibility of a novel intervention from a patient and practitioner perspective. 
However, I rejected this approach because later questions that would need to be 
tackled, relating to the efficacy of the intervention, would not best be served by a 
solely qualitative paradigm. Yet again, however, relying on an efficacy-based 
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paradigm (such as an RCT) that has been established to answer questions under 
decontextualisation or in optimal conditions would not produce the solutions 
needed for clinical practice (Kessler and Glasgow, 2011). Thus, neither a qualitative 
or quantitative approach alone would have accounted for the complexity of the 
subject, nor responded to the lack of evidence in the area. This led me to decide 
upon a mixed methods approach (Cresswell, 2009), which brought with it an 
inimitable set of challenges. 
This thesis embraces qualitative and quantitative approaches which are 
clearly derived from differing ontological and epistemological standpoints. A 
person’s ontological perspective refers to their view of the world and what they 
believe constitutes a social ‘reality’ (Savage, 2000, Mason, 2002). A person’s 
epistemological position communicates what they regard as evidence or knowledge 
in relation to these social realities (Mason, 2002, Barber, 2014). There has been 
much debate between both qualitative and quantitative researchers about what 
constitutes a reality and much discussion from mixed methods researchers about 
how to deal with these differences (Sale et al., 2002). Rather than selecting one rigid 
viewpoint, Mason (2002) argues that it is more productive to learn what we can 
from debates about the ability of research to uncover truths or to represent the 
realities of others, rather than to assume one argument has authority over another 
(Mason, 2002). Sale, Lohfeld and Brazil (2002) caution against combining qualitative 
and quantitative methods uncritically, without considering the underlying 
assumptions inherent in each approach. These differing standpoints have not only 
presented a challenge when designing and delivering this research, but also during 
the analysis and presentation of the results. Quantitative and qualitative approaches 
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each engender and are associated with a particular style of writing; quantitative 
styles often comprising of brief, segmented script with short sentences. Qualitative 
research, in contrast, is often textured as a thick narrative composition (Ponterotto, 
2006). Mixed methodologists have long discussed ways to successfully report and 
integrate such methods within the same study (Cresswell, 2009). However, the 
challenge in writing this thesis was guiding the reader through chapters that are 
written in contrasting styles.  
Overview 
A visual thesis map has been created to guide the reader through the research 
process and resulting thesis (see Figure 1). The stepped ‘stages’ mirror the ‘phased’ 
approach to evidence building commonly seen in RCTs and in recommendations 
issued in relation to trial design (for example, the Medical Research Council [MRC] 
guidance), which will be discussed in more detail throughout the thesis (Craig et al., 
2008). The scoping background literature review includes research relating to adults, 
young people and children of all ages. In the later stages of the thesis (Stage II), a 
narrower age range of young people (aged 12 to 17) has been focused upon. Stage I 
of this thesis describes how a focused ethnographic approach was used to inform 
Stage II of the research (a feasibility RCT). This focused ethnography has been 
published in a peer-reviewed, academic journal as an illustration of the innovative 
approach that was taken to sequencing mixed methods in the context of the trial 
design (Kitchen et al., 2017). The contextual information gained from Stage I was 
invaluable in understanding the boundaries into which the trial for Stage II of the 
research was to be implemented. Within the trial protocol for Stage II, both 
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quantitative and qualitative methods have been selected to measure symptom 
severity and explore the lived experience of the BA treatment through the accounts 
of young people, their parents/carers and clinicians. As such, it is important to 
emphasise how these apparently disparate approaches have been combined into a 
coherent piece of research that acknowledges the inherent diversity of the methods 
used. 
 
Figure 1: Thesis map: current chapter highlighted in purple 
One research tool that has helped achieve this coherence is reflexivity. 
Mason (2002) describes reflexivity as the process of thinking critically about what 
you are doing and why you are doing it. Reflexivity aids researchers in considering 
their motivations, personal experiences and inside knowledge of the setting, all of 
which can affect the way researchers conduct research (Wells et al., 2012). This was 
important in the context of my PhD research, because I have previously undertaken 
training in the intervention of interest (BA) and have prior experience of working in a 
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positivist trial environment, which could have led me towards biased expectations or 
judgements. As it was, being reflexive allowed me to acknowledge and account for 
inherent factors that might otherwise impact upon the rigour and, ultimately, the 
quality and utility of the research. Although this technique is most usually associated 
with qualitative research, it has been suggested that the application of reflexivity to 
quantitative research endeavours can promote transparency around the conduct 
and reporting of RCTs by providing a more accurate account of trial delivery (Wells et 
al., 2012). This is important because complex interventions, such as BA, are likely to 
produce complex outcomes (Kessler and Glasgow, 2011). Distinct but complimentary 
quantitative (structured outcome measures) and qualitative (interviews) methods 
were selected in Stage II of this research to account for this complexity. 
Consequently, I felt that there was value in applying a reflexive approach to my 
whole study. As a result, I was able to ask critical questions of myself and my 
research. 
This thesis begins with a traditional background literature review (Chapter 1), 
followed by a discussion of unpublished research in the area (Chapter 2). The 
subsequent chapter (Chapter 3) details the first study completed as part of my 
doctorate; the chapter describes purely qualitative research and is written in an 
ethnographic style. The next chapter (Chapter 4), which forms the main body of this 
thesis, is a mixed methods trial, which is reported according to the Consolidated 
Standards of Reporting Trials (CONSORT) guidance for the reporting of RCTs. Within 
this chapter the qualitative and quantitative results are reported on separately, in 
order to clearly delineate the learning from each method employed. The findings are 
then discussed in an integrated discussion at the end of the chapter. The final 
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chapter (Chapter 5) is an overview of the key learning from this doctoral research, 
written in a more personally reflective style.  
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Chapter 1 Background Literature 
This literature review is not systematic in nature, as from the outset I was aware of a 
systematic review, being undertaken at York University, of Behavioural Activation 
(BA) as a treatment for youth depression. Instead, a ‘scoping review’ was conducted 
to inform the research described within this thesis. A scoping review can be 
described as a narrative integration of the relevant evidence and can be particularly 
useful where there has been no knowledge-synthesis to date (Pham et al., 2014), as 
was the case at the start of my PhD. There is a lack of consensus on the methodology 
that should be used within scoping studies (Colquhoun et al., 2014) but I followed 
best practice guidance by using a formal search strategy in relation to this aspect of 
the literature review by searching for key words relating to BA and young people, 
across MEDLINE, EMBASE, PsycINFO, CINAHL and Cochrane Library databases. The 
scoping review presented below, focuses on literature relevant to the discussion of 
BA as a treatment for depression. It does not include literature related to the 
methods or methodology used in the research conducted as part of this thesis, as 
this additional literature will be discussed in the relevant chapters.  
This chapter starts by providing an overview of depression and then focuses 
on depression specifically in children and young people. An overview of treatments 
for depression in this population is then provided, followed by the rationale for 
considering BA as one such treatment. The application of BA to adults and children 
will then be discussed and the current literature summarised.  
  3 
Depression 
Across all societies, mental health conditions represent a substantial proportion of ill 
health (Patel et al., 2007). Depression is one such disorder, the prevalence and 
persistence of which has been linked to severely impaired quality of life and, in some 
cases, suicide (Kessler and Bromet, 2013, World Health Organization, 2017). In 2015, 
depression was ranked by the World Health Organization as the leading contributor 
to global disability, accounting for 7.5% of the total years lived with disability (World 
Health Organization, 2017). Globally, 300 million people were estimated to suffer 
from depression in 2015, equating to 4.4% of the world’s population (World Health 
Organization, 2017). In fact, depression is projected to be the second largest cause of 
world disease burden by 2020 and the primary cause by 2030 (World Health 
Organization, 2001, 2013). However, although depression is common worldwide, 
lifetime prevalence estimates are higher in wealthier countries, such as the UK 
(Kessler and Bromet, 2013). In England, in 2007, the economic cost of depression 
was estimated to be £1.7 billion and this is predicted to rise to £3 billion by 2026 
(National Institute for Health and Clinical Excellence, 2009a).  
The term depression came into regular use towards the end of the 
eighteenth century but has many different connotations (Goodyer, 2001), as 
illustrated below. Clinically, the term refers to symptoms and behaviours relating to 
changes in mood, thinking and activity, that are substantial enough to impair 
functioning (National Institute for Health and Clinical Excellence, 2005). 
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Depression is a diagnosable health condition and as such is distinct from the 
usual transient feelings of sadness or stress that most of the population experience 
at some point in their lifetimes (World Health Organization, 2017). Symptoms of 
depression can last from a few weeks upwards (World Health Organization, 2017). 
Although the root causes are, as yet, unclear, depression is understood to result 
from a complex interaction of social, biological and psychological factors (World 
Health Organization, 2001, Dwivedi and Varma, 1997). People who have experienced 
adverse life events are more likely to develop depression, and it can lead to 
subsequent life difficulties and worsened ability to cope with existing struggles 
(World Health Organization, 2001).  
The International Classification of Diseases (ICD-10) and the Diagnostic and 
Statistical Manual of Mental Disorders- Fifth Edition (DSM-V) are recognised as the 
two main classification systems for mental and behavioural disorders (World Health 
depression noun 
(unhappiness)(Cambridge University 
Press, 2017) 
the state of feeling very unhappy and 
without hope for the future: I was 
overwhelmed by feelings of depression.  
a mental illness in which a person is very 
unhappy and anxious (worried and 
nervous) for long periods and cannot 
have a normal life during these periods: 
Tiredness, loss of appetite, and sleeping 
problems are all classic symptoms of 
depression.  
 
clinical depression noun (Cambridge 
University Press, 2017) 
a mental illness that causes feelings of 
sadness and loss of hope, changes in 
sleeping and eating habits, loss of 
interest in your usual activities, and 
pains that have no physical explanation. 
  5 
Organization, 1992, American Psychiatric Association, 2013). In the ICD-10, 
depression is included under Mood (Affective) Disorders (F30-F39) and in the DSM-V 
clinical depression is known as Major Depressive Disorder (MDD). Central features 
shared across both categorisations are a change in affect or mood and, depending 
upon the number and severity of the symptoms, a depressive episode may be 
specified as mild, moderate or severe. 
Depression in children and young people 
Depression is already the leading cause of illness and disability in young people 
(World Health Organization, 2014a). Depression occurs in children and adolescents 
below the age of 15 years, but at lower rates than those reported in older age 
groups (World Health Organization, 2017). Observers had previously reported 
increases in the prevalence of depression in children and adolescents, evidenced by 
adolescent and adult cohort studies, as well as increases in rates of youth 
antidepressant prescribing (Kessler et al., 2003, Zito et al., 2003, Collishaw et al., 
2004). However, this was refuted by a large meta-analysis of studies conducted over 
a 30-year period, which found no evidence that children and adolescents born today 
were more likely than those from earlier generations at the same age to suffer from 
depression (Costello et al., 2006).1 Yet even if it is the case that the incidence of 
depression is not increasing, the disorder remains strikingly common in young 
people; current prevalence rates for children under 13 are estimated to be 2.8%, 
increasing markedly to 5.7% for adolescents aged 13 to 18 years old (Costello et al., 
2006). Gender differences are also evident with depression being considerably more 
                                                 
1
 A meta-analysis is a quantitative technique to provide a synthesis of the evidence, with the effects of 
multiple studies pooled to generate an overall picture of average treatment impact (Rutter et al., 
2008). 
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common in adolescent girls (5.9%) than adolescent boys (4.6%) (Costello et al., 
2006).  
There is general agreement that child and adolescent depression shares 
many similarities with adult depression (Birmaher et al., 1996, Dwivedi and Varma, 
1997). Depression in children and young people is characterised by persistent and 
pervasive sadness, anhedonia, boredom and/or irritability (Weisz et al., 2005). On an 
individual level, childhood depression can be long lasting, and extremely disabling 
(Birmaher et al., 1996); it is this functional impairment that separates depression 
from normal teenage mood swings (Weisz et al., 2005). Those diagnosed with 
depression experience high rates of self-harm and suicide (Patel et al., 2007) and 
tragically, suicide is now the leading cause of death in young women (aged 15 to 19) 
in Europe, overtaking deaths related to maternal mortality for the first time (World 
Health Organization, 2014b). Less is known about the numbers of children aged 
under 15 who attempt suicide, due to a lack of official statistics (National Society for 
the Prevention of Cruelty to Children, 2014). There is a strong relationship between 
poor mental health and reduced educational achievement, substance use, poor 
reproductive and sexual health outcomes and becoming a victim of violence 
(Birmaher et al., 1996, Patel et al., 2007). Moreover, depression in childhood often 
reoccurs during adulthood (Birmaher et al., 1996). This is compounded by the fact 
that the biggest risk factor for suicide is a previous attempt (World Health 
Organization, 2014b). Hence, mental illness in childhood can jeopardise not only 
current health but also future health and achievements; addressing young people’s 
mental-health needs is vital to enable them to fulfil their potential (Patel et al., 
2007). It is therefore essential that young people have timely access to appropriate 
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and effective treatment (National Institute for Health and Clinical Excellence, 2005). 
Despite this, many young people in the UK do not receive treatment for their 
depressive symptoms (Department of Health, 2011a). In a nationally representative 
epidemiological study of childhood psychiatric disorder, involving 10,438 children 
aged 5 to 15 years old, 929 were found to have a psychiatric disorder (Ford et al., 
2003). When nearly 600 of these families were followed up at 18-months, in order to 
assess their service usage, approximately half of these young people had not been in 
contact with any services and only a fifth had been in contact with specialist mental 
health services (Ford et al., 2003). 
Treatments for depression in children and young people 
Young people with depression are often treated in Child and Adolescent Mental 
Health Services (CAMHS), which are specialist multidisciplinary teams who provide 
skilled assessment and treatment for children, young people and their 
parents/carers (Edwards et al., 2008). Child and Adolescent Mental Health Services 
in the UK are generally structured using a four-tier system (see Table 1). 
Table 1: Description of the CAMHS four-tier system of organisation (adapted from 
Kitchen et al., 2017) 
Tier Description 
Tier 1 Staff in Tier 1 are not mental health specialists (they tend to be GPs, 
nurses etc.). They offer general advice and treatment for less severe 
mental health problems, mental health promotion and identification of 
problems that are early in development. Where required, they refer 
patients to more specialist services. 
Tier 2 Tier 2 are CAMHS specialists working in community and primary care 
settings who provide assessment and treatment to patients experiencing 
mental health difficulties, training to practitioners in Tier 1 and outreach 
to identify severe or complex needs requiring more specialist 
interventions. 
Tier 3 Tier 3 are multidisciplinary teams working in the community, providing a 
  8 
specialised service for patients with more severe, complex and/or 
persistent disorders. 
Tier 4 Tier 4 provides services for patients with the most serious difficulties and 
includes highly specialised outpatient teams, day or inpatient units. 
Most mental health disorders emerge during childhood and adolescence; 
therefore, this time-period represents an ideal opportunity for early intervention 
before symptoms become entrenched in later life (Patel et al., 2007). The National 
Institute for Health and Clinical Excellence (NICE) guidelines provide 
recommendations for good practice that are based on the best available evidence of 
clinical and cost effectiveness (National Institute for Health and Clinical Excellence, 
2005). Clinical Guideline 28 (2005) relates specifically to the treatment of depression 
in children and young people aged 5 to 18 years. In this guideline, NICE stresses the 
need for access to evidence-based psychotherapies as a first line treatment for 
depression in children and young people (National Institute for Health and Clinical 
Excellence, 2005). The term psychotherapy refers to a collection of non-medical 
interventions designed to reduce psychological distress and maladaptive behaviour, 
or increase deficient adaptive behaviour, through counselling, interaction, training or 
treatment (Weisz et al., 2005). 
Efficacious treatment options do exist for young people with depression. A 
large, well-conducted meta-analysis of 35 treatment outcome studies (Weisz et al., 
2006) reported the mean effect of psychotherapy was moderate (Cohen’s d of 0.34) 
indicating a small to medium treatment effect. The reliable treatment effects proved 
only durable in the relatively short term; effect sizes at one-year follow-up and 
beyond showed treatment effects were not maintained. However, despite the 
positive treatment effect observed, the authors suggest the modest improvements 
  9 
reported are not as large as those described for other youth disorders (Weisz et al., 
2006). This suggests renewed focus upon psychotherapies for depression in young 
people is timely. Furthermore, the literature review conducted as part of the meta-
analysis above (Weisz et al., 2006) identified variability in treatment effect across the 
differing approaches to depression care. Of the 44 studies included in the review, 33 
focused on cognitive change (i.e. Cognitive Behavioural Therapy [CBT] or other 
cognitive approaches) indicating the pervasiveness of this approach to treatment 
(Weisz et al., 2006). The meta-analysis included both published and non-published 
studies and did not find evidence of publication bias in the literature.  
A notable US-based Randomised Controlled Trial (RCT), the Treatment for 
Adolescents with Depression Study (TADS) evaluated the short and long-term 
effectiveness of Fluoxetine (Selective Serotonin Reuptake Inhibitor [SSRI] 
medication), CBT and ‘combined treatment’ that included CBT plus Fluoxetine (as 
well as a fourth comparator, a pill placebo, in the short-term) in 439 adolescents 
with mostly moderate to severe MDD (March et al., 2007). Short-term outcomes at 
12 weeks showed Fluoxetine and combined therapy were more efficacious than both 
CBT alone or a placebo. However, clinically meaningful improvement was seen in all 
three active conditions, indicating that a variety of treatment options can help to 
improve young people’s symptoms of depression. A minority of patients in the TADS 
study retained clinically important symptoms of suicidal ideation and, crucially, these 
symptoms were significantly more common in patients who received Fluoxetine 
alone rather than those who received CBT or combined treatment. Patients receiving 
Fluoxetine alone were twice as likely as those receiving combined or CBT treatment 
to experience a suicidal event, indicating that CBT is a protective factor. The 
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conclusion from the authors of this large trial was that combination therapy should 
be the preferred treatment option for adolescent depression.  
These results support the assertion that there is a role for psychotherapy in 
the treatment of depression in young people. However, a UK-based RCT of 208 
adolescents (aged 11-17 years old) found no clinical or cost-benefit to the addition of 
CBT to treatment with SSRIs for moderate to severely depressed CAMHS patients 
who were non-responsive to a brief psychosocial intervention (Goodyer et al., 2007). 
Prior to randomisation, many young people responded positively to the simple, brief 
psychosocial intervention that was offered and the authors suggest this component 
should be explored further.  
More recently, the Improving Mood with Psychoanalytic and Cognitive 
Therapies (IMPACT) study investigated three different approaches to treating 
adolescent depression in a UK context: short-term psychoanalytic psychotherapy, 
CBT and a brief psychosocial intervention (Goodyer et al., 2017). This RCT included 
465 adolescents (aged 11 to 17 years old) with a diagnosis of moderate to severe 
MDD, who were followed up for a year following treatment. At the end of the study 
follow-up period 70% of the sample, from across all treatment arms, had improved 
substantially. The IMPACT study demonstrates that all three treatments can be 
delivered in UK CAMHS with equal confidence. This is noteworthy because it 
indicates there was no evidence of superiority of CBT (delivered over 28 weeks) or 
short-term psychoanalytical therapy (delivered over 20 weeks), compared with the 
brief psychosocial intervention (delivered over 12 weeks), in maintenance of 
reduced depressive symptoms at one-year follow-up. The authors conclude that 
future research should focus on whether or not brief psychotherapies are of use in 
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community or primary care settings. Although, this study does not answer questions 
relating to long-term effectiveness. It is clear that psychotherapeutic treatment for 
young people can reduce the impact of the symptoms of depression but it remains 
to be seen which of the briefer treatment approaches are most efficacious in this 
respect. For progress in finding effective treatments for young people with 
depression to be maintained, competing treatments need to be assessed and 
compared in the most rigorous manner available (Everitt and Wessely, 2008). 
Rationale for behavioural activation treatment 
The majority of the evidence-based treatments for youth depression require 
practitioners to attend lengthy and costly training courses. Cognitive Behavioural 
Therapy is the most investigated of these evidence-based treatments. Although CBT 
is recommended by NICE for the treatment of depression in children and young 
people (National Institute for Health and Clinical Excellence, 2005), access for 
patients is often limited by the availability of trained professionals (Pass et al., 2017). 
The extensive training requirements and cost of employing more experienced staff 
have been a barrier to CAMHS teams providing such training for their staff members 
(Edwards et al., 2008, Pass et al., 2017). The Improving Access to Psychological 
Therapies (IAPT) initiative has sought to improve this situation, firstly for adults and 
then for young people. The Child and Young People’s IAPT (CYP IAPT) project was 
developed to improve the quality and provision of therapy for depression and 
anxiety in CAMHS from 2013 onwards (Department of Health, 2011a, b). 
Patel, Flisher, Hetrick and McGorry (2007) suggest that the key problems 
within mental health services are the shortage of mental health professionals and 
the low capacity of non-specialist mental-health professionals to provide quality 
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services to young people. One treatment regularly used by adult IAPT to address 
these challenges is BA. The CYP IAPT programme focuses on building collaborative 
relationships with children, young people and their parents/carers, and encourages 
clients to identify and work towards their own goals and seek improvements in 
symptoms and functioning (Department of Health, 2013a). From the perspective of 
service delivery, BA may meet the need for therapies that can be provided by less 
experienced staff (Pass et al., 2017). The reason it may be well-suited for 
dissemination to non-specialists is due to the simplicity of the BA approach, which 
means that it is easier to teach practitioners and more straightforward to administer 
than traditional, more complex, psychotherapies (Jacobson et al., 1996, Jacobson 
and Gortner, 2000, Davidson et al., 2014, Richards et al., 2016). Behavioural 
Activation, as a more parsimonious alternative to full CBT, requires fewer treatment 
sessions and a shorter duration of practitioner training: as the “law” of parsimony 
(also known as ‘Occam’s Razor’) suggests, among competing proposals it is the one 
with the fewest assumptions that should be selected. As a result, selecting BA as a 
treatment could assist increasing service capacity for psychological therapies in line 
with the CYP IAPT initiative. As an additional advantage, therefore, it is hypothesised 
that BA treatment could lead to cost-savings in CAMHS over traditional 
psychotherapies, as has been demonstrated in adult services (Ekers et al., 2011a, 
Richards et al., 2016). This is important in a context where services are required to 
become increasingly clinically and cost effective (Edwards et al., 2008).  
There are important limitations to current psychotherapeutic treatments for 
depression in young people (McCauley et al., 2011). The previously mentioned meta-
analysis of youth psychotherapy trials (Weisz et al., 2006) found CBT produced more 
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modest effects on depressive symptoms in children and adolescents, than in similar 
trials of adults. This finding suggests that young people and adults may engage 
differently with psychotherapy, thereby leading to differing treatment outcomes. 
Some commentators have suggested that the limited success of CBT trials in young 
people may be due to the level of cognitive sophistication required to utilise CBT 
fully (Ritschel et al., 2016, McCauley et al., 2011). In comparison, BA has been 
proposed as a less cognitively demanding alternative, which may therefore be better 
suited to young people (McCauley et al., 2011). The action orientated aims and 
simplicity of a BA approach may be developmentally appropriate for children and 
adolescents (McCauley et al., 2011). The findings of the meta-analysis also indicated 
studies utilising ‘non-cognitive’ treatments (such as behavioural approaches) 
demonstrated effects that were at least as robust as the cognitive treatments (Weisz 
et al., 2006). The authors conclude this may provide evidence that the most 
beneficial treatments for youth depression may not need to focus on altering 
cognitions.  
Research has further indicated that treatment duration is not correlated with 
outcome (Weisz et al., 2006, Goodyer et al., 2017), suggesting briefer treatments, 
such as BA, have the potential to be as effective as longer ones in young people. 
Moreover, the TADS study reported that half of their sample did not respond to CBT 
treatment at 12 weeks (short term follow-up) but, by week 18, 65% had responded 
(March et al., 2007). Previous commentators have noted this suggests treatment 
effects may be dependent upon receiving an adequate ‘dose’ (of nine or more 
sessions) and the treatment effects are not likely to be apparent for several months 
following treatment. This is particularly problematic in youth populations who are 
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prone to treatment drop-out (McCauley et al., 2011); in adolescent outpatient 
populations drop-out rates were found to range between approximately 16-75% (De 
Haan et al., 2013). The high number of CBT sessions required, coupled with the 
likelihood of treatment drop-out in this population, demonstrates a need for 
psychotherapies of a briefer duration, where improvement is seen earlier in the 
course of treatment. Generally, in BA treatment, the BA model is covered during the 
first or second treatment session meaning that gains can be seen early on during 
treatment (Ritschel et al., 2016). 
In light of the limitations of current treatments for depression and the 
inherent developmental factors present in a child and adolescent population, it is 
timely to explore novel treatment approaches that challenge the prominent 
cognitive paradigm, in order to extend treatment options for depression. It is CBT 
that is the current dominant treatment for depression, but owing to the limitations 
detailed above and the potential for BA to challenge some of these restrictions, this 
thesis considers BA as a plausible treatment option for young people with 
depression, which could potentially be deployed through CYP IAPT. 
Behavioural Theory 
Both the 2000 and 2008 editions of the Medical Research Council (MRC) framework 
for developing and evaluating complex interventions highlight the importance of a 
theoretical basis for interventions (Medical Research Council, 2000, Craig et al., 
2008). The roots of the treatment we now know as BA were established in a 
movement called behaviourism that began to influence Psychology in the early 
twentieth century, when behaviourists demonstrated that an individual’s behaviour 
could be influenced by changing the events immediately preceding it (Rutter et al., 
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2008). In 1952, Hans Eysenck coined the term ‘behaviour therapy’ to refer to the 
application of behavioural principles to the treatment of patients (Rutter et al., 
2008). Behavioural Activation is one such treatment. In 1976, Lewinsohn, Biglan and 
Zeiss published a BA treatment manual based upon the behavioural theory that 
depression is the result of low rates of positive reinforcement and inadequate social 
skills (cited in Kanter et al., 2010). Following this, behavioural treatments fell out of 
favour, replaced by cognitive treatments (Kanter et al., 2010). Interest in BA as a 
treatment for depression was revived following a component analysis of cognitive 
therapy, which showed most of the improvement in depressive symptoms could be 
accounted for by the behavioural, rather than the cognitive, components of CBT 
(Jacobson et al., 1996). Since then behavioural therapies have been refined and 
more recently have experienced renewed attention.  
Behavioural Activation is a collaborative, structured, time-limited 
psychotherapy informed by behaviour theory and is based on B. F. Skinner’s concept 
of operant conditioning (Kanter et al., 2009, Rutter et al., 2008). Skinner proposed 
that most behaviour occurs spontaneously and is often followed by a reward or 
punishment. These experiences dictate the form and frequency of future behaviour 
patterns. Accordingly, BA focuses on understanding the patient’s antecedent stimuli 
and consequent responses rather than the person’s “inner” motives (Rutter et al., 
2008). This is in clear contrast to cognitive psychological therapies such as CBT, 
which aim to modify the inner world of the individual (Rutter et al., 2008). The 
theory of causation also differs fundamentally: behaviour theory does not focus 
upon the reasons why a problem has arisen; instead, the focus is on the 
contingencies that maintain it (Rutter et al., 2008). A behavioural approach to 
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treatment ensures these external components are challenged with the patient, 
which leads to the learning of new, more helpful behaviours. In contrast, cognitive 
therapies often formulate inner turmoil as the result of incompatible beliefs and 
desires and the process of making these beliefs explicit leads to the resolution of 
such conflicts (Rutter et al., 2008).  
Behavioural Activation theory proposes that when positive reinforcement is 
lost from a person’s environment, depression results (Kanter et al., 2009). 
Depression is subsequently maintained through a cycle of avoidance of usual 
activities that, over time, leads to reduced contact with sources of positive 
reinforcement (Kanter et al., 2009). The introduction of BA therapy aims to break 
this cycle by increasing time spent in pleasurable or ‘healthy’ activities, thus 
increasing the opportunities for contact with stable sources of positive 
reinforcement, which in turn may improve functioning and mood (Kanter et al., 
2009, Davidson et al., 2014). Behavioural Activation focuses on the associations 
between the patient and their environment, as well as triggers and maladaptive 
coping strategies, which result in the cause and maintenance of depression (Hopko 
et al., 2003). 
The postulated method of change is therefore also different; traditional 
psychotherapies rely on an unconscious process whereas behavioural therapy 
demands active involvement in challenging maladaptive behaviours (Rutter et al., 
2008). In behavioural therapy, problems are defined as measurable, externally 
observable events in contrast to more general concerns that may be formulated in 
other psychotherapies (Rutter et al., 2008). A review of the component parts of BA 
interventions identified eight overarching commonalities (Kanter et al., 2010). 
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Although different versions of, or approaches to, BA exist, a central tenet that all 
share is monitoring a patient’s activities, a component called ‘activity scheduling’ 
(Kanter et al., 2009, Kanter et al., 2010). Activity scheduling helps the client to 
engage in their environment to reduce avoidance (which can be a barrier to 
partaking in behaviour that could be positively reinforcing) in order to lay the 
foundations to increase positive reinforcement in their lives (McCauley et al., 2016). 
Most of these activities are completed outside of the BA formal treatment sessions 
(Davidson et al., 2014). Activities have to be practical and achievable and more 
complex goals are required to be broken down into manageable steps (Davidson et 
al., 2014). Other component BA techniques or strategies include assessment of life 
goals or values, skills training/relaxation, contingency management, procedures 
targeting verbal behaviour or avoidance (Kanter et al., 2010). 
Behavioural Activation in adults 
Behavioural Activation is recommended as a treatment for depression in adults by 
NICE and is routinely provided by adult IAPT services (National Institute for Health 
and Clinical Excellence, 2009b). This is indicative of the strong evidence base for the 
treatment of adult populations using a BA approach.  
 A systematic review and meta-analysis identified 12 studies (incorporating 
476 people) where BA was compared to CBT in adults. There were no statistically 
significant differences between groups found in post-treatment depression symptom 
level or at follow up (Ekers et al., 2008). The parsimony argument mentioned 
previously as the foundation of the rationale for BA, is further strengthened by the 
results of another RCT of a BA intervention in adults (Ekers et al., 2011b), which 
demonstrated that BA could be delivered effectively by generic mental health 
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workers who had no previous psychotherapies training. In this context, BA has been 
found to be more cost-effective than usual care in adults with depression (Ekers et 
al., 2011a). A more recent meta-analysis of BA for depression in adults, updated the 
earlier manuscript from 2008 (Ekers et al., 2014). It considered BA versus control 
conditions or anti-depressant medication, identifying 26 RCTs including 1524 
participants. Most BA interventions were found to be individual or group-based, 
although two studies used a self-help approach. The results were comparable across 
different therapy formats or approaches. The meta-analysis compared BA for 
depression to a control treatment in 25 of these studies (including 31 comparisons) 
for 1088 participants. The meta-analysis of depression symptom level post-
treatment showed BA to be superior to the controls (SMD -0.74 [95% CI -0.91 to -
0.56]) indicating a large effect size in favour of BA (see Figure 2). Interestingly, in a 
sub-group analysis, three of the included studies used non-specialists to provide 
treatment and the effect sizes remained large (when compared to treatment 
delivered by specialists). These studies were of good quality, representing further 
support for the utility of dissemination of BA by non-specialists. Similarly, the 
authors explored whether the complexity of the BA intervention influenced the 
treatment effect sizes but found no association. The impact of the number of 
treatment sessions was also explored (median number was eight sessions) but this 
was not found to be associated with effect size. Again, this bolsters the parsimony 
argument, in that a simple, brief treatment is preferable over a more complex 
alternative such as CBT. Behavioural Activation was also compared to medication; 
four studies, including 283 participants, were identified but two were removed from 
the analysis due to poor quality metrics. The analysis found a non-significant effect 
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size in favour of BA (SMD -0.38 [95% CI -1.23 to 0.47]). The authors noted that the 
study quality was low in most studies and there was no evidence of publication bias. 
 
Figure 2: Reproduced with permission from Ekers et al., (2014), BA vs. control post-
treatment (ordered by effect size, high to low) 
More recently, BA has been compared to CBT in a large RCT (the COBRA 
study) of 440 adults with MDD to establish the clinical efficacy and cost-effectiveness 
of the treatments (Richards et al., 2016). The COBRA study found BA delivered by 
junior mental health workers (with less intensive and costly training) was not inferior 
to CBT delivered by more experienced therapists in reducing patient’s depressive 
symptoms. Alongside this, BA was found to be more cost-effective than CBT, which 
was attributed to the cost saving associated with using staff with no professional 
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training in psychological therapies. This is the largest trial of BA to date and the 
results suggest BA is a viable treatment for depression that compares favourably to 
CBT treatment. 
Behavioural Activation in children and young people 
Compared to the ubiquity of research surrounding BA treatment for depression in 
adults, there is considerably less BA research focusing on young people. Despite this, 
a number of adaptions have been suggested to BA in order for it to be delivered to 
children and adolescents, rather than adults. In Figure 3 and Table 2, the current 
evidence base for BA treatment for depression in children and young people has 
been presented in the form of an evidence hierarchy. Studies focusing on depression 
prevention have not been included. An evidence hierarchy is a framework for 
ranking evidence, that assists the reader in assessing the effectiveness of 
interventions based upon the quality of the research design used (Akobeng, 2005a, 
b). Although different pyramid designs exist (Murad et al., 2016), the central premise 
is the same, the pyramid indicates which studies should be given more weight where 
different study designs have been used to examine the same questions (Akobeng, 
2005b). Simple observational methods are illustrated at the bottom of the pyramid 
through to increasingly rigorous methodologies at the top; as the pyramid tapers so 
does the inherent risk of bias (Akobeng, 2005b). Evidence hierarchies can be used to 
guide health care professionals to make clinical decisions on the best available 
research evidence in tandem with their clinical expertise and patient values. This 
concept is known as evidence-based medicine or evidence based practice, the aim of 
which is to provide optimal patient care (Webber, 2014, Akobeng, 2005a). The 
evidence-based practice model suggests practitioners should accord greater weight 
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to evidence higher in the evidentiary hierarchy, such as systematic reviews or RCTs, 
as these studies have better internal validity (Webber, 2014). Internal validity is the 
extent to which it is free from bias (Higgins et al., 2011). Initial studies investigating 
the potential for BA to be utilised in children and adolescents have had some 
success. However, the vast majority of this evidence comprises of small, non-
randomised studies, case series or case studies. In the absence of other higher 
quality evidence, all forms of evidence should be considered (Webber, 2014). The 
following section details the current available evidence for BA for young people with 
depression. 
 
Figure 3: Evidence hierarchy illustrating the current evidence for BA treatment in 
children and young people* (see Table 2)
 
Systematic  
Review  
and Meta-Analysis 1 
RCT 2 
Randomised Feasibility Studies 3, Non-
Randomised Studies 4 or Case Series 5 
Case Studies 6 
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Table 2: Author, year and study title of research illustrated in Figure 3 
 Position in the evidence 
hierarchy 
Study 
Authors 
Year Study Title 
* Not included: lack of 
clarity over study design 
Davidson, 
et al. 
2014 Feasibility assessment of a brief, web-based behavioural activation intervention 
for adolescents with depressed mood. 
1 Systematic Review Tindall, et 
al. 
2017 Is behavioural activation effective in the treatment of depression in young 
people? A systematic review and meta-analysis. 
2 RCT Weersing, 
et al. 
 
Chu, et al. 
 
 
McCauley, 
et al. 
 
Stark  
 
2017 
 
 
2016 
 
 
2016 
 
 
1985 
(Unpublished) 
Brief behavioral therapy for pediatric anxiety and depression in primary care: A 
randomized clinical trial.  
 
Transdiagnostic group behavioural activation and exposure therapy for youth 
anxiety and depression: Initial randomized controlled trial.  
 
The adolescent behavioural activation program: Adapting behavioural activation 
as a treatment for depression in adolescence. 
 
A comparison of the relative efficacy of self-control therapy and behaviour 
therapy for the reduction of depression in children. 
3 Randomised Feasibility 
Studies 
Riley & 
Gaynor   
 
Douleh  
 
 
Arnott, et 
al. 
2014 
 
 
2013 
 
 
2012 
(Unpublished) 
Identifying mechanisms of change: Utilising single-participants methodology to 
better understand behaviour therapy for child depression. 
 
Motivational interviewing assessment and behaviour therapy as a stepped care 
approach to the treatment of adolescent depression. 
 
Body and mind: An evaluation study of the effectiveness of a brief intervention 
in obese and depressed youth. 
4 Non-Randomised 
Studies 
Ritschel, 
et al. 
 
Wallis, et 
2016 
 
 
2012 
Behavioral activation for major depression in adolescents: results from a pilot 
study.  
 
Behavioural activation for the treatment of rural adolescents with depression. 
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al. 
 
Ritschel, 
et al. 
 
Chu, et al.  
 
 
 
2011 
 
 
2009 
 
 
Behavioural activation for depressed teens: A pilot study.  
 
 
An initial description and pilot of group behavioral activation therapy for 
anxious and depressed youth. 
5 Case Series Jacob, et 
al. 
 
Tiffin, et 
al. 
 
Weersing, 
et al. 
 
Gaynor & 
Harris 
2013 
 
 
2012 
(Unpublished)  
 
2008 
 
 
2008 
Behavioural activation for the treatment of low-income, African American 
adolescents with major depressive disorder: a case series.  
 
Behavioural activation in young people- A feasibility study.  
 
 
Brief behavioral therapy for pediatric anxiety and depression: Piloting an 
integrated treatment approach. 
 
Single-participant assessment of treatment mediators: strategy description and 
examples from a behavioural activation intervention for depressed adolescents. 
6 Case Studies Pass, et al. 
 
 
Pass, et al. 
 
 
Pass, et al. 
 
 
Ruggiero, 
et al.  
 
McCauley, 
et al.  
2017 
 
 
2016 
 
 
2015 
 
 
2005 
 
 
2011 
Brief behavioral activation treatment for depressed adolescents delivered by 
nonspecialist clinicians: A case illustration. 
 
Brief behavioural activation for adolescent depression: Working with complexity 
and risk. 
 
Adapting brief behavioural activation (BA) for adolescent depression: a case 
example. 
 
Application of behavioral activation treatment for depression to an adolescent 
with a history of child maltreatment. 
 
Expanding behavioural activation to depressed adolescents: Lessons learned in 
treatment development. 
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Early Investigations of behavioural activation for young people with 
depression 
The first published case study of BA with an adolescent was in 2005 in the USA, 
where BA was applied to treat mild depression in a 17 year old female with a history 
of maltreatment; the results indicated positive treatment outcomes for the patient 
(Ruggiero et al., 2005). The 8-session intervention was based upon BA for Depression 
(BATD), which was established around the principle that depression is the result of 
reduced reinforcement for non-depressive healthy behaviours and increased 
reinforcement for unhealthy depressive behaviours (Kanter et al., 2010). The aim of 
BATD is to re-address this balance by increasing healthy behaviours. This case study 
did not include follow-up beyond the eight BA treatment sessions nor had the 
patient received a diagnosis of depression at baseline. Case studies are usually 
presented at the bottom of an evidence hierarchy pyramid (Figure 3), because they 
are considered to be anecdotal evidence and, therefore not an adequate study 
design to explore treatment efficacy; many psychiatric disorders improve 
spontaneously, so on the basis of this evidence, we are unable to attribute the 
improvement to the treatment provided (Everitt and Wessely, 2008).  
A series of these so-called anecdotes, known as a case series, can be criticised 
in the same manner. Data from four depressed adolescents who demonstrated 
remission following a BA intervention were used as individual cases to explore 
treatment mediators (Gaynor and Harris, 2008).2 Ten adolescents (aged 12-18 years 
old) from US community settings were screened and a diagnostic interview was 
                                                 
2
 A treatment mediator is a variable that mediates the effect of treatment on an outcome where the 
event occurs during treatment, is correlated with treatment and explains all or part of the effect of 
treatment on the outcome measure (Gaynor and Harris, 2008). 
  25 
completed to ascertain a DSM-IV diagnosis of major depression. Six met the inclusion 
criteria and two of these dropped out after the first treatment session. The 
intervention was ‘Values Based BA’, which included 12, one-hour sessions. All four 
participants who received treatment, reported positive change; BA increased 
activation (compared to behavioural disengagement) in the majority of cases and 
this was followed in half of cases by substantial reduction in depressive symptoms. 
For two of the young people, increased activation appeared to be a mediator, 
whereas decreased dysfunctional thinking did not emerge as a mediator.  
Behavioural activation for comorbid depression and anxiety  
A BA approach has been used for young people with both depression and anxiety 
symptoms. A US study explored the application of a primarily behavioural treatment 
to young people with comorbid anxiety and depression in primary care (Weersing et 
al., 2008). The authors term the treatment ‘Integrated Brief Behavioural Therapy’, 
which combines BA for depression and exposure therapy for anxiety. Although based 
in primary care, the staff who were trained to deliver the treatment had prior 
mental-health experience, which the authors note was not a typical resource in this 
setting. This study focused on the development of a brief treatment (8 sessions 
delivered over a 12-week period). The treatment was successfully applied to two 
young people (aged 13 and 17) who were followed up at 12 and 24 weeks.  
Group BA therapy was the next format of treatment to be commented on in 
the published literature; it was piloted with five young people (aged 12 to 14 years 
old) with comorbid depression and anxiety (Chu et al., 2009). This small pilot study 
using a 13-week group BA intervention was implemented in a large public middle 
school in the USA (Chu et al., 2009). Two out of the five young people recruited had a 
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primary diagnosis of MDD: however, all participants experienced at least sub-clinical 
levels of both anxiety and depressive disorders (Chu et al., 2009). Potential 
participants were identified as likely to meet the study inclusion criteria by school 
counsellors. One limitation of the study design was that the treatment was delivered 
by two mental health specialists who were not a typical resource available to the 
school, which limits the transferability of the findings and hinders implementation 
on a larger scale. Nevertheless, there were high levels of uptake (75%) and high 
levels of completion (80%) of the intervention (Chu et al., 2009), although some 
attendance issues were evident. The results suggested that the majority of 
participants experienced moderate benefits and there was an overall trend in 
improvement of symptoms (Chu et al., 2009). Due to the small sample size, no 
inferences could be made regarding the efficiency of the therapy. The major 
weakness in this study was the lack of a control group.  
In the USA, a case study documented the use of ‘Individual Behavioural 
Activation Therapy’ in a university based research clinic, with a 10 year old male, 
alongside exposure therapy for depression and anxiety (Chu et al., 2012). This case 
study echoed the earlier findings that BA may be a useful treatment option for young 
people experiencing mood and anxiety difficulties.  
In a larger randomised study, Chu and colleagues allocated 35 young people 
(aged 12 to 14) to ten one-hour group BA sessions or a 15-week waiting list control 
(Chu et al., 2016). Young people were followed up at four months and improvements 
in activation and fewer negative thoughts were observed. 
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Small-scale investigations of behavioural activation for young people with 
depression 
In another US-based study, McCauley and colleagues discuss the rationale for the 
application of BA to young people and the adaptation of the treatment following its 
unsuccessful application to a male 17 year old patient with MDD (McCauley et al., 
2011). This patient dropped out after 10 treatment sessions and the BA approach did 
not help to improve the patient’s depressive symptomology. The reasons for this 
were explored and the treatment was adapted in accordance with these findings.  
Other small pilot studies in the USA, and in Australia, demonstrate that BA is 
feasible and acceptable in secondary care settings for young people with depression 
(Ritschel et al., 2011, Wallis et al., 2012). A small US-based study using a within-
subject design found that six adolescents with a diagnosis of MDD who received a BA 
intervention showed significant improvements in depressive scores, with four 
participants no longer meeting the criteria for depression (Ritschel et al., 2011). 
Participants, aged 14 to 17, were offered a maximum of 22 sessions over 18 weeks at 
an outpatient adolescent mood clinic (Ritschel et al., 2011). However, the assessors 
responsible for collecting outcome data were not blinded to participants’ diagnostic 
or treatment status, which is a source of potential bias. In addition, no follow-up 
data was collected on the adolescents who underwent the intervention.  
In rural Australia, BA has been piloted as a treatment for depression for 
young people aged 13 to 18 years old, in a study which also used a within-subject 
design (Wallis et al., 2012). Participants were recruited through referrals from 
primary care to the local secondary care mental health service (Wallis et al., 2012). 
Five female adolescents, aged between 14 and 15 years old, experiencing mild to 
severe levels of depression, completed the 10-week BA programme (Wallis et al., 
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2012). Again, the results appeared to be promising, with all five patients displaying 
reduced symptoms of depression after the treatment (from baseline to completion) 
(Wallis et al., 2012). Both of these studies were limited, in that they did not include a 
control condition, which means the improvements noted may be attributable to 
something other than the BA treatment.  
A case series describing BA treatment for low-income, African American 
adolescents with depression also indicated it was feasible and acceptable (Jacob et 
al., 2013). Participants, aged 14 to 17, were recruited from a large urban hospital in 
the USA as part of standard clinic intake procedures and via flyers in community 
mental health clinics (Jacob et al., 2013). Potential participants were screened 
initially using a telephone interview, and a full diagnostic interview was completed 
for those who appeared eligible. Participants received between 14 and 17 BA 
therapy sessions. Clinician and patient ratings indicated that, in two out of the three 
cases reported on, patients no longer met the criteria for MDD (Jacob et al., 2013). 
However, due to study participants continuing medication alongside their BA 
treatment, it remains unclear as to whether it was the interaction between BA and 
medication that led to the reported improvements. Satisfaction ratings indicated 
that both patients and their parents/carers found the BA treatment acceptable 
(Jacob et al., 2013). Furthermore, the study team deemed BA to be a feasible 
treatment option in this context. 
A web-based BA intervention for American adolescents was the subject of 
another feasibility study (Davidson et al., 2014). This was in the context of a website 
called Bounce Back Now, which is a resource for disaster-affected adolescents and 
their families who are at risk of post-disaster mental health problems. One of the 
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four modules on the website focused on low mood and included a brief BA 
intervention. Researchers video-recorded 24 adolescents aged 12-17 (recruited from 
psychiatric clinics) undertaking the computerised intervention (the depression 
module that included the BA) and encouraged the adolescents to voice their 
opinions aloud whilst working through the module. Although this initial scoping 
study included participants with a broad range of depressive symptoms, over 70% 
did not meet the clinical cut-off for depression on the measure they utilised and it 
was based on only one-session of the intervention. This initial study was designed to 
test the module’s usability and received positive feedback but did not evaluate 
outcomes relating to mood. Bounce Back Now was subsequently evaluated in a 
population-based study of 2,000 families recruited from tornado-affected postcodes 
using an address-based sampling strategy. Participants were followed up at four and 
12-months to assess the rates of uptake and completion. They found low rates of 
uptake with only 36% accessing the site but over 60% of these completed the BA 
module. Again, there was no investigation of outcomes relating to mood. 
Behavioural activation for young people with depression in the UK 
As found in other international work, feasibility research conducted in UK school and 
primary care settings by the Mental Health Research Centre (MHRC) at Durham 
University has demonstrated that BA therapy is acceptable to young people, their 
parents and clinicians (Arnott et al., 2012, Tiffin et al., 2012). The MHRC studies were 
the first to explore the feasibility of BA in a UK context. The two, as yet unpublished, 
studies of young people with depression, one in a school setting (with adolescents 
with comorbid weight problems) and one in primary care, also demonstrated BA 
therapy was acceptable to young people, their parents and clinicians, but feasibility 
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issues with treatment delivery were evident in both environments. The learning 
gained from these studies will be discussed further in Chapter 2.  
Three further case studies indicated that delivery of BA would be feasible for 
young people in a UK CAMHS outpatient clinic (Pass et al., 2015, Pass et al., 2016, 
Pass et al., 2017). One case study focused on a 15-year-old female (Pass et al., 2015), 
whilst the other two were undertaken with 16-year-old females (Pass et al., 2016, 
Pass et al., 2017). All focused on adapting a brief BATD intervention for adolescents. 
However, as with much of the research conducted to date, they utilised a case study 
design, which limits any inferences that can be drawn from the evidence. Another 
UK-based study, which aims to assess the feasibility of integrating a BA approach 
into Tier 3 routine practice, has been registered but no results have yet been 
published (Health Research Authority, 2017).  
Larger-scale investigations of behavioural activation for young people with 
depression 
One study that has addressed many of the criticisms of previous work on the 
application of BA to young people with depression, is a large US study (McCauley et 
al., 2016). This RCT of 60 adolescents (aged 12 to 18 years old) with MDD, compared 
14 sessions of BA (delivered over 12-weeks) to usual evidenced-based care (i.e. CBT 
or Interpersonal Therapy) in a university hospital-based community mental health 
clinic. As RCTs are considered to be the ‘gold standard’ for evaluating the 
effectiveness of interventions (Akobeng, 2005b), they are situated higher in the 
evidence hierarchy than other trial designs such as case studies or series. The trial 
results indicated both treatment conditions produced statistically significant 
improvements in depression, functioning, activation and avoidance. McCauley and 
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colleagues (2016) conclude that the results of the pilot RCT provide support for the 
feasibility and clinical importance of BA in the treatment of adolescents with 
depression.  
Another US-based study evaluated BA treatment (maximum of 22 sessions) 
delivered to 28 adolescents, aged 14-17, with MDD over 18-weeks at an outpatient 
clinic (Ritschel et al., 2016). Participants were assessed using standardised outcome 
measures at baseline, midpoint and end of treatment and were followed up at three 
and six months. This study also collected qualitative data from semi-structured 
interviews following treatment. The authors conclude the results suggest BA is an 
effective treatment for adolescents with depression, as over 90% of those who 
completed treatment no longer met the criteria for MDD. There was also evidence 
these effects were maintained in the medium term. However, this study did not use 
a control condition and did not include all participants in their statistical analyses. 
Systematic review and meta-analysis of behavioural activation for young 
people 
Systematic reviews and meta-analyses are most often illustrated at the top of 
evidence-hierarchy pyramids, denoting the ability of this approach to synthesize the 
evidence. Systematic reviews can also be seen as a ‘lens’ through which evidence is 
viewed and appraised (Murad et al., 2016). As discussed at the start of this chapter, a 
systematic review exploring the effectiveness of BA as a treatment for depression in 
young people was undertaken at York University, which was published in 2017 
(Tindall et al., 2017). The systematic review and meta-analysis reported reductions in 
depression scores following BA treatment (Tindall et al., 2017). The authors used the 
term ‘BA’ to encompass all therapies based upon a broad behavioural approach to 
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the treatment of depression regardless of the specific terms used to describe the 
intervention. At first glance this review might appear to present a convincing 
argument that BA is an effective treatment for depression in children and young 
people, but the authors identified methodological problems in the included studies 
and emphasised the lack of good quality research in this area (Tindall et al., 2017). 
Ten studies were included in the systematic review, although only three of these 
were suitable to be included in the meta-analysis. Previously mentioned studies 
(Pass et al., 2015, Davidson et al., 2014) and another study that looked at depression 
prevention in US college students aged 17 and over (Reynolds et al., 2011) were 
excluded due to the participants not having received a diagnosis of depression at 
baseline. The lack of diagnostic assessment is unsurprising, in light of the findings of 
the aforementioned earlier systematic review (Weisz et al., 2005) where the authors 
found half of youth psychotherapy studies did not include an adequate diagnosis at 
baseline (either not at all, or not using a reliable standardised tool). Furthermore, 
the trial that constitutes a large part of this thesis (which will be described in Chapter 
4) was noted in the systematic review of the current BA literature but was excluded 
due to the study results being unavailable at the time of analysis. Only three RCTs 
were identified by the systematic search strategy used (McCauley et al., 2016, Chu et 
al., 2016, Stark, 1985), all three of which were in US populations. However, it was 
unclear how one of these studies (Chu et al., 2016) was identified as it did not 
appear to be available during the stated electronic search period, between July and 
August 2015. Another of the identified RCTs was derived from an unpublished 
doctoral thesis (Stark, 1985), which included a treatment the author termed 
behavior therapy, rather than the more specific BA. It was not made apparent, 
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therefore, how this research differed from much of the earlier behavioural work for 
young people with depression. The remaining seven studies all used within-
participant designs (Weersing et al., 2008, Chu et al., 2009, Ritschel et al., 2011, 
Wallis et al., 2012, Jacob et al., 2013, Douleh, 2013, Riley and Gaynor, 2014) and 
suffered from sources of bias. Overall, 170 participants were included across the 10 
studies, with participants ranging from 8 to 18 years old. When the RCT studies were 
combined within the meta-analysis, a statistically significant difference in Children’s 
Depression Rating Scale- Revised (CDRS-R) scores from pre- to post-treatment was 
found in favour of BA (see Figure 4). The authors concluded that there is preliminary 
evidence that BA may be an effective treatment for depression in young people. 
Interestingly, reduced anxiety scores and increased quality of life were also 
observed. Not only were reductions in depression scores reported following BA 
interventions across studies, those from the RCTs demonstrated a greater 
improvement when compared to the controls. However, these findings need to be 
interpreted with caution; due to the inconsistencies noted in one of the included 
RCTs, the results may not be accurate. The clearest message from the first 
systematic review and meta-analysis in the area was the poor quality and reporting 
of research to date, with many of the studies lacking the detail required to 
determine bias.  
Although all included studies, regardless of the methodology used, reported 
reductions in depression, this review (Tindall et al., 2017) did not include any 
evidence from a UK setting. As the MRC guidance cautions (Craig et al., 2008) 
systematic reviews of complex interventions can be problematic due to the 
difficulties of combining different variants of complex intervention packages of care 
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together. Despite the broad conceptualisation of BA and the systematic review of a 
wide variety of relevant databases, the search strategy used by Tindall and 
colleagues (2017) did not identify the full selection of literature described in this 
chapter. This could be due to the inclusion of the concept of activity monitoring (and 
associated terms) into the search, which may have constrained the search, raising 
the possibility that other relevant literature may have been missed. The rigorously 
conducted scoping review detailed in this chapter therefore compliments the 
systematic review findings and offers crucial insight into the diverse research 
conducted to date on this topic. 
 
 
Figure 4: Reproduced with permission from Tindall et al. (2017), a forest plot of all 
depression measures across RCTs included in the meta-analysis 
  35 
One large randomised study that was not included in the systematic review 
and meta-analysis by Tindall and colleagues (2017), is a trial by Weersing and 
colleagues (2017) that was only published following the review manuscript. A 
previously described approach to treating comorbid anxiety and depression in young 
people in primary care (Weersing et al., 2008) was investigated in a large RCT 
(Weersing et al., 2017). One hundred and eighty five young people (aged 8 to 16 
years old) were randomised to brief behavioural therapy (8-12 sessions of BA plus 
exposure therapy) or assisted referral to care (personalised referral to outpatient 
mental health care plus telephone support). The results indicated that BA treatment 
is associated with benefits superior to assisted referral. One limitation of this trial is 
that participants did not have to meet full DSM MDD criteria to be offered study 
entry. 
Observations from the background literature 
Rutter (2008) notes that child psychotherapists face a similar but differing set of 
challenges from therapists working with adults; he cautions against assuming that 
adult therapy will automatically translate into an effective treatment with young 
people. Although this background literature review was not systematic in nature it 
has furthered the field by synthesising what is known from all study designs rather 
than limiting to RCTs. Despite growing empirical evidence, there remains a paucity of 
research on BA treatment for young people and more high-quality studies are 
needed. Particularly so in the UK, as much of the promising evidence to date has 
been conducted in a US setting where the composition of health services is different 
and driven by private medical insurance. The research that underpins this thesis was 
therefore conducted at an opportune time, with adolescent mental health being 
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high on the policy agenda and the need within the National Health Service to find 
innovative, sustainable ways to provide psychological therapy, effectively, to greater 
numbers of adolescents. Treatments also need to be responsive to the needs of 
clinical practice (Kessler and Glasgow, 2011). In the context of growing theoretical 
and empirical support, BA may well meet the need for a therapy that is effective, 
brief and able to be disseminated in a complex varied CAMHS context by a variety of 
clinicians.  
Given the established need for further research on the delivery of BA to 
young people with depression in the UK, this thesis outlines the methods and 
findings of two studies (labelled Stage I and II) aiming to address this evidence gap. 
Relevant literature relating to the methodological approach used in each of these 
studies is presented at the beginning of each chapter and the results are situated in 
the context of the research presented above. The following chapter describes the 
unpublished feasibility work that was undertaken by myself and my colleagues at 
Durham University prior to this doctoral study, which had important implications for 
the work undertaken for this thesis. 
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Chapter 2 Feasibility Work 
Introduction 
The previous chapter considered the international and national evidence base for 
the use of Behavioural Activation (BA), as a treatment for depression in children and 
young people, across several settings. Three of these published accounts were single 
case studies undertaken in a UK Child and Adolescent Mental Health Service 
(CAMHS) setting (Pass et al., 2015, Pass et al., 2016, Pass et al., 2017). Further to 
these case studies, two additional studies (conducted by staff affiliated to the 
Mental Health Research Centre [MHRC] at Durham University) were highlighted that 
had been carried out in a UK general practice and secondary school setting (Arnott et 
al., 2012, Tiffin et al., 2012). As these two studies are unpublished, the following 
chapter discusses the findings of these feasibility studies, both of which aimed to 
assess the acceptability and feasibility of delivering BA as a treatment for depression 
in two distinct settings.  
Although the inclusion of research completed as part of a study team prior to 
commencing a PhD is not traditionally included in a thesis, in this case, omission of 
the detailed findings of these studies would have led to difficulties in adequately 
situating the research conducted as part of this thesis. The topic of this PhD was 
initially conceived after my involvement in these projects at Durham University; I 
was involved in the data collection for both studies, which was completed alongside 
more senior colleagues prior to the start of my PhD. The rationale, design and results 
of these studies are summarised, alongside my personal reflections on the learning 
garnered from these experiences. 
  39 
Behavioural Activation in Young People- A Feasibility Study in 
Primary Care (BAY-F) 
Introduction and aim 
Patient and public involvement (PPI) work with young people conducted prior to the 
BAY-F study indicated that BA would, in principle, be an acceptable treatment if 
delivered at GP surgeries. As a consequence, this small, within-subject feasibility 
study explored the acceptability and feasibility of using BA as an intervention for 
depression in young people delivered by Practice Nurses in a primary care setting. In 
the capacity of a Mental Health Support Administrator, I was responsible for the 
study implementation and adaptations to the treatment manual. 
Method 
Behavioural activation manual 
The BA treatment manual was developed in the USA and had been piloted informally 
in 40 young people with depression (McCauley, 2011). The development of this 12-
session manual, called ‘Adolescents Taking Action’ (ATA), has been detailed by 
McCauley and colleagues (McCauley et al., 2011); the initial sessions focus on 
introducing the BA model and individual conceptualisation of the model for the 
patient. Subsequent sessions focus on teaching the concepts that mood can be 
regulated by activity, guided activation, understanding mood versus goal directed 
behaviour, goal-setting and functional analysis. The ATA manual was anglicised for 
the BAY-F study and elements from a manual developed for a UK trial of BA in adults 
were also incorporated (Ekers et al., 2011b). 
Clinician training 
Two Nurse Practitioners were trained by a Tees, Esk and Wear Valleys (TEWV) 
National Health Service (NHS) Foundation Trust BA specialist via a five-day intensive 
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course. Practitioners were required to pass a competency assessment prior to 
delivering the therapy within the study. Both clinicians passed the competency 
assessment following the BA training. Clinician feedback indicated difficulties 
attending such lengthy training and suggestions were received that the training 
could be condensed into fewer days.  
Recruitment 
This study took place between January 2012 and April 2013. It was a non-
randomised feasibility study with a before and after design. A brief depression 
screening procedure, the Patient Health Questionnaire- 2 Item Version (PHQ-2) 
(Kroenke et al., 2003) plus a supplementary help-seeking question, was offered to 
consecutive young patients (aged 12 to 18 years old) seen by two GP-based Nurse 
Practitioners in two GP practices in the North East of England. Adolescents who 
scored above the prescribed cut-off on the screening tool (indicating possible 
depression) and requested help for their symptoms were offered a structured 
diagnostic interview with a Consultant Psychiatrist using the Kiddie-SADS-Present 
and Lifetime Version (K-SADS-PL) affective disorders supplement (Kaufman et al., 
1997). The K-SADS-PL includes the Children’s Global Assessment Scale (CGAS), a 
measure of current functioning. Participants over the age of 16 were asked to 
provide informed consent to participate. Young people under 16 were asked to 
provide informed assent and parents were asked for informed consent for their 
young person to participate. Young people found to have Major Depressive Disorder 
(MDD) were offered a BA manualised intervention for approximately one hour per 
week, up to a maximum of 12 sessions (total number of sessions was at the 
therapist’s discretion).  
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Data collection 
Participants were assessed at baseline and end of treatment using the Mood and 
Feelings Questionnaire- Short Form (MFQ-SF) (Angold et al., 1995). Qualitative 
feedback was sought from Nurse Practitioners, participants and their parents, which 
was collated via ad hoc notes made by the study team. 
 Ethical approval for the study was granted by Durham University School of 
Medicine and Health Ethics Sub-Committee and the NHS National Research Ethics 
Service for County Durham and Tees Valley 2 Committee. 
Results 
Both Nurse Practitioners reported that most young people approached to participate 
in the study completed the screening questionnaire, although we were unable to 
ascertain specific recruitment figures due to imprecise record keeping by the Nurse 
Practitioners involved. In addition, the Nurse Practitioners acknowledged that the 
screen was not deployed to consecutive patients as intended. Despite these 
difficulties in administrating the screening tool, seven females aged 12 to 18 years 
old were identified as eligible to participate in the diagnostic interview, all of whom 
agreed to attend. All participants were recruited from one GP practice; screening at 
the other practice did not identify any eligible patients during the study period. All 
participants who attended the diagnostic interview met the study inclusion criteria 
(MDD on the K-SADS-PL) and agreed to take part in the BA intervention. Of the seven 
young people who were recruited, four participants completed all BA sessions, one 
with an accompanying parent. The remaining three participants stopped attending 
sessions after the first three treatment sessions. None of those who dropped out of 
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treatment were able to be contacted for follow-up. All young people who completed 
treatment reported lower MFQ-SF scores following treatment than at baseline. 
 Practitioner feedback suggested drop-out may have been largely due to 
improvements in participants’ depressive symptoms. Similarly, in those young 
people who completed all BA sessions, the practitioner observed rapid 
improvements in depressive symptoms early on during treatment. The Nurse 
Practitioner reported difficulties in fitting the one-hour BA sessions into their usual 
20-minute appointment slots. As a consequence, the practitioner completed some 
BA sessions outside of their regular working hours. Feedback from participants 
indicated difficulties in commuting to the GP practice, both in terms of time around 
their other commitments (i.e. college, school, social), and financially. Despite this, 
participants commented positively on the BA therapy content and the practitioner 
delivering it. The treatment was also considered acceptable by practitioners, but 
they identified a need for greater flexibility within the manual to better tailor the 
treatment to each young individual. The treatment manual was refined as a 
consequence of this feedback. 
Reflections 
The study design was pragmatic and naturalistic, with a simple before and after 
measure. The screening procedure was unable to be implemented as intended by 
Nurse Practitioners and the quality of data recording was poor. This limited our 
ability to estimate a potential recruitment rate. We found young people who 
completed the BA sessions experienced improvements in their depressive symptoms 
following treatment. Although practitioners attributed the high levels of drop-out to 
improvements in participants’ depressive symptoms over the first few sessions, this 
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could not be verified because none of those who dropped out of treatment were 
able to be contacted to provide feedback. Similarly, in those young people who 
completed all BA sessions, depressive symptoms were reported to improve rapidly at 
the start of therapy, but this was not able to be formally captured as no interim 
measure of mood was taken. As a result, an additional measure of depression 
severity (MFQ-SF) was incorporated into the manual at baseline and weeks 4, 8 and 
12, in order to retain a measure of depression severity in the event of participant 
drop-out. Although no formal qualitative methodology or methods were used to 
obtain feedback, informal feedback was useful to inform adaptions to the ATA 
manual. The layout of sessions was altered and additional optional topics 
incorporated, on the concepts of rumination and mindfulness, so the treatment 
could be better tailored to the individual.  
Despite the discussed design concerns, it is still possible to observe feasibility 
issues relevant to my PhD research. Sessions were often carried out sporadically 
rather than via the intended weekly structure. The practitioner indicated that it was 
unfeasible to fit the lengthy one-hour appointments into their regular practice 
appointments of 20 minutes, meaning many sessions were completed in the staff 
member’s own time. This would not be sustainable nor transferable outside of the 
BAY-F study. This also indicated to me that further involvement from the 
management team would be advisable, rather than relying wholly on practitioners 
themselves to make the necessary space in work schedules. Feedback from study 
participants indicated difficulties in commuting to the GP practice, which also 
suggests the need to consider alternative youth-friendly settings. 
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Key learning points 
The screening procedure was acceptable to participants but burdensome to 
practitioners. The intervention itself was acceptable to young people and the 
practitioner, albeit this was a small feasibility study with no control condition 
involving only seven young people. There were also provisional indications that BA 
may be helpful in improving symptoms of depression in young people. Practitioners 
were able to be trained to deliver the intervention following minimal training, 
providing support for the view (from extant literature) that BA is easy to 
disseminate. However, it was not viable for the Nurse Practitioner to deliver such 
lengthy sessions as part of routine clinical practice and the setting caused access 
difficulties for many of the participating young people, which may have contributed 
to the high rates of drop-out observed. The conclusion of this feasibility study was 
therefore that alternative settings should be considered in which to deliver this 
acceptable and promising therapy. 
BODY and mind study: A school-based feasibility trial of 
behavioural activation as a treatment for young people with 
comorbid weight and mood difficulties 
Introduction and aim 
Traditional obesity treatments have not addressed the underlying links between 
mood, coping and eating behaviours, which may explain why they have been largely 
ineffective (Ebbeling et al., 2002). In contrast, BA has been hypothesised to have the 
potential to address these fundamental links, and BA for comorbid obesity and 
depression has been previously explored in adult populations (Pagoto et al., 2008). 
The BODY and Mind study aimed to investigate the acceptability, practicality and 
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impact of a BA intervention for young people who were overweight or obese with 
symptoms of low mood or depression. In the capacity of a Research Associate (with 
no previous psychotherapies training), I was responsible for assisting in the school 
screening, delivery of the intervention and collection of the outcome measures, with 
the exception of the qualitative interviews. The results presented below have been 
written up for publication in an academic journal. 
Method 
Study design 
This was a small, unblinded, mixed methods, feasibility Randomised Controlled Trial 
(RCT) with a waiting list control. 
Recruitment 
Data collection started in November 2012 and ended in March 2013. The study site, 
a school in the North East of England, was selected because students came from a 
diverse variety of backgrounds and ethnicities. In light of the findings from the BAY-F 
study, it was felt a secondary school setting may address some of the difficulties 
young people experienced in accessing their GP surgery.  
All students in year groups 7 to 10 (aged 11-15 years old) were invited to 
participate in a systematic screening procedure. Pupils were provided with 
information on the study and those who wished to take part were asked to complete 
the PHQ-2 plus a supplementary help-seeking question during afternoon registration 
and were then weighed and measured to work out their Body Mass Index (BMI) in a 
private room. An alternative approach was used for year 7 pupils in light of their 
younger age; the information and questionnaire were sent home to parents/carers 
who were asked to complete the materials with their child. Children who scored 
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above the prescribed cut offs on both weight and mood measures were eligible for 
the next stage of the study, a diagnostic interview.  
The consent procedure mirrored that used in the BAY-F study. Depression 
(MDD) or significant depressive symptoms (i.e., Depressive Disorder Not Otherwise 
Specified) were confirmed during the diagnostic interview using the affective 
disorders schedule from the K-SADS-PL administered by a Consultant Psychiatrist. 
Low mood was measured using the MFQ-SF, self-esteem with the Rosenberg Self-
Esteem Measure (RSE) (Rosenberg, 1965), functioning with the CGAS and health and 
social functioning with the Health of the Nation Outcome Scales for Children and 
Adolescents (HoNOSCA) (Gowers et al., 1999).  
Behavioural activation intervention 
Young people were asked if they were happy to be randomly allocated to take part 
in the intervention straight away or to wait for 4-6 weeks prior to starting (waiting-
list control). The BA intervention was then delivered for up to 12 sessions (total 
number of sessions was at the therapist’s discretion). The study used training 
procedures and the BA manual adapted from the BAY-F study. Fidelity measures 
(ratings of audio recordings of treatment sessions) were completed to ensure 
treatment remained true to the BA model. Sessions were arranged after school 
hours or during school holidays at the on-site school sports centre. Parents were 
encouraged to participate. 
Data collection 
Young people were weighed/measured and completed the MFQ-SF, RSE, CGAS and 
HoNOSCA at regular intervals across the intervention period and at the end of 
treatment. Following treatment, participants and their parents were invited to 
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attend a semi-structured qualitative interview with an otherwise uninvolved 
researcher. 
Ethical approval for the study was granted by Durham University Department 
of Psychology Ethics Advisory Sub-Committee. 
Results 
Recruitment 
A total of 1126 pupils were invited to the initial screening (see Appendix 1 for a 
Consolidated Standards of Reporting Trials [CONSORT] diagram of the flow of 
participant identification and recruitment). Five hundred and fifty seven agreed to 
participate, giving a 49.5% consent rate (60% for years 8 to 10 and 19% for year 7). 
Of the participating pupils (n= 557), 33 scored above the prescribed cut off for both 
weight and mood giving an eligibility rate of 5.9%. Nine of the 33 pupils invited to the 
diagnostic interview agreed to attend. From the nine diagnostic interviewees, eight 
young people were eligible for the intervention (aged 13-15 years old). All young 
people who were asked agreed to be randomised. Four were allocated to each 
treatment arm (either BA or a waiting-list prior to BA).  
Intervention 
Participants completed between 8 and 11 sessions of BA, with seven out of eight 
young people completing all BA sessions prescribed by the therapist. Session 
attendance was high with only one participant missing their final session. However, 
some cancellations were rearranged due to ill health, missed appointments and 
transport difficulties, and two sessions were of necessity delivered in tandem, due to 
the families’ other commitments (i.e., 8 BA sessions were delivered over 7 sessions). 
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A random 10% of sessions were rated for fidelity by the BA trainer and were deemed 
true to the BA model. 
Qualitative interviews 
Seven of the eight study participants agreed to take part in the qualitative follow-up 
interview; one participant was unable to be contacted (see Appendix 1 for examples 
of the identified themes). 
The screening process was not viewed positively by the young people 
involved. School was viewed as a place of competing pressures and not an 
appropriate setting in which to ask sensitive questions relating to weight and mood. 
When asked about future study design, young people expressed a willingness to 
undergo randomisation to individual sessions of BA or other psychological therapies 
(or a waiting-list control for such treatments) but were less keen to be randomised 
to a medication treatment arm or to a group-based intervention. They reported high 
levels of satisfaction with BA session content, frequency and duration, as well as 
with the therapist. Most young people stated they would recommend the 
intervention to others experiencing similar difficulties, indicating the acceptability of 
the treatment to young people. Some young people reported significant and 
sustained improvements in mood and self-esteem.  
In contrast, several barriers were highlighted by those young people who 
struggled to maintain the improvements observed during their treatment. The 
therapist and young people both stressed difficulties with scheduling appointments, 
particularly during school holidays, which resulted in significant breaks in the 
intervention delivery in the waiting-list group (which ran over the school holidays).  
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Parents reported that they had found the intervention highly acceptable, 
although parental difficulty in participating due to other commitments was 
highlighted as a feasibility issue. Parents were perceived as ‘gatekeepers’, who held 
the power to restrict or provide opportunities for the young person. Some parents 
were concerned that some manual worksheets were difficult to understand for 
young people. The feedback obtained from the study was used to adapt the 
materials and treatment accordingly. 
Outcomes 
Overall, from baseline to the end of treatment there was an effect size of 0.02 
recorded for BMI. The effect-size for self-esteem (RSE scores) was 1.31 indicating a 
large effect. For depressive symptoms (MFQ-SF), the effect size was 0.76, again 
indicating a large effect. A MFQ-SF cut-off score of 7 or below indicates remission, 
which was achieved in five cases at the end of treatment (although one participant 
did not meet these criteria at baseline). In the remaining two cases, a decrease in 
MFQ-SF score was evident indicating improved mood not reaching the cut-off 
criteria. A large effect size was reported in current functioning (CGAS) of 1.71 and 
health and social functioning (HoNOSCA) of 1.55. These statistics exclude the one 
participant who was unavailable for the final planned treatment session. No 
significant events were recorded during or after the intervention and there was no 
evidence of any harms or unintended effects. As would be expected for BMI over 
such a short follow-up period, little change was observed. In contrast, notable 
improvements were seen in mood, self-esteem and functioning. However, due to the 
small sample size these results need to be interpreted with caution. 
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Reflections 
Feasibility and acceptability issues were evident with the screening procedure. Large 
numbers of young people had to be screened to identify low numbers of eligible 
participants indicating mass screening was unfeasible. It would be more efficient to 
screen populations more at risk of depression, such as in secondary care. Further to 
this, few of those identified as potentially eligible accepted the invitation to a 
diagnostic interview. This suggested that the recruitment materials could be 
improved and may reflect the lack of PPI input prior to the start of the BODY and 
Mind study.  
In contrast to the screening procedure, the BA intervention was judged to be 
both feasible and acceptable to young people, parents and the therapist. Low 
attrition rates further support the acceptability of the intervention. Despite being 
underpowered to detect significant change over the treatment duration, 
improvements in self-esteem, functioning and mood ratings were observed. There 
were no clear suggestions of improvements in BMI scores. 
Treatment delivery in a school setting presented challenges. The inability to 
offer treatment sessions across school holidays or during school hours represented a 
barrier for young people and their parents, leading to gaps in treatment. The ability 
to offer more flexibility in the timing of treatment sessions would enable delivery of 
the treatment via the intended weekly format, and may facilitate greater parental 
involvement which seems likely to improve delivery of the treatment. Although 
parental components were included in the ATA manual, these were mainly delivered 
separately to the young person’s treatment sessions. Parents acted as gatekeepers 
to resources and for this reason, integrating their involvement into their young 
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person’s treatment sessions would enable greater collaboration. Overall, the 
adapted ATA manual and treatment approach was acceptable to young people, their 
parents and therapist, which was able to be delivered by a therapist with no 
previous psychotherapies training. 
The participants were demographically representative of young people for 
the geographical area they were sampled from. As there were no study drop-outs, 
data were almost complete, with the exception of a missing set of outcome 
measures at the final session from one participant and a qualitative interview for a 
separate young person. Unlike in the BAY-F study, a formal qualitative evaluation 
element was included to explore young people’s experience of the intervention, 
although this was limited by the lack of a formal method of analysis. As a single 
therapist was involved, it is not possible to generalize to other clinicians. However, 
the results suggest inexperienced therapists can be trained following a brief training 
course, indicating BA has the potential for dissemination to a wide variety of 
providers (i.e. teachers, support staff, youth workers). 
Despite the positive outcomes reported, this investigation had some clear 
limitations. Firstly, although appropriate in a feasibility RCT, this study involved a 
very small number of children. Secondly, there was no long term follow up, which 
should be corrected in future trials. Thirdly, the waiting-list control period was short, 
which made it less likely that changes would be detected. The exploratory statistics 
are also underpowered to estimate effect sizes on the panel of outcome measures. 
In addition, no diagnostic interview was conducted following treatment so we do not 
know if the sample still met the criteria for a depressive disorder. Finally, no direct 
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measures of physical activity were included; future trials should incorporate such a 
tool.  
Key learning points 
This study is the first to explore the feasibility of BA as a treatment for comorbid low 
mood and overweight/obesity in young people. Mass school-based screening was 
costly and unacceptable, yielding low numbers of eligible pupils. This finding 
combined with the difficulties encountered with continuity over the school holidays, 
supports the use of settings other than schools to deliver treatment. In summary, 
these findings make a strong case for further exploration of the intervention. Our 
findings further suggest that the control condition should be one which young 
people would perceive as acceptable (such as an alternative psychotherapy).  
Case study: a young person’s account of receiving behavioural 
activation treatment 
As well as reflecting upon the methodological strengths, weaknesses and learning 
gained from these studies, I was interested in understanding how young people had 
personally experienced BA as an intervention. One participant from the BODY and 
Mind study had already expressed a desire to support the University with future 
research projects and so, under the supervision of an experienced qualitative 
researcher, I conducted an interview with this young person, with the hope that 
their feedback would inform the design of future BA intervention trials and provide 
information that could be shared with future participants. A pseudonym3 has been 
used to preserve anonymity and confidentiality.  
                                                 
3
 A pseudonym is a fictional name assigned to a person, group or place. 
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The interview had an opened-ended framework with no fixed question 
schedule. The young person was initially asked to describe whether they had found 
BA beneficial or problematic, with subsequent questions being modified in light of 
Dan’s response.   
When asked to reflect upon the benefits of BA treatment, Dan commented 
upon aspects of increased self-awareness of his mood. He highlighted how BA 
treatment had led to the development of a working relationship with the therapist 
and the improvement of existing connections with his family members: 
“It was a good experience but it’s hard to describe. It helped you learn 
about yourself and how you cope with things emotionally. It was good to 
have a talk and establish a bond with your therapist/coach. This way you 
were more willing to share your personal information. It was good to talk 
as it felt like a chat at times. It made it a lot less formal and it made me 
feel more relaxed as sessions were flexible. If it had been more formal 
you would have been watching your words. It also helped how I 
interacted with my Dad, it sort of helped that out” 
This excerpt shows the importance of flexibility in therapy, as well as the importance 
of a cathartic and supportive relationship with a therapist. Dan reported that the 
relaxed nature of the interactions was a facilitator for successful treatment.  
Dan had his BA sessions once a week, for eight to ten weeks. This was, he said: 
“not too much, not too little. We did a lot of talking and completing worksheets but 
it was a good balance”. But there were also less positive aspects to treatment: 
“It was a bit stressful at times, like having debates with my Dad why I was 
going for therapy. Also the homework/take-home tasks were a bit long 
sometimes, no one likes doing work I guess but it has to be done at the 
end of the day” 
This highlights the challenging nature of BA, as established behaviours are 
questioned in order to explore and use alternative coping mechanisms. Along with 
this inevitably comes stress and hard work. Dan and I concluded that it would be 
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beneficial and important to highlight this in the information sheets of future studies 
providing BA treatment. 
 Finally, he was asked if he would recommend BA to other young people who 
were in a similar situation. He responded positively: “I would recommend it. It was a 
good experience. It didn’t feel like a therapy for depression”. These final 
endorsements help to explain why BA is so acceptable to young people; it is non-
stigmatising and practical. This dialogue may be helpful when approaching young 
people to take part in such therapy. In particular, it may be important to inform 
young people that there may be elements of therapy that are stressful or time-
consuming, but that these are necessary parts of BA that ultimately facilitate 
behavioural and mood related change. 
Conclusions 
Although all studies described above were conducted prior to my PhD, and in 
collaboration with other more senior members of MHRC staff, they are important in 
the narrative of this body of work. They have contributed towards my personal 
understandings of the potential utility of a BA approach for treating depression in 
children and young people, as well as adding to the sparse published literature 
currently available in the UK. Our feasibility work has made a strong case for further 
exploration of this promising treatment. The BAY-F study indicated the BA treatment 
was feasible but could not be delivered by Nurse Practitioners in primary care. The 
feasibility work in schools was acceptable and appeared feasible, however it was not 
a generalisable approach as the therapist was not a resource usually available in a 
school setting. Furthermore and perhaps most importantly, the therapist was 
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supervised by a BA expert and Consultant Psychiatrist who would not be accessible 
in a school setting. Without this support and risk supervision, delivery in a school 
setting would not be feasible. This influenced me to conduct my research in a 
CAMHS environment where those support and supervision structures would be in 
place, despite the plans of the research team to further explore the use of BA in 
school settings. The importance of adequate supervision of non-specialists delivering 
BA to young people has been reinforced in other applications of BA (Pass et al., 
2017). However, whilst the CAMHS setting might appear to address many of the 
challenges experienced in school and primary care, it was a novel context in which to 
implement BA. Accordingly, some form of exploratory study was indicated. The 
following chapter discusses the first study conducted as part of my PhD research, a 
focused ethnography which served to explore CAMHS as a potential site for a 
planned trial of a BA intervention. 
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Chapter 3 Stage I: A Focused 
Ethnography of a Child and 
Adolescent Mental Health Service 
Site 
The following study describes the focused ethnography that has been used to inform 
the design of Stage II of the research. This study was the consequence of initial site 
visits highlighting my lack of knowledge about the setting and in light of the need to 
make informed decisions in relation to the trial design. I will begin by discussing the 
aims, methodology and will then discuss how the findings led to alterations in the 
trial protocol of Stage II of this thesis. 
Study background 
Prior to the implementation of the trial around which this doctoral study was 
planned, site visits were organised with the respective Child and Adolescent Mental 
Health Service (CAMHS) Team Managers at two potential study sites. These site visits 
were an opportunity to acquire contextual knowledge of the CAMHS teams and the 
available site resources, to inform the trial protocol (now Stage II of the research). In 
fact, these visits only served to highlight the complex nature of CAMHS care for 
young people with depression, and it became clear to me that the breadth and 
depth of information required could not be obtained solely from such site visits. 
Settings such as CAMHS may be characterised as “complex systems”, due to their 
multi-faceted, fluid and ever-changing context, with such environments being more 
similar to a dynamic ecology (Wells et al., 2012). Furthermore, the information that 
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was gained from the meetings with the Team Managers indicated that, without a 
greater understanding of the setting, the trial would meet insurmountable barriers 
and may be of limited relevance if the depression intervention was not able to 
account for the intricacies of clinical practice. This dictated the need for a more in-
depth, longitudinal assessment of the study site, in order to understand these 
complexities fully and successfully design and implement a trial in this setting. Access 
to the site for the purposes of a pre-design stage of research was negotiated with 
one of the Team Managers, in exchange for me taking on a voluntary role within the 
CAMHS team whilst conducting the research. As a result, I was embedded into one 
of the CAMHS teams as an unpaid Assistant Psychologist for a two-year period 
(starting two months prior to the start of data collection for Stage I of the study in 
order to complete mandatory training). An ethnographic approach was selected as 
the most appropriate way to study and understand the setting. 
Introduction and aims 
Randomised Controlled Trials (RCTs) are generally considered to be the best way to 
measure the efficacy of clinical interventions (Stephenson and Imrie, 1998, 
Torgerson and Torgerson, 2008). However, the findings of such trials have often 
been criticised for their lack of applicability to real-world clinical practice (Savage, 
2000, Kessler and Glasgow, 2011). This has been of particular concern for 
researchers evaluating complex interventions (Stephenson and Imrie, 1998, Wells et 
al., 2012), where an intervention may have been studied in a highly controlled 
research setting but has then encountered difficulties when implemented by clinical 
services. This has led to a move towards more ‘pragmatic’ trial designs that take 
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account of the intended setting (Stephenson and Imrie, 1998) and which aim to 
bridge the observed disparity between clinical research and clinical practice. The 
rigorous process of trial design needs to be informed by the clinical setting as this 
can improve quality and clinical relevance, as well as limit the waste of resources 
within the trial (Webber, 2014). This is all the more important, when considered in 
light of the fact that the evidence base for the National Institute for Health and Care 
Excellence (NICE) guidelines is principally developed from RCT evidence (Gould, 
2010). A vital step in designing a pragmatic trial is to have an in-depth knowledge 
and understanding of the context into which the proposed trial is to be 
implemented. Context can be described as the setting in which an event, statement 
or idea occurs; it is not limited to the physical environment as it may also refer to 
anything that has an impact upon an individual’s behaviour in that setting. Previous 
research has emphasised the impact of context upon the implementation of 
interventions, suggesting the need to account for this with local-level responses in 
the intervention setting (Wells et al., 2012, Lewis and Russell, 2013). As such, 
understanding the environment in which a trial will be conducted is critical to the 
successful implementation of the subsequent intervention.  
 Utilising the experience of professionals who have a good working knowledge 
of the study site has also been recommended as a way to inform research (Kendall, 
2003). The utility of this approach has previously been demonstrated by Wells and 
colleagues (2012) who explored ‘behind the scenes’ in RCTs of complex interventions 
in order to understand the perceptions of staff and researchers towards the research 
being undertaken and how this may impact upon the implementation of the 
intervention. The application of staff expertise to inform planned research has been 
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referred to as “captured wisdom” (Webber, 2014). This phrase seems particularly 
fitting, as exploring staff views may provide insight into their experiences and 
knowledge of how the research findings can become better integrated into their 
working environment. Furthermore, the inclusion of clinicians’ views has been found 
to facilitate strategies that improve the efficacy of the trial itself (Turner-Halliday et 
al., 2014). Pragmatic trial designs that benefit from consultation with staff at the 
proposed study site may lead to well-designed trials that are more acceptable to 
staff. Currently there is limited literature available on how modern, multi-
disciplinary, CAMHS teams engage with intervention trials, and it remains to be 
investigated how staff members feel about the proposed research and how these 
beliefs are played out in context. Although Kendall (2003) suggests early involvement 
of local research support units and fellow researchers to inform trial protocols, this 
would not meet the need I observed for in-depth, site-specific knowledge. Local 
research support units or researchers would be unlikely to have adequate 
knowledge of the subtle, nuanced behaviours that may affect decisions relating to 
trial design. 
 Another explanation for the reported chasm between research and practice 
is the limitations of traditional research designs (Barlow, 1981). Despite the 
identified need for more pragmatic trial designs and the recognised value of 
incorporating clinicians’ views into proposed research, there has been a lack of focus 
on methodologies to guide researchers in this endeavour. One suggestion has been 
to utilise a mixed methods approach by combining qualitative research components 
with a RCT design (Cresswell, 2009). The addition of qualitative research methods 
can counter many of the limitations of quantitative RCT data, allowing access to 
  61 
‘embedded processes’ occurring in the setting by focusing upon the context of 
individuals’ lives (Barber, 2014). Despite this, a recent review found only a third of 
recently completed RCTs of complex interventions included a qualitative element 
(Lewin et al., 2009). Most common, were those carried out before the trials; the 
aims of these studies included to develop or inform the study hypothesis, 
intervention or selection of outcome measures, or to understand the context of the 
setting. Other examples include the more classic anthropological study, which used a 
longitudinal ethnography- running alongside the trial- to explore professional 
research subjects’ experiences of participating in clinical drugs trials (Abadie, 2010). 
As with many qualitative explorations of trial subjects, however, this application of 
qualitative methodology focuses on gathering data during the trial itself so was not 
intended to influence the trial design. An alternative approach to adapting trials to 
suit the proposed setting is the addition of a pre-design element. Webber (2014) 
used an orthodox longitudinal ethnography to develop a complex intervention for a 
planned trial in a social work setting, while another study used a ‘targeted’ 
ethnography to adapt a US HIV prevention to a Brazilian setting (Wainberg et al., 
2007). However, both studies focussed solely on informing the interventions, rather 
than the trial design.  
Another study had the long-term aim to increase patient adherence to 
medication and used a traditional ethnography to inform future research trials and 
direct future research avenues more generally (Gargeya and Holme, 2013), rather 
than a specific trial. Some researchers have utilised a pre-design component with the 
aim of informing the subsequent trial design but there have been questions raised 
about the methodology used. One research team used a rapid ethnography to 
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investigate breast-feeding practices in an area where they intended to implement an 
intervention to improve breastfeeding rates (Guerrero et al., 1999). Although they 
used the data to inform a planned trial, I would (in line with the majority opinion on 
ethnography’s defining characteristics) suggest it cannot be classified as an 
ethnography due to the lack of participant observation which is generally considered 
to be the central feature of the methodology. A multiple explanatory case study 
design was used to explore the impact of the research setting within eight RCTs of 
complex interventions (Wells et al., 2012). Although the authors did not refer to this 
as a rapid or focused ethnography, the aims and methods used could be considered 
to be in keeping with this approach. Again this research focused on exploring the 
role of context within RCTs, rather than prior to their implementation. Interpretive 
phenomenological analysis with adolescent trial participants, their parents and 
physiotherapists delivering the intervention has been used alongside a RCT feasibility 
study (Toye et al., 2016). This led to specific recommendations for improved trial 
design in the pilot study but did not use an ethnographic methodology. Another 
study utilised a rapid ethnography to inform the design of a behaviour change 
sexually transmitted disease trial across five countries in a community setting (US 
National Insitute for Mental Health Collaborative HIV/Sexually Transmitted Disease 
Prevention Trial Group, 2007). Although the findings did lead to some alterations in 
the trial design, it mainly focussed on local adaption of the study intervention. As 
such, data collection was restricted to a very limited number of pre-defined features 
designed to inform the future intervention (i.e. behavioural outcomes, social groups 
to target, key stakeholders, potential recruitment sites), in contrast to the broader 
inductive stance required to inform the trial design from conception in this study. 
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Potential barriers may be encountered upon implementation of the trial that are not 
just limited to difficulties with the intervention itself: as such, if the methodology is 
too narrow or fixed it may not account for important contextual findings. We suggest 
there is potential in sequencing an ethnographic component prior to the RCT to 
inform the trial design (Kitchen et al., 2017). This approach has been used previously 
as a pre-design component to determine the feasibility of conducting a RCT (Turner-
Halliday et al., 2014). A pre-design component to trials may be particularly 
appropriate because principle investigators are advised to make as few changes as 
possible during a trial in order to maintain the quality of the study (Kendall, 2003). A 
pre-design aspect allows the opportunity to identify and correct potential errors or 
pre-empt barriers in a first draft of the protocol, affording the chance to compromise 
between what is methodologically ideal and what is achievable within the clinical 
setting. Most importantly, a well-designed, methodologically sound RCT evaluating 
an intervention can be powerful in changing practice, which may in turn improve 
patient outcomes (Kendall, 2003). When this is considered in light of the Medical 
Research Council (MRC) guidance (Craig et al., 2008), that states context is a crucial 
consideration in trial design, what works in one setting may not be as effective or 
even be harmful elsewhere. 
This pre-design qualitative study utilised a focused ethnographic 
methodology to inform a forthcoming RCT within a CAMHS context.     
Principle research aim 
To gain an understanding of the context into which Stage II of the research would be 
implemented; identifying the individual and organisational factors relevant to the 
design and feasibility of the planned depression trial. 
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Research objectives 
 To document the staff culture, site procedures and facilities at the proposed 
site. 
 To describe CAMHS patient care pathways for depression in this setting to 
inform decisions about the population, intervention, control group and 
outcomes. 
 To understand staff attitudes towards research, the proposed trial and 
related training opportunities. 
Methodology and method 
Setting 
This study focuses on a single large CAMHS team in the North East of England (one of 
the original proposed study sites for the Stage II of the research). Staff from this 
service are aligned to one of three providers, all centrally commissioned, based 
within the same site and composed of: Tier 2 (targeted services), specialist Tier 3 and 
Learning Disability (LD) services (Board of Directors, 2012, Affleck and Seed, 2015).4  
The focus of this study was on Tier 2 and Tier 3 services, which accounted for all 
patients except those with a clinically significant LD. The decision to exclude patients 
with LD was taken because the intervention had been designed for young people 
with a reading age closely matched to their actual age, which would exclude all 
young people from the LD service. The CAMHS service offers multi-disciplinary 
assessments, treatments and therapeutic interventions, which are provided onsite 
                                                 
4
 The full reference has not been included to avoid being in contravention of ethical agreements on 
anonymity. 
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and through outreach work for young people living within the local area, which has 
an approximate population of around 200,000 (Board of Directors, 2012).  
The site is in County Durham, which is ranked in the top 30% of the most 
deprived authorities across England (Durham County Council, 2015).5 Residents of 
County Durham experience particularly high levels of income, health and 
employment deprivation (Durham County Council, 2015). Mental health disorders, 
particularly those relating to mood and anxiety, appear to be a key driver of the high 
levels of health deprivation (Durham County Council, 2015). There has been an 
improvement noted in some areas of deprivation in the region, however child 
income deprivation has been increasing (Durham County Council, 2015). Child 
income deprivation refers to children living in families in receipt of income support, 
income-based job-seekers allowance, pension credit guarantee or child tax credit 
(Durham County Council, 2015); reflecting the increasing prevalence of inequalities 
for children in the area. These statistics give an impression of the difficulties typical 
families using the CAMHS facility face. 
Methodology 
An ethnography was conducted over a six-month period (October 2014 to March 
2015). An ethnography can be defined as the study of social interactions, behaviours 
and beliefs that occur within a group from a shared setting (Barber, 2014, Reeves et 
al., 2008). However, the term ethnography has a dual use, as it refers both to the 
process of research and the written product of the study (Savage, 2000). In this case, 
the term ethnography has been used to refer to the methodology for conducting the 
                                                 
5
 The concept of deprivation reflects various socioeconomic inequalities between and within areas, 
across seven distinct domains of income, employment, health/disability, education/training, barriers 
to housing and services, living environment and crime (Durham County Council, 2015). 
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research, rather than the resulting narrative composition. Ethnography was the most 
suitable methodology for addressing the research aim in this setting as it ensured an 
appropriate and rigorous approach to data collection, providing rich, holistic insights 
that could not have been obtained from alternative approaches such as surveys or 
focus groups. The approach allowed staff knowledge to be meaningfully 
contextualised, and space to consider personal, interpersonal, managerial and 
societal influences on behaviour. Savage (2000) notes that, for these reasons, an 
ethnographic approach can be particularly useful in pre-design stages of research, to 
provide the depth and breadth of data required. For instance, Gargeya and Holme 
(2013) describe the benefits of using ethnography at the early stages of a 
pharmaceutical clinical trial, stating that the approach takes the data “from insight to 
impact within the tightly-defined scope of clinical trials” (p166). They note the 
seeming incompatibility of these disparate methodologies; a clinical trial 
representing a controlled, artificial environment and an ethnography seeking to 
observe the real-life uninhibited realities of the setting. Although these 
methodologies seem contradictory, the importance of context is the unifying 
feature. In an ethnography, all learning is cited in the unique context of the setting in 
which it occurred whilst, in a trial, context is vital in order to control the potentially 
confounding impacts from the environment.  
There has been confusion and disagreement amongst academics as to the 
essential features of an ethnography. The defining element, upon which most agree, 
is that an ethnography involves some aspect of participant observation, which 
crucially allows examination of issues in the context in which they occur (Savage, 
2000). Another issue of contention arises as new models and applications for 
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ethnography are undertaken, which challenge some of the established features of 
traditional ethnographies. One such feature is the amount of time spent by the 
ethnographer in the field. Historically, ethnographies were defined by their time-
intensive nature, where researchers would spend many years immersing themselves 
in novel cultures. In the 1980s, models for more rapid assessments of settings were 
found to be useful to inform interventions (US National Insitute for Mental Health 
Collaborative HIV/Sexually Transmitted Disease Prevention Trial Group, 2007) which 
are often referred to as rapid, focused or micro-ethnographic methodologies (Cruz 
and Higginbottom, 2013). Since then, guidance on how focused ethnographies can 
be used in healthcare settings to specifically address distinct issues or shared cultural 
experiences has been produced (Cruz and Higginbottom, 2013). The ethnography 
described in this thesis was ‘focused’, in that I entered the field with established 
research questions in relation to the participant observation aspect of the data 
collection, which served to shorten the length of fieldwork required. The active 
intervention arm of the proposed trial had already been identified as Behavioural 
Activation (BA). The pre-defined research questions were:  
1. Is there a need for BA therapy in this service? 
2. What would be the barriers to implementation of a RCT of this 
intervention? 
3. What are the normal care pathways for patients with depression in this 
service? 
4. How might a BA RCT fit into these existing pathways? 
The length of the participant observation was also ’focused’ by the need to inform 
the subsequent stage of research within the timeframe of a PhD. For this reason, the 
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study was undertaken over a period of six months. The focused approach has been 
criticised for not allowing sufficient time for the researcher to become fully 
integrated into the setting, raising questions relating to the validity of the 
observations. Focussed ethnographers have responded to this by placing greater 
emphasis upon the findings from participant interviews; as the research questions 
are pre-defined, they can more easily be explored using this method (Cruz and 
Higginbottom, 2013). Therefore, in contrast to a traditional ethnography, the 
descriptive core of this study is more reliant on staff interviews. Participant 
observation and other methods applied have been used to contextualise the 
resulting analysis and aid interpretation. 
Data collection methods 
Savage (2000) has argued for the greater use of ethnography within health care 
research as it enables the combination of a range of both qualitative and 
quantitative methods, thus benefiting from both individually and in complement. In 
this case, data was collected for this ethnography using participant observation, 
document analysis and interviews, each of which will be discussed in further detail 
below. The use of these seemingly disparate methods is guided and unified by the 
overarching ethnographic methodology. And, as in the rest of the thesis, I took a 
reflexive approach to the conduct of this study. Reflexivity enables attention to be 
focused upon the process of knowledge construction, especially to the effect of the 
researcher (Mason, 2002). This is crucial in an ethnographic approach, owing to the 
relationship between the researcher and the participants (Reeves et al., 2008). Three 
data collection methods were selected to ensure that a multi-facetted picture of the 
setting was obtained in the short time period available for data collection. 
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Participant observation 
Participant observation affords the opportunity to view behaviour in a naturalistic 
setting and therefore to understand beliefs and actions in context (Mason, 2002, 
Barber, 2014). Participant observation was undertaken throughout the ethnographic 
study period on a purposive basis, providing evidence of staff behaviours, culture 
and real-life decision-making and compromises. Data collection was purposive in the 
sense that it was not systematic nor was information sought out in a pre-determined 
fashion. Rather, informal discussions with clinicians, who I understood were likely to 
shed informed light on particular subjects, led to an in-depth understanding of staff 
backgrounds and clinical activities. Participant observation also allowed information 
to be generated that related to the administrative procedures surrounding patient 
depression pathways through the service. 
One key advantage of participant observation is the opportunity to counter 
the socially desirable responses that may be met using other methods, and to allow 
observation of behaviours that staff have become unaware of (i.e., entrenched or 
tacit behaviours) or those that they are unwilling to articulate. This enables the 
identification of inconsistencies in the way staff present themselves (for example, 
when compared with the findings from formal interviews) with how they act in 
everyday practice, illuminating any discrepancies between intent and outcome 
(Barber, 2014). For this reason, participant observation and interviews were utilised 
alongside each other to gain a fuller picture of everyday realities for staff in the 
service. Documentary analysis was completed alongside participant observation to 
allow a comparison between the information available and how protocols are 
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interpreted by staff as this is likely to shed light on how new procedures may be 
adopted by the service (Barber, 2014). 
Participant observation differs from many qualitative methods in that it 
involves minimal interference from the researcher (Barber, 2014). Despite this, 
attention needs to be given to the integration of the researcher into the research 
setting. In this study, integration within the CAMHS team was achieved by 
conforming to the expectations of the setting in terms of dress code, working hours, 
taking on a clinical caseload appropriate to the honorary role, being added to the 
team mailing lists, using desks in the CAMHS offices, as well as attending a variety of 
meetings and supervision sessions alongside existing staff. Prior to data collection, I 
undertook all usual National Health Service (NHS) Trust induction procedures, such 
as reading the staff handbook and attending IT training, in addition to familiarising 
myself with the NICE guidance for depression in Children and Young People (National 
Institute for Health and Clinical Excellence, 2005). All other guidance or training was 
provided once the study period had commenced. Extensive descriptive notes were 
made in a field diary during and following each visit, including any reflexive 
summaries. During meetings, I often volunteered to write the meeting minutes in 
order to normalise my note taking with a view to reducing the impact of an observer 
on routine behaviour. In other circumstances, I made notes immediately following 
informal conversations or observations rather than during such encounters, so as to 
not make staff feel uncomfortable. A benefit of using an ‘informal’ approach to data 
collection enables the ethnographer to probe emerging issues or ask questions 
about unusual events in a naturalistic manner often leading to candid responses 
(Reeves et al., 2008).  
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The information generated using this data collection method was then used 
to inform the development of an interview schedule for the formal interviews. As 
areas of interest were observed, they were investigated- or tested- further by way of 
informal discussions or explored via the formal interviews. All clinical and 
administrative staff were invited to participate in the observational element and 
there were no exclusion criteria. 
Formal interviews 
One-to-one interviews are the most common qualitative data collection method 
(Barber, 2014), and also form part of an ethnographer’s suite of data generation 
tools. Interviews can vary from being completely unstructured, allowing participants 
to talk about any topic they wish, to those that are tightly focussed upon the topic of 
the researcher’s interest (Clough and Nutbrown, 2012). In this study, semi-
structured individual interviews were selected in order to explore the pre-defined 
research areas but with the complement of open-ended questions that offer 
interviewees the freedom to highlight issues of importance in their own decision-
making processes (Mason, 2002). The interviews were designed to illustrate staff’s 
understanding of the information and treatment guidance issued in relation to 
depression, barriers and facilitators to implementation of this guidance and the 
proposed study. In addition, the aim was to collect or confirm information on staff 
opinions and observations, particularly on sensitive topics that they may be reluctant 
to discuss in front of other members of their team. The resultant staff narratives 
provide a rich, thick description of their experiences and opinions (Ponterotto, 
2006). Alternative methods such as focus groups may have restricted staff’s 
willingness to discuss sensitive topics in front of their colleagues and caused practical 
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difficulties with finding a suitable time for numerous staff to congregate in the 
context of a busy service.  
Key stakeholders for the interviews were identified during the participant 
observation stage and the identified staff were then invited to attend formal 
interviews. The interviews were formal in the sense that they were booked in 
advance, followed an interview guide, took place in a private office and were audio 
recorded. It is common for ethnographic questions to emerge from the field. An 
interview guide covering the core topic areas had been pre-prepared during the 
period of participant observation and was amended to explore emerging concepts 
that arose in the field or previous interviews (see Table 3). Interviews were 
audiotaped and transcribed verbatim using an encrypted Trust-approved recording 
device. Interview participants were offered the opportunity to read through their 
interview transcripts following the interview and were invited to indicate extracts 
that they preferred were not used in verbatim quotes; this approach has been used 
in previous research (O’Cathain et al., 2014), but was used in this case at the request 
of the Team Manager. 
Table 3: Interview Topic Guide 
Staff interview questions 
1. What treatments do patients with depression, aged 12 to 17, usually receive 
in your service? 
2. How do you think a new talking therapy such as Behavioural Activation (BA) 
will fit into the existing care provided by the team? 
3. How do you personally feel about the prospect of a trial of this new 
treatment in your service? 
4. How do you think other members of staff feel? 
5. Are there any reasons that you think a trial of BA might be difficult in your 
service? 
6. Are there any benefits to offering a new treatment such as BA? 
7. Are there any negatives? 
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8. What could we do to ensure the smooth implementation of the trial? 
9. Do you have any other thoughts that you would like to share? 
Document analysis 
Documents can be a useful source of information, particularly relating to policy 
(Barber, 2014). Rather than just being an ‘inert’ product, documents are often linked 
to individual’s everyday practice and routine (Barber, 2014). Documentary analysis 
can therefore shed light onto individual actions and processes in the context that 
they occur. Documentary data were generated through analysis of relevant paper 
and electronic documents collected during the study period on an opportunistic 
basis. Data was not collected systematically because this would not represent the 
way in which information was disseminated to staff. Instead, by being added to staff 
mailing lists, reading staff notice boards and attending team meetings I encountered 
information in the same way staff within the team would in their day-to-day 
practice. The aim of this approach was to embed myself, as far as was possible, into 
the natural staff setting and experience the information flow as a staff member. The 
purpose was to obtain basic facts about the service, its protocols and enable an 
understanding of the information flow throughout the team. 
Ethical considerations 
Ethical approval for this project was obtained from the Durham University School of 
Medicine, Pharmacy and Health Ethics Sub-Committee (ref: ESC2/2014/06; see 
Appendix 2) and it was registered with the local Trust Clinical Assurance and 
Registration Steering Group Committee (ref: 4188CYPS14). The study was discussed 
with the National Research Ethics Service as no patients were involved in this study, 
NHS ethical approval was not deemed to be required. 
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There were a number of ethical considerations when designing this study. 
Participant observation itself raises many issues, particularly surrounding participant 
consent (Mason, 2002). For this reason, efforts were made to ensure the consent 
procedure allowed staff to decline participation and did not cause undue distress. 
Prior to the start of the study, a PowerPoint presentation was given to the team 
about the ethnography, followed by a question and answer session for staff. All 
members of the CAMHS team (n=26) were then invited to participate; these staff 
members received a paper information sheet (see Appendix 3) and were able to 
‘opt-out’ of the study by completing a form and returning it to a sealed box in a staff 
communal area. This allowed staff to opt-out without their Team Manager’s or 
colleagues’ knowledge, lowering the chances they would be coerced into 
participating. There was no paper consent form at this stage as, on balance, this 
seemed to be an unnecessary staff burden. Therefore, in the absence of receiving a 
completed opt-out form, staff were assumed to agree to participation. Participants 
were regularly reminded of my role as a researcher and offered the opportunity to 
be removed from the study at any time. If staff opted out, no further data would be 
recorded relating to them from that point onwards but they were made aware in the 
information sheet that any data collected prior to this point would be retained. The 
reason for this is that the field notes were recorded anonymously, referring only to 
staff grade (not individuals) so it would not be possible to review the field diary and 
remove references to that staff member. Furthermore, even if staff opted-out, they 
would still be present whilst observations of other members of the team were being 
completed. Although opt-out participants would not be commented upon in the field 
notes, they also could not fully be excluded from the research process. During the 
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study observation period, only one opt-out form was received, this form was 
received on the final day of the observation. This staff member was not present for 
any observations on the final day so no data had to be overlooked.  
Despite the favourable recruitment rates, I had cause to reflect upon the 
success of the first contact made with staff as part of the study. I approached staff 
with a paper information sheet and a formal consent protocol that was both 
unfriendly and immediately alienated myself from the team. I highlighted myself as 
the researcher and thus staff as the subjects of my research; I was subsequently 
regarded with suspicion and apprehension at the start of the observation period, 
which took many weeks to overcome. The damaging impact of this can be 
demonstrated by several incidents during the first weeks of the observation; when I 
approached groups of staff engaged in conversation, they would awkwardly trail off 
their discussions upon my arrival. On reflection, the consent process could have 
been better aligned to the aims of the study by being more informal or the formal 
consent process occurring in advance of the study with reminders once the research 
started. This has to be weighed against the necessity of staff being fully informed 
about the ethnographer’s role and the purposes of the research. 
Once staff had been identified as a key member of the team, they were 
invited to the formal interviews either verbally or by email. At the start of each 
interview, staff received a paper information sheet and were asked to complete and 
sign a paper consent form (see Appendix 4). This consent procedure also felt very 
formal but was appropriate to the sensitive nature of some of the topics that could 
be covered during the interviews.  
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Other commentators propose an ‘embedded’ approach to ethnography to 
enable the researcher to see the ‘world view’ of the organisation (Lewis and Russell, 
2011). This raises concerns about ensuring separation between the role of 
researcher and that of a CAMHS team member and how these dual roles would be 
managed during the study. This was addressed by ensuring that staff were clear 
about the purpose of me being onsite by making repeated reminders during the 
observation, as well as via the information sheets and presentation made to the 
team. Power differentials often exist between researchers and their participants 
(Barber, 2014). This is particularly common in observational studies but was less 
sensitive in this situation due to my lower ranking honorary position in the team as 
an Assistant Psychologist, where I was generally equal to or below all members of 
observed staff within the team hierarchy. However, it remained a risk that staff may 
have had anxieties sharing knowledge with me, particularly if this related to 
information that may portray their team negatively or highlight errors in their own 
practice. This risk was outweighed by the opportunity for the research to identify 
and report poor practice. In addition, staff members were offered the opportunity to 
read back through their interview transcripts prior to analysis. This reflected the 
sensitive nature of some of the topics covered and was designed to increase staff 
participation in the study (at the suggestion of the Team Manager). Perceived 
pressure from the service to report favourable findings may also have been an issue; 
this was addressed using reflexivity in the field diary and transparency in the 
reporting of the study. 
It was also a possibility that patients may have been indirectly observed (i.e., 
if a service user representative attended a staff meeting) so it was agreed to remove 
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any references to non-staff members in field notes and transcripts. Similarly, staff 
details were removed from interview quotes to preserve anonymity. These were in 
addition to the usual considerations around information governance and 
preservation of confidentiality. Data was stored in a de-identified manner, according 
to Trust and University guidelines and digital recordings were securely destroyed 
following transcription. Paper data will continue to be stored for three years from 
the end of the study. 
Researcher dispositions 
Initially I felt very uneasy about observing others. Like previous ethnographers in 
similar settings (Cudmore and Sondermeyer, 2007), I found that as my research 
progressed, my role within the team changed; however, the direction of that change 
was in the opposing direction. While Cudmore and Sondermeyer (2007) reported 
becoming more objective ethnographers, I felt myself sympathising increasingly with 
the staff, whereas initially I had viewed them more objectively. 
As a white female with English as my first language, I matched the profile of 
the vast majority of the team. I also shared common attributes such as being non-
disabled, heterosexual, being born in the North East of England and educated to 
degree level, with a background in health/psychology. I differed from many 
members of the team in that my accent was considered “posh”, and I was identified 
as “not a local” as I did not live in the same geographical county. I was also younger 
than many staff and did not have an employment contract with the Trust. Some of 
these judgements were transient; early judgements were later challenged during the 
course of the study. For example, after I referred to my umbrella as a “brolly” a 
nurse stated she was satisfied I was from the North East, despite my “funny accent”. 
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Lewis & Russell (2011) reported similar preconceptions and expectations about 
researchers whilst undertaking an ethnography in the North-East of England. My 
positionality was particularly important in light of the way meetings were often 
segmented by discipline; for example, the ‘psychologists’ often met separately to the 
Clinical Nurse Specialists. I naturally was accepted into the psychology aspect of the 
team due to my undergraduate psychology training. 
Dispositions are not only based in such “demographic” considerations, but 
also personal or scientifically contingent world views. Although there is no consensus 
among ethnographers about the epistemology, or theory of knowledge, that 
underpins an ethnographic account it was still an important element to consider 
(Savage, 2000, Mason, 2002). Similarly, ontology or the beliefs about the basis of the 
‘social world’ also required thought (Mason, 2002, Barber, 2014). Historically, 
positivism has been a dominant viewpoint, which understands the natural world as 
something that can be controlled, resulting in a measurable and singular truth 
(Barber, 2014). A positivist stance is taken in Stage II of the research, where a trial 
methodology is utilised; in contrast, this focused ethnographic study (Stage I) 
approached meaning and knowledge from a constructionist perspective. This 
necessary shift in perspective reveals some of the difficulties in marrying and 
integrated mixed methods research into a coherent body of work. Constructivism 
argues that there is no ultimate objective reality, instead the social world can only be 
perceived by the individual (Barber, 2014). In the case of this research, this view 
holds that the researcher and staff are making sense of their reality by attributing 
and constructing meaning in relation to the setting. Thus, there is no intention to try 
to distil this meaning by attempting to quantify observations.  
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Data collection 
In all, seventeen documents were collected (consisting of meeting minutes, emails 
and a PowerPoint presentation), 158 hours of observation were conducted and six 
staff interviews (lasting between 16-25 minutes) were undertaken. Staff observed 
included Team Managers, Consultant Clinical Psychologists/Psychiatrists, Clinical 
Psychologists, Clinical Nurse Specialists, a Specialist Advisory Teacher, an 
Administrative Coordinator, a Community Clinician, a Child Psychotherapist, CAMHS 
Clinicians, an Associate Practitioner, an Associate Specialist, a Research Assistant and 
an Assistant Psychologist. A manager headed each ‘Tier’ of the team; both managers 
(Tier 2 and Tier 3) had a clinical background and one also had prior research 
experience. Staff came from a vast array of professional and non-professional 
backgrounds; predominantly nursing, psychology and psychiatry but also social work, 
commissioning, research, addiction services and unskilled care roles. All staff asked, 
agreed to be interviewed (identified key stakeholders who were invited to interview 
can be seen in Table 4). Some staff were very comfortable in the formal interview 
environment and answered questions directly and comprehensively. Others were 
more guarded and one particular manager’s responses sounded automated as if they 
were reading from a script. No amendments were requested to be made to the 
interview transcripts by the participating staff. The meetings observed ranged from 
informal, spontaneous meetings with only two staff present, to official meetings 
headed by a manager where agendas were circulated in advance and official minutes 
recorded. 
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Table 4: Pseudonyms and characteristics of the formal interview participants 6 
Pseudonym Tier Affiliation 
Joan 2 Specialised 
Claire 2 Managerial 
Leanne 3 Junior 
Jackie 3 Psychology/Managerial 
Judy 3 Managerial 
Sarah 3 Psychology 
Data analysis 
Mason (2002) refers to ability of qualitative research to intimately connect context 
with explanation. Staff accounts therefore, have to be situated in the context in 
which they were stated. An inductive approach was taken to data analysis to enable 
meanings to emerge from the data through in-depth examination of all the data sets. 
This analysis occurred at the end of the data collection period drawing on 
experiential knowledge from the field, with the exception of the interview 
transcripts, which were reviewed following each interview in order to alter the 
interview topic guide to explore emerging issues.  
As the ethnographer, I transcribed each interview transcript and typed up 
field notes into an electronic format in order to re-familiarise myself with the data. 
Data were coded for emergent themes, which were verified by a second coder 
(Patrick Welsh) independently (Braun and Clarke, 2013). I read the interview 
transcripts and other data sources several times to familiarise myself with the data 
prior to applying thematic codes according to the principles of Braun and Clarke 
(2013). The second coder read through the data sources independently and a 
meeting was then held between both researchers. As the ethnographer, I led this 
                                                 
6
 Notes: ‘Junior’ refers to unqualified staff; ‘Specialised’ to nurses or Primary Mental Health Workers 
(PMHWs); ‘Psychology’ to any qualified professionals aligned to psychology and ‘Managerial’ any staff 
members with significant managerial responsibilities. 
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meeting where I discussed the identified themes with the second coder and 
provided the contextualisation necessary to assist the second coder’s interpretations 
and then a consensus was reached. A second coder was employed in order to help 
manage objectivity, an approach that has been used previously (Wells et al., 2012). 
This sits somewhat at odds with the traditional concept of a longitudinal 
ethnography, where the knowledge of and basis for interpretation by the 
ethnographer has been honed over many months or years of participant 
observation. In such circumstances, a second coder would not have the capacity to 
assist in data analysis. In contrast, this focused ethnography was more reliant upon 
interview transcripts. The benefit of a focused approach lies in the opportunity to 
expedite the data collection, with any “shortfall” in time spent in the field 
compensated for by enabling multiple coders to participate in the analysis, offering 
the opportunity for reflection upon the findings.  
Methodological triangulation was used to provide more comprehensive 
insights into each emergent theme (Savage, 2000). Data triangulation generally 
refers to the collection of data on the same topic utilising differing methods of data 
collection (Reeves et al., 2008). The term itself can be misleading, implying a precise 
focus (illustrated by the converging data collection methods) and thus, a positivist 
epistemological basis for the study (Mason, 2002, Barber, 2014). More recent 
modern commentators have distanced themselves from these “quantitative” 
connotations. They instead use the term ‘crystallization’ (Barber, 2014), which 
describes the use of different datasets to look at the same phenomena through a 
different lens. Instead, in this study the term triangulation is more loosely used to 
refer to establishing corroboration or contradiction either between differing 
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methods but also between different participants’ accounts of phenomena. Crucially, 
this acknowledges and enables exploration of the sources of apparently alternative 
explanations.  
Another important consideration was my role in the data collection and 
analysis, as it is acknowledged that I was responsible for selecting which data to 
collect and which data to present in this thesis (Mason, 2002). As previously 
discussed, reflexivity is the consideration of the impact the researcher has had on 
the data collated and on the research process (Barber, 2014, Mason, 2002): this 
impact was reflexively under consideration throughout the study, in order to 
delineate the effects of a sole researcher on data collection methods and 
methodology.  
Results 
Presentation of the results 
The findings are presented in the form of a thick description of research encounters 
in the aforementioned CAMHS team; this format lends itself to illustrating the 
complexities of the setting in a clear format. Lengthy quotes alongside 
interpretations are an accepted way to present such ethnographic data (Ponterotto, 
2006). Some data have been presented visually, which has been recommended as a 
way to illustrate themes or concepts (Mason, 2002), rather than relying upon a 
conventional textural description. This approach was thought to be particularly 
useful for readers who are not familiar with reading qualitative or mixed methods 
research. It is important to note, then, that the presentation and content of this 
chapter will differ markedly from what one might expect from a thesis centred on an 
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RCT. Additionally, as previously mentioned, the main body of these qualitative 
results leans more heavily on formal staff interviews, which differs from the usual 
presentation of ethnographies that emphasise the findings from participant 
observation. The tone and manner of presentation of the following narrative reflects 
these caveats. 
The site 
The outside of the CAMHS building does not immediately reveal its purpose, except 
for the tell-tale blue and white NHS sign subtly displaying the building’s name. The 
car park is full to capacity, as are all access roads, with staff and carers’ cars. Once 
inside, the impression is friendly and child-focussed, with brightly coloured chairs, 
walls and toys on display in the waiting area. The ground floor of the building is 
designed to be patient-facing, whereas the staff-only second floor is clinician-facing. 
Downstairs there are a large number of treatment rooms that are well kept, 
colourful and varied. Upstairs there are two large open-plan offices lined with 
computer desks, and private offices lead off from this main space. Upstairs is 
relatively barren compared to the colourful, chaotic environment downstairs, with 
little personalisation of walls or desks evident. Centrally, there is a communal space, 
which is reserved for lunch and staff meetings, as well as a small kitchen. The first 
time I enter the upstairs staff area, I am hit by the noise of staff talking and phones 
ringing. My immediate panic was where to sit, as most desks appeared to be 
occupied and no one seemed aware of my presence. After finding an unoccupied 
desk, I sat down and tried to be friendly. Staff situated at desks around my computer 
were busy but responded by being friendly in return. This became ‘my desk’ 
(according to my new colleagues), despite the strict NHS policy that every desk is a 
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‘hot-desk’ available for anyone’s use and the fact that, on many occasions, I arrived 
to find my desk otherwise occupied by one of the many staff who use the site. The 
allocation of my own space grounded me within the setting and provided 
reassurance of my acceptance within the team. 
The research commenced at a time of considerable change within the service 
format of CAMHS. As such, the enduring impression of the setting was of a chaotic 
service experiencing an intensive period of change. At the start of the placement, I 
found it difficult to concentrate due to the bustling environment and the chatty 
nature of the staff. Several weeks later (subsequent to the start of the ethnography), 
a new initiative to increase working hours was introduced, extending consulting 
hours to 12 hours a day Monday to Thursday as well as additional coverage on a 
Saturday. There were no additional staff members allocated to compensate for these 
changes, which resulted in staff being spread more thinly, greatly impacting upon 
the atmosphere and morale of the team. This was one of many ‘initiatives’ staff felt 
had been laden upon them in this time of austerity. I certainly found I had to adapt 
to changes in the service’s circumstances, politics and policies over the relatively 
short period of observation. 
During my time in the service I shadowed various staff members in their 
usual roles, selecting the staff member to shadow was largely decided on a 
pragmatic basis of which staff had patients with low mood on that day. I rotated 
days and times during my placement to ensure I gained a rounded view of the 
service. I was invited to meetings at a team, professional (i.e., psychology) and 
individual (i.e., case discussions) level. 
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Themes from the data 
After analysing the resulting ethnographic data, four themes emerged; non-clinically 
orientated variance in practice, diagnosis, capacity and staff economy. As can be 
seen in Figure 5 there is significant overlap between the themes, with staff economy 
being central to the other themes but also a distinct theme in itself. The thematic 
content has been summarised in Table 5 and the results are presented in further 
detail below, in terms of the factors that impacted upon elements of the planned 
trial.  
 
Figure 5: Diagrammatic representation of the identified themes 
 
Non-Clinically Orientated 
Variance in Practice 
Staff 
Economy 
Capacity 
Diagnosis 
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Table 5: Four emerging themes 
Theme Description 
Non-Clinically Orientated 
Variation in Practice 
This theme involves changes to practice described by 
staff, including the rationale for treatment decisions that 
are often based upon resource availability rather than 
clinical need. 
Diagnosis This theme consists of staff beliefs and behaviours 
relating to the treatment and diagnosis of depression. 
Capacity This theme consists of the time to engage with research 
or to attend training and space to psychologically 
consider or incorporate learning into practice. 
Staff Economy This theme is characterised by staff changes and 
shortages. 
 
Non-clinically orientated variance in practice 
It was important to explore how staff responded to the current guidance 
surrounding the treatment of young people with depression. Interviews and 
observation suggested staff have a good working knowledge of the NICE guidance 
relating to the treatment of depression in children and young people (National 
Institute for Health and Clinical Excellence, 2005). Furthermore, documentary 
analysis provided evidence that information relating to this guidance was 
disseminated to the team during the study period. Despite this familiarity, barriers to 
implementation of the guidance were identified that subsequently led to disparities 
in patient management. In situations where NICE treatment was not offered, staff 
were generally aware that they were deviating from the recommendations and 
expressed a desire to maintain “evidence-based practice”. The treatment patients 
received depended upon a number of factors such as the previous training staff had 
received, the Tier of care to which the patient was allocated for treatment and staff’s 
personal preferences. There were two sub-themes within this strand; the impact of 
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staff’s differing backgrounds and the impact of a stretched service, each of which will 
be discussed in further detail. 
Impact of staff backgrounds 
In relation to how staff would currently treat low mood or depression in Tier 2 of the 
service, Claire (Tier 2 [T2] Managerial) explained that due to the diversity of staff 
within the team, “at the moment, it’s a bit of a hit-and-miss scenario”. As Joan (T2 
Specialised) explained, this variability between different staff members could be 
explained by the different roles that staff had undertaken prior to joining the CAMHS 
team and the impact their differing backgrounds had on their approach to treating 
patients: “I think cos we tend to go and do different things. We’re all different 
backgrounds, PMHWs [Primary Mental Health Workers] and we all have different 
ways of treating people”. 
Linked to this were suggestions that some members of staff struggled to 
adapt to the ever-changing job roles that were a common occurrence as the service 
attempted to cope with a battery of changes, and which staff blamed on austerity 
measures. The impact of these changes was tangible within the team and was raised 
an inordinate number of times in casual conversations, formal meetings and 
correspondence. 
Staff had assorted training backgrounds, and a variety of training 
opportunities were available to them during the period of the observation. The 
desire to implement evidence-based practice was highlighted by the team several 
times both when staff were observed and when they were interviewed; some staff 
were able to achieve this by attending accredited training programmes through the 
Children and Young People’s Improving Access to Psychological Therapies (CYP IAPT) 
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Service Transformation Programme, whereas others learnt the required skills 
second-hand from colleagues. Staff expressed a preference for members of the team 
to have received formal training and highlighted this as a way to improve current 
practice in treating young people with depression. Staff described these two 
differing approaches to learning psychotherapy skills, using the Cognitive 
Behavioural Therapy (CBT) model as an example: 
“We’ve had some CAMHS staff that has been off to do IAPT so they have 
been trained in CBT… there’s a lot of the staff that’s got that awareness 
level of CBT so although they can’t use CBT in, in such form they can use 
approaches of CBT” [Claire, T2 Managerial] 
“[To improve current practice: young people need] access across the 
board to someone who’s CBT-trained and if they’re not getting that then 
I would kind of be asking what are they getting from a clinician who isn’t 
CBT-trained? But whether they’ve kind of obviously picked up the 
principles and haven’t had formal training but they’ve done kind of 
workshops and that kind of thing and just from experience because 
they’ve been in CAMHS for 20/30 years kind of thing. That they’re able to 
kind of, I suppose they know what they are doing and what’s worked in 
the past for their clients with depression” [Leanne, T3 Junior] 
In response to this, staff noted incongruities between the treatments being offered 
to patients due to the different training that staff may have undertaken. Some staff 
raised concerns about the implications of learning therapeutic skills informally. One 
staff member was concerned that young people were being treated for depression in 
Tier 2 but were not receiving evidence-based practice:  
“Depression is, if you don’t deal with it early on, it can reoccur and it, it 
can be really debilitating for people so we need to tackle it and treat it at 
this early stage [in Tier 2]. I don’t have a concern with it being treated in 
Tier 2, I do have a concern about it being treated in Tier 2 by staff who 
aren’t trained in the treatments for it” [Jackie, T3 
Psychology/Managerial] 
An informal approach to staff supervision was also observed; during staff discussions 
informal advice and support were offered about how best to treat patients. 
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Impact of a stretched service 
Compounding the variances in training across the CAMHS team, there are a number 
of tensions within the service that made it difficult to deliver treatment according to 
the recommended NICE guidance. Sarah (T3 Psychology) reported that young people 
allocated to Tier 3 currently had to be assigned to a clinician for treatment “based on 
space rather than need”. Several narratives referred to this patient management 
approach and detailed how young people in the service were assigned to care:  
“[I]t depends on what information we get and it depends on what staff 
we’ve got. If it’s a young person that they, you know that’s presenting 
with some depression and we haven’t got a CBT appointment then we’ll 
put them into another appointment” [Judy, T3 Managerial] 
“Well I suppose [ideally] it would depend on the clinician individual 
approach…adhering to the guidelines really and I suppose the young 
people being assigned to the most appropriate people for their 
difficulties. I know that doesn’t always happen because of the sheer 
volume of referrals and lack of capacity that we’ve got” [Leanne, T3 
Junior] 
“[T]he really bad point is really that if we need specific CBT …we then 
have to put it into Tier 3 for them to have that because actually we 
haven’t got enough CBT practitioners in Tier 2 but that doesn’t, that 
doesn’t mean that the young person should be in Tier 3. It’s just, that’s 
the only way they access CBT” [Claire, T2 Managerial] 
Staff explained that these treatment decisions were based upon the availability of 
resources rather than the patient’s clinical need. This can be linked to another 
identified theme from the data, which will be explored in further detail below, which 
is that of staff economy. Notably, there were not enough staff within the team to 
provide treatment according to NICE guidance due to staff capacity being reduced, 
and also there being too few staff who were adequately trained in NICE 
recommended therapies. These difficulties were observed in situ, as illustrated in a 
field note entry:  
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“Recently the team have been allocating referrals to any clinician (unless 
a specific treatment such as CBT has been suggested). This means that 
they are not [made] based on their severity (i.e. more severe cases are 
not seen by more experienced clinicians currently)” [1.45pm, 3rd Dec 
2014] 
Management noted “it’s better that [patients are] seen than wait” highlighting the 
difficult decisions and compromises that have to be made in a stretched service. 
Furthermore, staff and patient preferences were often unable to be effected due to 
the burden of large caseloads, with staff reporting an inability to see patients in a 
weekly or bi-weekly format which they felt was required for successful treatment. 
Leanne (T3 Junior) complained that “it’s too long between sessions, [we] need to 
keep the momentum going and the progress”. I sensed that staff were attempting to 
cope with these difficulties by implementing what they see as short-term measures 
or ‘fixes’ in order to process the vast number of referrals the service has been 
receiving. Staff often shared their hopes that the situation would improve so that 
these difficult compromises no longer needed to be made. 
Diagnosis 
Beliefs surrounding diagnoses were divergent and rooted in staff’s professional 
training backgrounds; paralleling the impact of previous staff experiences on patient 
care in the non-clinically orientated variance in practice theme. This concept can be 
illustrated in a vignette involving Jackie (T3 Psychology/Managerial), who has 
undertaken postgraduate training in psychology. She recounted, in utter disbelief, an 
encounter with a Tier 3 nurse who had recently completed a CYP IAPT training 
course to become a CBT therapist. The nurse had explained to Jackie that it was one 
of her core beliefs as a nurse that you do not diagnose. Despite moving from an 
assessment-based to a treatment-based role, the nurse was reluctant to treat young 
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people who had received a ‘clinical diagnosis’. Jackie had probed whether it was 
possible to treat any patient without identifying the condition being treated, and 
then questioned the nurse with sarcasm, “identifying something as depression goes 
against your core belief of your profession?” Jackie had concluded by advising the 
nurse to re-evaluate their standpoint in light of their recent re-training as a 
psychotherapist.  
 Despite the often disparate views that are grounded in staff’s professional 
affiliations, staff agreed on whose role it was to diagnose depression. Staff in Tier 2 
clearly articulated that diagnosis did not fall under their remit: 
“No, in Tier 2 we wouldn’t diagnose depression. We would obviously pick 
up the signs and symptoms from the young person’s presentation and 
the ROMs [Routine Outcome Measures]. Using tools, but if they wanted 
a clinical diagnosis of depression then it would have to go to a Consultant 
in Specialist CAMHS” [Claire, T2 Managerial] 
It was also clear that depression was rarely seen in isolation and was often 
accompanied by a myriad of comorbidities. Audit data collected whilst on site 
confirmed that 60% of patients experiencing low mood or depression had at least 
one comorbidity. Interestingly, staff noted diagnoses of depression were rarely made 
in practice: this was observed, as well as reported in interviews. The ramifications of 
this were evident when, during a team meeting, a ‘depression pathway’ that had 
been recently piloted within the service was discussed. This treatment pathway 
required patients to have received a formal clinical diagnosis of depression. The 
substantial clinical burden of patients with depression was illustrated in a 
PowerPoint presentation given to the team where depression was highlighted as one 
of the most prevalent conditions that the service treats. Yet, due to the fact that the 
vast majority of these patients had not received an official diagnosis, the depression 
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pathway could not be implemented due to a lack of eligible young people. There was 
discussion during the team meeting about how to solve this issue but the action 
decided upon was to feed it back to the commissioner of the pathway as the team 
did not have the resources to address the problem. Furthermore, staff lacked 
confidence in decision-making surrounding depression, often relying upon the 
expertise of specific professionals within the multidisciplinary team: 
“Often people send [patients] to a medic [Psychiatrist] because they 
want the medic to make the decision because they don’t feel confident 
doing it themselves’ [Sarah, T3 Psychology] 
In this context, some staff tended to separate the symptoms of depression from a 
clinical diagnosis of depression itself. They placed importance on the concept of a 
diagnosis, indicating this may alter the way they worked with patients who had 
received a clinical diagnosis:  
“When you talk about depression though, do you mean clinical 
depression, that’s got a diagnosis?” [Joan, T2 Specialised] 
“Not if it’s clinical depression, no we wouldn’t [treat it], no we would 
treat low mood but young people will often tell you that they’re 
depressed without having the diagnosis criteria for depression…” [Joan] 
There was agreement on where depression should be treated within the service 
structure: low mood or depression without significant self-harm in Tier 2 and 
depression with self-harm or severe depression without self-harm within Tier 3. Staff 
identified what they termed vague, early onset or early-stage depression that would 
sit within Tier 2 but some staff felt Tier 2 should not be allocated patients who had 
received a diagnosis of depression at all.  
“I think if we could, I think depression probably shouldn’t sit in Tier 2. I 
think it should sit in Tier 3. But I think we should have more people in 
Tier 3 so that if Tier 2 gets a whiff of depression they’re not keeping it, 
they can pass it straight in” [Sarah, T3 Psychology] 
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Treating young people who had received a diagnosis of depression could be stress-
inducing for staff. Lower-grade staff in particular, described a lack of confidence in 
dealing with young people with a diagnosis of depression: 
“I have to say that I tend not to keep people who have [a diagnosis], 
particularly if they think they’re depressed. Low mood I might keep them 
for a little while but I’d tend to pass them on. I’m quite risk adverse 
really. And not being mental-health trained…” [Joan, T2 Specialised] 
I think that by highlighting to people that what they are dealing with is 
depression then it might raise their anxieties a little bit” [Jackie, T3 
Psychology/Managerial] 
In contrast some staff felt confident dealing with depression in their roles within Tier 
2. Joan (T2 Specialised) commented:  
“There are some people [members of the Tier 2 team] who’d hold onto 
them because that’s their background” 
Again, this highlights the influence of staff backgrounds as illustrated in the non-
clinically orientated variance in practice theme. Concerns surrounding staff 
confidence were expressed at senior levels of the Trust. For example, an email from 
the Trust Chief Executive noted a lack of self-confidence when it comes to decisions 
about what information to communicate to friends and family of patients who are 
receiving treatment in the Trust.  
Staff suggested a barrier to patients with depression being treated in Tier 3 is 
a lack of staff capacity. This parallels the staff economy theme that appears to be an 
explanatory factor in many of the observed individual and managerial decisions 
made in the service. 
Capacity 
There were two uniting aspects to the capacity theme; time and psychological 
capacity. As I was planning for a pragmatic trial, where the intention was to train 
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existing staff from the service to deliver the intervention, it was important to explore 
staff perceptions towards the different types of training that were currently available 
to the team in order to evaluate how the BA training may fit into this context. 
‘Headspace’ was the term used by participants to describe the mental capacity to 
consider training, as well as the opportunity to mentally incorporate or absorb this 
learning in order to be able to implement it into their everyday practice. Staff made 
a distinction between these two converging aspects of “time and space” or 
“headspace and capacity”. Staff felt their needs relating to the physical aspects of 
time were being better met than those related to the psychological side, which were 
often overlooked. 
Psychological capacity 
Psychological capacity is the time or headspace for staff to mentally consider the 
training opportunity or incorporate the learning from training courses into practice. 
When Judy (T3 Managerial) was asked what would influence staff to utilise training 
opportunities, she responded: “headspace and capacity I would say are probably one 
of the main things”. One member of staff used the term headspace to describe her 
thoughts whilst considering taking part in training: 
“I do think they would really want to do it and find it helpful but it’s 
gonna be the way that they are approached really because, headspace. If 
you catch someone on a difficult day and they’re back to back with 
clients they might not have room in their head to think about something 
else but if it’s done kind of obviously on a convenient day and just kind of 
putting it to them in the right way” [Leanne, T3 Junior] 
Staff thus introduced the concept of headspace spontaneously without being 
prompted. In this context, the shared terminology was used to describe the need for 
more thinking space. This also highlights that the timing and content of the way in 
which staff were approached to participate in training is important. However, 
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headspace is less readily defined than the concept of time, as it appeared to mean 
different things to different people. Claire (T2 Managerial) described a similar 
concept whereby staff required time to incorporate learning from training into 
practice: 
“From my experience it’s about support and I think that if…you give that 
person the time, the opportunity to not only do the training but them to 
put it into practice and they get the outcomes and feel much better 
about it. There’s lots of times where people have gone and asked for 
training, gone off and done the training and come back and not done 
anything with it”.  
“I think given the pressures on the service, the demand of the referrals 
that are coming in. It’s not always easy to put things into practice”. 
The Tier 2 team described how they had implemented processes to overcome the 
difficulties associated with lack of headspace. This involved it being made a 
requirement for any staff members who had requested to attend training to 
feedback the learning outcomes to the rest of the team at their monthly meetings. 
Time 
Time was characterised by the competing priorities staff faced: service pressures in 
terms of the number of patient consultations, the strict time limits available in which 
to do this, mandatory Trust training, as well as the overarching concern to help the 
young people they were seeing. Although training opportunities were prevalent, 
varied and well received, time was a barrier to staff engagement: 
“…there is quite a lot of training around but it’s having the time to do it 
often” [Joan, T2 Specialised] 
“I suppose fitting in the kind of time to do it in their diary. I know it is 
only five days but with clinicians being booked up quite far in advance it 
will have to be kind of planned quite early on I think” [Leanne, T3 Junior] 
Despite this, staff were keen to explore the possibility of new alternative treatment 
approaches, especially those that did not involve lengthy training: 
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“I think there is always kind of room for more treatments and things. 
Particularly with [BA] being so easy to kind of train in, so obviously just 
five days which is a lot easier to squeeze into someone’s diary than doing 
a diploma for a year or something” [Leanne, T3 Junior] 
Effective planning was highlighted as a facilitator to allow staff to partake in the 
available training opportunities but was weighed against the time burden of the 
training itself. This cost-benefit analysis by staff led them to make an assessment of 
their capacity to participate in training, highlighting the significant cross-over with 
the theme of staff economy. Unsurprisingly, staff economy was often the reason 
staff gave for difficulties with demands upon their time. Staff referred to the burden 
of training and noted the competing commitments that they had to balance in their 
everyday practice. Staff identified Team Managers as key facilitators, particularly in 
navigating difficulties with staff capacity. The role of the manager was highlighted as 
central to alleviating these pressures, as Jackie’s comment reveals: 
“My concerns are that the staff are overwhelmed and busy and doing all 
sorts of other things and I’m hoping that the managers have 
remembered that they are doing this BA training and they’ve left time 
and space for it” [Jackie, T3 Psychology/Managerial] 
These pressures on staff time due to staff economy have damaged the morale of the 
team, meaning that any discussion of research was met with a groan and intense 
questioning of exactly how much time it was going to ‘cost’ them. Staff chose to 
highlight how these pressures had led to difficulties finding the time to complete and 
implement tasks. These demands were replicated in the documentary data (reports 
and meeting minutes) collected onsite, which described increased workloads and 
pressure, combined with decreased staffing levels.   
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Staff economy 
This theme was central to the other identified themes (see Figure 5) and was found 
to be relevant to many of the barriers to trial implementation. In the context of the 
new working hours, staff economy was characterised by staff changes, decreases in 
existing staff capacity and staff shortages. Despite a number of new staff being 
recruited during the study period, staff expressed concern that they “can’t see kids 
quick enough”. Staffing shortages were combined with an increased number of 
referrals to the service:  
“…at the moment, the staffing is quite difficult and the numbers are 
quite difficult” [Joan, T2 Specialised] 
“…with staff numbers kind of becoming reduced over the previous year 
and going forward because we do have staff members leaving. Staff 
members reducing to…part-time hours when they’ve previously been 
full-time” [Leanne, T3 Junior] 
“…high staff turnover provides inconsistency for families and the more 
staff that leave the greater struggle on staff who remain” [Meeting 
Minutes] 
Staff shortages combined with the increased workload were verified in official 
documentation. The minutes of a Psychology meeting reported “from January 
psychology staff will be thin on the ground for at least 12 months” and “direct 
activity has increased”. There was a suggestion that these shortages were 
particularly pertinent in the middle job-grade bandings in Tier 3. In contrast, another 
Tier 3 staff member believed the number of staff was adequate to meet the service 
need but highlighted the problem was in individual staff capacity to provide 
treatment due to staff taking on other competing commitments. Staff articulated 
there had been a change in the profile of the cases they were seeing in the service, 
with a trend towards them becoming more severe. The emotional and physical 
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impact of these pressures was tangible, and observable: staff eating lunch at their 
desk, if at all; staff making patient notes whilst sat in their cars (to negate the need 
to return to their base). The stress of staffing issues was never far from the 
discussion. Staff felt placed in impossible situations and were repeatedly presented 
with difficult choices:  
“…the group acknowledged it’s hard to say no to additional work 
requests despite no capacity” [Meeting Minutes] 
“[A] lot is outside of our control such as staffing budgets but to remain 
focused on what we can control- in the sessions with our clients to be the 
most effective clinicians we can be” [Meeting Minutes] 
An additional pressure came from the many calls from concerned parents/carers 
who noted waiting times and altered appointments as the most common grievances. 
In contrast, the team also received many messages of thanks, giving weight to one 
staff’s belief that once patients are receiving treatment they are “getting a good 
deal” (Sarah, T3 Psychology). 
As indicated in the non-clinically orientated variance in practice theme, the 
reported difficulties were anticipated to be of a transitory nature, with Joan (T2 
Specialised) stating “we have got big caseloads at the moment that we don’t 
normally have”. Staff suggested that this was a direct result of staff economy 
measures, which had led to them feel overburdened, stressed and under pressure to 
see increasing numbers of patients in the same allocated time. Various alternate 
strategies were suggested to overcome the observed difficulties with the new 
working hours such as improving staff planning, utilising lower grade staff for less 
specialist tasks, implementing more locality-based working and ensuring new staff 
appointments fill the skill gaps within the team. 
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In such a strained environment, research was felt to be a competing 
responsibility or another worry. One, which did not sit well against its more urgent 
counterparts:  
“I guess the only issue [with a trial running in the service]…would be if it 
feels like people are getting taken out of the team again… people will 
resent that” [Sarah, T3 Psychology] 
The value of research was weighed up against the time staff had available in a 
stretched service. Research was not considered to be a priority in such a stressful 
environment, despite the stated desire for evidence-based treatment. When Judy 
(T3 Managerial) was asked if she could foresee any difficulties, she simply said that 
the biggest barrier to research was “staff, staffing. The staff to do it”. Practical 
suggestions included planning training several months in advance and delivery being 
spread over several weeks rather than being condensed into one. 
“Just because of the pressures, I have to admit the workers within our 
team have got a conscience so actually if they’re gonna be out of the 
building for four days they know that actually when they come back 
they’ve either got four days of referrals to look at, four days of telephone 
calls to ring back, four days of appointments to either cancel or rearrange 
so actually if we do it in two blocks of two…least it would be split nicely 
in the diaries so they don’t feel that it’s a huge pressure taken out” 
[Claire, T2 Managerial]  
Staff mentioned the need for support with research projects and again, managers 
were highlighted as vital in facilitating the implementation of research or training 
opportunities. Claire (T2 Managerial) stated that it is the manager’s role to “stop that 
merry-go round from going”. Others furthered this suggestion by recommending 
better communication between researchers and managers. 
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Discussion 
This novel approach to sequencing mixed methods to inform RCT design has resulted 
in the identification of four multifaceted and interlinking themes. The complexity of 
the findings reflects the intricacies of the setting; unsurprisingly, the implications for 
the trial design in Stage II are equally complex. In this section, the interpretation of 
the findings in a broader context will be discussed, followed by the specific 
implications for the trial design, as well as the strengths and limitations of the 
ethnography study.  
Conducting an ethnography whilst working in the setting was challenging. As 
an Assistant Psychologist “on placement “, staff already had their preconceptions 
about me and had assigned me an organisational role. Similar to Cudmore and 
Sondermeyer (2007) I experienced tensions between my dual role as an ‘insider’ and 
‘outsider’. Although such experiences are well documented, I found particular 
difficulties in identifying what was irregular practice due to not being a full insider. 
Interpretation of the findings 
The narratives discussed in this study point to a hectic team under pressure. During 
this period of austerity, CAMHS has had to function in an environment where 
demand frequently outstrips capacity. This ethnography highlights such ‘economic’ 
restrictions as central to the other themes that emerged. Staff economy arose as an 
explanatory factor for the other three themes; representing both an individual 
barrier in terms of staff’s ability to treat patients and a barrier at the 
managerial/organisational level of the service, due to a lack of available clinicians to 
treat patients. In light of these resource issues, research and training were 
understandably not prioritised over the more pressing matters of direct patient care 
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and administration. This finding aligns with previous research in specialist CAMHS, 
which found that when a substantial lack of resources were available to the team it 
affected staff’s ability to engage in training opportunities (Edwards et al., 2008). 
Despite this, the findings indicated a number of conditions that could increase the 
likelihood of staff becoming involved in research and training. Both time and 
psychological space were perceived as vitally important to allow staff to make the 
best use of the opportunities offered. In line with our findings, Edwards et al. (2008) 
also found release from clinical duties and specific time set aside for learning were 
key facilitators in this respect. Effective managerial support to prioritise, protect and 
plan research and training opportunities acted as a key facilitator; allowing staff to 
overcome difficulties with capacity. Likewise, Edwards and colleagues (2008) found 
that strong leadership from CAMHS managers enabled staff training and similarly, 
they also noted this was mediated by financial constraints (Edwards et al., 2008). 
Previous research has also found resource and capacity constraints affected the 
therapeutic journey young people took through CAMHS (Turner-Halliday et al., 
2014). Although we found indications that this may have been the case, this was 
outside of the remit of this focused ethnography. 
Staff demonstrated good knowledge of NICE guidance for the treatment of 
depression in children and young people, which was in contrast to previous research 
that found a lack of awareness of, and poor familiarity with, clinical practice 
guidelines among physicians (Cabana et al., 1999). Although it was reassuring that 
clinicians were knowledgeable about evidence-based practice and treatment 
recommendations, in practice, depression care was not always provided in line with 
this guidance. There were physical and environmental barriers to optimum delivery 
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identified during this ethnography and these differed from the individual and social 
barriers staff encountered following guidelines identified in previous work (Cabana 
et al., 1999). Although in this study staff were aware when they deviated from best 
practice, they were prevented from following guidance due to a lack of resources. 
This appeared to be to the detriment of patients who may not have received care 
recommended by NICE or have been unnecessarily allocated to a higher Tier of care 
than required. The lack of staff trained in CBT was surprising in light of the CYP IAPT 
initiative that was intended to tackle such issues. It also raises questions about the 
utility of current training mechanisms for practitioners, which may not be sensitive 
to staff requirements, such as the time necessary for ‘headspace’. As in our study, 
CAMHS clinicians have previously been reported as keen to attend and engage with 
training programmes (Edwards et al., 2008). This ethnography implies the reality 
may be more complicated than previously evidenced, and efforts to implement new 
treatments or training may need to go further than just providing a training course 
or disseminating appropriate information. This is an important consideration, if BA is 
to prove efficacious in the future.  
As in previous work (Turner-Halliday et al., 2014) we found treatment as 
usual was ‘non-specific’, in that it was rarely a named treatment approach such as 
CBT, and that treatment was case-dependent with CAMHS responding to each 
individual. During the ethnography staff identified CBT as a gold-standard treatment 
but this wasn’t the treatment necessarily delivered in practice due to resource 
limitations. Our results suggest a Treatment As Usual (TAU) comparator condition to 
our novel BA treatment arm would be both feasible and represent high internal 
validity. 
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The ethnography has provided knowledge of the structure and processes 
occurring with the CAMHS team. The informal systems created by staff to share their 
professional knowledge, were in sharp contrast to the formal organisation of the 
team. Staff without official psychotherapies training learnt therapeutic skills second 
hand from colleagues, experimentation or observation. This is at odds with NICE 
guidance (National Institute for Health and Clinical Excellence, 2005) which 
recommends psychological therapies should be delivered by therapists who are also 
trained child and adolescent mental healthcare professionals. This ethnography’s 
findings are also reminiscent of the research summarised by Barlow (1981); like in 
our study, the clinicians observed by Barlow described themselves as eclectic and 
learning from clinical experience rather than guided by research findings. Barlow 
(1981) noted that Clinical Psychologists reported acquiring their techniques through 
observation of tutors or pupils and using this acquired knowledge to alter their own 
therapeutic procedures basing subsequent decisions upon ‘trial-and-error’ in their 
own clinical practice. Although our ethnography did not indicate clinicians would 
deviate from the evidence based practice principle in such a manner, the fact that 
staff in our ethnography considered themselves to be eclectic in selecting their client 
referents could represent a risk that clinicians may become disenfranchised from the 
research process. However, most staff observed during the ethnography were found 
to be open to the concept of research within their team, under the proviso that it did 
not become another burden in an overwhelmed service. These findings are pertinent 
to researchers and policy makers, especially in the context of the CYP IAPT Service 
Improvement Programme and the NHS priorities surrounding research (NHS 
England, 2017). The observed informal culture of learning, combined with the impact 
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of the new working hours, lessened opportunities for clinical case discussions and 
obstructed new knowledge entering the team, which inevitably has an impact on any 
proposed research. 
Ethnography was founded in social anthropology, where historically it was 
assumed that all members of communities share common cultural beliefs and 
practices (Savage, 2000). Although staff agreed on many issues, there was a certain 
degree of polarity present in other areas, which is more in keeping with 
contemporary commentators and anthropologists who have rejected those earlier 
theories, instead suggesting individual members of groups may hold vastly differing 
views. Some staff from non-clinical backgrounds or lower-grade staff were 
reportedly struggling to work with formal diagnoses in practice, in contrast to their 
clinically trained counterparts who were comfortable diagnosing and treating 
patients with a diagnosis. Furthermore, the factors leading to non-clinically 
orientated variation in practice were also observed to be stratified according to 
professional background. The impact of staff backgrounds is in line with the findings 
from many large-scale studies and multi-site trials that have found substantial 
differences in implementation of interventions across staff types (Kessler and 
Glasgow, 2011). Yet, although previous research found there was a varied 
composition of professional disciplines within CAMHS which resulted in differing 
training needs, our finding differed in the respect that we did not find that these 
differences were reflected in patient care (Edwards et al., 2008). The staff narratives 
described the differing viewpoints of staff within the team and represent the 
difficulties of being amalgamated into multidisciplinary CAMHS teams. This led to 
power imbalances within the team, which have been previously observed between 
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individuals in healthcare settings (Savage, 2000). In this case, the ultimate power was 
seen to be in the hands of the Team Managers who were identified as the individuals 
who could impose practice change. These findings indicate a need for researchers 
and subsequently policy makers to account for the intricacies of real life social 
interactions and relationships within the team and be sensitive to this diversity from 
the research design stage through to the intervention implementation. Poignantly, 
the dangers of informal learning by staff that were identified in this ethnography by 
staff, highlight the risks of research not being relevant to clinicians. 
Implications for the trial design 
Previous research relating to the benefits of qualitative research in a trials context 
has been criticised for not clearly articulating how the knowledge gained will be used 
to inform the trial (Toye et al., 2016). Wells et al. (2012) argue context is vital in 
order to judge the transferability of the complex intervention that is being evaluated 
within a RCT. Through the ethnography, a rich understanding of the organisational 
climate and culture was gained, which was used to inform the trial design of Stage II 
of the thesis. This ethnographic data, relating to the practice setting in which the 
trial was delivered, will also assist readers who may consider delivering a BA 
intervention in other settings in the future. In general, this study shows support for 
pragmatic trial designs that account for the real-life complexities of clinical practice 
(Tunis et al., 2003). Previous research in the North East of England (Lewis and 
Russell, 2013) reported a lack of an opportunity to address staff’s concerns and 
preconceptions prior to the research. This pre-design, focused ethnography offered 
an opportunity to overcome some of the negative preconceptions associated with 
research prior to the start of the trial, which helped to foster a more collaborative 
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attitude between myself, as the ethnographer, and the staff in the CAMHS team. The 
results from the four themes identified in the ethnography directly informed the 
protocol of the planned depression trial (see Table 6). The multifaceted and 
interlinking themes that were identified from the complex setting has led to the 
impact upon the trial protocol being equally complex. In an attempt to simplify these 
implications, they have been presented in tabular form and will be discussed in 
further detail below. 
Table 6: Illustration of how the key findings from the Stage I ethnography led to 
changes in the trial protocol in Stage II (adapted from Kitchen et al., 2017) 
Theme Evidence Implication for Planned Trial 
Non-clinically 
orientated 
variation in 
practice and 
diagnosis 
Differing Staff 
Backgrounds 
Selection of 
an 
appropriate 
control arm 
Stratified 
Randomisation 
by Tier 
Recruitment 
of a variety of 
staff from 
both Tier 2 
and Tier 3 
Differing Staff 
Training 
Experiences 
Staff economy 
Staff 
Turnover/Job 
Role Fluidity 
Recruitment of excess 
staff/study sites 
Non-clinically 
orientated 
variation in 
practice, staff 
economy and 
capacity 
Lack of Staff 
Capacity/Staff 
Stress 
Five days of 
training split 
over several 
weeks and 
planned in 
advance 
Self-selected 
sample 
Capacity Feedback from Training to Team 
Cluster 
randomisation 
may reduce 
treatment 
contamination 
Non-clinically 
orientated 
variation in 
practice 
Informal Staff 
Supervision  
Group supervision to facilitate 
learning 
Informal Learning 
of Therapeutic 
Skills 
Capacity Headspace Five days of 
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training split 
over several 
weeks and 
planned in 
advance 
Diagnosis 
Lack of Staff 
Confidence  
Use of a structured interview tool to provide a 
DSM diagnosis by researcher 
Lack of Diagnoses 
Non-clinically 
orientated 
variation in 
practice and staff 
economy 
Speed of Patient 
Treatment 
Reduce treatment delay by recruiting more staff 
to deliver the intervention and recruitment 
speed by adding additional study sites 
Diagnosis Comorbidities 
Participant inclusion criteria to include 
comorbidities 
Diagnosis and 
staff economy 
Depression 
treated in both 
Tiers 
Recruitment 
across Tier 2 
and Tier 3 
Stratified Randomisation by 
Tier 
Non-clinically 
orientated 
variation in 
practice 
Staff Treatment 
Preferences and 
Individual 
Differences 
Perceptions regarding delivery to be explored in 
qualitative interviews with staff and patients 
Staff economy and 
capacity 
Staff and Patient 
Management 
Attendance at regular management meetings 
Many of the barriers to research that were experienced in this ethnography 
were seen by the CAMHS team as local issues that were irrelevant to the proposed 
research, and their impact upon the planned research was not previously 
understood. The data provide comprehensive insights into the usual care pathways 
surrounding depression in this service, which has enabled the effective allocation of 
trial resources to the most appropriate sources and allowed refinement of the trial 
design. Specifically, changes to the service provision during the observation led to 
internal waiting lists within the service, which would have severely impacted upon 
the viability of the trial. However, due to the knowledge obtained, protocols could 
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be implemented to alter the recruitment strategy within the trial, thus limiting the 
impact of these treatment delays. Another example would be, if the inclusion criteria 
had excluded comorbidities, 60% of those with depression in the service would have 
been excluded from Stage II of the research. Thus, a broader inclusion criteria was 
utilised, which has the added benefit of improving internal validity as the trial 
participants will be more representative of the patients in the service. Differences 
observed between Tiers suggested this may be a factor that could affect the results 
and be a source of bias. This variable could be an important predictor of outcome so 
could be controlled for in the trial protocol via stratification during the 
randomisation process. Staff economy and capacity themes suggested close working 
with service managers to provide forewarning of issues that may impact upon the 
trial. As such, regular management meetings were planned.  
Staff economy, capacity and non-clinically orientated variation in practice 
themes combined to account for the main barriers to research within the setting. 
Significant staff turnover led to various difficulties within the service; most notably 
impacting upon provision of service. Previous research suggests when extensive 
healthcare restructuring occurs at the same time as the introduction of a clinical 
intervention it can lead to uncertainty and high staff turnover (Franx et al., 2012); 
this may translate into slow or reduced recruitment rates in a trial context. This 
would be particularly disruptive when relying upon training existing CAMHS staff 
who may then leave the service. This has been accounted for in the RCT in Stage II by 
training more staff than required, which has the added benefit of sharing the burden 
of research and assists in maintaining patient recruitment and intervention delivery 
  109 
in the event of staff dropout. Additional study sites will provide a greater pool of 
staff to recruit from in the event of low rates of patient or staff uptake.  
These findings also raise the question of whether a target-driven service is 
the most appropriate setting in which to conduct research. The Stage II trial protocol 
thus has a strong focus upon the feasibility of a trial in this complex setting. Capacity 
and staff economy themes demonstrate practical arrangements, such as splitting the 
training across different weeks, which may increase accessibility for busy staff. An 
additional benefit of this approach would be increased opportunities for headspace.  
Supervision is an important component to ensure fidelity to the BA treatment 
model. Informal supervision was observed in practice, which suggests intervention 
supervision should be in keeping with a group-learning mechanism. Therefore, a 
group supervision approach may be suitable and may also meet the requirement for 
headspace to incorporate learning into practice following the intervention training. 
However, learning therapeutic skills second-hand may indicate that therapeutic 
contamination could be an issue. Contamination of the control group can lead to 
biased estimates of effect size (Hemming et al., 2017). In a trial, cluster 
randomisation would be one way to account for this. Cluster randomisation involves 
randomising groups of individuals (i.e., all patients from one CAMHS team) to either 
the intervention or control conditions. However, this trial design has been criticised 
for being statistically inefficient compared to trials that use individual randomisation 
with the same number of participants (Hemming et al., 2017). Individual 
randomisation is the process of individuals being randomly allocated to receive 
either an experimental condition or an alternative (such as remaining on a waiting 
list or standard treatment). 
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Staff mistrust of diagnoses would not usually present a problem, due to the 
lack of need for a formal depression diagnosis in routine practice; however, in 
research projects where a formal diagnosis is often part of the inclusion criteria it 
represents a barrier to research. It was initially anticipated that the diagnoses 
provided by the service would be adequate to enrol participants into the Stage II 
trial, but the ethnography suggests diagnoses are made infrequently and require 
patients to be transferred to Tier 3 of the service, which leads to treatment delay. 
While many psychotherapy trials rely upon official diagnoses, the results of this 
study suggest a more pragmatic choice may be to work outside of a diagnostic 
criteria. However, this needs to be considered against the need for an accurate and 
standardised definition of depression across RCTs to compare research findings. It 
was also anticipated from the initial site meetings that it would be possible to make 
use of depression classification codes (on patient’s electronic records) but due to the 
lack of diagnoses these were infrequently assigned to patients. As such, a formal 
diagnosis was judged to be necessary in Stage II of the research to maintain the 
quality and rigour of the RCT. The lack of formal diagnoses provided by the service 
represented a practical barrier to research recruitment, which would require 
additional resource allocation to overcome in order to deploy a researcher-
administered diagnostic interview (assigning DSM criteria). This ethnographic study 
also suggested some staff will find working with clinical diagnoses easier than others 
due to their previous training and work experiences. An improved understanding of 
this issue enabled information regarding the rationale for a diagnostic interview to 
be added to staff study training in Stage II, to reassure staff. A variety of staff were 
invited to enrol as therapists in the trial and their experiences in relation to treating 
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young people will be explored qualitatively. This diversity is also important as a first 
step to exploring whether some staff may be better suited to intervention delivery 
than others.  
Understanding the disparities in patient management was useful in selecting 
a control arm for the planned trial, ensuring it would also be clinically relevant. 
During discussions with the team managers at the initial site meetings, CBT was 
proposed as a potential comparator to BA treatment. The focussed ethnography 
demonstrated that very few young people in practice received ‘pure’ CBT (by an 
adequately trained therapist) so, if CBT had been selected, it would have limited the 
generalisability of the research to practice because it would not represent routine 
care. Therefore selecting TAU as a comparator condition may account for the 
diversity in clinician approaches to depression treatment and preserve the external 
validity of the trial.  
Methodological reflections 
There has been a growing interest in and evidence base for, utilising a pre-trial 
qualitative element to improve trial design. A systematic review identified a growing 
number of qualitative components being conducted prior to RCTs (Lewin et al., 
2009), although few of these used an ethnographic methodology which appears to 
be well suited to this endeavour. As discussed earlier in the chapter, few of the pre-
design components are used to inform the subsequent trial design from conception. 
Lewin et al (2009) suggest trialists should prioritise qualitative input later in RCT 
development due to the usual linear model of evaluation. This is in contrast to the 
MRC guidance (Craig et al., 2008) that emphasises the need for flexibility in that 
development may be linear, cyclical or staged in another format. This ethnography 
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has extended the discussion around methods that can be used to inform trial design 
of context in this respect and added to the published literature in the area (Kitchen 
et al., 2017). Randomised trials offer a good quality of evidence but may limit the 
applicability of the research findings to practice. This study’s application of 
sequencing mixed methods, as described in this thesis, challenges current paradigms 
of method as well as parameters of success. Researchers have suggested clarification 
of both general and project-specific threats to internal and external validity should 
be encouraged and considered as a sign of researcher integrity rather than a symbol 
of investigator ability (Wells et al., 2012). This ethnography recognises the 
constraints upon researchers in terms of time and resources and suggests a focussed 
ethnography can limit the misuse of both time and resources within trials by 
adequately informing the design. This approach fits well with moves towards more 
pragmatic trial designs (Tunis et al., 2003). 
There were some elements of the study methodology that were less 
successful. The novel ‘blended’ approach to analysis attempted to reconcile an 
ethnographic methodology with a focused approach. An approach using multiple 
coders marries well in a trials context where research teams are the norm. As 
previously noted, merging different epistemological positions (Dikomitis, 2016) can 
cause difficulties. Although from the outset of this PhD, the dissonance between the 
constructionist ethnography and positivist trial was acknowledged, overall the 
ethnography had more positivist leanings than would traditionally be the case. This 
caused difficulties when it was suggested that I employ a second coder in order to 
manage objectivity within the ethnography. As the second coder had not been 
immersed in the setting and thus had limited understanding of the context of the 
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transcripts they were analysing, this left me defending my interpretations. This study 
therefore exemplifies the challenges of working at this interface of social sciences 
and trials, and has also added to the literature on focused ethnographic fieldwork in 
clinical settings. In particular the data stress the importance, noted by other 
researchers, of addressing local problems when designing RCTs (Moore et al., 2015). 
A focused ethnography may therefore be an important addition to a trialist’s toolbox 
at a developmental stage of trial design.  
Strengths and limitations 
Mason (2002) highlights a fundamental strength of qualitative research; is its ability 
to understand context, diversity, nuance and process in a complex and 
multidimensional social world. For this study, ethnography illuminated how the 
service, staff discourses and relationships worked and the significance of the 
meanings they generated. This qualitative approach highlighted a wide array of 
dimensions of the social world illustrating what Mason (2002) described as the 
texture and weave of everyday life. A focused ethnography has illuminated pitfalls 
prior to the trial that site meetings or other methodologies would have failed to 
access. Although the approach taken was focused, the inductive stance was broad 
enough to allow for the degree of exploratory inquiry necessary to address the study 
aims. An unanticipated benefit of using an ethnographic approach was that it 
enabled bonds to be built with staff prior to the trial in Stage II, which helped to 
foster successful subsequent working relationships. Ethnographies, even those of a 
rapid nature, are resource intensive and thus, costly. I would argue that by bridging 
the gap between research and practice, resources within the trial were better 
utilised.  
  114 
A further strength of the ethnography was that there was only one staff 
member who opted out of the observation and as this was on the final day of data 
collection this did not impact upon data generation. There were also no refusals to 
participate in the staff interviews. This indicates that despite initial difficulties 
integrating into the setting, staff were happy to participate in interviews with me 
and comfortable with my presence. 
 The methodological approach may be criticised by ethnographic purists who 
believe rapid, short-term fieldwork can never adequately integrate the researcher 
into the setting and thus, does not have the capacity to answer such complex 
questions. They may raise questions about the validity of relying upon interview data 
due to criticisms of interviews as a strategy to illuminate beliefs (Mason, 2002). 
These criticisms are important to address; for example, there were suggestions in 
one interview that a participant may have been misleading me (due to their 
reluctance to answer questions). This could lead to doubts about the authenticity of 
this account when coupled with the same manager’s request to review the interview 
transcripts. The very act of allowing interviewees to review their transcripts may be 
controversial amongst qualitative researchers (Mason, 2002), as it could potentially 
enable participants to select socially desirable responses and screen out truthful 
information they do not wish others to be privy too. In this case, however, no 
amendments were made to the transcripts. More importantly, whilst interviews may 
have a more prominent position than is traditionally the case in ethnographic 
research, the other methods utilised- of observation and documentary analysis- 
provide alternative accounts through triangulation. As observational and 
documentary data was collected on an opportunistic or purposive basis, important 
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information may have been missed but this has to be weighed against the benefits of 
using a naturalistic approach, which may have been compromised if a more 
systematic data collection method had been used. Whilst all relevant professions 
were represented in the participant observation, no Psychiatrists were included in 
the interview sample as they were not deemed to be key stakeholders, as due to the 
composition of the CAMHS team they rarely deliver psychological therapy. 
Another key limitation was the lack of information obtained on staff’s 
professional training or educational backgrounds; this information was asked for in 
later interviews, but was not collated in a formal manner nor was such information 
gathered for staff who were being observed. Such data would have been valuable in 
strengthening, or refuting, the connections between professional background and 
behaviour observed. Additionally, all key stakeholders were female, although this is 
this is reflective of the composition of the CAMHS team as a whole.  
The stance and conceptualisation of a single ethnographer has been 
previously criticised (Cruz and Higginbottom, 2013), however in this ethnography the 
informed view of the embedded ethnographer was more powerful than an 
uninvolved researcher. Future research using a focused ethnography would best be 
analysed by sole or multiple ethnographers based in the setting.  
There are inherent limitations in this study, as the views obtained were from 
professionals within one service, so the findings may reflect a particular local 
“culture” rather than individual or generalisable perspectives. When reflecting upon 
my role as an ethnographer, my background in psychology immediately aligned me 
towards the psychology professionals in the team. Consequently, I may have been 
skewed to interpret issues from an alternative perspective to nursing staff for 
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example, which is a deficit of using the conceptual orientation of a single researcher. 
This was countered through reflexivity and supervision, in order to re-cast the 
familiar as something novel in order to explore it further (Barber, 2014). As with any 
qualitative methodology, the results were not intended to be generalisable; 
however, there are aspects of this research that could be transferable to other 
settings. The strength of this qualitative approach lies in its ability to allow the 
complex nature of this particular CAMHS team to be characterised, and to 
understand the realities of staff experience. This learning has been used to inform 
the planned trial and similar study sites in Stage II of research and the methodology 
could be of use in other trials, such as an approach that has been used previously in 
a multi-site trial to inform researchers of the local differences between sites (US 
National Insitute for Mental Health Collaborative HIV/Sexually Transmitted Disease 
Prevention Trial Group, 2007). Although qualitative research is capable of producing 
well-founded cross-generalities (Mason, 2002), in this case, small differences could 
affect trial design detrimentally so caution is required. The focused nature of the 
ethnography may have precluded additional informative information being included 
in the analysis and the cost of ethnographic studies may be prohibitive. It could be 
argued that qualitative interviews alone may be a more cost-effective way to obtain 
similar data in light of these criticisms. 
Conclusions 
The broader achievement of this study is that it provides a useful case study to 
illustrate the utility of a focused ethnography to inform the design of a RCT. The pre-
design stage enabled adaptions to be made to the protocol for Stage II at a point 
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when appropriate modification was still possible. Staff knowledge was successfully 
captured and utilised to create a pragmatic trial protocol that is able to respond to 
and can be readily implemented into a real world setting. The subsequently adapted 
trial is undoubtedly more closely aligned to clinical practice, more feasible and more 
acceptable to staff. This ensures strong external study validity, which is vitally 
important to satisfy clinicians and policy makers that this novel treatment is credible 
in the context of the realities of everyday NHS practice. Without the input of the 
ethnographic methodology, the original trial protocol would not have addressed 
local barriers to the trial and treatment nor allocated resources effectively and thus, 
it would have met insurmountable barriers upon implementation. This data has 
provided important insights into the practical and organisational boundaries into 
which the intervention would be implemented and situated the trial. The following 
chapter discusses the RCT that comprises Stage II of this thesis.
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Chapter 4 Stage II: A randomised 
controlled feasibility trial of 
Behavioural Activation treatment 
for young people with depression in 
Child and Adolescent Mental Health 
Services: Introduction and Methods 
Introduction and aims 
As discussed in the background literature review (Chapter 1), the paucity of evidence 
for Behavioural Activation (BA) as a treatment for depression in young people has 
recently been highlighted in a systematic review of the evidence (Tindall et al., 
2017). The systematic review included only ten studies, many of which had 
methodological limitations, indicating an absence of high quality evidence in the 
field. Furthermore, none of the included studies were in a UK setting, limiting the 
relevance of the findings to UK practitioners. The feasibility study that comprises 
Stage II of this research has been designed as a first step towards addressing some of 
the identified gaps in the literature. This study represents Medical Research Council 
(MRC) ‘phase II’ feasibility research, which aims to examine methodological, 
procedural and clinical uncertainties (Craig et al., 2008). This Randomised Controlled 
Trial (RCT) was undertaken to assess whether or not the trial design was appropriate 
and feasible with regard to patient and staff recruitment and retention, acceptability 
of the BA intervention and study procedures, as well as adherence to the treatment 
protocol. This trial comprises the largest component of this thesis, as such it has 
been separated into five sub-chapters to assist the reader. This first segment 
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describes the introduction to the study and the methods utilised, the second portion 
(on page 167) describes the flow of participants throughout the study and the 
recruitment data gathered. The third instalment (from page 188) discusses primarily 
the quantitative results (although some contextual qualitative data has been 
included), which is followed by the fourth sub-chapter (from page 220) on the 
qualitative analysis. The chapter ends with an integrated discussion of the mixed-
methods results and conclusion (from page 274). 
There is a lack of consensus on the terminology that should be used to 
describe the preparatory phase for a trial (O’Cathain et al., 2015). This study has 
been referred to as a feasibility study due to the aims and objectives of Stage II of 
this research focusing on whether or not this study can be done, should it be done 
and if so, how should it be done (Eldridge et al., 2016b). This stance is in line with the 
Consolidated Standards of Reporting Trials (CONSORT) guidance for pilot/feasibility 
studies (Eldridge et al., 2016a). Equally this study could be considered to be a pilot 
study as there is a general consensus that a trial can be considered a pilot when it is 
estimated to be either too small to detect a minimally important effect size and/or is 
evaluating an incomplete intervention (Torgerson and Torgerson, 2008). The 
National Institute for Health Research (NIHR) note feasibility studies should not 
compare the outcome of interest (National Institute for Health Research, 2017), and 
although we have cautiously explored the data for the purposes of the thesis this 
was not an aim of this study. This study is also not consistent with the NIHR’s 
definition of a pilot study as a variety of outcome measures have been deployed and 
a variety of recruitment methods used with a view to selecting a limited number of 
these in a future larger pilot trial. Although the utility of accurate description of the 
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phase of study is acknowledged, this trial reflects the difficulties in assigning the 
appropriate terminology to complex studies at any stage of research. All other 
elements of the study are consistent with an NIHR defined feasibility study (National 
Institute for Health Research, 2017). Eldridge and colleagues (Eldridge et al., 2016b) 
created a framework to define pilot and feasibility studies using a Delphi survey. 
They define pilot studies as a subset of feasibility studies, rather than the two being 
mutually exclusive; the distinctive design component that separates pilots as distinct 
entities is that they are a small version of a future larger powered trial (Eldridge et 
al., 2016b). Thus, by adhering to this broader definition we have labelled this RCT as 
a feasibility study.  
The intervention (BA) that this study has been designed to investigate, can be 
described as a complex intervention according to MRC guidance (Craig et al., 2008). 
The trial has been designed in line with this guidance which recommends the use of 
feasibility studies prior to ‘phase III’ trials. The MRC guidance for complex 
interventions states that the purpose of the feasibility/pilot stage is to engage in an 
iterative process of development, feasibility and piloting, evaluation and 
implementation, testing procedures for acceptability, estimating 
recruitment/retention rates and calculating appropriate sample sizes. 
Principle research aim 
To assess the feasibility of a trial of a BA treatment for depression in young people in 
a Child and Adolescent Mental Health Service (CAMHS) setting. 
Research objectives 
The study has a number of primary objectives: 
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1. To assess how many CAMHS sites accept the invitation to participate in 
research; 
2. To assess the best way to approach potential participants by exploring 
recruitment rates and feedback from participants and clinicians; 
3. To determine whether the eligibility criteria for patients were too open or 
too restrictive by estimating feasibility and recruitment rates; 
4. To assess retention of participants by estimating three and six-month 
follow up rates; 
5. To assess the acceptability of the BA intervention to patients and their 
caregivers through session attendance, qualitative interviews and survey 
feedback; 
6. To assess the acceptability of the BA intervention to CAMHS staff via 
qualitative interviews. 
Secondary objectives: 
1. To investigate the completion of questionnaires and outcome measures 
as methods to measure efficacy of the intervention within a larger trial. 
2. To pilot the end of treatment survey designed for this trial. 
3. To measure key outcome domains (for completion rates, missing data, 
estimates, variances and 95% Confidence Intervals (CIs) for the difference 
between intervention arms) for participants. 
Preparatory work 
Prior to the conception of the trial, feasibility work was completed which has been 
summarised earlier in the thesis (Chapter 2). Knowledge gained was combined with 
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the findings from Stage I of this study (see Chapter 3) to inform the design of the trial 
protocol and this was amended in light of additional feedback obtained through 
stakeholder involvement. These preparatory approaches are summarised below, 
alongside the key aspects of setting up this new study in this setting. 
Feasibility work 
Extensive feasibility work has influenced the design of this study; for example, the 
setting of this trial was a direct result of the feasibility issues experienced during two 
earlier studies in school and primary care settings (see Chapter 2), combined with 
the findings of the focused ethnography in Stage I (discussed in Chapter 3). Alongside 
this knowledge, the advent of the Child and Young Person’s Improving Access to 
Psychological Therapies (CYP IAPT) service improvement programme provided a 
potential framework within which to train and deploy CAMHS practitioners to deliver 
BA. The presence of a potential mechanism for delivery of any novel treatment is 
vital to its future implementation in the setting. 
Patient and public involvement  
There is a moral argument for involving patients and members of the public in health 
care research, which is founded on ethical and democratic principles (Wilson et al., 
2015). There is an additional policy argument, which can be illustrated in guidance 
issued by the National Health Service (NHS), research funders and governing bodies 
suggesting public involvement is often a requirement of conducting research (Wilson 
et al., 2015, Staley, 2009). The added value of Patient and Public Involvement (PPI) 
was explored in a literature review and report prepared on behalf of INVOLVE, a 
NIHR national advisory group that promotes and supports greater public 
involvement in NHS, public health and social care research. They found PPI had a 
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wide-ranging impact on the research, community organisations, wider community, 
researchers, PPI members and subsequent research participants (Staley, 2009). 
Furthermore, meaningful stakeholder involvement can have a beneficial impact 
upon trial design (Staley, 2009), which may boost study recruitment and improve 
patient outcomes (Wilson et al., 2015). Crucially, PPI has been found to influence the 
way research findings have been used to bring about change, such as influencing 
clinical practice (Staley, 2009). In the context of youth mental health research, like 
Dan (in Chapter 2), other young people have previously demonstrated a desire to be 
involved from the conceptualisation of a research project (Mawn et al., 2016). The 
learning points and recommendations from research conducted by Mawn et al 
(2016) were followed in terms of facilitating PPI input from young people in a 
meaningful manner.  
Equally, it was important that the views of parents and carers were also 
considered. A parent, whose children were under the care of CAMHS, was recruited 
through an advertisement in the waiting area of a community CAMHS team (the site 
of the focused ethnography). This parent representative provided feedback on the 
proposed recruitment letter for families, the parent/carer information sheet and 
other aspects of the study design. This led to changes in the language, content and 
design of the documents. One example of this was the addition of flow charts to the 
study information sheets to improve clarity. The study protocol described the 
intention to make first contact with families via letter; the parent representative felt 
that this approach was impersonal, formal and would not provide the opportunity 
for families to ask questions. The parent representative suggested they would prefer 
to be first approached about the study by their clinician. Therefore, both approaches 
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were used in the trial and the success of each was explored through the recruitment 
figures and during the qualitative interviews in order to assess the most suitable 
recruitment strategy. The parent representative also suggested offering a financial 
incentive to encourage families to attend the initial information session. In light of 
this and as an acknowledgement of the time required to complete the assessments, 
all families were offered a £10 high street voucher for attending research 
assessment sessions in order to minimise study attrition (up to a maximum of £30 
for taking part in the study). Information relating to the financial incentive was 
added to the information sheets, as advised by INVOLVE (INVOLVE, 2016). However, 
our reimbursement rates are lower than those offered by INVOLVE who suggest 
around £25 for a one hour task that does not require pre-preparation; our reduced 
rate reflects the financial limitations of a PhD and the lower age of the participants. 
‘Youth Speak’, a PPI group of young people aged 14-24 who aim to ensure 
that the views of young people are embedded into all stages of research 
development, were consulted. A verbal presentation was made to the group about 
the proposed study in August 2014, followed by a group exercise focused on 
developing a study name and poster. Members of the PPI group contributed to the 
development of a youth-friendly study title (‘the BUDDY study’: Behavioural 
Activation for Major Depressive Disorder in Youth) after initial feedback that the 
scientific title was too complex. A full title may have also increased expectancy 
effects, as in the scientific title BA is the focus of the study. On several occasions, 
volunteers from Youth Speak (both male and female aged 14-17) were consulted on 
an individual basis to provide more in-depth feedback. In particular, they were asked 
for their thoughts on parental involvement, recruitment methods, diagnostic 
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feedback, study burden and appropriate reimbursement for participation. The young 
people’s information sheets and consent form were reviewed by young people (of 
the intended age ranges) in order to ensure the language, structure and design was 
youth-friendly and easy to understand. One important amendment following this 
review was changing the term Treatment As Usual (TAU) to ‘combined treatment’ in 
the participant study materials to make it as “enticing” as the novel treatment. 
Another suggestion was to add a photograph of the assessor to the information 
sheets, as it was reported that this may make people feel more comfortable and 
counter expectations of what researchers look like. As an additional control, all 
information sheets had a Flesch Reading Index of above 60, which is the 
recommended level for plain English for teenagers. The Flesch Reading Index scores 
range from 0 to 100 with a lower score being more difficult to read; the score is 
calculated using sentence length and polysyllabic words to determine difficulty 
(D’Alessandro et al., 2001). It has also been recommend that interview topic guides 
should be shown to a similar audience to the planned interview participants to elicit 
feedback (Clough and Nutbrown, 2012). In this case, the topic guides for the 
qualitative interviews were piloted with young people from Youth Speak. They were 
asked how it would feel to be asked those questions, whether they understood them 
and whether there was anything the research team could do to put them at ease. 
This feedback led to amendments to the interview topic guide. 
Site visits 
The trial (Stage II of the research) took place directly following Stage I, the focused 
ethnography. As such, the CAMHS team at one of the study sites (Site One) were 
familiar with my presence onsite and I continued in my role as an Assistant 
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Psychologist in order to coordinate the implementation of the trial. As identified in 
Stage I, additional study sites were necessary to reduce the burden for staff 
participating in the study as well as to ensure adequate participant recruitment into 
the study. Two additional sites were identified as they had expressed an interest in 
participating in the BUDDY study via one of the managers at the original site after 
hearing about the research. These two sites were acceptable as additional study 
sites due to their geographical proximity to Site One. Site Two was a large CAMHS 
team (a similar size to Site One) whereas Site Three was approximately half the size. 
Only the Tier 2 team from Site Three were included, as Tier 3 of this service was 
mainly comprised of staff above pay grade 7 (which excluded them from this study 
as it is part of the study rationale that BA may be able to be disseminated to lower-
grade practitioners). After receiving information to suggest the two additional sites 
were interested in participating in the BUDDY Study, I approached the Team 
Manager at each site. At Site Two, information relating to the BUDDY study was then 
presented verbally to the Team Manager and at Site Three a PowerPoint 
presentation was made to the CAMHS team (as per the manager’s request) to invite 
them to participate. The managers from all three sites approached, agreed to 
participate. Individual staff members were then given the choice of whether or not 
to be involved in a personal capacity as discussed below. 
Clinician training (June 2015) 
Further to the presentations inviting CAMHS teams to be a recruitment site for the 
BUDDY study itself, PowerPoint presentations were made to Tier 2 staff from each of 
the three sites to invite individual members of staff to be trained in the BA 
intervention. Staff were invited to nominate themselves for a place on the BA 
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training course; all but one of those present agreed to be considered for a place on 
the BA training (n= 16). Members of Tier 3 staff (pay grades 4-7) were approached 
individually or via their Team Manager and invited to participate; again all but one 
member of staff asked, agreed to be considered (n= 18). The two staff (one from Tier 
2 and one from Tier 3) who declined the invitation to attend the training, reported 
this was due to their current commitments to the CYP IAPT training programme 
therefore they were allocated to provide care in the TAU control arm. From the pool 
of staff who agreed to be considered for BA training, I selected those who would 
attend the BA training and those who would provide treatment in the comparator 
arm. Efforts were made to ensure staff (from pay grades 4-7) in each treatment arm 
were matched on gender, age, professional background, pay grade and previous 
training to reduce bias; however, a pragmatic approach was taken in the sense that 
staff’s availability to attend the training was a factor in selection. Higher grade staff 
(band 8 and above) were not considered for the study training, as one of the primary 
advantages of BA over other treatment options is the ability for it to be disseminated 
to lower grade staff. However, this meant all senior staff were assigned to provide 
TAU, which is a source of bias due to the clustering of staff with greater experience 
and higher qualifications in the control arm. Staff from the Learning Disabilities (LD) 
Service were excluded due to the intervention not being suitable for LD patients (as 
the manual materials require a minimum reading age), as were Band 3 members of 
staff as they do not hold their own caseloads of patients (so would not be able to 
provide treatment independently in either study arm).  
Behavioural Activation training consisted of a three-day course focussing on 
the BA model taught by a specialist from the NHS Trust. A participatory learning 
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approach was used in the training with didactic presentations, role-play, homework 
and group critiques. Twelve CAMHS practitioners were invited; a total of 10 attended 
the training, with each study site sending between one and six members of staff on 
the training. Two invited staff members did not attend the training session; one was 
unwell and the other was absent (they later reported being too busy to attend). At 
the end of the training there was a half-day competency assessment, which clinicians 
had to pass to proceed to providing BA therapy in the trial. If they did not pass the 
competency assessment, further training was provided as necessary and the amount 
of extra training was recorded. Competency was assessed using the ‘Quality of 
Behavioural Activation (Short Form)’ Measure (as used in a previous trial of COBRA; 
Richards et al., 2016); the rating scale scores staff on a scale of 0-84. We used a cut-
off of ≥40 as an acceptable level of competence (as used in the COBRA trial). There 
was also a half-day study orientation session provided, which was attended by all 
staff providing the intervention. In total, the study training was four days long, which 
was split into two parts and held across two separate weeks, as per the staff 
preferences in Stage I.  
Only one staff member (pay band 4) did not pass the competency assessment 
(scoring 36 on the Quality of Behavioural Activation scale), further training was 
provided (three extra half days) but the competency assessment was not re-
administered. The reason for this was because the staff responsible for the allocation 
of patients to clinicians within this site noted the combination of the level of risk 
inherent in the Tier 3 population, the research diagnosis of depression and the 
clinician’s low pay grade meant no referrals would be received that were appropriate 
to be allocated to this staff member. This was not an issue at any other sites, as no 
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other teams put forward a band 4 for the BA training. Therefore, 9 staff 
(representing all three study sites) progressed as therapists in the BUDDY study. 
Modification to the behavioural activation treatment manual 
Previous research has highlighted the main benefit of using a manualised approach 
to treatment within a RCT is to standardise practice and provide clarity on the 
treatment being provided (Webber, 2014, Olubokun, 2017). A manual may also serve 
as a link between the structured requirements of research and the clinical needs of 
practice (Olubokun, 2017). As previously described in Chapter 2, a 12-session BA 
treatment manual developed and piloted in the USA with 40 young people at an 
insurance-driven private outpatient mental health clinic (McCauley, 2011) was 
edited to be suitable for UK-based young people. Content from a manual used in a 
UK-based trial of BA in adults (Ekers et al., 2011b) was added to the American 
manual. The subsequently developed manual was used to administer BA over 12 
sessions to young people in the two previously mentioned UK-based feasibility 
studies (see Chapter 2). Qualitative participant, parent and clinician feedback from 
these studies was later incorporated into the manual. For the purposes of the 
current study, the adapted manual was condensed so that it could be delivered over 
eight, rather than 12 sessions to be in keeping with the CAMHS Tier 2 session limit 
for brief interventions. Rather than the interim outcome measures used in the BODY 
and Mind study, Routine Outcome Measures (ROMs) were added into each session 
agenda to bring the study in line with the usual CYP IAPT session monitoring 
procedures in CAMHS. See Appendix 5 for an overview of the adapted eight-session 
manual. The manual was further adapted following the results of this trial.  
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Ethical considerations 
Approvals and trial registration 
Prior to the ethics application for this feasibility study being submitted for ethical 
review, it was peer reviewed by a member of staff from Durham University who was 
independent to the supervisory team. The suggested changes were made to the 
application which was then submitted to the School of Medicine, Pharmacy and 
Health Research Ethics Sub-Committee (ref: ESC2/2014/14) and subsequently to the 
National Research Ethics Committee (ref: 15/NE/0002) and finally to Tees, Esk and 
Wear Valleys Research and Development (ref: 0360/15) team for approval. See 
Appendix 6 for approval and insurance documentation. The trial was registered with 
the ISRCTN Registry, a clinical trial registry recognised by the World Health 
Organisation (ref: ISRCTN52147450). It is just as important for a feasibility or pilot to 
be registered with a unique identifier as it is for a definitive trial (Eldridge et al., 
2016a). Registration ensures transparency and accountability and ensures all on-
going work is in the public domain. 
Key amendments 
First approach to patients 
There were a number of ethical dilemmas to contend with whilst designing this 
study. Initially I decided that, as the researcher responsible for recruitment, I would 
make contact with potential participants as soon as they were referred to CAMHS 
(i.e. before they were seen by a CAMHS clinician); however, this could have been 
potentially confusing for vulnerable patients and may have led to unnecessary 
contact with patients not suffering from depression. The study was re-designed to 
ensure CAMHS staff would always be the first contact for young people entering the 
service. Similarly, all research contact following recruitment to the study, was 
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provided by a researcher rather than a healthcare professional. This distinction 
ensured the clinical relationship between the clinician and young person was not 
impeded by research-related matters, and that roles remained clear and distinct. 
Inclusion/exclusion criteria 
When considering the inclusion and exclusion criteria, young people fulfilling the 
criteria for acute suicidality (defined as more than three self-harm events requiring 
hospitalisation in the past year) were initially excluded from participating. During site 
visits, CAMHS staff reported that many of the young people who they routinely see 
in the service may fulfil these criteria because self-harm/suicidality is so closely 
linked to depression and often as a precaution a young person would be taken to 
hospital regardless of the seriousness of the event. It was felt that it was important 
to ensure the participants in the study were representative of CAMHS usual patients. 
This needed to be considered against the risks associated with evaluating a new 
treatment option in a novel population and in light of the tensions between internal 
and external validity. After due consideration and in line with the pragmatic stance 
of the trial, young people with suicidal ideation or previous self-harm/suicide 
attempts were included. As a precaution, young people deemed to require ‘urgent’ 
care by their clinician were excluded due to concerns that the administration of the 
trial would lead to treatment delay. 
Consent procedure 
The study included patients who were a vulnerable population in terms of their 
younger age. In light of this, a variety of strategies in addition to those routinely 
employed by CAMHS were put in place to safeguard participants. Although English 
legislation does not prevent young people under the age of 16 from consenting to 
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their own medical treatment, it was acknowledged that these young people may be 
susceptible to coercion. For this reason, young people aged 12 to 15 were required 
to provide both written young person assent and parental/carer consent to take part 
in the study. However, there may still be ethical issues surrounding the role of 
parents/carers providing consent on the behalf of young people who have the 
capacity to consent themselves (Royal College of Psychiatrists’ Working Party, 2001). 
Young people aged 16 to 17 were deemed able to consent for themselves (without 
parental consent) in line with the English Family Law Reform Act 1969, section 8(1) 
1969 (Family Law Reform Act, 1969). This stance is further supported in professional 
guidance published by the British Medical Association (British Medical Association, 
2016). As an additional safeguard, as the researcher responsible for taking consent, I 
was trained in assessment of capacity by an Adolescent Psychiatrist. 
Risk procedure 
The content of the intervention itself was an important consideration. In any study 
of a novel treatment, there is a risk that the intervention may not be effective. The 
previous feasibility work reduced this risk and the clinical setting ensured alternative 
support was available if necessary. Furthermore, an integral aspect to the CYP IAPT 
programme is monitoring patient outcomes; one way this is documented is through 
the use of ROMs, which are administered to young people and their families before, 
during and following treatment. Failure to progress with BA treatment or any risks 
could be quickly identified via ROMs or the clinical judgement of trained CAMHS 
professionals. The need to monitor study participants had to be considered against 
the potential to create a large study burden for participants. The study was therefore 
designed to be in keeping with the Caldicott Principles (Department of Health, 
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2013b); a large amount of the data collected is routinely recorded by CAMHS and 
additional data collection has been kept to the minimum amount to address the 
study aims. 
Data collection methods 
Focus groups were initially considered (over individual interviews) as a qualitative 
data collection method but they, or even group semi-structured interviews, would 
not protect or encourage individual’s responses (O’Cathain et al., 2015). There would 
have been ethical concerns around bringing together young people who may 
otherwise not have known each other’s diagnosis of depression, and about asking 
sensitive questions on the topic in a group setting. Neither would the approach have 
provided the insight needed into individual perspectives of treatment suitability. 
Although more time-intensive, an approach based on individual semi-structured 
interviews was preferred. 
Method 
Study sample size 
Sample size calculations are not always required for pilot/feasibility studies (Thabane 
et al., 2010). Since this is a feasibility study, a sample size calculation was not 
performed because the trial is not powered to detect differences (as then it would 
no longer be a feasibility trial). It is appropriate for the focus of a feasibility/pilot to 
be an assessment of feasibility, when it is not appropriately powered to assess 
statistical significance (Thabane et al., 2010). Although, one of the objectives of this 
feasibility study is to provide estimates of the mean and Standard Deviation (SD) of 
the effect size of the outcome measures in order to inform the power calculations of 
a larger trial. 
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The sample size of a feasibility/pilot study should be guided by it being large 
enough to provide useful information about the aspects that are being assessed for 
feasibility (Thabane et al., 2010). Numerical simulation studies suggest estimates of 
the variance of an outcome metric tend to stabilise at around 30 observations 
(Lancaster et al., 2004). In terms of qualitative research within a trials setting, sample 
sizes typically range between 5-20 individuals (O’Cathain et al., 2015). Stage I of this 
research indicated that given the participant population, we should anticipate a 
moderate level of attrition. Based on this information, this feasibility study aimed to 
recruit a minimum of 20 and a maximum of 40 participants. This sample would be 
large enough to provide sufficient information relating to the practicalities of 
delivering the intervention, recruitment, uptake and attrition (Torgerson and 
Torgerson, 2008), whilst also providing adequate recruitment to the qualitative 
interviews (taking into account those who may refuse to participate) and stable 
estimates for the outcome measures. 
Study population 
Participants were drawn from the three study sites’ normal intake and caseload of 
patients during the study recruitment period. Young people were considered to be a 
study participant at the point of randomisation; all those randomised met the study 
inclusion criteria below. It is important that the trial sample is representative of the 
target population (Thabane et al., 2010). 
Study inclusion criteria 
1. Aged between 12 and 17 years old;  
2. Young person to give valid informed assent (if under 16); 
3. Young person to give valid informed consent (if 16 or over); 
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4. Parent/Carer of young person (under 16) to give valid informed consent; 
5. Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnosis of 
Major Depressive Disorder (MDD) according to the Kiddie-SADS-Present 
and Lifetime (K-SADS-PL) version. 
Exclusion criteria 
1. Does not meet the DSM criteria for MDD according to the K-SADS-PL;  
2. Presence of significant active substance abuse/dependence; 
3. Previous unfavourable response to an adequate regime of Cognitive 
Behavioural Therapy (CBT) in the past year; 
4. Deemed by a clinician to require urgent care. 
Design  
There were many issues to consider when deciding upon an appropriate research 
design. The feasibility RCT was designed in line with MRC guidance for complex 
interventions so that if the results were favourable it could be scaled-up into a phase 
III effectiveness RCT in the future (Craig et al., 2008). This guidance suggests the 
staged progression of evidence generation, as this is the early stage of work 
evaluating BA as a treatment, the feasibility has to be first established before 
efficacy can be considered. Primarily, the aims of the study dictated the design but 
ethical considerations, preparatory work, the practicalities of the setting and the 
resources available also had to be considered.  
RCTs have been criticised for lack of applicability to real-world and costs 
associated with undertaking them (Stephenson and Imrie, 1998). These criticisms are 
particularly true for explanatory trials, which aim to establish a cause and effect 
relationship, over ‘pragmatic trials’ where the focus is upon relevance to practice. 
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The effect of an intervention in a real-world setting (effectiveness) may differ from 
an ideal research setting (efficacy). It was important to consider the information the 
CAMHS service or policy makers require in order to consider implementing novel 
treatments and to ensure that this study design would suitably inform a larger trial 
to address those questions. Clinical trials designed to assist healthcare decision 
makers are known as pragmatic trials (Tunis et al., 2003). It is acknowledged that 
pragmatic trials may need to employ both qualitative and quantitative methods 
(Kessler and Glasgow, 2011). Cresswell (2009) described different ways that 
qualitative and quantitative data collection can be combined, these designs fall 
broadly under two headings; concurrent and sequential. In sequential designs 
qualitative and quantitative methods are combined in series, one after the other. In 
concurrent designs, both methods are conducted alongside each other. In Stage II, 
methods will be combined concurrently in what Cresswell (2009) terms a ‘concurrent 
triangulation strategy’ whereby mixed methods are collected concurrently and then 
compared. 
The BUDDY study is a multi-site, randomised controlled, two-arm, 
conventional parallel group, unblinded clinical feasibility trial with an embedded 
qualitative component, comparing individual BA to TAU (see Figure 6). The primary 
objective of the feasibility study was to identify the likely recruitment, retention, 
adherence and attrition rates that could be expected in a future trial. It was 
therefore critical that participants were offered the same treatment options as they 
would in a future trial to ensure that the recruitment rate was not overestimated. In 
a larger trial, a control arm is important to see how BA compares to the normal 
treatment regime, not just whether or not it was helpful treatment option. However, 
  138 
the primary function of using a control arm in this study was to test out participants’ 
tolerance to randomisation and the acceptability of this particular control treatment 
option. A cross-over design was not appropriate because the aim of treatment was 
remission from symptoms of depression so it would not have been possible to 
provide the two treatments sequentially. It would have also been unethical to use a 
negative control (i.e. a waiting-list control) in a clinical help-seeking sample because 
participants would have to wait before being provided with any treatment, which 
would raise ethical and risk-related problems.  
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Figure 6: Illustration of the pathways through the trial for participants that meet the study inclusion criteria
Provisionally 
Eligible 
Participants 
Diagnostic/ 
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Assessment 
Behavioural 
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Follow-up 
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Using qualitative methods in partnership with quantitative methods can 
provide a fuller picture of the matter under investigation (Barber, 2014, Kitchen et 
al., 2017) and their use has been recommended as an addition to RCT design 
(Thabane et al., 2010, O’Cathain et al., 2015). The quantitative and qualitative 
methods selected serve to illuminate differing aspects of the same phenomena 
under study; that is, the feasibility and acceptability of BA as a treatment option. The 
quantitative methods were selected to examine participant treatment outcomes, 
toleration to randomisation and recruitment processes, whereas the qualitative 
methods explored participant and staff experiences of the processes underlying 
those outcomes. However, there was no intention to compare qualitative findings 
between the two treatment groups, which is an approach that has been used in 
previous trials (Torgerson and Torgerson, 2008); instead, the purpose was to 
enhance the exploration of the novel treatment arm in-depth in order to provide a 
multi-dimensional insight to inform the format and content of the intervention in a 
subsequent larger trial. Often the addition of a qualitative element to a trial is seen 
only as an adjunct to a mainly quantitative methodology rather than a fundamental 
aspect of data collection (Mason, 2002). It was of primary importance to understand 
the CAMHS staff’s attitudes and experience of the training and delivery of BA 
therapy as well as the young people and their caregiver’s perspectives of their 
involvement in the trial and receiving the treatment. Thus, the qualitative data 
collection was an essential component in order to address the trial aims and 
objectives. Mixed methodologists have proposed that the shortcomings of 
quantitative approaches can be addressed by the strengths of qualitative approaches 
and vice versa. In fact, the two approaches can be complementary (Barber, 2014, 
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O’Cathain et al., 2015). This means it is well suited to assessing the acceptability and 
feasibility of a novel treatment approach, in this case BA, from the perspectives of 
those receiving, supporting and administering the intervention.  
One challenge with blending often disparate research paradigms is that it is 
difficult to combine incommensurate epistemological and ontological assumptions 
together into a coherent study (Barber, 2014). The central aim of embedding a 
qualitative component within this feasibility trial was to provide rich, holistic insights 
into the findings of the trial from a patient, caregiver and staff perspective. Although 
there is a clear dialogue between researchers regarding the utility of mixed methods, 
there is less clarity regarding the use of a conceptual or theoretical frameworks to 
guide inquiry (Evans et al., 2011). Mixed methods is consistent with the world-view 
of pragmatism (Evans et al., 2011); a pragmatic stance embraces multiple 
paradigmatic traditions and an alternative philosophical framework that de-
emphasises differences in philosophical traditions in order to select a practical and 
rational approach to mixing methods.  
There are two main sources of bias that can impact upon the interpretation 
of the trial findings; selection bias where the two treatment groups differ in some 
systematic way, and observer/information bias where there are systematic 
differences in the way info is being collected for the groups (Kendall, 2003). Bias 
within a trial can invalidate the study design and as such, make the results less 
reliable (Akobeng, 2005a); much of this bias can be reduced through the design of 
the RCT (Akobeng, 2005b). 
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Randomisation 
Random allocation or randomisation is a procedure where individuals are selected 
for either treatment or control groups entirely by chance (Kim and Skin, 2014). In a 
RCT these two groups are followed-up to see if there are differences between 
participant outcomes in the two groups (Kendall, 2003, Akobeng, 2005b). 
Randomisation seeks to balance out external influences between groups so that the 
‘true’ effect of the intervention is detectable (Stephenson and Imrie, 1998). 
Randomisation is the best way of controlling for selection bias (and thus, the 
unbalanced allocation of potential confounding factors), which can lead to 
inaccurate results (Akobeng, 2005b, Torgerson and Torgerson, 2008). Selection bias 
occurs when the person responsible for allocating participants to care, consciously or 
unconsciously decides upon the care given based upon the individual’s attributes 
leading to uneven representation of that characteristic in the two arms. 
Randomisation controls for selection bias by making it more likely that there will be 
baseline balancing of known and unknown systematic differences (confounding 
variables) between intervention groups, and therefore random allocation is 
important for internal study validity (Akobeng, 2005b, Petrie and Sabin, 2009). 
Randomisation is superior to non-random methods because it is generally 
unpredictable and difficult to subvert (Torgerson and Torgerson, 2008).  
Simple randomisation was considered for its simplicity and robustness 
(Torgerson and Torgerson, 2008). A major drawback of this approach is that the two 
treatment groups rarely end up equal, which was important with such a small 
sample size. One way to overcome this difficulty is to recruit participants in pairs; 
‘pairwise randomisation’ (note: this is not paired randomisation [i.e. when 
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participants are matched on particular characteristics]). Once two eligible 
participants have been recruited; one is randomised to the intervention and one to 
the control group. This approach would be unethical in a small feasibility study 
because due to the unpredictable recruitment rate, participants may experience 
treatment delays whilst waiting for the next participant to enter the study. Blocked 
randomisation can ensure roughly equal treatment groups (Kendall, 2003, Akobeng, 
2005b), which was desirable in this study. However, blocked randomisation can add 
to the complexity of the process increasing the chances of human error leading to 
technical bias. In addition, small or repeated block sizes can lead to predictability in 
non-blinded trials (Kendall, 2003, Kim and Skin, 2014). The primary concern in this 
study was to achieve roughly numerically balanced trial arms to allow better 
prediction of treatment resource utilisation.  
When all facets were considered, a blocked randomisation approach was 
selected. Two separate randomisation lists were created; one for Site One and a 
second for Sites Two and Three (these two geographical locations were 
amalgamated due to their similarities and the fact that some staff worked across 
both sites). Each randomisation list incorporated stratification for depression 
severity (either mild/moderate or severe depression) and Tier (either 2 or 3) to 
reflect sources of potential bias. Stratification enables balancing (whereas chance 
may not) of potentially confounding variables between groups, which helps to 
remove selection bias based upon those known potentially confounding factors 
(Kendall, 2003, Akobeng, 2005b). Stratification ensures that a potential baseline 
confounding variable is equally distributed between the two groups (Kendall, 2003). 
A statistician (independent to the research team) used R software to generate the 
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four lists of random numbers prior to the start of the study (two lists for each ‘site’; 
one representing depression severity and one the Tier). These two lists were 
subsequently incorporated into a master list for each site, which were stored as 
different tabs on one master spreadsheet. The block size was concealed from the 
study team and only revealed after recruitment had ended. As each patient was 
accepted into the trial (at the point when they provided consent at the diagnostic 
interview stage) they were assigned to the next consecutive number on one of the 
two random digit lists depending upon the severity of their depression and Tier; if 
the number they were assigned was odd they were allocated to the BA treatment 
arm and if it was even they were allocated to the control arm. It should be noted, 
however, that ‘random’ numbers generated by a computer are not truly random; 
they are pseudo-random because a computer utilises deterministic mechanisms, 
such as clock speed to produce random numbers, so prediction is technically 
possible (Torgerson and Torgerson, 2008).  
Allocation concealment is a technique to prevent selection bias whereby the 
researcher is blinded to the method of randomisation so that they are unable to 
predict which treatment group the participant will be allocated to (Kim and Skin, 
2014). The allocation sequence was concealed from the researcher responsible for 
enrolling and assessing participants, allocation was not revealed until the assessor 
had provided participant details to the secretary. Telephone (sometimes known as 
‘distance’) randomisation was used, where a secretary from the study site 
telephoned an otherwise uninvolved secretary at the university who held the 
randomisation list (two volunteers undertook this role). Telephone randomisation is 
the preferred method for concealing allocation in RCTs as it means the investigator 
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who recruits the participant is uninvolved in the process of allocation (Akobeng, 
2005b). The secretary at the study site was provided with the relevant details for the 
new participant to be randomised and then telephoned the university secretary. The 
university secretary enrolled and issued the treatment allocation that assigned 
participants to the interventions. I then received an email from the university 
secretary with the allocation information so I could inform the clinical team and 
manually assign the participant to an appropriate clinician for that treatment arm. 
This remote approach is preferable over more traditional methods such as 
sequentially numbered sealed envelopes, which can be opened once participants 
have agreed to enter the study. These envelopes can be easily tampered with so may 
lead to selection effects (Torgerson and Torgerson, 2008). It is more rigorous to 
remove the researcher responsible for collecting the outcome measures from the 
process of randomisation because it reduces bias. This was a practical option in light 
of the resource restraints. Electronic rather than paper randomisation lists are 
preferable due to the likelihood of improved data entry and storage (Kim and Skin, 
2014). 
Blinding 
Within RCTs, there is always the risk that participants, clinicians or assessors have 
preconceptions relating to the treatments offered in the study; this can lead to 
intentional or unintentional bias during the treatment or collection of outcome 
measures (Akobeng, 2005b). Blinding is the term given to the process of ensuring 
that researchers, participants (and their families) and/or clinicians (and in some 
cases statisticians) are unaware of, or ‘blinded’ to, the intervention to which the 
participant has been allocated (Petrie and Sabin, 2009, Kim and Skin, 2014). The 
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purpose of blinding within an RCT is to avoid bias during the completion of outcome 
measures, analysis and/or interpretation of results due to participants (i.e. 
treatment recipients, parents, clinicians, researchers, statisticians) providing 
responses that they believe are desirable. For example, if the researcher responsible 
for completing a diagnostic assessment believes a positive result in favour of the 
novel treatment may make publication more likely, they may (consciously or 
unconsciously) complete the assessments for those in the novel treatment arm more 
positively than the control arm.  
Although it was possible to remove the researcher responsible for conducting 
follow-up assessments from the randomisation process, as the sole researcher on 
the trial I was unable to be blinded after participant assignment to intervention 
groups. Clinicians were unable to be blinded due to the need for them to be trained 
and deliver the prescribed intervention and in order to ensure patient records were 
accurate. Patients and caregivers were also not able to be blinded as it would have 
been unethical and they were required to provide informed consent to participate. 
This is an acceptable approach for complex interventions, where it is often 
unfeasible to blind certain people to allocation (Eldridge et al., 2016a). A mix of 
clinician, parent and self-rated measures were included, most outcome measures 
were highly structured reducing the opportunity for bias. 
Data collection timetable 
Recruitment was scheduled between March 2015 to March 2016. Those randomised 
were followed up at three and six months from the date of randomisation. At three 
months, follow-up requests were sent two weeks prior to the follow-up due date 
(and assessments were completed at the earliest opportunity) and reminder letters 
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continued until four and a half months post-baseline (the halfway point between 
three and six-month follow-up). Six-month follow-up requests were sent two weeks 
prior to the due date and continued until seven and a half months post-baseline. Any 
responses received outside of this active follow-up period were still followed up. 
Qualitative interviews with participants who had received BA treatment (and their 
parents/carers) were offered at treatment completion; this was either at three-
month follow-up or a separate appointment held after their three-month follow-up 
session (if they had not completed BA treatment by the three-month follow-up 
stage). Qualitative interviews with clinicians took place during or after clinicians were 
administering BA so that staff had a varied caseload of patients at various stages of 
treatment on which to reflect.  
Recruitment 
Study participants were sourced from the pool of young people referred to CAMHS 
or currently on staff caseloads during the study recruitment period. Young people 
attended CAMHS and were assessed by their clinician in the usual manner, without 
involvement from the researcher. They were not approached to participate in the 
study until they had had at least one appointment with a CAMHS clinician. The first 
step in identifying eligible participants (those meeting the inclusion criteria above) 
was to invite those who may be eligible to hear more about the study, and, if they 
wished to participate, ask them to complete further assessments. As such, a 
provisional eligibility criterion was developed to provide a simple way to screen for 
potential participants in the study. Young people aged 12 to 17 years old with 
clinically significant depressive symptoms (as assessed by parent/carer, child or 
clinician) who were not receiving treatment for these symptoms were considered to 
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be provisionally eligible. Clinicians were also asked not to approach patients who 
were assigned to the LD team or required urgent care (this was also the case with 
researcher-led approaches). Three different approaches were utilised in parallel to 
determine provisional eligibility;  
• A case note review; 
• A study poster; 
• Clinician approach. 
Case note review 
The electronic case notes of patients currently allocated to clinicians at the 
participating CAMHS sites were reviewed using the Trust’s electronic records system 
(PARIS). Patient notes had to be accessed via a ‘case manager’ platform and each 
study site was hosted on a distinct platform within PARIS (where each Tier had to be 
accessed separately). Utilising the case manager platforms, each member of staff 
aligned to that Tier could be viewed and the patients on that staff member’s 
caseload could be accessed via a drop down list. The case note review started with 
the first staff member’s caseload and proceeded down the list of staff members in 
that Tier (staff were displayed in alphabetical order by surname); reviewing each 
staff member’s caseload in turn. Young people’s case notes were displayed in the 
same way and were also accessed in alphabetical order. Each patient screened was 
recorded in the study recruitment spreadsheet. The case note review continued 
during the participant recruitment period (when time was available). 
When a young person was identified as provisionally eligible, the family were 
contacted via post. Provisionally eligible families were sent an information pack (see 
Appendix 7), including an invitation letter, ‘consent-to-contact’ letter and study 
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information sheet (information sheets were printed from the relevant sections of the 
parental, or young person [either aged 12-15 or 16-17] baseline booklets) and a pre-
paid addressed return envelope. Families were asked to read the information sheets 
(the pack included a parent/carer version and an age-appropriate version for the 
young person) and return the consent-to-contact form to indicate whether or not 
they would like to hear more about the study by attending an information session 
(potentially progressing to a diagnostic interview to assess their suitability for the 
trial). Those that declined further information were not contacted again and those 
that were happy to hear more about the study were sent an appointment letter for 
an information session. Young people were encouraged to bring a parent/carer to 
these appointments, even if they were aged over 15. 
Poster 
A poster (see Appendix 8) was displayed in the waiting rooms of each participating 
CAMHS team advertising the study (and the provisionally eligibility criteria); Site Two 
and Three displayed one large (A0) poster and in Site One, due to the design of the 
waiting area two large posters were displayed. In all cases, the posters were 
accompanied by business cards with the study name and researcher contact details 
on. Patients and their families could use these contact details to directly refer 
themselves into the study. When families made contact (via telephone or email), 
their provisional eligibility was assessed by accessing their case notes using PARIS. 
Families were then informed (via telephone or email) if they were provisionally 
eligible for the BUDDY study; those that were ineligible were informed over the 
phone and were not contacted again. Those that were provisionally eligible received 
information sheets (parent/carer and age-appropriate young person version) and an 
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appointment letter to attend an information session (and potentially a diagnostic 
interview). 
Clinician approach 
The final way potential participants were referred into the BUDDY study was by their 
CAMHS clinician; this could occur in several different ways. Patients may have been 
approached during a routine appointment by their clinician (if the clinician judged 
them to be provisionally eligible) where they would be provided with basic verbal 
information relating to the study and the clinician would seek permission for 
researcher contact and ask if they were happy to receive further information (verbal 
consent-to-contact). If this was the case, families were sent the study information 
sheets and appointment letter for an information session (as above in the poster 
recruitment approach). Similarly, a clinician may have identified the young person 
during a routine appointment but the clinician may not have approached them. 
Another option would be that clinicians may have identified a patient as 
provisionally eligible based upon information in a referral (i.e., prior to seeing the 
patient) or reviewed their own caseload (for patients they had previously seen). In 
cases where a verbal consent-to-contact had not been received, an information pack 
(as in the case note review) would be sent to the family by post and they would be 
asked to return the paper consent-to-contact form. Only families that indicated they 
were happy to be contacted would be invited to an information session (and possible 
diagnostic interview).  
Clinicians were informed and reminded about the study through information 
presented at their team meetings, as well as study eligibility criteria that was 
circulated via emails from the Team Managers on a regular basis. In response to 
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repeated requests from staff for clarification of the eligibility criteria, posters (A4) 
were displayed in staff offices (see Appendix 8) with an overview of the provisional 
eligibility criteria and guidance on how to refer patients into the BUDDY study. The 
colours on these posters were changed half-way through recruitment to ensure they 
continued to capture the staff’s attention. I also regularly fed back recruitment 
figures to the CAMHS teams at staff meetings in order to raise the profile of the 
study. 
Measures used 
According to MRC guidance, a crucial aspect of the design of an evaluation is the 
choice of outcome measures (Craig et al., 2008). A variety of evidence-based routine 
and research measures were selected (see Table 7 below for the time points each 
was collected). The selection of outcome measures was informed by the feasibility 
and preparatory work for the BUDDY study and based upon the need to measure 
clinically relevant outcome measures, provide a research DSM diagnosis and limit 
the burden upon participants. At diagnostic interview, measures were taken to 
confirm study eligibility; this data was considered as the baseline measures for those 
progressing to enter the study. Young people who were randomised were then 
followed-up at three months (post-randomisation) where an exit interview was 
completed to repeat baseline measures and at six-month follow-up a telephone 
interview was completed to repeat selected outcome measures. Regular ROMs were 
also collected at each treatment session in both arms. The outcome measures used 
have been described in further detail below. 
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Table 7: Time-points outcome measures administered across both study arms 
 Baseline Three-month 
follow-up 
Six-month 
follow-up 
K-SADS-PLa      
MFQ-Cb       
MFQ-Pc       
RSE d       
CGASe      
BADSf       
End of Treatment Survey     
a
 Kiddie-SADS-Present and Lifetime Version (K-SADS-PL) provides DSM-IV diagnostic criteria for MDD 
b
 Mood and Feelings Questionnaire: Long Version Child Self-Report (MFQ-C) 
c
 Mood and Feelings Questionnaire: Long Version Parent Self-Report (MFQ-P) 
d
 Rosenberg Self-Esteem Scale (RSE) 
e
 Children’s Global Assessment Scale (CGAS) 
f
 Behavioral Activation for Depression Scale: Short Form (BADS) 
Diagnostic interview  
A depression diagnosis (MDD DSM-IV) was confirmed using the affective disorders 
schedule from the K-SADS-PL at baseline (diagnostic interview) and three-month 
follow-up. The K-SADS-PL is a semi-structured interview for children and their 
parents, which assesses both current and past diagnoses (Kaufman et al., 1997). 
From the information provided during the assessment it is possible to assign severity 
ratings to the young person’s symptomology (see severity criteria in Appendix 9). 
The advantage of the K-SADS-PL is that it provides algorithms for assigning DSM-III 
and DSM-IV diagnoses (American Psychiatric Association, 1987, 1994). A 
standardised diagnostic interview was used due to the criticisms of previous work in 
the field (Tindall et al., 2017), where young people were recruited into studies who 
had not received a diagnosis of depression at baseline. The K-SADS-PL has also been 
used in other BA RCTs involving young people (Ritschel et al., 2016), so it provides a 
comparable outcome measure with other literature. A structured diagnostic 
interview was also selected to ensure replicability and reliability. That said, it should 
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be noted that the purpose of diagnosing depression was for research purposes so, 
although the diagnostic information was recorded on patient’s electronic care 
records (via PARIS), it was not explicitly fed back to families. The rationale for this 
was due to the findings of Stage I that indicated diagnoses were not usually made in 
the service. The K-SADS-PL has been described as the ‘gold standard’ to diagnose 
depression (Wood et al., 1995). The ‘present and lifetime’ version has been 
purported to improve diagnostic reliability when compared to previous versions and 
because it allows the researcher the flexibility to alter the probes to suit the 
developmental level of the child; this was important when including young people 
aged 12 to 17 years old. In adolescents, the K-SADS-PL is designed to be 
administered to the young person first and then their caregiver as a secondary 
source of information. This design is supported by findings that children provide 
more accurate information about their mental state than their parents (Barrett et al., 
1991). Clinical judgement was used to resolve any discrepancies between child and 
parental reports.  
The structure of the K-SADS-PL involves completing: 
1. An unstructured introductory interview (10 to 15 minutes) with each 
informant separately. 
2. A diagnostic screening interview (5 to 10 minutes) with each informant 
separately. 
3. The supplement completion checklist (3-5 minutes) with each informant 
separately. 
4. The appropriate diagnostic supplements (the affective disorders schedule 
in this case) with each informant separately. 
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5. The summary lifetime diagnoses checklist and the Children’s Global 
Assessment Scale (CGAS; 5-10 minutes) after synthesising data and 
resolving any discrepancies.  
In total the instrument takes between 35 and 75 minutes to administer per 
informant (Kaufman et al., 1997). Young people were eligible for the study if they 
met the DSM (III or IV) criteria for MDD on the affective disorders supplement of the 
K-SADS-PL. 
Self-report measures 
The Mood and Feelings Questionnaire (MFQ) long version is a depression scale 
aligned to DSM-III-R criteria for MDD (Angold et al., 1987). There is a 33-item self-
rated version for children (MFQ-C) and a 34-item parallel version for parents to rate 
their child (MFQ-P). The self-report version MFQ demonstrated acceptable reliability 
in adolescent psychiatric outpatients aged 10 to 19 years old (Wood et al., 1995). 
The questionnaire asks respondents to rate symptoms (over the past two weeks) as 
true (scoring two), sometimes true (scoring 1) or not true (scoring zero); totalling a 
maximum score of 64. The higher the score, the more severe the low mood; we used 
the cut-off of ≥27 on the child version and ≥21 on the parental version to indicate a 
positive screen for depression.  
The Rosenberg Self-Esteem Scale (RSE) is a 10-item self-report measure for 
self-esteem where young people are asked to rate items on a four-point Likert scale 
from strongly agree to strongly disagree (Rosenberg, 1965). The higher the score, the 
higher the self-esteem; a cut-off of ≤14 indicates low self-esteem.   
The Behavioural Activation for Depression Scale (BADS) has been used to 
monitor self-reported activity, avoidance and impairment over the past week 
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(Manos et al., 2011). It consists of 9 questions, each rated on a seven-point scale 
ranging from 0 (not at all) to 6 (completely); higher scores represent increased 
activation. This scale has not been validated in an adolescent population but was 
selected due to an absence of alternative measures. 
An end of treatment survey comprising of fixed and open-ended questions, 
was administered to explore the acceptability of the study and treatment options 
with participants and their caregivers, in both treatment arms. This survey was 
designed specifically to evaluate this study and was not a ROM in the CAMHS service. 
The CYP IAPT programme mandates the collection of measures of 
assessment, review and discharge and frequent session-by-session measures 
designed to help support discussion and monitor progress towards treatment goals 
(Department of Health, 2013a, Wolpert et al., 2012). Routinely collected outcome 
measures were obtained via PARIS; young people were asked to complete the 
Revised Children’s Anxiety and Depression Scale to monitor depressive symptoms 
and the Strengths and Difficulties Questionnaire to provide information on 
emotional, conduct, attention and peer relationship difficulties. The Health of the 
Nation Outcome Scale Children and Adolescents was conducted by clinicians as a 
brief metric of other psychiatric symptoms. Guidelines issued for CYP IAPT advise at 
least one ROM should be completed per session (Wolpert et al., 2012); these 
measures were especially useful to monitor patients who withdrew or dropped out 
of treatment. The acceptability of each treatment arm was evaluated by the 
Commission for Health Improvement, a routinely collected experience of service 
questionnaire given at final treatment session by the clinician to patients. 
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To assist with estimating potential recruitment rates in a larger trial, the 
number of eligible young people, the number agreeing to diagnostic interview, those 
diagnosed with depression and those agreeing to proceed into the trial were 
recorded as per good practice (Eldridge et al., 2016a). Significant (i.e. drop out) or 
adverse events and treatment session descriptions from PARIS were also noted. 
Treatment content 
The comparison condition (TAU) represents standard care in CAMHS; participants 
receiving TAU received treatments deemed appropriate by their CAMHS 
professional; there were no restrictions, protocol or extra training given. The 
treatment participants received was recorded by their clinician using the usual 
mechanism on PARIS (a drop-down box where a variety of treatment approaches can 
be selected). Treatment as usual was provided by clinicians who had not been 
trained in the BA intervention. Clinicians in the BA arm used the manual to 
implement BA for eight sessions (see Appendix 5 for an overview of manual session 
content). Participants were considered to have received BA if they received one or 
more treatment sessions (a criterion decided by the BA expert). The reason for this 
was due to the treatment rationale and model were covered during BA session 1. 
Clinicians were asked to restrict other psychotherapies whilst delivering the BA 
intervention but were told they could provide any additional psychotherapy as 
deemed necessary following delivery of BA (this was recorded on PARIS). Sessions of 
BA are designed to be delivered face-to-face, spaced about one week apart and last 
around one hour. Staff delivering BA attended monthly group supervision sessions 
and had access to individual telephone supervision with a BA expert as and when 
staff required it. During the trial, treatment fidelity to the BA model was assessed in 
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a randomly selected 10% (decided using a random number generator and a matrix) 
of BA treatment sessions that were digitally recorded, using a digital audio recording 
device approved by the Trust. These recordings were coded by the BA trainer using a 
fidelity measure, which was used in the BODY and Mind study in Chapter 2 and a 
previous BA trial (Ekers et al., 2011b). In both arms, clinicians were advised of the 
outcomes of any research assessments via PARIS. Therapists provided either BA or 
TAU within the study. 
Procedure 
Information session 
Families of those who were deemed to be provisionally eligible and who agreed to 
hear more about the study were asked to attend an information session. The 
appointments were held onsite at their local CAMHS site in a private treatment 
room. Any families who refused this invitation were noted. Families were provided 
with a verbal summary of the study (additional copies of the paper information 
sheets were also available) and families were given the opportunity to ask any 
questions. Families would then be asked if they would like to take part in the BUDDY 
study and were provided with a paper consent form; young people aged 16 and 17 
were asked to completed an informed consent form and those aged 15 and under to 
complete an informed assent form as well as a parental informed consent form (see 
Appendix 7). If consent was provided, young people (and parents/carers if present) 
proceeded to a diagnostic interview (K-SADS-PL) during the same meeting. Those 
that did not provide consent continued their care as normal within CAMHS and took 
no further part in the study. Each family attending the information sessions (even if 
they did not progress to the diagnostic interview) received £10 in vouchers. 
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Diagnostic interview 
Families who provided consent at the end of the information session progressed to 
the diagnostic interview during the same appointment where the K-SADS-PL, MFQ-C, 
MFQ-P (if aged 15 and under), RSE, CGAS and BADS were administered. The results 
of these assessments were compared against the study inclusion and exclusion 
criteria. At the end of the diagnostic interview families were informed that they 
would receive a letter to indicate whether or not they were suitable to take part and 
if so, which treatment they had been allocated to.  
Following this appointment, a secretary from the CAMHS team was asked to 
randomise the patient by telephoning the independent secretaries who held the 
randomisation lists. The CAMHS secretary provided the name, Tier, severity of 
depression and study site. Participants were be subsequently allocated to BA or TAU; 
on some occasions this involved changing their clinician if they have already been 
allocated to a practitioner by the service at the time of randomisation. A letter was 
written following randomisation to inform participant’s general practitioners of their 
participation in the study. 
Exit interview 
The structured diagnostic interview (K-SADS-PL) was repeated three-months after 
the diagnostic interview. Participants were reminded of their right not to participate 
in case they wished to withdraw their consent. Remission from depression was 
defined as no longer meeting the criteria for MDD according to the K-SADS-PL. The 
MFQ-C (and MFQ-P if necessary), RSE and BADS were repeated and the end of 
treatment survey was also administered at this point to young people and the 
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parents/carers of those under 16 (see Appendix 10 for the follow-up workbooks). 
Families were given £10 in vouchers for attending. 
Qualitative interviews 
All participants in the BA treatment arm (and their caregivers) were invited to attend 
a semi-structured in-depth qualitative interview. Data collection continued until no 
similar issues were raised, a concept called data saturation. Young people were 
offered the option of an interview alone or with a parent/carer present. If they had 
completed BA treatment at the three-month exit interview the qualitative interview 
was held at the same appointment; if not, it was held during a separate appointment 
at a later date (where they received an additional £10). This interview followed a 
topic guide (see Appendix 11) of semi-structured, open-ended questions where 
interviewees were encouraged to talk about the topics of most importance to them. 
Exploring topics of interest to the participants enables a greater understanding of 
the outcomes that patients deem most relevant, rather than those of interest to the 
researcher (Torgerson and Torgerson, 2008). The topic guide was designed to be 
open but with prompts designed to elicit additional information on both views on 
the trial and wider experiences, both positive and negative.  
All staff responsible for delivering the BA intervention in the study were also 
asked to attend a similar interview (see Topic Guide in Appendix 11). Staff were 
provided with a paper information sheet and consent was sought at the time of the 
interview (see Appendix 12). The findings will inform the refinement of the 
treatment manual and intervention following the trial. All interviews took place in 
the staff or young person’s usual CAMHS site, in a private room. 
  160 
Telephone follow-up 
The MFQ has been reported to be a useful measure of clinical remission in 
adolescent psychiatric outpatients (Wood et al., 1995). Six-months after the post-
diagnostic interview, all participants received a telephone call to re-administer the 
MFQ(s) and RSE to assess medium-term outcomes. This took approximately 15 
minutes and marked the end of study involvement. 
Dissemination 
A lay summary of the results was sent to all participants and clinicians who 
participated in the trial (see Appendix 13). Service team managers were also written 
to and a PowerPoint presentation was offered to disseminate the results to the 
wider team. 
Data management 
Paper data was stored in a de-identified format (using unique codes) in a locked 
filing cabinet onsite at the University. Electronic patient data were stored in a secure 
file on the university computer, which only the research team has access to. A 
backup will be kept on a password-protected encrypted data stick. Data will be 
destroyed securely after a period of 10 years.  
Data from the trial were entered and stored on Excel spreadsheets. Each row 
of data corresponded to a different individual in the study and each column to a 
variable (repeated at different time points); numerical codes were assigned to 
categorical data where necessary (i.e., 1 for yes and 0 for no) and missing data were 
indicated with a full stop. 
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Data analysis 
Quantitative data analysis 
The quantitative results are presented following the Consolidate Standards of 
Reporting Trials (CONSORT) guidelines for randomised pilot and feasibility trials 
(Eldridge et al., 2016a). The CONSORT guidelines aim to improve the transparency 
and quality of reporting of RCTs. The extension to the 2010 guideline focuses on 
advice for external pilot and feasibility trials, where effectiveness or efficacy is not 
the primary focus.  
Quantitative data were exported from Excel into STATA (version 13.1, 
StataCorp), a specialist statistical package, to carry out analyses. Quantitative 
analyses with inferential statistics are presented for the following numerical 
outcome variables: MFQ-C, MFQ-P, RSE, CGAS, and categorical depression status on 
the K-SADS-PL. Descriptive statistics only have been included for the BADS, the 
categorical severity ratings on the K-SADS-PL and the end of treatment survey. For 
the MFQ-C and MFQ-P variables, higher scores represent lower mood; therefore, a 
negative gradient over time represents improvement. For the RSE and CGAS 
variables, higher scores indicate higher self-esteem and functioning respectively; 
therefore a positive gradient represents improvement over time. In terms of 
presenting data for the clinical endpoints, mean (SD) for continuous outcomes and 
raw count (%) for categorical variables are reported.  
The validity of the conclusions drawn from the data relies upon the 
appropriate analysis being conducted and a requirement that the underlying 
assumptions inherent in the proposed statistical analysis are satisfied (Petrie and 
Sabin, 2009). Data were examined in order to determine whether parametric or non-
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parametric tests were appropriate. A one-way ANOVA (parametric) or Kruskal-Wallis 
(non-parametric) test would have been used in order to explore the comparability of 
the patient characteristics between treatment groups at baseline and investigate any 
differences in those who have and have not dropped out at follow-up. For the K-
SADS-PL depression status data, a binary logistic regression was used to assess 
whether the odds of remission were greater in the BA arm than the TAU arm. For the 
MFQ-C, RSE and CGAS data, effect sizes for the BA versus TAU were calculated via 
the ‘e-size’ command of STATA. The exception to this is where the missing outcomes 
were multiply imputed. In this case, the effect sizes were estimated via recombining 
the results of linear regressions for the imputed datasets using the ‘mi estimate’ 
syntax in STATA. Calculation of effect sizes is not strictly appropriate for feasibility 
studies; as such, this was not planned in the original protocol. However, upon 
reflection and for the purposes of this thesis, the methods that would be used in a 
larger trial have been mimicked in a post-hoc reflective analysis. For outcomes on a 
continuous scale, a commonly used effect scale for group comparisons is Cohen’s d, 
defined as the difference between two means divided by the pooled standard 
deviation of those means (Cohen, 1992). Cohen (1992) suggests a value of 0.2, or 
less, is indicative of a small effect, approximately 0.5 a medium effect and around 0.8 
a large effect. Cohen’s d was selected to report effect sizes over Hedges g as Hedges 
is typically used in samples smaller than 20. The size of the group difference is the 
key statistic, which will be presented with CIs as a measure of the precision with 
which this has been estimated. The CIs enable consideration of the range of possible 
values that could be potentially consistent with the data and thus permit assessment 
of whether effects within this range of magnitudes may be of clinical importance 
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(Rutter et al., 2008, Akobeng, 2005b). Typically, any estimates of effects using 
participant outcomes as they are likely to be measured in a future definitive RCT 
would be reported as estimates with 95% CIs without p-values because 
feasibility/pilot trials are not powered for testing hypotheses about effectiveness 
(Eldridge et al., 2016a). In this case, results have been presented with p-values, 
bearing in mind the risk of ‘fishing’ for significance (via multiple tests and outcomes) 
and the probable lack of power in a feasibility study. A p-value can be thought of as 
the probability that the observed difference (or one more extreme) between the two 
treatment groups occurred solely by chance (Akobeng, 2005b). 
Missing data, even at this feasibility stage, is a major threat to the validity of 
the results of the trial and represents a challenge in how to address this at this stage 
and in a larger trial (Akobeng, 2005b). Although it is common in RCTs to have missing 
data at follow-up due to drop-out, unless this data is missing completely at random it 
could be a source of bias of treatment effect. As such, extensive efforts were made 
to follow-up families by offering a financial incentive, reminder letters and 
rearranging missed appointments. Participants lost to attrition could not be included 
in the descriptive statistics; however, missing data has been accounted for in some 
of the exploratory statistical analyses. 
There are various ways to deal with missing data when it is analysed, such as 
conducting ‘Per Protocol’ (PP) or on-treatment analyses (where only those who 
receive treatment as detailed in the protocol are included) or Intention-To-Treat 
(ITT) analyses where all randomised participants are included. A meta-
epidemiological study, based on a collection of meta-analyses of RCTs, found 
excluding participants with missing data from the analyses can bias results; with the 
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degree and direction of such bias being unpredictable (Nüesch et al., 2009). When 
participants who were randomised are excluded from the analysis it can defeat the 
purpose of random allocation, thus leading to bias as we can no longer be confident 
that important baseline prognostic factors between the two groups are similar 
(Akobeng, 2005b). Per protocol or on-treatment analyses are therefore not 
recommended, as they often lead to biased treatment comparisons (Petrie and 
Sabin, 2009). Therefore, no PP analyses have been undertaken.  
An ITT analysis has been conducted for all participant randomised where data 
is available. With an ITT analysis you can account for the missing data in several 
ways, such as by using the ‘Last Observation Carried Forward’ (LOCF) or by using a 
statistical process called Multiple Imputation (MI) to work out a plausible missing 
value.  Here ITT analyses have been conducted, where all participants assigned to a 
treatment group at randomisation are analysed in that group regardless of whether 
they followed the treatment regime. Two methods were used to insert the missing 
values; firstly LOCF and secondly MI. The LOCF approach simply uses the last data 
point observed and inputs it to the next data point (i.e., where baseline data has 
been collected but there is no three-month follow-up data, the baseline score would 
be used at the three-month time point). This approach assumes that the missing 
value is equal to the last observation made which can bias results in either direction 
as it fails to reflect the uncertainty around missing values (Nüesch et al., 2009). To 
address some of the deficits of LOCF, MI was also used, which allows for uncertainty 
around missing data by creating many imputed data sets sampled from predictive 
distributions modelled on the available set of observations, rather than just one 
replaced value (Sterne et al., 2009).  
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All statistical analyses using STATA were completed alongside one of my 
supervisors (Paul Tiffin), as becoming fully competent in the design and application 
of advanced statistical techniques (such as MI) was beyond the remit of this PhD. In a 
larger trial where additional resources were available, a statistician would be 
consulted to design and implement a data analysis plan. Four of the included Figures 
(Figures 18-21) were produced by my supervisor’s assistant, from STATA using the 
package ‘coefplot’ to my specifications. 
Qualitative data analysis 
Qualitative interviews were audio recorded and transcribed verbatim. Identifying 
information was then removed from the transcripts to anonymise the data. 
Pseudonyms were given to preserve anonymity and assist the reader in identifying 
the speaker. The qualitative analysis focused on remaining true to the participants’ 
voices and developing responses to the research questions, rather than using a 
methodology that relies more heavily on researcher interpretations. An inductive 
approach to qualitative data analysis was utilised, in which meanings emerged from 
the data through iterative exploration of the data set, using a thematic analysis 
approach according to the principles of Braun and Clarke (2006). Thematic analysis is 
considered to be an appropriate approach to analysing qualitative data in the 
context of a feasibility trial (O’Cathain et al., 2015). Other methods of data analysis 
were considered (such as framework analysis) but these would not have enabled 
adequate exploration of the feasibility of this novel treatment approach in a complex 
clinical setting, which demanded an unrestrained and exploratory approach.  
Qualitative transcripts were read several times to familiarise myself with the 
data. An initial thematic framework was developed, based upon the early transcripts 
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and field diary entries, following which data were assigned to the themes drawn out 
from the transcripts. During analysis the themes, relationship between themes and 
interpretation were discussed with my supervisory team. In addition to the interview 
data, contextual information to assist the analysis was obtained from the free text 
box in the patient’s case records on the Trust’s electronic patient records system 
(PARIS). Rather than being used to corroborate participants’ accounts, this 
information was used as ‘stimulus material’ (Barber, 2014) to situate participant’s 
narratives within the context of therapy delivery by providing information about the 
number of sessions delivered and staff perspectives on those sessions. Again, this 
reflects the acknowledgement of the importance of context in the analysis, as well as 
content. It also allowed identification of the staff assigned to each participant, in 
order to establish links between staff and patient narratives. As in Stage I of this 
thesis, Figures have been used to create a visual to aid in illustrating the results. 
The following section moves on to discuss the recruitment results.
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Stage II Recruitment Results 
Presentation of the results 
As this is a mixed methods trial, the qualitative and quantitative data relating to the 
study recruitment will be presented together under relevant sub-headings 
(Cresswell, 2009). Where necessary, recruitment approaches begin with a descriptive 
prelude. This is followed by relevant qualitative findings, and then any related 
quantitative results. Each section ends with an integrated summary. The success of 
the study design and randomisation are then detailed. Direct quotes have been 
included where relevant, to enable the reader to judge the quality of research and 
claims made (Mason, 2002). 
Patient recruitment 
Recruitment was initially projected to last one year; in practice, it took place over a 
17-month period; from March 2015 to July 2016. Trial recruitment was stopped at 
the end of the defined recruitment period: any potential participants who had not 
progressed to entering the study by July 2016 were not included (i.e., those on 
internal service waiting lists). The study formally ended seven and a half months 
following the date the final participant was randomised into the study (March 2017). 
Flow of patients through the trial 
A total of 351 young people were screened for inclusion in the BUDDY study from 
three CAMHS. Patients were referred to the study via three different recruitment 
methods; a researcher case note review, by clinicians during routine appointments 
or a poster displayed in CAMHS waiting rooms enabling patients or their families to 
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refer themselves into the study. Two hundred and sixty seven young people were 
screened in the case note review (eight of which were deemed provisionally eligible), 
four families contacted the study team after seeing the study poster (three of which 
were provisionally eligible) and 80 were approached by their CAMHS clinician (53 
were provisionally eligible). Following screening 287 patients were excluded, leaving 
64 who met the provisional eligibility criteria; a rate of 18%. Those identified as 
provisionally eligible were invited to attend a diagnostic interview. Following this 
invitation, a further 38 were excluded prior to the diagnostic interview due to no 
longer meeting the inclusion criteria (n= 1), being discharged from the service (n= 
15), transferred to a Tier not participating in the study (n= 3), declining participation 
(n= 10) or being withdrawn by their clinician (n= 9). Twenty-six were subsequently 
assessed for eligibility using the K-SADS-PL diagnostic interview. Twenty five (96%) 
were identified as having MDD and met the study inclusion criteria (prior to 
randomisation, one of these patients was excluded by the clinical team due to the 
severity of their condition, two further patients remained on an internal waiting list 
and were not allocated to a clinician within the timeframe of the study), leading to 
22 patients being randomised into the trial (see CONSORT diagram in Figure 7). From 
the pool of original patients screened and referred to the study, those randomised 
represented an inclusion rate of 6.3%. Eleven participants (50%) were allocated to 
BA and 11 (50%) to TAU. In the BA arm, one participant was excluded from the study 
post-randomisation by their CAMHS clinician and was not offered BA treatment (or 
invited to follow-up assessments) and another did not respond to a letter from the 
service so was discharged prior to treatment. In the TAU arm, two patients were also 
discharged prior to receiving any treatment. Primary outcome data (K-SADS-PL MDD 
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diagnosis at three-month follow-up) were available for 15 patients (68%), 
representing a loss to follow-up of 32% (36% in BA group and 27% in the TAU group). 
Two of those randomised to BA treatment did not attend and one other declined to 
attend the three and six-month follow-up sessions. Two others did not attend the 
six-month follow-up appointment. In the TAU arm, one participant did not attend 
follow-up at three or six months and two others did not attend three-month follow-
up but did complete six-month follow-up. At six-month follow up, 11 patients were 
retained (including the two participants who did not provide three-month follow-up 
data), with a loss to follow up of 50% at six-months (55% in BA group and 45% in the 
TAU group). Further details relating to the exclusion of potential participants at each 
stage will be detailed below. 
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Figure 7: CONSORT Diagram: flow of participants through the BUDDY study. 
*Identified by case note review (n= 267), study poster (n= 4) or clinician (n =80)
 
 
 
 
 
 
 
 
 
 
Provisionally eligible (n= 64) 
Excluded (n= 38) 
  Excluded by clinician (n = 9) 
Discharged/transferred (n =18) 
Declined to participate (n= 10) 
No longer meets eligibility criteria (n = 1) 
Lost to follow-up (n= 6)
 Excluded (n= 1)
 Withdrawn (n= 1)
 Lost to follow-up (did not respond) (n= 4) 
 
Lost to follow-up (n= 4) 
 Excluded (as above: n= 1) 
 Withdrawn (n= 1) 
 Lost to follow-up (did not respond) (n= 2) 
 
Allocated to BA intervention (n= 11) 
 Received allocated intervention (n= 9) 
 Did not receive allocated intervention  (n=2): 
one discharged from service and one 
removed due to risk by clinicians 
Lost to follow-up (n= 3)
 Lost to follow-up (did not respond) (n= 3) 
 
Allocated to TAU (n= 11) 
 Received allocated intervention (n= 9) 
 Did not receive allocated intervention  (n= 2): 
both discharged from service by clinicians 
(one returned to service later) 
Lost to follow-up (n= 5)
 Lost to follow-up (did not respond) (n= 5) 
Allocation 
6-month follow-up 
3-month follow-up 
Randomized (n= 22) 
Screening 
Assessed for eligibility (n= 351)* 
Excluded (n= 287) 
   Not meeting inclusion criteria (n= 286) 
   Declined to participate (n= 1) 
Eligibility Assessed (n= 26) 
Assessment 
Excluded (n= 4) 
   Not meeting inclusion criteria (n= 1) 
   Other reasons (n= 3) 
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In Table 8, participants assigned to BA treatment have been allocated a 
pseudonym to preserve anonymity, assist in differentiating between participants and 
to aid interpretation of the findings. Six of those young people assigned to BA 
treatment and five of their parents attended a qualitative follow-up interview once 
treatment was complete (indicated in bold in Table 8). When participating young 
people were asked if they would like their parents to be present during their 
interview all but one invited their parents to attend (n= 5); this one young person 
opted to attend alone due to their parents’ lack of availability. In Table 9, all 
clinicians trained in the BA intervention (those that progressed to participate in the 
study) have also been assigned pseudonyms; five of the participating staff were 
interviewed (indicated in bold). One member of staff declined the offer of an 
interview, due to a lack of time. In all combinations of therapist/young person, either 
the member of staff delivering the therapy or the young person receiving it were 
able to be interviewed. In order to assist with identifying which quotes are from a 
staff or a participant pseudonym; staff have been assigned an identification number 
preceded by an ‘S’ and participants a number starting with ‘P’. 
Table 8: Participant pseudonyms and characteristics; bold font indicates those who 
attended the qualitative interview 
Pseudonym Identifier Number of BA 
Sessions 
Gender Age Tier 
Jennifer* P1 2 f 14 3 
Frankie* P2 3 f  17 3 
David P3 8 m 17 3 
Jessica*** P4 0 f 17 2 
Estelle P5 8 f 14 2 
Lucy P6 8 f 13 2 
Sophie*** P7 0 f 16 2 
Victoria* P8 7 f 14 2 
Connor* P9 4 m 14 2 
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Neive* P10 3 f 15 2 
Alicia P11 8 f 17 3 
Participants where: *treatment incomplete *** treatment not started 
Table 9: Staff pseudonyms and characteristics; bold font indicates those who 
attended the qualitative interview 
Pseudonym Identifier Number of BA 
patients 
Gender Age Tier 
Geoff S1 3 (2*) m - 2 
Nicola S2 2 (1**) f - 2 
Shane S3 1 m - 3 
Paul S4 2 (1***) m - 2 
Sharon S5 2 (1*) f - 3 
Bridget S6 1* f - 3 
Number of the clinician’s patients where: *treatment was incomplete **excluded by researchers from 
the study *** treatment not started 
As detailed in the methods section, three different methods for recruiting patients 
into the study were used and evaluated to assess their suitability for recruiting 
participants into this feasibility trial: a case note review of patient electronic records, 
a poster displayed in the site waiting rooms asking patients to identify themselves as 
suitable for the study and identification of patients by clinicians during routine 
appointments. Patients were deemed provisionally eligible if aged between 12 and 
17 years old, were not under the care of the LD team or had a LD that may have 
made it difficult for them to engage in the intervention, had not started 
psychotherapy and depression symptomology had been noted in their records. 
Recruitment approach 
Case note review 
A case note review was conducted at two of the three study sites; Site One and Site 
Three. The case note review at Site Two was unable to be effected due to a lack of 
resource. Both initiated reviews covered only a sub-section of the available case 
notes, due to a lack of time to complete the full reviews as intended. The main 
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reason for this was the lack of functionality in the Trust patient records system 
(PARIS) which made it impossible to refine patient searches, meaning that each case 
note had to be reviewed individually, rendering the process extremely labour-
intensive. Although aware of many of these difficulties prior to the start of the study 
(from Stage I of the research), there were additional unanticipated factors that 
compounded these problems when using this method of patient screening. When an 
individual patient record was accessed, it had to be manually cross-checked against 
the study recruitment spreadsheet (of those case notes already reviewed) in order to 
check for duplication. Duplication was particularly problematic when screening case 
notes in this way; for example, one patient may have had an assessment in Tier 2, 
progressed to Tier 3 for a more specialist assessment and then been allocated to a 
‘lead professional’ who required a cognitive assessment to be completed by a ‘co-
worker’. This would lead to the young person being on the caseloads of four staff 
members. In some cases, once the clinician’s work with the young person had been 
completed, the patient may have been removed from the staff’s caseload but this 
occurred on an ad hoc basis. As such, each staff member had large numbers of 
patients on their caseloads and some patients were therefore reviewed multiple 
times, leading the case note review to be inefficient. Another difficulty was the order 
and number of patients on a staff’s caseload changed on a daily or weekly basis (i.e. 
when new patients were added or removed), which made it difficult to crosscheck 
against the recruitment spreadsheet. Additionally, once a patient ID had been cross-
checked against the spreadsheet for duplication, several different screens had to be 
accessed to obtain the required information. If the young person was excluded due 
to being outside the required age range, this information could be found easily 
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within a few seconds as it was on the PARIS patient header; however, assessing if the 
patient had an LD (but not one severe enough to enable them to be treated by the 
LD team), depressive symptoms or had received psychotherapy was much more 
challenging and often involved reading through tens of individual clinical entries 
which could take up to 20 minutes per patient case note. Due to the difficulties 
described and the success of the other two methods of recruitment, there was less 
reliance upon this method of participant recruitment and, relatively early on in the 
recruitment period, clinician identification was prioritised over case note review 
tasks. 
In contrast to the difficulties experienced implementing this method of case 
finding, during the qualitative interviews when CAMHS clinicians were asked about 
how families were identified to take part in the study, Shane (S3) felt a case note 
review must have been a helpful method, yielding many potential participants. 
During the participant and carer interviews there were no comments relating to this 
approach method, which is not surprising as none of the families taking part in the 
interviews were ultimately recruited in this way. 
At Site One, 178 electronic patient records were screened for provisional 
eligibility for the study, yielding one provisionally eligible patient. One further patient 
was provisionally eligible but had previously been approached by their clinician 
where they declined the invitation to participate (so was considered not to be 
provisionally eligible). At Site Three, the electronic patient records of 89 young 
people were screened, yielding eight young people who were provisionally eligible 
(84 of these case notes were reviewed by an Assistant Psychologist to facilitate 
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identification of potential participants). See Table 10 for further details of the 
profiles of the patients screened using this method. 
Table 10: Patient characteristics of those screened in the case note review 
 Site One Site 
Three 
No. screened 178 89 
Male 148 52 
Female 30 36 
Unknown Gender 0 1 
Median Age 11 10 
Excluded for Age 96 57 
Excluded for LD 7 0 
Excluded already receiving treatment 24 15 
Excluded no depressive symptomology 48 9 
Excluded previously been approached 1 0 
Excluded duplicate 1 0 
No. provisionally eligible 1 8 
Of the 267 patients screened using this method, only 9 (3.4%) were provisionally 
eligible. One of these had to be subsequently excluded as, between the point when 
they were identified via the case note review and when they were contacted to 
participate in the study, they had started group therapy for their depressive 
symptoms. Eight participants (3% of those screened using this method) therefore 
went forward as provisionally eligible. 
Poster recruitment 
Three members of staff participating in the qualitative interviews commented 
specifically on the presence of the poster in their CAMHS waiting room, which they 
felt was of good quality and a helpful way to approach participants. When young 
people were interviewed, Jennifer (P1) and her carer described how they were 
recruited to participate in the BUDDY study after viewing the poster that was 
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displayed in the waiting room of the CAMHS they were attending and they were 
happy with this approach. They noted that their main motivation to participate was 
that they felt taking part in the study might ensure that they were given treatment 
after a long wait in the service already.  
Four young people (all female, median age 14) were recruited directly using 
the poster. It is unknown how many patients viewed this poster. These four young 
people or their parents used the email or telephone number displayed on the 
poster/contact card to alert the research team directly. Of the four patients 
recruited using this method, three (75%) were provisionally eligible. When eligibility 
was checked for one patient, they had already started receiving psychotherapy so 
had to be excluded. A further four young people were prompted by the poster to 
approach their clinician about the study. The clinician then approached the research 
team on their behalf so they are reported under the clinician approach figures. 
Clinician recruitment 
Clinician recruitment took two forms; referral by the clinician to the research team 
(where the researcher invited the participant to hear more about the study by letter) 
or direct approach by the clinician. One parent (who had seen the study poster and 
expressed an interest in the study to their clinician) reported that their poor literacy 
had led to difficulties reading the study information provided. Although this problem 
was able to be resolved at their next appointment with their clinician who went 
through the information with the family. During the qualitative interviews, all five 
participating young people (and four carers) reported that they were happy with 
being approached by their clinician and could not identify a more preferable way to 
be asked to participate. Lucy (P6) said “I think it was good the way they [the clinician] 
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dealt with it, how they put it across”. Jessica (P4) also felt “quite positive about it 
[the clinician recruitment process] because I didn’t feel like it was forced on me in 
any way, and I felt like I was welcome to talk about anything that I wanted, or leave 
anything”. Estelle’s parent (P5) reported the recruitment process happened quickly. 
This was in contrast to the long wait for the service, which they were dissatisfied 
with and had complained about prior to entering the study. Similarly, Lucy had an 
expectation that taking part in the study would lead to receiving care quicker than 
usual. When young people were asked to consider alternative approaches, David 
(P3) felt a letter (as he received from the research team following the initial clinician 
approach) would be preferable to being approached via a telephone call. 
When staff were interviewed, they reported being pleased with their role in 
recruiting potential participants during their routine consultations, feeling that it 
worked well for them and the families they were approaching, as well as it appearing 
to be a successful way to recruit patients into the study. Although Geoff (S1) felt that 
“it took a little while to get it into your mind-set”, once he had taken on this 
recruitment role he felt it led to the successful recruitment of a significant number of 
potential participants. This reference to requiring time to absorb the recruitment 
criteria appears to echo one of the earlier findings in Stage I, relating to the concept 
of staff ‘headspace’ and the importance of this in order to participate in research 
(see Chapter 3). Shane (S3) highlighted the benefits of the researcher being available 
to support staff in their role of identifying potential participants; “a lot of people, 
even though the criteria for their entry into the study were made quite explicit, 
wouldn’t understand [the study entry criteria], both service users and staff”. Shane 
described the availability of a researcher onsite as an important control to stop the 
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recruitment of unsuitable applicants due to the misinterpretation of recruitment 
criteria by inexperienced staff. This can again be linked back to staff confidence, 
which was illustrated ethnographically in Chapter 3. Paul (S4) discussed how Tier 2 
staff were particularly well suited to undertaking a recruitment role due to the 
numbers of patients that they see and that they often undertook initial assessments 
when young people were referred to the service, suggesting that “it seemed to be an 
opportune time to pick them up”. In contrast, Geoff felt that Tier 2 staff were 
restricted due to their assessment sessions being too short to obtain the information 
required to make a decision about young people’s suitability for the BUDDY study. 
One member of staff, Sharon (S5) thought a more efficient strategy would be to 
attend staff referral meetings, although she implied these were not currently taking 
place in her team. Nicola (S2) proposed that to increase accessibility to the study 
young people could be recruited from outside of CAMHS by drawing a wider net to 
include schools, possibly via school councillors. Shane (S3) felt GPs may be in the 
best position to provide referrals into the study. In a broader sense, he discussed the 
importance of approaching the right staff to participate in the project, rather than 
just focusing on recruiting the right patients.  
“I think the key to getting people involved and getting the right people 
involved isn’t about how you approach the families, it’s about how you 
approach the staff. And I think if more staff who are doing initial 
assessments, if the primary mental health teams who are doing access to 
service appointments, maybe even GPs who have this information 
available, assuming they’d be able to [refer] straight in… Have the 
information of this is what makes a person suitable, then I think if they 
had that information and understood it and remembered it, that’s how 
you’d get the best influx I think” [Shane S3]  
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The amount and depth of feedback received from staff, demonstrated the level of 
investment in the BUDDY study and provided insight into plausible alternative ways 
to approach young people to participate in future studies. 
In addition to the four young people who were recruited by their clinician 
through the study poster, a further 76 young people were recruited directly by their 
clinician (see Table 11). Of the 80 patients referred via this method, 53 (66.3%) were 
provisionally eligible. The majority of those deemed provisionally eligible were 
recruited by Tier 2 staff. See Table 11 for a breakdown of the reasons the 27 were 
excluded; of those instances where the patient was already receiving treatment (n= 
5); three were receiving Cognitive Behavioural Therapy (CBT), one Dialectical 
Behaviour Therapy (DBT) and one an unspecified treatment. In three cases, patients 
no longer met the criteria for low mood; the depressive episode had resolved for one 
of these patients (as assessed by a Psychiatrist) and in the other two cases, although 
the initial referral to the service indicated low mood, this was not found when the 
patient was assessed by a clinician. Where clinicians withdrew participants (n= 2), 
one clinician wished to keep patient for a case study in their CYP IAPT training course 
and another expressed concern that the patient had ulterior motives for attending 
CAMHS so would be unsuitable to participate. Where patients declined participation 
(n= 3) this was due to families returning the consent-to-contact form indicating they 
did not want to receive further details relating to the study. Two young people were 
referred outside of the study recruitment window so their eligibility was not 
assessed. Notifications in error (n= 2) were due to clinicians selecting the incorrect 
alert function on PARIS where they alerted the whole CAMHS team to the case 
rather than the intended clinicians. 
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Table 11: Patient characteristics of those referred into the study via clinicians 
 Site One Site Two Site 
Three 
No. referred 47 28 5 
Male 12 8 0 
Female 35 18 5 
Unknown Gender 0 2 0 
Median Age 15 16 15 
Excluded for Age 1 0 0 
Excluded for LD 1 0 0 
Excluded already receiving treatment  5 0 0 
Excluded no depressive symptomology  3 0 0 
Excluded withdrawn by clinician 2 0 0 
Excluded patient declined 3 0 0 
Excluded urgent care required 2 4 0 
Excluded outside recruitment window 1 0 1 
Excluded notification in error 1 1 0 
Excluded duplicate 0 2 0 
No. provisionally eligible 28 21 4 
Patient recruitment summary 
All three recruitment strategies appeared to be well received by patients, their 
parents/carers and clinicians, with no negative comments on the methods of 
recruitment trialled. However, the case note review was not found to be feasible 
from a researcher perspective. The poster content and presentation appeared to be 
satisfactory to staff and patients recruited via this method. Clinician approach was 
acceptable to patients and valued by staff, despite initial reservations. There was a 
lack of consensus on which Tier would be best placed to recruit participants into the 
study. Despite one member of staff raising concerns that assessment sessions may 
be too short within Tier 2, clinicians were found to be accurate at identifying 
provisionally eligible young people and the majority of provisionally eligible 
participants were recruited from Tier 2.  
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We were interested in exploring which of the three recruitment methods 
yielded the greatest number of provisionally eligible patients. Figure 8 (i) illustrates 
the proportion of patients subsequently deemed provisionally eligible recruited 
using each different method or combination of approaches. Clinician-led approaches 
were responsible for recruiting the greatest number of provisionally eligible patients; 
82.8% of participants were recruited by clinicians compared to 4.7% who were self-
identified and 12.5% who were identified by researchers. However, the results also 
suggest that self-selection (via the poster) was an effective approach; with 75% of 
those identified using this method being provisionally eligible compared to 66.3% for 
clinician-led and 3% for research-led approaches (see Figure 8 [ii]). 
i)     ii) 
 
Figure 8: Pie-chart illustrating i) the numbers of provisionally eligible patients 
derived from each different recruitment method ii) the proportion of those 
identified from the total number screened using each recruitment method 
Participant Eligibility 
Those deemed to be provisionally eligible (n = 64) were invited to an information 
session and subsequent diagnostic interview. Thirty-eight of these provisionally 
eligible participants were excluded prior to being able to attend an information 
Case note
Poster
Clinician
Case note
Poster
Clinician
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session. One of these also no longer met the provisional inclusion criteria. Fifteen 
had been discharged from CAMHS care (patients dropping out/withdrawing from the 
service or staff discharge due to improvements in depressive symptomology, the 
availability of alternate service provision or no response from families to letters from 
the service) and a further three patients had been transferred to Tier 3 of Site Three 
where no clinicians were able to be trained in BA so had to be excluded. Ten of those 
invited, declined after receiving the study materials (one of these was after attending 
the information session); one stated they did not like the weekly format of BA (and 
wanted to receive treatment on a monthly basis), one did not want to risk being 
allocated to another clinician after meeting their current clinician (i.e. during 
randomisation), one did not like talking therapies, five did not provide a reason and 
two did not attend the information session. Nine were excluded by their clinician; 
one clinician was not happy for the research team to approach the patient, three 
thought the case was too complex or BA was too simple, one wanted to use the 
patient as a case study for their CYP IAPT training course, one felt another 
comorbidity needed to be prioritised, one patient required urgent treatment and 
two clinicians felt a group therapy approached was needed. Therefore, 26 patients 
progressed to assessment in the K-SADS-PL diagnostic interview. One young person 
did not meet the criteria for MDD during the K-SADS-PL assessment, leaving 25 
young people who met the study inclusion criteria. Following the diagnostic 
interview, the CAMHS team withdrew one participant due to the disclosure of 
additional risk during the K-SADS-PL; this occurred prior to randomisation. Two 
further patients remained on an internal waiting list and were not allocated to a 
clinician within the timeframe of the study. These patients could not be included in 
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the study because they would not have been able to be randomised due to the 
stratification in the randomisation list requiring knowledge of which Tier their 
allocated clinician worked in. This lead to 22 patients being randomised into the trial. 
Qualitative feedback on treatment allocation 
Young person and caregiver views on the treatment options offered 
An important part of any psychotherapy trial, particularly at the feasibility stage, is to 
understand how young people and their parents/carers might view the different 
treatment options offered to them. In this study, families were offered either BA or 
TAU (described as ‘Combined Treatment’ in the study materials). This was explored 
with those allocated to BA treatment during the qualitative interviews and across 
both treatment groups in the end of treatment survey at the three-month follow-up.  
One parent felt the researcher had expressed a preference in favour of BA “because 
if I remember rightly you talked to us about it and this one was the best one”, so the 
patient was pleased with their allocation to BA. This impression was most likely 
gained from the treatment description because the same parent also noted “…this is 
all new to us” when asked if they had any prior expectations of the type of 
treatments that would be offered to them. However, their young person Estelle (P5) 
stated:  
“I didn’t know anything about the other option, so I didn’t have a 
favourite because I didn’t know about them. So that was fine” 
No young people or other parents expressed a preference for either treatment 
option. As indicated by Estelle above, it was common for participants and their 
families to not have an in depth knowledge about either of the treatment options 
available. In fact, Jennifer (P1) reported that she was not aware that the two 
treatment options were different to one another and Frankie (P2) and their parent 
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suggested they may have forgotten about what each treatment consisted of but 
were happy with the one they were allocated. Two other young people clearly stated 
that they did not prefer one treatment over the other, with David (P3) saying “I 
didn’t really mind. I didn’t really care which one I went on”. He went on to explain 
that he didn’t have any pre-conceived expectations prior to treatment of what type 
of care to expect. This was seconded by Jessica (P4) who stated:  
“I didn’t really mind which one I got. I was happy to talk to anyone about 
it at that point, I think, because I was, I don’t know, I didn’t really know 
what would do what differently so yeah I didn’t mind at all”  
Jessica had been offered CBT in the past, which had shaped her expectations of 
treatment. Although a cognitive approach had been helpful to her, she remained 
open minded to other treatment options: “I didn’t really know much about the 
others because it was just what I had been offered. So I didn’t really have a 
preference” and “I was quite open to it and what it involved”. Frankie’s parent 
reiterated the sentiments of their young person above, saying:  
“We just thought we’d give it a go, love, didn’t we? And we went with a 
bit of an open mind and decided to do one session and see how it went. I 
think [Frankie] was just happy to go along with whatever was suggested” 
Lucy (P6) stated “I wouldn’t have minded either of them. I think they both seemed 
pretty good”. Their parent then continued by saying “We didn’t know anything about 
the process anyway because we’ve never been involved in anything like this. So it 
wouldn’t have mattered, I don’t think which one, which route we went down really”. 
This lack of previous experience meant they had no prior knowledge on which to 
base any expectations of the type of treatment they would be offered. There is a 
clear message from this feedback that families did not have a preference for any 
particular treatment approach, they were open-minded to different care options and 
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most were naïve to the treatments offered routinely by the service. Worryingly, 
most families did not appear to have fully understood the different treatment 
options offered in the study. It may be that they had not retained this information 
several months after being presented with it or that they had not understood it at 
the time. This may be linked to the faith that families invested in the service or in the 
researcher, trusting in them to provide appropriate care. 
Only one member of a participating family (a parent of Jennifer P1) expressed 
any alternative treatment preference to those that were offered. This carer would 
have liked to have been offered hypnotherapy as a treatment option because it 
would mean “they [the CAMHS team] could have changed the way [Jennifer] 
thought without [her] having to put in any effort”. Such expressions should perhaps 
alert us to whether, and if so, how families’ prior expectations of treatment might 
influence subsequent engagement in their care. In this case, for instance, the parent 
did not want their young person to be an active participant in their treatment 
although this was only the case for one family.  
Fifteen young people and ten parents completed the survey at the end of 
their treatment; seven (64%) of those who had been randomised to receive BA 
treatment (and four of their parents) and eight (73%) who had been randomised to 
receive TAU (and six of their parents). When asked whether they would have 
preferred the other option of treatment to the one they received; 57% (4/7) of those 
allocated to BA said they would not have preferred treatment as usual and 43% (3/7) 
didn’t mind which treatment they were allocated to. This is in contrast to the 
findings in the qualitative interviews reported above, where most participants 
reported no treatment preference. Of those allocated to TAU, 12.5% (1/8) would not 
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have preferred BA treatment, 12.5 % (1/8) would have preferred BA treatment and 
75% (6/8) didn’t mind. 
Staff reflections on allocation of patients to treatment 
Although staff were not specifically asked about the treatment options offered, 
some staff members chose to provide feedback on the way patients were allocated 
to treatment or the treatment content within the study. Shane (S3) identified that, 
from a systems perspective, the randomisation process - particularly the 
stratification of staff by Tier (Tier 2 and Tier 3) - led to uneven numbers of young 
people being recruited within each Tier of each CAMHS service (at each site).  
“The allocation of service users to staff based on assessed risk and based 
on CAMHS service structure. So service users are predominantly initially 
seen by primary mental health workers and formally Tier 2, and those 
primary mental health workers would then if the risk was severe enough 
refer on to specialist CAMHS Tier 3. Because of the nature of your 
allocation system, we were finding that Tier 3 weren’t seeing many 
people who were suitable for this study, because they’d either had prior 
intervention or the risk was so high there were very staff that they were 
able to be allocated to because of I suppose the limited training budget 
involved and the time demands on more experienced staff. Which meant 
from what I gather there was a huge influx of people suitable for Tier 2 
services for PMHWs, but not suitable for CAMHS Tier 3 services” [Shane, 
S3] 
The statement above is evidence of the enthusiasm and investment staff made to 
participate in the study and the disappointment expressed by this staff member that 
more eligible young people had not progressed into the study in the Tier that they 
worked in (Tier 3). This staff member had an in-depth understanding of the study 
design and offered his views on how this could be improved. He observed that Tier 3 
were seeing fewer eligible patients as many of the Tier 3 patients were excluded 
from the study due to prior intervention in Tier 2 or their risk level being too high 
(i.e. requiring urgent care). This meant that they did not meet the study entry 
  187 
criteria, which would have implications for a larger trial where these issues would 
become magnified. In the context of this study it meant there was more demand on 
staff trained in Tier 2 than those in Tier 3, which placed an uneven burden on those 
participating and offered less of an opportunity for Tier 3 staff to practice and utilise 
the skills learnt in the BA training. 
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Stage II Quantitative Results 
Presentation of the results 
The results in the following section are mainly quantitative but qualitative data have 
been added where relevant to reduce repetition in the qualitative results section 
that follows and to provide context to the quantitative results. As in the recruitment 
results above, participant and staff pseudonyms have been used for the qualitative 
data (see Table 8 for participant pseudonyms illustrated with a ‘P’ and staff 
pseudonyms in Table 9 illustrated with a ‘S’). 
Data quality 
In any study, whether the approach is qualitative or quantitative, there is the 
potential for errors to occur in a dataset when collecting, transcribing and entering 
data (Petrie and Sabin, 2009). Errors can lead to misinterpretation of the study 
results.  
After completion of the data collection, the randomisation list was revealed. 
The statistician had employed a repeated block size of eight. At this point, an error 
was identified. The error was made by one of the University secretaries completing 
the remote telephone randomisation and occurred when they misallocated one 
participant to the incorrect study site (due to the two separate site randomisation 
lists). Although this participant received the intended treatment allocation, it meant 
some participants following this allocation were allocated to the incorrect treatment 
group. In addition, one practitioner allocated to provide treatment in the BA arm 
was instructed by their Team Manager to also provide CBT in the control arm due to 
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a lack of other CBT practitioners for one participant. This is important because it 
could be a source of treatment contamination. 
To reduce the chance of errors, the quantitative data set were visually 
examined for outliers or errors and data were entered onto the spreadsheet and 
then cross-checked against the raw data (original questionnaires) prior to analysis. 
This was possible with such a small data set but in a larger trial other methods, such 
as double data entry (where data is entered twice and the two data sets are 
compared using a computer program) may be required to reduce the chance of 
errors. An error was identified due to the MFQ-C score being entered twice; once in 
the correct column and then in the MFQ-P column. This was identified on visual 
inspection as the young person was aged 17 so should not have had a parental 
questionnaire completed. Identified outliers were cross-checked with source records 
and found to be genuine scores. 
Baseline diagnostic assessment 
After providing consent to participate, young people proceeded to the diagnostic 
interview (K-SADS-PL [including CGAS]) and were asked to complete other measures 
(MFQ-C [and MFQ-P for parents RSE and BADS). Those deemed eligible were 
randomised following this assessment appointment; the characteristics of those 
randomised to participate in the trial are reported below. 
Although young people were not specifically asked about the baseline 
assessments in their qualitative interviews, Jessica (P4) said “talking about 
everything on such a large scale in one session was helpful because it was 
uncovering everything at the same time…and after talking to you about everything it 
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was kind of easier to see the bigger picture”. This provides some provisional 
indications that the baseline assessments were acceptable to participants. 
The baseline characteristics at first research assessment prior to 
randomisation of all randomised participants can be seen in Table 12 (82% female; 
mean age 15 years and 7 months [1 year and 2 months SD]) which have been 
presented according to treatment group. Ethnicity data was unable to be collected 
from PARIS. Average depression score as measured by the MFQ-C at baseline was 
34.73 points, over the threshold of 29 or more as a screen for depression. Average 
depression score as measured by the MFQ-P at baseline was 29.38 points, again over 
the threshold of 21 or more as a screen for depression. Average self-esteem score as 
measured by the RSE at baseline was 11.77 points was below 15, which is an 
indication of low self-esteem. Average CGAS score was 57.1 indicating variable 
functioning with sporadic difficulties or symptoms in several but not all social areas 
of the young person’s life (as rated by the researcher). According to the BADS, 
participants varied in terms of their ability to complete tasks, the amount and type of 
self-reported activity they undertook (as well as whether they enjoyed those 
activities), avoidance and rumination. Most reported taking part in few activities 
over the past week, did not report making good decisions relating to the type of 
activities or situations they put themselves in and tended not to consider themselves 
active or having achieved the goals they had set themselves. The number of 
comorbidities that participants met the screening threshold for according to the K-
SADS-PL was high, demonstrating the complexity of the patients treated as part of 
this study. All eligible participants met the screening threshold for co-morbid 
overanxious/generalized anxiety disorder.  
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Table 12: Baseline participant characteristics as randomised 
Characteristics  BA (n= 11) TAU (n= 11) 
Sex, No. (%)                          Female 9 (81.8) 9 (81.8) 
 Male 2 (18.2) 2 (18.2) 
Age at consent, y:m Mean (SD) 15:8 (1:5) 15:5 (1:0) 
 Median (range) 15:10 
(13:11-17:7) 
15:7  
(13:8-16:10) 
K-SADS-PL, No. (%) No. (%) with data 11 (100) 11 (100) 
Diagnosis* MDD 11 (100) 11 (100) 
 Melancholic 4 (36.4) 4 (36.4) 
 Atypical 2 (18.2) 2 (18.2) 
Severity Mild 4 (36.4) 6 (54.5) 
 Moderate 3 (27.3) 2 (18.2) 
 Severe 4 (36.4) 3 (27.3) 
Comorbidities* No. (%)  11 (100) 11 (100) 
 Mean (SD) 4.55 (1.21) 3.64 (1.75) 
 Median (range) 5 (2-6) 4 (1-6) 
 Mania 1 (9.1) 1 (9.1) 
 Panic Disorder 4 (36.4) 4 (36.4) 
 Separation Anxiety Disorder 6 (54.5) 3 (27.3) 
 Avoidant Disorder/Social 
Phobia 
6 (54.5) 5 (4.5) 
 Agoraphobia & Specific Phobias 3 (27.3) 2 (18.2) 
 Overanxious/Generalized 
Anxiety Disorder 
11 (100) 11 (100) 
 Anorexia Nervosa 1 (9.1) 1 (9.1) 
 Bulimia Nervosa 1 (9.1) 0 (0) 
 Attention Deficit Hyperactivity 
Disorder 
4 (36.4) 1 (9.1) 
 Oppositional Defiant Disorder 4 (36.4) 1 (9.1) 
 Conduct Disorder 4 (36.4) 4 (36.4) 
 Tic Disorders 1 (9.1) 1 (9.1) 
 Post-Traumatic Stress Disorder 4 (36.4) 6 (54.5) 
MFQ-C scorea No. (%) with data 11 (100) 11 (100) 
 Mean (SD) 33.91  
(11.8) 
35.55 
(11.09) 
 Median (range) 34 (17-58) 35 (18-50) 
MFQ-P scoreb No. (%) with data 6 (100**) 7 (100**) 
 Mean (SD) 29.83 (7.36) 29 (8.58) 
 Median (range) 28 (23-42) 32 (16-38) 
RSE scorec No. (%) with data 11 (100) 11 (100) 
 Mean (SD) 11.09 (4.37) 12.45 (4.84) 
 Median (range) 11 (5-20) 13 (6-21) 
CGAS scored No. (%) with data 11 (100) 11 (100) 
 Mean (SD) 54.55 (9.47) 59.64 (6.8) 
 Median (range) 58 (30-65) 59 (50-68) 
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BADSe No. (%) with data 11 (100) 11 (100) 
a
 Mood and Feelings Questionnaire: Long Version Child Self-Report (MFQ-C) score range, 0-66; higher 
scores indicate worse mood. 
b
 Mood and Feelings Questionnaire: Long Version Parent Self-Report (MFQ-P) score range, 0-68; 
higher scores indicate worse mood. 
c
 Rosenberg Self-Esteem Measure (RSE) score range, 0-30; scores between 15 and 25 are in the 
normal range, scores below 15 suggest low self-esteem. 
d
 Children’s Global Assessment Scale (CGAS) score range, 1-100; scores between 1-10 extremely 
impaired, 11-20 very severely impaired, 21-30 severe problems, 31-40 serious problems, 41-50 
obvious problems, 51-60 some noticeable problems, 61-70 some problems, 71-80 doing alright, 81-90 
doing well and 91-100 doing very well. 
e
 Behavioral Activation for Depression Scale: Short Form (BADS) no score range as not validated in this 
population. Used only for descriptive purposes.
  
*
Diagnostic categories/comorbidities are not mutually exclusive (i.e. one participant may meet the 
criteria for multiple depression-types/comorbidities)  
**100% of those asked; only those young people aged 15 and under required parental consent to 
participate so only those parents were asked to complete the MFQ-P. 
The continuous variables have been explored using the median and 
interquartile range to evaluate the impact of outliers across the psychometric scale 
scores and have been illustrated graphically to explore the distribution of scores. 
Each outcome measure will be discussed in turn. 
Mood and Feelings Questionnaire- Child Version (MFQ-C) 
The median MFQ-C score (n= 22) was 34.5 at baseline (range 17-58) and the 
interquartile range was 16.25 (26[Q1] - 42.5[Q3]). Prior to building a frequency 
distribution table, the number of class intervals in which to present the MFQ-C score 
data in a histogram were decided according to ‘Sturges’ Rule’. When applied to the 
MFQ-C data set, Sturges’ Rule dictates the need to choose the smallest integer k 
such that 2k ≥ n (see Table 13); as k= 5 was greater than our n value of 22, five 
intervals were selected. As well as the number of intervals, the size of each interval 
was decided using the maximum MFQ-C score of 58 and the minimum of 17 (range = 
41). Each interval size is the difference in the maximum and minimum value divided 
by the number of intervals plus 1; giving an interval size of 9. Plots did not reveal a 
normal distribution on a histogram as the data set is not symmetrical (see Figure 9). 
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Table 13: Possible integers’ for k 
Integers for k 
For k = 1, we have 21 = 2 
For k = 2, we have 22 = 4 
For k = 3, we have 23 = 8 
For k = 4, we have 24 = 16 
For k = 5, we have 25 = 32 
 
 
Figure 9: Histogram illustrating the frequency of MFQ-C scores at baseline 
Mood and Feelings Questionnaire- Parent Version 
The median MFQ-P score (n= 13) was 31 at baseline (range 16-42) and the 
interquartile range was 13 (23[Q1] - 36[Q3]). When applied to the MFQ-P data set, 
Sturges’ Rule dictated the smallest integer (of k such that 2k ≥ n; see Table 13) was 
k= 4 which was greater than the n value of 13, so four intervals were selected. The 
interval size was decided using the maximum score of 42, the minimum of 16 and 
range of 26 (the difference in the maximum and minimum value divided by the 
number of intervals plus 1); giving an interval size of 7. Plots did not reveal a normal 
distribution on a histogram (see Figure 10). 
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Figure 10: Histogram illustrating the frequency of MFQ-P scores at baseline 
Rosenberg Self-Esteem (RSE) 
The median RSE score (n= 22) was 11.5 at baseline (range 5-21) and the interquartile 
range was 6 (8[Q1] - 14[Q3]). When applied to the RSE data set, Sturges’ Rule 
indicated k = 5 was greater than the n value of 22 (see Table 13), so five intervals 
were selected. The size of each interval was decided using the maximum score of 21, 
the minimum of 5 and range of 16. Each interval size is the difference in the 
maximum and minimum value divided by the number of intervals plus 1; giving an 
interval size of 4. Plots did not reveal a normal distribution on a histogram (see 
Figure 11). 
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Figure 11: Histogram illustrating the frequency of RSE scores at baseline 
Children’s Global Assessment Scale (CGAS) 
The median CGAS score (n= 22) was 58.5 at baseline (range 30-68) and the 
interquartile range was 5.75 (54.25[Q1] - 60[Q3]). When applied to the CGAS data 
set, Sturges’ Rule indicated k= 5 was greater than the n value of 22 (see Table 13), so 
five intervals were selected. The size of each interval was decided using the 
maximum score of 68, the minimum of 30 and range of 38. Each interval size is the 
difference in the maximum and minimum value divided by the number of intervals 
plus 1; giving an interval size of 9. Plots did not reveal a normal distribution on a 
histogram (see Figure 12). 
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Figure 12: Histogram illustrating the frequency of CGAS scores at baseline 
Treatment Group Differences 
Randomisation should distribute known and unknown factors equally between the 
two groups, however due to the small sample size and the error in random allocation 
this was explored formally. Due to the small number of observations, with measures 
that followed a non-normal distribution any formal tests for inter-group differences 
were non-parametric in nature. Non-parametric tests offer a more conservative 
estimate of effect. A Kruskal-Wallis one-way analysis of variance was used to test for 
differences in baseline characteristics between treatment groups post-
randomisation. There were two reasons for this; firstly, the size of each treatment 
group does not meet the sample size guidelines for the parametric alternative 
(ANOVA) of a minimum group size of 15 participants (Petrie and Sabin, 2009). 
Secondly, we cannot be confident that the data are normally distributed on the basis 
of Figures 9-12. In addition, there is no utility in using formal distribution tests (such 
as the Kolmogorov–Smirnov test) with such as small sample, as the test would lack 
the power to provide meaningful results.  
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No statistically significant differences were observed in scores at baseline 
between the two groups using a formal Kruskal-Wallis test on MFQ-C (BA mean = 
33.91, SD = 11.8; TAU mean = 35.55, SD = 11.09; χ2 for difference 0.24, p = 0.6), MFQ-
P (BA mean = 29.83, SD = 7.36; TAU mean = 29, SD = 8.58; χ2 for difference 0.05, p = 
0.83), RSE (BA mean = 11.09, SD = 4.37; TAU mean = 12.45; SD = 4.84; χ2 for 
difference 0.39, p = 0.5) or CGAS (BA mean = 54.55, SD = 9.47; TAU mean = 59.64, SD 
= 6.8; χ2 for difference 1.10, p = 0.3). The two treatment groups were equal in size 
and comparable in patient characteristics at baseline. 
Treatment delivery 
Delivery of usual care 
Clinicians in the BA arm were given specific instructions of the details to record on 
PARIS in relation to the delivery of the BA treatment (i.e., a brief description of the 
details of the manual that they covered during the session, any ROMs completed). 
There was an assumption that clinicians in the TAU arm would record their sessions 
in the same way, according to the guidance they had been issued through the CYP 
IAPT service improvement programme (noted in Stage I). This guidance emphasises 
the importance of accurate record keeping and the deployment of ROMs to monitor 
treatment outcomes. As it was, clinician record keeping in the TAU arm was 
generally of a very poor quality; although there was a great variation across teams 
and between individuals. As a result of the poor record keeping in relation to the 
occurrence and content of treatment sessions, it was extremely difficult to obtain 
even basic information from PARIS. Further to this, the process of obtaining the 
required information meant screening every entry of each patient’s electronic 
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records for the study period, which could range from one or two to over one 
hundred entries across multiple pages per patient that had been entered by multiple 
clinicians. Many records were incomplete or contradictory. Appendix 14 provides an 
overview of the treatment pathways that young people who were randomised to 
TAU as part of the BUDDY study took through CAMHS.  
Delivery of Behavioural activation 
One clinician that received BA training left the service prior to treating patients in the 
study, another member of staff was unable to take on any BA patients during the 
study period due to taking on an additional management role. A further member of 
staff did not have any patients at their CAMHS site who were allocated to BA during 
the study period. Behavioural Activation was delivered by six clinicians (mean 
caseload of 1.8 randomised patients). Of the 11 patients allocated to BA, the nine 
participants who started treatment received on average 5.7 BA sessions (median, 7; 
range 2-8) over 4-13 weeks (median, 8). Of the two participants who did not start 
treatment, one patient was removed from the study (Sophie P7) by the clinical team 
and one was discharged (Jessica P4) from the service before treatment began. The 
average session duration was 49 minutes (range 30-80 minutes). Appendix 15 
provides further details of the treatment pathways young people who were 
randomised to BA as part of the BUDDY study took through CAMHS. 
Follow-up assessments 
Response time 
The average response time to assessments are detailed below in Table 14 from dates 
logged during the trial (although these do not account for non-working days, such as 
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bank holidays or weekends where it was not possible to complete assessments/post 
documents). The delay between receiving the referral and posting the materials 
reflects the difficulties accessing the electronic records system; as the researcher 
needed to be onsite to access participant personal details but had to be at the 
University to post the packs, this inevitably led to delays. Materials were posted 
second class so the delay from materials posted to first assessment reflects this and 
also the necessity of booking a room for the assessment to be held in, which 
frequently caused further delays. The delay from first assessment to randomisation 
was modest but could have been reduced if the remote randomisation service was 
available every day; however, due to relying upon people’s good will this was not 
possible in this study. Both three and six month follow-ups on average were over 
three weeks late; this reflected difficulties booking rooms and also the fact that 
many young people missed or cancelled multiple appointments so they had to be 
rearranged at a later date. 
Table 14: Response Time (days) 
Average Time Mean Days (including 
weekends and bank holidays) 
Referral received to materials posted 19 
Materials posted to first assessment 28 
First assessment to randomisation 7 
Date three-month assessment due to completion 21 
Date six-month assessment due to completion  29 
Impact of missing data 
One reason one may complete an ITT analysis is due to concerns with the low rates 
of follow-up in the study, which may introduce bias if those participants who have 
dropped out differ in some respect to those who have attended follow-up 
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assessments. In order to investigate this, the baseline scores on the numerical 
variables were compared for those that did and those that did not drop out of the 
primary end-point at three-month follow-up.  
There were no significant differences seen between those dropping out at 
three-month follow-up and those attending follow-up. Although those dropping out 
at three months appeared to have slightly higher baseline MFQ mood ratings on 
average, these were not found to be statistically significant for the MFQ-C (dropout 
mean = 37.14, SD = 14.79; no dropout mean = 33.6, SD = 9.51; χ2 = 0.28, p = 0.6), or 
MFQ-P scores (dropout mean = 31.8, SD = 5.12; no dropout mean = 27.88, SD = 8.97; 
χ2 = 0.60, p = 0.4). Average scores on the CGAS were almost identical in the two 
groups, also indicating no significant differences (dropout mean = 57, SD = 5.23; no 
dropout mean = 57.13, SD = 9.78; χ2 = 0.28, p = 0.6). In addition, although lower RSE 
scores (lower scores indicating lower self-esteem) can be seen in those dropping out 
(dropout mean = 9.86, SD = 4.38; no dropout mean = 12.67, SD = 4.5; χ2 = 1.52, p = 
0.2) again this was non-significant. This indicates the remaining sample at three-
month follow-up was broadly similar to those who entered the study. 
Accounting for missing data 
As a very large proportion of data was missing (particularly at six-month follow-up), if 
this was to be replicated in a larger trial it would represent a threat to the validity of 
the results. One significant concern when evaluating treatments for depression, is 
that the patients most severely ill may be the least likely to attend follow-up. If this 
was the case, it would be a source of bias because it is likely to give an overly 
optimistic view of the treatment by inflating the effect sizes of the treatment if the 
missing data is ignored. In this case, those remaining at three-month follow-up were 
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not found to differ significantly to those that entered the study at baseline in terms 
of depression symptoms, self-esteem and functioning. Despite this, it is important to 
explore the impact the missing data may have had on the results via a sensitivity 
analysis. 
Descriptive statistics and exploratory statistical analyses 
Complete baseline assessments (K-SADS-PL, MFQ-C, MFQ-P, CGAS, and RSE) were 
available for all participants. Of those that provided follow-up data at three and six 
months, only one questionnaire score was missing due to one parent not attending 
the session at three months (their young person attended alone). The quantitative 
results are summarised in Table 15 showing numerical data at baseline, three and six 
month follow-up for all participants randomised into the BUDDY study presented by 
treatment group. 
Table 15: Comparison of groups for Outcome Measure Means (SD) 
 Baseline Three-month follow-up Six-month follow-up 
BA TAU BA TAU BA TAU 
MFQ-C 33.91 
(11.80) 
35.55 
(11.09) 
23.43 
(9.59) 
30.5 
(8.67) 
15.8 
(6.22) 
26.67 
(12.6) 
MFQ-P 29.83 
(7.36) 
29  
(8.58) 
29.33 
(8.62) 
26.6 
(15.79) 
11  
(1.41) 
27  
(4.76) 
RSE 11.09 
(4.37) 
12.45 
(4.84) 
14.57 
(4.79) 
13.5 
(4.38) 
15.8 
(5.22) 
14.5 
(5.09) 
CGAS 54.55 
(9.47) 
59.64 
(6.80) 
65.29 
(14.03) 
56.63 
(7.82) 
. . 
Depression diagnosis at follow-up (K-SADS-PL depression status)   
The three-month follow-up represented the primary analysis point in this research 
and MDD status, as assessed by the K-SADS-PL, was the main outcome measure. 
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Depression status (MDD diagnosis or not) and depression severity 
(mild/moderate/severe) has been illustrated in Figures 13 and 14 according to the 
treatment group participants were assigned to at baseline and three-month follow-
up. In Figure 13 and Table 16, there is a much larger reduction in those who meet 
the criteria for MDD on the K-SADS-PL in the BA treatment group compared to the 
TAU group, where a more modest reduction was observed. At baseline all 
participants were depressed (as per the study inclusion criteria), so a logistic 
regression was conducted to predict the odds of remission by treatment group at 
three-month follow-up. Due to the small number of observations, bootstrapping was 
used to sample (with replacement) over the distribution to derive the standard 
errors for the logistic regression models. In this case, the estimates of the standard 
errors stabilised after 3000 repeated bootstrapped samples. Those in the BA arm 
had nine times the odds of those in TAU to achieve remission, which was of 
borderline statistical significance (χ2 = 3.35, p = 0.07). However when this was re-ran 
without bootstrapped standard errors the effect of BA was significant at the p<.05 
level (See Table 17). Therefore the analyses suggest that there was a trend towards 
those receiving BA treatment to achieve remission from depression.  
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Figure 13: Baseline and three-month follow-up results (for those with available 
data) for a diagnosis of MDD on the K-SADS-PL 
 
 
Figure 14: Severity level on the K-SADS-PL at baseline and three-month follow-up 
on the K-SDADS-PL. None represents non-MDD (so could indicate Depressive 
Disorder Not Otherwise Specified for example or no depression diagnosis at all) 
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Table 16: Showing the numbers of young people who achieved remission from 
depression according to treatment arm 
Treatment No remission from 
MDD 
Remission from 
MDD 
Total 
TAU 7 1 8 
BA 3 4 7 
Total 10 5 15 
 
Table 17: Results from a logistic regression analysis predicting remission from 
depression according to treatment group 
 Observed 
Odds Ratio 
Bootstrap 
Std. Err. 
Z P>|z| 95% Confidence 
Interval 
Treatment 9.33 8.85 2.35 0.02 1.45 59.92 
As diagnosis of depression (MDD) is a dichotomous response (has 
depression/does not have depression), the responses on the K-SADS-PL depression 
interview were used to give a severity rating of the level of depression 
(mild/moderate/severe), to allow examination of any changes in depressive 
symptomology. In Figure 14, we observe that those who still meet the criteria for a 
diagnosis of MDD at three-month follow-up appear to be less severe in the BA arm 
(with a larger number experiencing mild or moderate depression) than the TAU 
(where there were a larger number with moderate and some participants who had 
severe depression). 
Depression self-rated symptoms at follow-up (MFQ-C) 
Figures 15 and 16 show a graphical representation of individual participant’s MFQ-C 
scores at baseline, three and six-month follow-up (where follow-up data were 
available) in the BA and TAU arms respectively. At three-month follow-up, there was 
a downward trend in all scores for the BA participants except in one case where a 
strong increase in MFQ-C score can be seen between baseline and follow-up. At 
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three-month follow-up, the graph is flatter and more mixed for TAU participants 
with around half the scores increasing and the other half decreasing. Scores 
improved for both arms between randomisation and three-month follow-up, more 
so for the BA arm (from 33.91 at baseline to a score of 23.91 at three-months) than 
for the TAU arm (35.55 to 30.5). 
 
Figure 15: Participants in the BA arm, MFQ-C scores at baseline, three and six-
month follow-up (for those who have follow-up data available) 
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Figure 16: Participants in the TAU arm, MFQ-C scores at baseline, three and six-
month follow-up (where follow-up data was available) 
In a fully powered trial, to assess whether these trends reflect real 
associations or are the result of fluctuations caused by the variability in the data we 
would look at score by treatment group and report effect sizes using Cohen’s d. Here 
the post-treatment group differences (at three-month follow-up) were therefore 
compared using linear regressions. Mean effect size using only the actual data 
collected (i.e. excluding participants who did not have data available at three-month 
follow-up) resulted in a moderate effect size with a Cohen’s d of 0.78 (95% CI -0.29 
to 1.82). If we conduct an ITT analysis using the LOCF method to replace missing 
values at three-month follow-up, the effect size based on a mean comparison 
Cohen’s d was 0.31 (95% CI -1.15 to 0.53) indicating a smaller, but again moderate 
effect. This indicates on average those in the BA arm scored a third of an SD lower on 
the MFQ-C than those in the TAU arm. This means that those in the BA group 
reported, on average, less severe depressive symptoms compared to those in the 
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TAU arm. However, since the 95% CI crosses zero, we cannot say that there was a 
significant effect of treatment. This lack of significant effect may suggest that there is 
indeed no effect of the treatment over and above TAU, or it may reflect the small 
sample size in this study, meaning that the study was not sufficiently powered to 
detect a clinically significant difference in scores with 95% confidence that this 
observed difference is not due to chance.  
An additional ITT analysis whereby MI was used to create datasets with 
imputed missing values at three month follow-up was also conducted. Following this, 
linear regressions predicting outcomes from treatment group for the imputed 
datasets were conducted and the results recombined using the MI regress command 
in STATA. Baseline MFQ-C scores, age, sex and service Tier were incorporated during 
the missing data modelling in order to inform the imputed values. That is, a missing 
data model was postulated under the ‘Missing at Random’ assumption, whereby the 
missing outcome values were related to the observed values at baseline, as they 
were for participants where the outcomes were present. Treatment allocation was 
not incorporated into the missing data modelling process because imputed values 
conditioned on allocated group may have overestimated the treatment effect. This is 
because it would be based on the assumption that those with missing data at follow-
up outcomes would have had a similar treatment response to those with complete 
data. This assumption is not generally plausible, as those who drop out of treatment 
may do so due to reasons related to responsiveness. Thus, including group allocation 
when informing the imputed values is likely to have exaggerated any treatment 
effect. An ITT analysis was conducted for the MFQ-C scores using 10, 100, 300 and 
1000 imputations; deciding upon 100 imputations as the results stabilised at this 
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point. It was clear from the results from the imputed datasets that there was a lot of 
uncertainty owing to the missing outcomes and relatively small number of 
observations.  
Intention to treat analyses with multiply imputed data with all randomised 
participants from baseline to three-month follow-up (BA=11, TAU =11) showed an 
effect size based on a mean comparison of 0.74 (95% CIs -0.34 to 1.83). This is the 
value of the standardised regression coefficient (the raw beta was -7.07 which was 
then divided by the SD of 9.50) representing an average estimated reduction of 
approximately three-quarters of an SD on the MFQ-C for those in the BA vs TAU 
group. Thus, this value, analogous to Cohen’s d (which could not directly be 
calculated in STATA for multiply imputed datasets) indicates a large effect of BA 
compared to TAU. It is unsurprising that the results from the imputed dataset 
present a more favourable estimate of the relative effect of BA than using LOCF. This 
is because LOCF tends to underestimate treatment effects, especially in this 
scenario, where the ‘last observation carried forward’ is the baseline symptom score. 
Thus using the imputed values likely gives the most plausible estimates of the true 
effect size, though it should be noted that the CIs around these estimates were very 
wide. At six months, the improvements appeared to be maintained in both arms; 
improvements in the BA arm were steeper (from 23.43 to 15.8) than those in the 
TAU arm (30.5 to 26.67). Average change in each treatment group at three and six-
month follow-up has been plotted with CIs (Figure 17).   
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Figure 17: Average change MFQ-C scores across participants from each treatment 
group at three and six-month follow-up with CIs 
Depression parent-rated symptoms at follow-up (MFQ-P) 
Figure 18 shows a graphical representation of the average MFQ-P scores at baseline, 
three and six-month follow-up according to treatment group assigned (where follow-
up data was available). Higher scores indicate worse mood. The numbers were even 
smaller on this variable than the child-rated version, due to parental ratings only 
being taken for young people under 16. Scores improved for both arms between 
randomisation and three-month follow-up, more so for the TAU arm (from 29 at 
baseline to a score of 26.6 at three-months) than for the BA arm (29.83 to 29.33). A 
linear regression was not conducted on the MFQ-P score due to the small numbers 
of observations and the large variability seen in the MFQ-C where there were a 
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greater number of observations. At six months, the improvement continued in the 
BA arm (29.33 to 11) but those in the TAU arm were not maintained (26.6 to 27). 
 
Figure 18: Average participant score on the MFQ-P according to treatment group at 
baseline, three and six-month follow-up with CIs 
Self-Esteem at follow-up (RSE) 
Figure 19 shows a graphical representation of the RSE scores at baseline, three and 
six-months according to treatment group assigned (where follow-up data was 
available). Lower scores indicate poor self-esteem with those below 15 suggesting 
low self-esteem. There is a trend in improvement in RSE scores in the BA treatment 
arm, indicating improved levels of self-reported self-esteem. The trend is the TAU 
arm appears to be much flatter, with a slight trend towards improvement. Scores 
improved for both arms between randomisation and three-month follow-up, more 
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so for the BA arm (from 11.09 at baseline to a score of 14.57 at three-months) than 
for the TAU arm (12.45 to 13.5). Mean effect size using only the actual data collected 
(excluding participants who did not have data available at three-month follow-up) 
was indicated by a Cohen’s d of 0.23 (95% CI -0.79 to 1.25), indicating a modest 
effect on self-esteem. If we use LOCF to fill in the missing outcomes data, Cohen’s d 
is 0.02 (95% CI -.82 to .85) suggesting a very small effect. If we use MI to fill in the 
missing three-month follow-up outcome data, Cohen’s d is 0.24 (standardised 
regression coefficient 1.07/SD 4.44; 95% CIs -0.93 to 1.41) indicating a small effect. 
As seen in the MFQ-C results, using LOCF to account for missing data provides a 
more conservative estimate of effect size. At six months, the improvements 
appeared to be maintained in both arms; in the BA arm (from 14.57 to 15.8) and TAU 
arm (13.5 to 14.5). 
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Figure 19: Average sores on the RSE measure are shown in the diagram below at 
baseline, 3 and 6 month follow-up with CIs 
Functioning at follow-up (CGAS) 
Figure 20 shows a graphical representation of the CGAS scores at baseline and three-
month follow-up according to treatment group assigned (where follow-up data was 
available). Higher scores indicate improved functioning. There is a trend towards 
improvement in functioning in the BA arm compared to a trend towards lowered 
functioning in the TAU arm. Scores improved in the BA arm but worsened in the TAU 
arm between randomisation and three-month follow-up; BA arm (from 54.55 at 
baseline to a score of 65.29 at three-months) and TAU (59.64 to 56.63). Mean effect 
size using only the actual data collected (excluding participants who did not have 
data available) was a Cohen’s d of 0.78 (95% CI -0.29 to 1.82), indicating a large 
effect size. If we use LOCF to fill in the missing data, Cohen’s d is 0.43 (95% CI -0.43 
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to 1.27) indicating a large effect size. If we use multiple imputation to fill in the data, 
Cohen’s d is 0.75 (standardised regression coefficient 8.66/SD 11.62; 95% CIs -0.40 to 
1.83) indicating a large effect. 
 
Figure 20: Participants allocated to BA or TAU with baseline and three-month 
follow-up CGAS scores where data is available showing CIs 
Activation at follow-up (BADS) 
Mean score has been compared between baseline and three-month follow-up. In the 
BA arm, there was a very slight improvement seen in the ability to complete tasks, in 
the TAU arm this was larger (BA: 2.57 to 2.43 [negatively scored]; TAU: 4.25 to 3.75), 
avoidance (BA [negatively scored]; 2.86 to 2.57; TAU 3.63 to 2.25), rumination (BA: 
4.43 to 3.14; TAU 4.75 to 4), less likelihood of engaging in activities to distract from 
mood problems (BA: 2.71 to 2.29; TAU 3.63 to 3.13). On average in both arms young 
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people reported an improvement in the amount and type of activities they were 
undertaking (BA: 2.14 to 2.71; TAU: 2.75 to 3.13) and the number of activities they 
were engaged in (BA: 1.5 to 2.43; TAU: 2.38 to 2.5). In terms of their ability to make 
good decisions about what type of activities they did or the situations they put 
themselves into, a slight improvement was seen in the BA arm but not the TAU arm 
(BA: 1.86 to 2.86; TAU 2.75 to 2.38) and there was a similar finding for being an 
active person and achieving goals (BA; 1.71 to 2; TAU; 3.13 to 2.25) and enjoyment of 
activities (BA: 2.86 to 4.14; TAU: 3.88 to 3.75). Self-esteem had increased in the BA 
arm (3.86 to 2.43) but remained the same in TAU (3.13). 
End of treatment survey 
The results of the quantitative Likert scale responses are summarised in Figures 21 
and 22 and the responses from the free-text boxes are discussed below. Seven 
young people from the BA arm and eight from the TAU arm (who attended the 
three-month follow-up interviews) completed the end of treatment survey with their 
accompanying parents. 
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Figure 21: Combination of feedback from both young people and their parents on 
BA and Treatment As Usual (TAU) using a four-point Likert scale relating to how 
helpful they found their treatment 
 
Figure 22: Combination of feedback from both young people and their parents on 
BA and Treatment As Usual (TAU) using a four-point Likert scale relating to how 
happy they were with their treatment 
When those young people assigned to BA treatment were asked if they found 
the treatment they were offered helpful; five (5/7) reported BA was helpful to some 
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degree whilst one did not find it helpful (one did not receive treatment so could not 
comment). Three (3/4) of their parents found BA treatment to be helpful to some 
degree and one did not. See Figure 21 where the young person and their parent’s 
responses have been collated and compared between treatment arms. In addition, 
free text box responses indicated one young person assigned to BA treatment valued 
that their feelings were acknowledged, they were listened to whilst also being given 
practical advice during their four sessions. One young person who received the full 
course of BA, liked that the approach was based upon them helping themselves 
rather than having to rely upon other people. Their parent found it helpful that BA 
focused upon things their young person used to enjoy and how they could revive 
these interests. They also noted that BA treatment was non-blaming; helping their 
young person to realise it was not their fault that they felt the way they did. Another 
young person, who completed the full course of treatment, felt that their BA 
practitioner was lovely and really helpful and that the BA treatment helped them a 
lot. This young person’s parent liked the weekly format of the BA sessions. Another 
parent whose young person received the full course of BA, found the BA treatment 
easy to follow and understand. In response to the survey question asking if they 
were happy with the BA treatment they had received, six young people reported 
they were happy to some degree whilst one was ‘very unhappy’. All four parents 
asked were happy to some degree with BA treatment (see Figure 22). Most young 
people and their parents did not have any negative comments about participating in 
the study or receiving BA treatment. One young person’s parent commented they 
“didn’t do much” in BA treatment after receiving two sessions. One young person 
explained how they didn’t like “CAMHS in general” and did not like one of their 
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clinicians (although this was not the practitioner who delivered BA). One parent felt 
they already knew most of what was taught during the BA sessions.  
Eight young people (and six parents) reported upon their experiences of TAU 
(see Figure 21). Five young people stated it was helpful to some degree and two did 
not find it helpful. One young person and their parent reported not receiving any 
treatment so could not comment. Three parents reported it was helpful to some 
degree whilst one did not find it helpful (one parent reported not being present 
during treatment so was unable to comment). In a free-text box, one young person 
reported it was helpful to have the opportunity to speak to someone about how they 
were feeling. One young person described how usual care had allowed them to 
identify their unhelpful behaviours. Their carer felt that treatment had enabled an 
understanding of the types of unhelpful thinking that can have negative impacts and 
provided the foundation for healthier mental habits. One young person valued that 
their clinician “took what I said seriously and were understanding”. Their parent liked 
how the clinician asked for their young person’s opinion and plenty of time was 
given to her at each appointment so there were no feelings of being rushed. Another 
young person commented that their clinician provided them with good ways to cope 
with their feelings. In contrast, their parent felt they hadn’t yet received any 
treatment. Four other families reported either only having an assessment or no 
treatment to date. Despite their treatment not going ahead, one young person felt 
the process had improved their understanding surrounding panic attacks. When 
asked on the survey if they were happy with the TAU they had received, six young 
people reported they were happy to some degree whilst two were not. Four parents 
were happy to some degree whilst two were not (see Figure 22). One young person, 
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receiving usual care, stated that they had not heard from their clinician in a while. 
Their parent stated they needed to learn skills relating to how to manage their young 
person’s mood swings and would have liked to have received more knowledge of 
what treatment as usual would consist of. One young person felt no care had really 
been offered other than “discussing things”. Their parent felt it was unhelpful that 
they were never given an opportunity to speak to the clinician alone, as their young 
person was always present they felt they could not be totally open with CAMHS 
staff. One young person felt disappointed that they weren’t able to bring themselves 
out of their low mood and their parent felt that the primary difficulty seemed to be 
moving from understanding at an intellectual level to engaging with the techniques 
in an emotionally meaningful way. The parent reported that there was an ‘emotional 
disconnect’ which made the benefits of treatment difficult to access. Another young 
person felt there was a lot of repetition in their TAU. Of those who received BA 
therapy, five young people and four parents felt they would continue to use the skills 
they learnt during treatment, whilst two young people did not. One young person 
did not feel like they could comment. Of those who received usual care, five young 
people and three of their parents felt they would continue to use the skills they had 
learnt during treatment, whilst two young people and one parent did not. In 
addition, one young person and two parents did not feel they could comment. 
Fidelity measures 
No session recordings were made as requested by clinicians in the randomly selected 
10% of treatment sessions. As such the fidelity measure could not be deployed. This 
was either due to clinician error using the recording equipment or refusal by the 
patient or clinician to record the session. 
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Routine Outcome Measures (ROMs) 
I planned to collect and analyse ROMs, however clinicians completed these 
inconsistently; some clinicians followed the CYP IAPT guidance closely using a 
minimum of one ROM per treatment session whilst others did not administer any. 
For this reason, there was insufficient data to provide a summary of ROMs.  
Adverse events 
No adverse events were recorded during the study period. 
Summary of BUDDY trial quantitative results 
The study sample was an adolescent population recruited exclusively from referrals 
to CAMHS. As would be expected, there was an overrepresentation of females. The 
sample was mild to severely depressed, with a high number of likely comorbidities, 
low-self-esteem and poor functioning. BA treatment resulted in favourable 
outcomes across a range of measures when compared to usual care. Although these 
between-group analyses were conducted post-hoc, and as such, were exploratory in 
nature. This is unsurprising as the number of treatment sessions in usual care were 
not controlled for and the descriptive summary suggested participants in the usual 
care arm received fewer treatment sessions. The results presented in this section 
indicate the acceptability of BA treatment to many young people, the outcome 
measures were able to be appropriately deployed and young people generally 
experienced positive treatment outcomes in terms of mood, self-esteem, activation 
and functioning. The following section will discuss the qualitative findings of the 
study. 
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Stage II Qualitative Results 
Presentation of the results 
This section presents the qualitative thematic analysis of interviews conducted with 
young people (alongside their parents in some cases) and clinicians. Interviews with 
young people, participating parents and staff allocated to the BA treatment arm 
explored their perceptions of their involvement in the BUDDY study, the feasibility 
and acceptability of the trial and the intervention itself.  
Firstly, feedback on the format and delivery of BA therapy, a vital element of 
the acceptability and feasibility of treatment, is presented. This is followed by a 
contextual description of instances where young people did not receive the full 
complement of eight BA sessions. Secondly, families’ and clinicians’ treatment 
experiences and the impact of treatment is explored. The section concludes with an 
integrated summary of all qualitative interview results. 
The same participant and staff pseudonyms have been used as in the 
previous results sections (see Table 8 for participant pseudonyms illustrated with a 
‘P’ and staff pseudonyms in Table 9 illustrated with a ‘S’). 
Data quality 
Interview audio files were professionally transcribed verbatim, and transcripts were 
checked for accuracy against audio files prior to analysis. No transcription errors 
were identified. Attention was taken to use quotes in the language participants used, 
rather than editing to make quotes grammatically correct. This was felt to be 
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particularly important for young people to ensure the presentation of the data was 
an appropriate representation of their views. 
Results 
Format for the delivery of therapy 
In order to inform the delivery of the intervention in a future trial, families and staff 
were asked about their preferences and experiences in relation to the layout and 
delivery of the BA sessions. The following section is presented under the areas that 
the interview topic guides followed; enquiring about the format, length, number and 
timing of treatment sessions and staff were also asked for their opinions on the 
format of treatment from a service delivery perspective. The desired degree and 
content of parental participation is then discussed. 
Weekly format 
Staff, young people and their families were all supportive of a regularly, weekly 
delivery structure. Although Jessica (P4) did not complete any BA sessions, by 
drawing on prior treatment experience she suggested that the format of the weekly 
sessions would be appropriate: 
“I think I’d had the monthly [format] when I was in year 10, and I felt like 
too much happened and I felt too differently every month to go through 
it properly. So I think weekly would have been quite helpful had I still 
been in the place that I was when I first decided to do [the study]. 
Because yeah I did feel like a lot was changing with me every week, and I 
was feeling a lot of different things, so yeah it would have been helpful” 
Two parents reported satisfaction with the weekly format of sessions, one of their 
children (Frankie P2) also reported that the length and weekly delivery of sessions 
was suitable. Another parent and their child (Estelle P5) felt that the weekly format 
was more successful than a longer duration between sessions because it made it 
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easier to remember what had been happening in the young person’s life, and 
enabled them to reflect upon the success of goals that had been set during 
treatment. This information could then be used to effectively inform the BA 
treatment session. Similarly, Lucy (P6) also found the weekly format useful to 
achieve her treatment goals but would not have wanted to have had treatment 
sessions more often than once a week:  
“I think the length was pretty good, because we could work through 
what had happened in the previous week. And also what should happen 
in the next week. So I think it was a good amount of time” 
“I think a week is probably the shortest it could have been. Maybe a 
week to three weeks separately, but I think a week was pretty good” 
David (P3) reported that he did not receive his BA sessions in the prescribed weekly 
format, but that a weekly format would have been preferable:  
“I had [BA sessions] all over the place. Like I would miss a session for 
three weeks because no one was there to, like [Sharon S5] wasn’t there, 
she was on holiday or something, and I think that sort of affected the 
entire experience” 
 “…there was long periods of time where I didn’t have a session, and I 
think that sort of messed it up” 
David noted these gaps between treatment sessions were to the detriment of his 
depression treatment.  
Staff echoed the sentiments of the young people and their families above, 
feeling that a weekly format was suitable:  
“[Having a week between treatment sessions means]…you can make 
progress. A week is a long time in therapy” [Nicola S2]  
“I think having more than a week between our sessions they remember 
even less of what we talked about” [Shane S3] 
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Another staff member (Paul S4) commented that after he had become familiar with 
the manual materials, he felt the treatment “just seemed to flow” due to the regular 
format, with a week in between each session seeming appropriate.  
Treatment Session Length 
The treatment session length (of up to an hour) was viewed positively, but young 
people and clinician’s suggested adaptions could be made. David (P3) felt that each 
treatment session was too short and reflected on whether or not this may be the 
case for other young people or whether his Autism Spectrum Disorder (ASD) 
comorbidity may have had an impact upon his ability to engage with his therapist: 
“… I find it very hard to speak to people and it’s, and when you’re sort of 
just sitting there with somebody it’s hard. Like it’s hard to explain to 
someone how you’re feeling, so like the amount of time you’re given” 
 “…I don’t really know how you can sort of explain a lot of things and get 
across to somebody in half an hour” 
David (P3) found that he did not have enough time to become comfortable with his 
therapist during the short sessions; he estimated his average session length was 30 
minutes but he would have preferred each session to last around 50 minutes. The 
treatment session length was confirmed in David’s case notes, varying from 30 to 45 
minutes, with an average of 32 minutes. As previously mentioned, this young person 
was suffering from an ASD, which may have affected his ability to open-up during 
treatment sessions. However, another young person (Frankie P2) who shared David’s 
ASD comorbidity felt the length of the sessions was acceptable. A further young 
person, Estelle (P5), also felt that the length of each session was ample.  
Shane (S3) reported that from a staff perspective there was too much 
information to work through in certain sessions. Staff stated that the session length 
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was suitable but that the manual materials needed to be reduced for some sessions 
to be delivered within the one-hour timeframe: 
“There was, I think it was week five or six… about 13 pieces of paper that 
you need to take. So worksheets, information sheets, parent sheets, 
outcome measures, and I think that’s, I mean I’m big on outcome 
measures, I think they’re fantastic, but I think 13 pieces of paper is a bit 
much. Even for the kids who are well engaged and the kids who go to 
school and are used to coming home with piles of paper, they don’t want 
13 pieces in an hour” [Shane S3] 
“…one of the [session] packs was very long and it was a bit of a race to 
get through it” [Nicola S2] 
This feedback suggests there is scope for the manual materials to be further refined. 
In fact, some clinicians and young people felt the manual acted as a barrier to 
treatment for this reason, which will be discussed in further detail below. 
Number of treatment sessions 
Most young people did not report that they required a greater number of BA 
sessions. One young person for example, David (P3), felt he had received an 
adequate number of treatment sessions. Lucy (P6) also found she had received a 
sufficient number of sessions:  
“I think it was about just right. It was enough time to work on one certain 
thing and then have another step to go through, and just enough where 
it got to the point where I could start to help myself a lot more” 
For some families, however, the number of treatment sessions was not sufficient. 
Estelle’s (P5) family identified that the number of sessions had been helpful in 
treating Estelle’s depression but that she needed more time to focus on her anxiety. 
Estelle’s clinician Nicola (S2) seconded these viewpoints and did not feel that BA had 
been useful in addressing Estelle’s generalised anxiety, although it was not clear 
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whether this was due to the content of the BA treatment or the limited number of 
treatment sessions: 
“There’s ingrained stuff with [Estelle P5] about generalised anxiety that 
BA wouldn’t shift, because she needs something longer. Perhaps even 
later she could do with medication of some sort, because it really was 
ingrained stuff that she had” [Nicola S2] 
Estelle’s parent suggested further BA treatment to address anxiety could take the 
format of group sessions but Estelle contradicted this view, as she reported she 
would feel more comfortable receiving individual treatment sessions. Comorbid 
conditions, such as anxiety, were felt by many families and clinicians to represent a 
barrier to successful treatment that will be discussed in further detail below. 
There was mixed feedback from staff members in relation to the optimum 
amount of treatment sessions. One staff member, Sharon (S5) felt the number of BA 
sessions was adequate. For other staff members, the number of treatment sessions 
should be decided based upon the individual client. When reflecting upon the 
treatment of a complex family (Victoria [P8]; who did not attend follow up so was 
unable to be interviewed), Paul (S4), reported that it took several sessions to identify 
and target ingrained avoidance behaviours and so concluded that the flexibility to 
have more sessions if necessary may have been useful. Another clinician, Geoff (S1), 
indicated that the number of sessions was appropriate to the needs of the young 
people, but not the needs of the service in terms of the pressure stemming from 
waiting lists for access to the service, the demand for and the capacity of the service 
to provide treatment.  
“I think that one of the difficulties was in terms of the eight sessions, and 
whether that was, was that, it was appropriate to need but could we 
justify that amount of time if we were applying that to a number of 
different cases, because that would have severely impacted or would 
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severely have impacted upon our capacity in terms of addressing that 
demand. And that’s where the pressure is at the present time” [Geoff S1] 
This is reminiscent of the issues with capacity observed during the ethnography in 
Stage I of this research. Further to this, as well as difficulties in delivering manual 
content within the one-hour treatment session noted above, it was also difficult for 
staff to cover all of the concepts within the manual in the number of treatment 
sessions provided. Shane (S3) reported difficulties in delivering the manual material 
within the eight allocated BA sessions: 
“For the content that we were provided with, the number of sessions 
was nowhere near sufficient. Particularly working with I’d say the more 
internally focused teenagers… we did stick to the eight sessions and a 
follow-up. But unfortunately we were forced to miss some of the manual 
out. It was I suppose yeah, it was just quite tricky”  
Shane highlighted the need to make his own adaptions to the manual to fit the BA 
treatment into his usual practice.  
Timing of treatment sessions 
Most families chose not to comment upon the timing of their treatment sessions, 
however for one family accessing treatment sessions on a regular basis presented 
difficulties. Estelle (P5) and her family felt that it would have been helpful if the BA 
sessions were offered after school rather than only being available during school 
hours: 
“Coming out of school sometimes, sometimes I think it could be aimed 
more for after school than having to drag [Estelle] out of school every 
week. Phoning the school and saying that [Estelle] had an appointment 
that was getting like… [pulls face]” [Estelle’s [P5] parent] 
“The school don’t know I come here. They just think I have a lot of 
doctors’ appointments” [Estelle P5] 
Highlighting the need for a broader consideration of the professionals involved in the 
young people’s care when organising therapy delivery. Furthermore, the family 
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suggested that parental availability should also be assessed, with Estelle’s (P5) 
parent commenting:  
“I think it was, the reason why we managed to get to them all was that 
we organised them so that it fitted in with us. And it was fine because I 
only work two days a week. I would imagine that people who work full 
time may have problems getting the time off to come to sessions” 
These comments focus upon how the CAMHS service is delivered, rather than the BA 
treatment specifically, although they offer insight into the preferences of families. 
However, more relevant to the specific delivery of BA, Estelle (P5) and her family felt 
that it was difficult to go from a weekly format to no sessions at all:  
“The thing is now it’s done, we don’t know, we’re pretty much in the 
dark of what we’re going to do now, and how [Estelle] feels about, 
because she’s got no more counselling sessions or anything. It just feels 
like right that’s it, get on with your life now” [Estelle’s [P5] parent] 
“…for that type of thing I think it was enough. But I’m just wondering 
what’s going to happen now if you know what I mean” [Estelle P5] 
This suggests staggering the final sessions or providing top-up or follow-up sessions 
may be useful to reassure families and provide continuity of care. 
Service Delivery Considerations 
Geoff (S1) questioned in a service context where BA would be best placed to sit; 
whether it would be in the prevention, early intervention or specialist element of the 
service. Staff suggested BA may be best placed as an additional psychotherapeutic 
tool, alongside other treatments in clinical practice or that other treatments could be 
used as an adjunct to specifically target comorbidities. Sharon (S5) probed whether 
BA should be delivered in its current format or integrated into existing approaches, 
stating the overall BA approach: 
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“[BA] is quite a good idea that you can incorporate into other therapies, 
but I found it as I say very restricted and long drawn out to do it as a 
complete therapy” [Sharon S5] 
“I think [BA] made some difference, I’m not sure, because [Estelle P5] 
had generalised anxiety, whether it was going to be the only method to 
use on her” [Nicola S2] 
“Treatment did what it could, but she [Estelle] probably needed CBT, 
working longer on thinking errors possibly” [Nicola] 
When asked what it was about CBT that may be more beneficial than the BA 
approach, Nicola (S2) said: 
“I think the two could be done together. I just think there needs to be a 
component where you really look at the way you think… I think BA has a 
really good use for low mood, not ingrained behaviour such as 
generalised anxiety, maybe that could be part of it, but it’s a very useful 
component to use” 
Nicola reveals a reliance upon cognitive approaches that focus more upon changing 
young people’s thought patterns, such as CBT that aims to redress young people’s 
‘thinking errors’. This may indicate a lack of therapist equipoise in that, the novel BA 
treatment was not viewed as positively as existing treatments for depression used in 
the service. Therapist equipoise is where the clinician holds no preference or 
knowledge for choosing one treatment over another, which could be a source of bias 
in the trial if Nicola has more confidence in the treatments provided as part of the 
usual care arm. Shane (S3) felt the prescriptive nature of the manual was not the 
best approach to utilise in a CAMHS setting, and wondered if the session time could 
be better utilised by incorporating suggestions for agenda items directed by the 
young people. He highlighted the difficulties implementing BA in a manualised 
format and how this may be at odds with the usual clinical guidance: 
“The other gripe that I want to throw in is thinking about service user 
choice I think is really important. And I think in being quite prescriptive 
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with this, is the amount of sessions you have and this is the layout of 
them. The first activity for every week is agenda setting, and if you’ve set 
an agenda that has 13 items of worksheets that you need to go through, 
and the young person says well actually I’ve had a rubbish week, you’d 
lose all the scope to do that therapeutic work and to build on that 
therapeutic alliance. I think if you’re going to have a very strict, very 
prescriptive and manualised therapy there’s absolutely no point 
pretending that it’s collaborative and that it’s service user informed. 
Prescriptive and collaborative are two very different things. Sorry, rant 
over” [Shane S3] 
Unpacking whether this dissatisfaction lay with the treatment manual format or the 
concept of a manual itself will be vital to the future implementation of the 
treatment. This concept has been discussed in further detail in Chapter 5 in relation 
to how it could be explored in future research. 
Parental involvement 
The degree of parental involvement in young people’s treatment was important to 
explore, as this may have affected the young person’s treatment experience or 
engagement. There was no clear consensus across the interviewees about the 
optimum level of parental participation in treatment, but, with the exception of one 
case, there was agreement between most parent and child dyads about what 
worked for them as a family, highlighting the importance of service user choice in 
therapy. 
Preference towards more parental input 
David’s (P3) parent felt that the fact that David attended the BA sessions on his own 
provided independence for him, but also found it represented a barrier to providing 
appropriate parental support during his treatment.  
“…I was saying to [David] when he came home… what’s your homework 
for this week? Nothing! And I never knew whether he did have 
homework or he didn’t, what tasks he was supposed to fulfil… and then 
I’m trying to motivate him to go out. And I didn’t know if it was 
constructive or not” 
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“And I just thought it was a nice thing for [David and Sharon [S5] his 
therapist] so I sort of stepped away. But at the same time because I’ve 
been involved in most things I would have rather she’d phoned me about 
something and what they do. Because people, I mean people with… 
[ASD] notoriously keep things to themselves, and if you don’t want to 
talk you don’t want to talk to us do you [David]? That’s it, dismissed, and 
I’m dismissed” 
David’s mother suggested that due to his ASD, David only conveyed a limited amount 
of information about his BA sessions to his parent. As such, his parent required 
additional information from David’s therapist, Sharon (S5), about the content of his 
care plan. Having limited knowledge about David’s treatment content led to a lack of 
faith in the prescribed treatment. The parent suggested that a phone call between 
parents not involved in the treatment and the therapist would be beneficial to 
counter this limitation, or alternatively, the young person’s between-session 
homework tasks could be written down and shared with the caregiver. Sharon 
agreed that greater parental involvement for David may have been advantageous: 
“My client didn’t choose to bring his parent…but I can perhaps see how 
that would have been helpful because the parent could have encouraged 
the client and could have helped the client understand some things” 
As was the case for Sharon (S5) above, the utility of parental involvement was 
recognised by other clinicians. The level and format of parental involvement had to 
be determined by considering patient preferences. This represented a challenge on 
occasions where the therapist recognised the need for parental involvement, but the 
young person did not. Shane (S3) commented: 
“I think involvement of parents would have been helpful. I think it’s a 
tricky one because [Alicia P11] specifically didn’t want parents to be 
involved in the sessions. But I think acknowledgement of parents, [she 
was] quite dependent on parents, and I think parents reinforcing that, it 
would be useful if you did this, would have made a huge difference”  
“I mean with the service user I was working with they didn’t want 
parents involved in their therapy sessions, and they were very closed 
around parents; however were happy for me to see parents separately. 
Now how that fits into the eight session model I’m not sure” 
Another families’ clinician, Paul (S4), felt the level of parental involvement could be 
strengthened and the materials for parents could be improved. One suggestion was 
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to introduce a weekly briefing for parents about what their young person and the 
therapist had been working on. Paul highlighted his work with Victoria (P8) and the 
role her parents played in maintaining Victoria’s depression, and the difficulties of 
engaging her parents in treatment. Often her parents would drop Victoria outside of 
the CAMHS centre and refuse to come in. Paul felt the parental role in therapy could 
be tailored to improve the support parents provide to their young person, rather 
than being focused on more general skills, such as communication. Paul provided the 
example of Victoria’s parents thinking it was completely normal for their daughter to 
spend all night in her bedroom and how they had inadvertently been encouraging 
low mood behaviour. Paul suggested the family needed to be directly involved in 
Victoria’s care, in order for her parents to provide her with appropriate and well-
directed support in improving her depressive symptoms. Again, the commentary 
above highlights that there will not be a ‘one size fits all’ approach concerning 
parental involvement. 
Although clinicians and one parent felt more parental input would have improved 
the delivery of BA, there were no young people who suggested they would have 
preferred more parental involvement. In most cases where parents were involved in 
young people’s BA sessions, young people were content with the amount of parental 
input and could identify benefits stemming from this collaboration.  
Benefits of parental involvement 
Frankie (P2) requested that their parent attend all their BA sessions. Frankie found 
this helpful because their parent was able to remind them to employ the skills learnt 
during treatment in their everyday life. Lucy (P6) and her family reflected upon the 
benefits of BA treatment with parental involvement:  
“I think personally because of what had happened I was quite detached 
from my family, so at first I didn’t want them to be involved. But I think 
maybe part of it should be getting back the attachment of normal 
things”[Lucy]  
“I found it better when [Lucy] was talking more with us at home, and I 
think the way that she was, was improved when that happened more as 
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well” [Lucy’s parent] 
Lucy was comfortable with her parents being involved in her BA treatment but 
suggested this involvement was most useful towards the end of treatment to help 
her trouble-shoot barriers to goal-setting and activity scheduling. Staff recognised 
the importance of collaborating with parents and considered it to be crucial to 
treatment success: 
“Getting the parents on board was really important. That was very good. 
I can imagine if you didn’t have a parent that was on board that would be 
a lot harder. So you’re relying on parents to be on board” [Nicola S2]  
“[Estelle’s [P5] parent] was sort of sent, you know, it was BA gold really, 
she was sent from heaven and she was a perfect angel. Very obedient, 
was on board, yeah I just couldn’t fault her” [Nicola] 
When Nicola reflected on the involvement of Estelle’s (P5) parent during the BA 
sessions she felt the parent’s enthusiasm and support was a key facilitator for 
Estelle’s improved mood. 
Despite these positive aspects of parental involvement, some young people chose to 
highlight either potential, or experienced, difficulties with their parents being 
involved in their care. 
Difficulties with parental involvement 
The desire of David’s (P3) parent to be more involved in his care, was not echoed by 
David himself. David’s reluctance to have his parent involved in his treatment was 
questioned by his parent during the qualitative interview, and it was clear from this 
exchange that their perspectives differed on what constituted ‘success’ in therapy. 
Between-session tasks were a particular challenge, where the tasks agreed between 
David and his clinician, Sharon (S5), were not valued by his parent. This was 
illustrated when the parent/child dyad were discussing a recent chance meeting 
between the David and an old friend: 
“One of the brilliant things that we did on the way back, we bumped into 
a lovely boy that [David] used to know at school…Neither of them spoke 
a lot, but he just seems such a lovely boy. And they’ve swapped numbers 
getting off the bus coming here. And they went out, which was brilliant. 
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But [David] has not contacted him since” [David’s parent] 
The parent felt this was an opportunity David had not taken advantage of to connect 
with an old friend, whereas David retorted:  
“The thing is… I’d have felt compelled to talk to him, and when we used 
to hang out we didn’t talk a lot. We were just on the computers and we 
were just sort of, sometimes make like a conversation with each other 
for like a few seconds and go back on the computers, and you can’t really 
do that. You feel compelled to talk to somebody” 
David pointed out he had completed the between-session task he had been set by 
Sharon (S5), which was to speak to the friend over the phone. But it was not the task 
his parent would have preferred, which was meeting in person. This implies a 
possible advantage of a lack of parental involvement, in that the young person can 
focus on their own values and aims during treatment (a central objective of BA 
treatment), rather than their parent’s priorities. It also illustrates the difficulties that 
arise when young people can identify ‘depressed’ or ‘unhealthy’ behaviours, such as 
sitting on computer games or not communicating with friends, but their uninvolved 
parents have not learnt the same lesson, due to them not being present during the 
BA treatment sessions. These instances are illustrative of how worldviews can differ 
between young people and their parents; in David’s case, on the desired qualities of 
a friendship. Jessica (P4) who did not receive any BA treatment, expressed it thus:  
“I think it would have depended on what relationship people have with 
their parents. Because I know that I would be fine with my parents being 
involved, I think I would feel quite uncomfortable because they’d be 
listening to me talking about things to do with [my sister] that are very 
personal. And then I’ve had previous issues with my Dad… It’s hard 
because I would rather keep him out of it when I know that my 
relationship at the moment is fine with him. But then in general I 
wouldn’t mind them being involved. I think I just felt that I was fine to 
talk about it on my own, and then keep talking to them and informing 
them at home, but also it’s a nicer way to talk about because it’s an 
overview, they don’t have to see me going through it if you get what I 
mean” 
Jessica (P4) focused upon the stresses related to revisiting past events whilst parents 
were present, and her concerns about the impact this may have on current 
relationships within the family. She also highlighted the difficulties young people 
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might have when translating the dialogue following therapy sessions to parents at 
home who are not involved in their treatment. Other families also encountered the 
discomfort of discussing sensitive issues during BA therapy sessions: 
“I liked [my parent] there some of the times. Some of the times it was 
just a bit like she doesn’t, I don’t know. It’s like she knows what to say 
but it’s not hundred percent correct, do you know what I mean?” [Estelle 
P5] 
“I felt like I didn’t want to be there sometimes. I did. Most of the time 
towards the end I would have, I think I went in for about the last four or 
five sessions, and I don’t think I needed to be there. I’d rather, because I 
feel like [Estelle] clams up when I’m here and she won’t talk. So I feel like 
I was going in time and time again, I felt like it was wrong, I shouldn’t 
be… And then if she wanted to talk to me when she came out then I’d be 
there, but I’d rather not have been in the sessions all the time” [Estelle’s 
parent] 
Estelle’s (P5) parent felt that her reticence to be involved, stemmed from a feeling 
that Estelle, and other young people, would be more open with her therapist 
without a parent being present. Both Estelle (P5) and her parent reported being 
worried about disclosing information during treatment sessions that would be 
upsetting for each other. This suggests parental involvement can be a barrier to the 
young person engaging with the treatment. Estelle’s therapist (Nicola S2) reflected 
on her experiences with patients outside of the BUDDY study, stating that on some 
occasions parental involvement was unhelpful because she had observed mental 
health problems and coping styles run in families, leading to parents maintaining 
their young person’s problems. This presents a dilemma in terms of how best to 
involve parents in future iterations of the BA manual. Although Shane (S3) felt 
increased parental involvement in Alicia’s (P11) care would have been helpful, he 
also anticipated this may have presented problems in itself: 
“I think the difficulty with involving a parent in therapeutic work with a 
child and young person is always going to be the issues that the parent 
brings to the table. And I think it was really difficult in my session with 
the parent who brought their own mental health concerns with them. 
Some of the hour that we spent together had to be around helping them 
identify what was a realistic expectation, what was an understanding of 
the young person’s mood dropping and what was their own anxiety 
around the young person’s mood dropping …. And in essence integrating 
that into your sessions would be combining high levels of low mood, high 
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levels of anxiety in two people and then trying to direct it all into one 
behavioural approach. I think [it] would be a nightmare, depending on 
the parent of course”  
This highlights the perceived detriment of families bringing their own mental health 
concerns into their young people’s treatment sessions. It also relates back to earlier 
sentiments where some clinician suggested the flexibility to have more BA sessions 
would have been advantageous. It also represents a barrier to the young person’s 
treatment, which is likely to be outside of their control. 
From a staff perspective, Geoff (S1) reported variable parental involvement; in one 
case, he worked with a parent who he felt was very committed (Lucy P6) whereas in 
the two other families, the parents were less dedicated in terms of their engagement 
(Connor P9; Neive P10). Geoff pointed out that although some parents were less 
actively engaged in their young person’s treatment sessions, they remained 
committed to their young person’s recovery, which appeared to be more important 
than the level of actual involvement. The most important factor for Geoff was 
whether or not the young person was progressing and moving forward with 
treatment. Although he recognised the role that parents played in supporting the 
young person to maintain the changes made during treatment, he felt this was not a 
central issue to the implementation of the provision of BA. It may be significant that 
this clinical viewpoint differed so markedly from his patient, Lucy’s perspective that 
her parent’s involvement played a key role in her life returning to “normal” following 
BA treatment. 
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Deployment of Behavioural Activation  
Interrupted treatment pathways 
One of the ways to assess the feasibility of a novel treatment option is whether it can 
be delivered as intended: this was also explored during the qualitative interviews 
with staff, young people and their families. The criteria for what was considered 
premature termination of treatment was different in the qualitative verses the 
quantitative sub-chapter. In the qualitative section, the threshold was anyone who 
did not receive eight sessions, in order to explore the reasons provided for 
termination of treatment. In contrast, in the exploratory statistical analyses one 
session was considered to be an adequate ‘dose’ of BA treatment (as the BA model is 
discussed and an individual formulation identified during session one). In some cases 
where individuals did not receive the full complement of treatment sessions, 
participants did not attend the qualitative interview so information was obtained 
from the participant’s case notes (via the electronic records system [PARIS]) to 
provide information relating to their treatment pathway. Information from patient 
case notes was also valuable to contextualise young people’s arguments. Each young 
person’s treatment be discussed as an individual narrative drawing from interview 
and case note data. 
Patient did not receive BA: treatment was not started due to patient’s non-
attendance 
Jessica (P4) did not start her BA sessions, and explained that this was due to her and 
her parents initially forgetting about the therapy appointments. When the family 
realised they had missed these appointments, they contacted their clinician (Paul S4) 
to rearrange the sessions. As Jessica was about to turn 18, she would not have been 
able to have a full course of BA prior to being discharged from the service and when 
this was discussed with her, she felt she had improved enough to not warrant 
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treatment. Jessica felt this improvement was mainly due to a change in family 
circumstance that had improved her home life. 
Another young person, Sophie (P7) did not start her BA sessions with Nicola (S2) as 
she was removed from the study by the CAMHS team. When Sophie came into the 
CAMHS service, during the study recruitment period, she was deemed to be 
relatively low risk and was assigned to treatment in Tier 2; however, during her first 
BA session she disclosed further information, which meant she was considered to be 
a much higher risk patient. At this point, she was transferred to Tier 3 for treatment 
by the specialist team, but could not be randomised within the BUDDY study because 
the patient needed to be allocated to the first available clinician (i.e. not necessarily 
a clinician involved in the trial), and as this treatment was required urgently, she no 
longer met the study inclusion criteria. In light of this, Sophie was not contacted by 
the research team again. 
Patient received two sessions of BA: treatment was stopped prematurely by 
clinician 
The clinician (Bridget S6) ceased BA treatment prematurely due to concerns over 
Jennifer’s (P1) capacity to continue. Treatment was stopped whilst the IQ of the 
young person was assessed (there were particular concerns over her processing 
speed). Although patients within LD services were excluded from participating in the 
BUDDY study, it may be that a minimum intelligence level or reading age may be 
required to engage with the study materials. The perspective of the young person as 
to why their BA therapy ended was that they were too tired to engage in treatment. 
Unfortunately, Bridget, the clinician responsible for treating Jennifer, was unable to 
be interviewed due to her heavy workload so was unable to offer an additional 
perspective. This in itself, may be indicative of a potential barrier to the clinician 
delivering BA as intended; namely, that Bridget lacked the time to provide treatment 
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as directed and instead, looked for opportunities to deflect the onus onto other 
clinicians (i.e. the clinician responsible for assessing IQ). This would seem reasonable 
in light of the findings of the non-clinically orientated variation in practice theme 
from the focused ethnography that indicated clinicians provided care that was easily 
available rather than based upon an individual’s needs when the service was under 
pressure. However, according to the case notes made by Bridget, Jennifer engaged 
well during the initial session and “seemed to have a good grasp of what BA was 
about”. During the second session, Jennifer was described as unfocused and tired. 
She had not achieved the goal that had been agreed with Bridget, which was to 
make a new friend whilst away on holiday. However, this goal did not meet the 
requirements of a BA goal that should be SMART (Specific, Measurable, Achievable, 
Rewarding and Timely), a topic that was covered during session 1, and which should 
have been addressed by the clinician when the goal was being set. As this had not 
been done, it had to be attended to during the second session. In session three, 
Jennifer was described as more alert than previously but could not remember 
concepts discussed during previous sessions, so the manual content from session 
three was not delivered. Another possibility is that Bridget had not received 
adequate training to deliver the treatment appropriately, although this was unable 
to be assessed as the treatment session was not recorded. Bridget did not believe a 
BA approach would be helpful for this patient and terminated BA treatment at this 
point. Again, this hints at some staff members perceiving the BA treatment as less 
adequate than other available treatments. Subsequently, however, the IQ (and 
processing speed) of this young person was found to be within the normal range. 
Interestingly, the patient in the case discussed above was the young person of the 
previously mentioned parent who would have preferred hypnotherapy as a 
treatment option, due to the level of engagement and mental resource required to 
engage in treatment.  
During his interview, Geoff (S1) reflected on the care of Connor (P9; who 
declined the offer of a qualitative interview) who only received four sessions of BA. 
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Connor was described by Geoff as having “quite a heavy overload of oppositional 
defined conduct disorder type behaviour” combined with being “less articulate, less 
intelligent”. The clinician used this seemingly derogatory language with the caveat 
that it was not meant in a demeaning way, rather, the clinician was attempting to 
articulate the difficulties this young person faced in engaging with him. Geoff 
reported the structured format of therapy was difficult for Connor, particularly the 
concept of the between-session tasks. Geoff was, however, unable to unpick the 
reasons why this patient struggled to engage with the treatment (i.e. whether or not 
this was due to a lack of cognitive ability). When this reflection is considered 
alongside the case of Jennifer (P1) above, it suggests that intelligence was perceived 
to be a barrier to young people’s participation in treatment by their clinicians. The 
case notes Geoff produced for Connor’s BA sessions illustrate the difficulties of 
working with a young person who is conduct disordered, and also the challenges that 
young people face in their daily lives. In the week between Connor’s assessment 
session and first BA session, Geoff learned that Connor had received a temporary 
exclusion from school due to an altercation with a teacher. Despite this, Connor 
engaged well during the BA session, alongside a family member, and utilised his 
between-session task to address his behaviour in school by using a ‘time-out card’. 
The time-out card enabled Connor to remove himself from his lesson when feeling 
agitated and offered the opportunity for him to seek out help from a school Support 
Worker. When Connor attended his second appointment, he told Geoff he had been 
permanently excluded from school and there had also been a medical emergency 
within his family. The BA session was unable to be completed due to Connor bringing 
two of his friends to his appointment. When session two was rearranged, he 
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attended with a family member who reported some improvement in Connor’s 
behaviour at home and Connor described distancing himself from his friendship 
group, who he felt were a stimulus for his anti-social conduct. At session three, he 
attended with another friend (despite being specifically asked to only bring an adult 
family member or to come alone); he had been unable to complete his between-
session task because of having to move out of his home due to the earlier family 
medical emergency. At this point, Geoff and Connor had a discussion regarding the 
direction of treatment and Connor reported his mood had improved so decided he 
would not need all eight sessions. He did attend session four with a family member, 
where further anti-social behaviour was reported. Connor was offered a fifth BA 
session but did not attend his appointment or respond to a follow-up letter so was 
discharged from the service. Again, this highlights the complex population involved 
in the study, the requirement to be psychologically prepared to engage in treatment 
and the impact of a turbulent home life on treatment. This raises a broader issue in 
whether or not such rigid treatments are ever going to be able to adequately 
respond to the complexity of the target population. 
Geoff (S1) also reflected upon working with another client, Neive (P10; who 
was uncontactable for the qualitative interview), who only received three sessions of 
BA before withdrawing from treatment in favour of the families’ request for Neive to 
be assessed for medication. Geoff wondered whether intellectual ability or 
motivation to change was what presented a barrier to her care:  
“I think it’s about the issue of commitment isn’t it? Where it worked well 
the people were committed; where it didn’t work so well was in that 
young person who felt less or possibly had more difficulty in being able to 
record what they did. Now whether that’s about motivation or whether 
that’s about cognitive ability, I don’t know” 
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The case notes for Neive again show the complexity of working with young people. 
Neive attended session one alone and according to Geoff, appeared engaged. Neive 
attended session two with two family members, where her home life was described 
by her family as a disordered environment where there were frequent 
confrontations both within and external to the family home. Although Neive had 
completed the between-session task set in session one and was motivated to 
participate in the second session, Geoff noted she had some difficulty understanding 
certain BA concepts. She attended session three with a parent who reported her 
behaviour was worse at home, and that Neive “did not feel that the BA was 
working”. Neive denied that there were any difficulties between her and Geoff (as 
the clinician wondered if his gender may have been a barrier) but she felt that her 
impending exams needed to be her focus. This suggests therapy must be offered at a 
time in young people’s lives when they are willing and able to participate. For this 
reason, the family stated their preference that Neive received medication, as it was 
more convenient. The family were discharged after no further engagement. This 
highlights the often turbulent home lives of young people living in a 
socioeconomically deprived area and the realities of delivering therapy in this 
context. In fact, the experiences of individuals who discontinued treatment and the 
clinicians working with them raise the possibility that it may be naïve to think that BA 
treatment will be applicable to all young people. Rather, like the CAMHS clinicians 
reported in the focused ethnography, young people may not have the ‘headspace’ to 
commit to a talking treatment, such as BA, which required active participation. 
Patient received three sessions of BA: treatment was stopped prematurely by 
clinician  
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Sharon (S5) ceased BA treatment for Frankie (P2) citing that she felt that the young 
person did not require further sessions of BA. According to Sharon’s notes, Frankie 
engaged well with BA in session one, despite being “very verbose” and apparently 
distracted and directing attention towards matters not included in the manual. No 
difficulties were reported during session two, although Frankie had not completed 
the between-session task, which was discussed and re-administered. In session 
three, Frankie had not completed the re-administered between-session task. The 
clinician was pleased with the range of activities Frankie was currently engaging in 
and noted that the young person: 
“…fully realises it was their anxiety and fear of doing things that was 
making [them] feel unmotivated and is fully committed to engaging in 
more activities where [they] can” 
Sharon went on to explain that both Frankie and their parent reported that Frankie’s 
mood and difficulties with motivation had improved, so the clinician suggested 
terminating BA at this point, which the family agreed to. The reasons for the 
termination of treatment were explored at the interview with Frankie, who was 
somewhat unsure why their treatment had stopped but felt that it was their own 
decision to end treatment sessions. 
 “I don’t know, I just thought, like think, I just came to the conclusion 
myself that that’s it, you know. Like there’s only so much that therapy 
can do” [Frankie] 
“[Sharon] talked to us last time, didn’t she, and said look she felt that 
you’d gone as far as you could, what did you think about it? And you kind 
of agreed didn’t you? ... So three [sessions] seemed all right, and then 
you’ve got two sessions just to chat to [Sharon] haven’t you this week 
and next” [Frankie’s parent] 
Frankie felt the sessions received had enabled them to arrive at a level of acceptance 
about their depression: 
“Like basically I’ve realised that depression and mental health issues kind 
of run in my family, and so chances are it’s not just a slump thing, it’s 
probably a lifelong thing that I’m going to have to deal with. And just 
letting it completely ruin my life is no way to go about it, so I’ve just got 
to figure out how to drive this thing along and learn to cope with it, and 
just try and function as well as possible and just not let it destroy us”  
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Frankie’s quote above echoes some of the concerns raised by clinicians of parents 
bringing their own mental health concerns into treatment sessions but, in this case, 
the young person takes a more matter-of-fact approach. Frankie states that 
understanding their family problems has enabled them to move forward by gaining a 
level of acceptance with the status quo. Frankie describes the learning process 
undertaken and suggests that although they did not have the eight recommended 
sessions, they came away from treatment with further insight into their depression. 
However, it is important to note that Frankie reported they had been unable to 
complete all of their goals within the few sessions offered. 
In both cases where treatment was started and terminated prematurely by the 
clinician, there was evidence that both therapists (Sharon S5 and Bridget S6) did not 
always deliver the BA as per protocol. Furthermore, the parent of another of 
Sharon’s patients recounted how Sharon had not challenged their young person’s 
(David P3) excuses for not using public transport during their between-session task:  
“There’s no real motivation is there if there’s nobody at the other end to 
meet you and do something. So it’s still a work in progress isn’t it, and 
[Sharon] was fine with it wasn’t she when we kind of explained that was 
the issue” 
In one other case, where the young person was not given the full complement of 
eight BA sessions (Victoria [P8] who did not respond to repeated requests to 
participate in the interview), the participant received seven sessions as prescribed by 
her practitioner. 
Barriers/facilitators to treatment 
In addition to the parental and treatment delivery barriers and facilitators identified 
above, young people and staff identified various issues that affected clinicians’ or 
patient’s ability to engage in or complete BA treatment. These obstacles fell loosely 
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into two different groupings; internal and external barriers (see Table 18 below). 
Internal barriers were often related to thoughts, feelings or abilities that restricted 
the young person’s participation in treatment. External barriers were perceived to be 
outside of the young person’s control and broadly related to obstacles that restricted 
them achieving their treatment goals. Some examples of these themes have been 
referenced in the discussion above, as they were relevant to the format and delivery 
of treatment. An overview of the internal and external overarching themes is 
discussed below, separated into each individual theme.  
Table 18: Themes emerging from the qualitative interviews 
Overarching Theme Theme Description 
Internal 
barriers/facilitators 
Motivation Motivation could be a barrier or facilitator for 
BA treatment. One aspect was acceptance 
and/or acknowledgement of depression. This 
theme also incorporated young people’s 
motivation to change their depressive status. 
Young people, their families and clinicians 
acknowledged that effort was required in 
order to make changes in their life.  
Comorbid 
Conditions / 
Individual 
Differences 
Comorbidities or individual differences were a 
barrier to engagement in the intervention. 
Young people, their families and their 
clinicians reflected upon the impact these 
difficulties had upon their depression, 
treatment experience and the impact of the 
intervention. 
Memory/ 
Intelligence 
Some young people and clinicians reported 
that poor memory or perceived intelligence 
was a barrier to successful treatment. 
External 
barriers/facilitators 
Support 
Network 
The level of support available to young people 
whilst undergoing treatment was a barrier 
when friends or parents were unavailable to 
help young people achieve their treatment 
goals or when other’s poor mental health 
impacted upon the young person’s own mood. 
However, friends and family could also be a 
vital source of support. 
Resources Barriers to young people achieving their 
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treatment goals could be of a practical nature, 
such as a lack of financial autonomy or 
conceptual, such as a lack of freedom from 
parents. 
Environmental 
Impact 
Environmental restraints, such as living in a 
rural location, presented a barrier to 
opportunities for activation. Other 
serendipitous events could act as a facilitator 
to young people’s achievements during 
treatment. 
Treatment 
Specific 
Factors 
Barriers and facilitators were also identified in 
the materials and/or content of the therapy. 
Also incorporated here are families’ perceived 
therapeutic alliance with their clinician and 
therapist equipoise- the extent to which 
clinicians had belief or faith in the treatment 
they were providing. This theme includes 
beliefs about how BA would fit into staff’s 
usual practice. 
Internal barriers and facilitators 
Internal barriers to BA treatment were perceived as being under the control of the 
individual, and were often difficult to tackle (see Figure 23). As identified by young 
people, their parents and clinicians, internal barriers included motivation, 
comorbidities or individual differences and difficulties with remembering or 
understanding the content of BA sessions.  
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Figure 23: Pictorial representation of identified internal barriers to successful BA treatment by young people, their parents and clinicians 
Internal 
Barriers / 
Facilitators 
Genetics / 
Comorbid 
Conditions 
Memory / 
Intelligence 
Motivation / 
Acceptance 
of Depression 
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Motivation 
For some young people, motivation to participate in BA treatment and/or to improve 
their depressive symptoms was a key barrier and/or facilitator in their treatment 
progress. Estelle (P5) struggled with low motivation, and initially found it difficult to 
complete the tasks set by Nicola (S2), despite valuing them as part of her BA 
treatment:  
“Not to do with the tasks, but more personally. Like if [the depression] 
was really bad and I just really couldn’t have the motivation to do 
anything. But usually with [the BA] I would try and put that first, and 
even if I really felt like not doing anything I would still try. But overall [the 
scheduled tasks] were pretty good” [Estelle]  
“…motivation, I didn’t have a lot of that, and I was pretty lazy and didn’t 
like doing anything, I think that was, the fact that I had to suddenly put in 
quite a bit more effort than I would…” [Estelle] 
She linked this poor motivation to her own individual traits, and it is striking that she 
spoke about these characteristics in the past tense. Her parent confirmed that 
despite these initial difficulties with motivating herself to actively participate in her 
BA treatment, Estelle had subsequently engaged well. The parent pointed out that 
the reason Estelle had succeeded during the treatment was a direct result of the 
effort she had put in. Estelle agreed with her parent’s sentiment. Again, this is an 
occasion where the young person’s subjective view of the situation did not initially 
tally with their caregiver’s view of the situation. Or, indeed, their own view of 
themselves.  
Staff members also clearly articulated how success in therapy was related to 
the impetus of each individual themselves. Shane (S3) said: 
“Involvement with particular aspects and particular tasks I think is 
predominantly down to the young person themselves”  
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“It really depends on how engaged with the model the young person is. 
The first service user I saw [Alicia P11] as I mentioned was completely 
disengaged. Effectively she wanted to have a chat in our sessions, and 
was able to relate items back to the BA model but I think largely to 
appease me rather than as a therapeutic benefit for themselves... But 
that wasn’t an instance of oh I didn’t have time, I was too busy, or I didn’t 
have time, I forgot; it was oh yeah I remember that sheet, but I just didn’t 
think it was worth doing”.  
“Filling out an activity sheet is actually really difficult unless you do it at 
the time. And getting that motivation for somebody who’s got that high 
level of low mood is not always feasible”  
Shane highlights it is not enough to attend treatment sessions and complete the 
tasks set, there must be a desire to improve their depressive symptoms. Geoff (S1) 
seconded the view that the success of treatment was dependent upon the young 
person’s commitment and motivation to change. He found BA treatment worked 
well when the young person wanted to engage and move forward with treatment, 
such as in the case of Lucy (P6). Geoff was able to consider this against his 
experiences with less motivated young people, such as Connor (P9) and Neive (P10), 
who were much less engaged. This echoes the earlier views on parental involvement 
related to caregiver engagement in the goals of treatment. Lucy (P6) focused on her 
internal motivation to change and desire to improve her mood as a key treatment 
facilitator:  
“I attended all of [the sessions] on the right dates. And I think it was 
because I knew that I needed help with things, I wanted the help with it. 
But it had taken quite a bit of time, like two years to come to terms with I 
would need help with this and I can’t do it by myself. And I think some 
people might miss [the opportunity] if they still can’t accept that 
somebody can help them with it. And [depression] is something that can 
be not necessarily fixed but dealt with and controlled” 
Lucy emphasises both the importance of being ready to make changes to her life, 
and an ability to gain a level of acceptance in relation to her depressive symptoms. In 
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this case, she found that although depression may not necessarily be able to be fully 
eliminated, it could be controlled. Lucy’s experience illuminates the driving factors 
behind her motivation to engage with BA treatment. For other young people, it was 
harder to define their sources of motivation: it wasn’t clear whether the motivation 
was internal, or whether it was the external support offered by their therapist that 
led to improvements in their mood. Jennifer (P1), for example, felt “under pressure” 
during treatment but was not able to identify from whom the pressure originated. 
Her parent felt this pressure was a positive thing and it was responsible for 
“pushing” Jennifer through treatment. Frankie’s parent suggested that this internal 
barrier of motivation intertwined with the external barrier of support networks, as, 
without the support of external individuals, the young person may lose their own 
sense of motivation: 
“There’s no real motivation is there if there’s nobody at the other end to 
meet you and do something” [Frankie’s parent] 
Comorbid conditions/individual differences 
As mentioned earlier, some staff and young people found the participant’s comorbid 
conditions of anxiety, conduct disorder or ASD, influenced their experiences of BA. 
For some young people this meant they required a greater number of BA sessions in 
order to allow more time to focus on their comorbidity; for others, a one-to-one 
‘talking therapy’ may not have been appropriate, or an alternative to BA treatment 
may have been necessary. In contrast, other young people who shared these 
comorbidities (of anxiety and ASD) did not identify them as a barrier to engaging 
with BA treatment. Similarly, young people identified individual differences, such as 
genetics, as a factor in treatment.  
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Linked to the theme of motivation described above, Frankie (P2) felt that some 
things were beyond an individual’s control, such as inherited characteristics:  
“Like there is only so much that therapy can do…Like basically I’ve 
realised that depression and mental health issues kind of run in my 
family, and so chances are it’s not just a slump thing, it’s probably a 
lifelong thing that I’m going to have to deal with”  
Frankie reflects that factors, such as genetics or family circumstances, cannot be 
changed, but do need to be acknowledged as Frankie felt they were fundamental to 
the development of Frankie’s own depression and should be a consideration during 
treatment. Frankie valued that these aspects were able to be included in their own 
individual BA treatment formulation. 
Comorbid conditions also interacted with treatment. One young person’s 
diagnosis of an ASD meant they found it difficult to engage with various aspects of 
their therapy. David (P3) reflected:  
“Yeah. I found [BA] somewhat helpful, but I found it quite awkward, 
because I’m not used to being, I don’t really like being in a room with just 
one person. I find it very hard to speak to people and it’s, and when 
you’re sort of just sitting there with somebody it’s hard” 
The one-to-one sessions were a social challenge for David, as were many of the 
activities proposed by his clinician Sharon (S5). David felt that he most likely had a 
different treatment experience to other young people his age, due to his ASD 
diagnosis. David’s clinician, Sharon (S5) found that David’s personality and ASD made 
it difficult for him to be flexible or open-minded to alternative activities (to his usual 
solitary interests) during therapy. Several staff members felt that such comorbid 
conditions presented a barrier to successful treatment:  
“I think the other difficulty I found is looking at comorbidities. I know as 
part of your study you included, it was any comorbidity was it? Any 
comorbidity providing the risk wasn’t massively immediately severe. So 
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one of the difficulties I found was comorbids, you know, 
neurodevelopmental disorders, I found working with a young person 
with an ASD, with Asperger’s, it was particularly difficult because 
sometimes the internal barriers and external barriers all were very 
blurred. In that it’s very, well it’s very easy, throughout all of the 
psychoeducation that this service user had had from their diagnosis of 
Asperger’s, they were very quick to say I want to be more socially active, 
I do approach groups of people, but I often get rejected from those 
groups of people because I’m socially awkward. I’m socially awkward 
because I have Asperger’s. I’ve done skills training; they’ve told me 
sometimes people are going to reject me because I’m socially awkward. 
So in that aspect I think it often feels like there are elements of cognitive 
therapy that are needed within that. And I think with the work I did, the 
BA I did that was solely low mood and a bit of anxiety as well, BA was 
spot on perfect. It couldn’t have worked better. But I think when you’ve 
got ASD and potentially ADHD as well, you do have to think about how 
you can integrate that with other therapies. And that might just be my 
psychological stance on it” [Shane S3] 
“It was difficult for my client to think of tasks he wanted to complete. 
And a lot of times he would say the same thing” [Sharon S5] 
“[H]e didn’t have many interests. He only had very specific interests as he 
had ASD, and a lot of them were introspective introverted interests that 
didn’t involve him getting out and about, which is really what he needed 
to do. So it was quite difficult” [Sharon S5] 
Shane (S3) highlights how useful BA treatment was to improve low mood symptoms 
but suggested additional ‘cognitive’ elements may be required for young people with 
neurodevelopmental difficulties, such as those with an ASD. This echoes earlier 
sentiments from other clinicians. Sharon felt so strongly about this that she went on 
to suggest that BA may not be appropriate for complex young people such as David. 
Sharon reflected that BA may be more suitable for young people with less ingrained 
difficulties who are motivated to make changes to their routines: 
“I think if you have very simple cases or working with clients who are 
already coping quite well and are very motivated, it’s kind of, it offers 
them a few more little tricks to put into their resiliencies, which will be 
quite useful. But I think for more complex clients that really need a 
relationship and proper understanding and empathy, I don’t think it’s 
very good” 
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This feedback may reflect Sharon’s experience in the BUDDY study of dealing with 
two complex Tier 3 individuals (David P3 and Frankie P2), both of whom had an ASD 
diagnosis. David was not alone in finding that his comorbidity influenced his ability to 
engage in the BA treatment. Estelle (P5) found that her comorbid anxiety 
complicated treating her symptoms of low mood; she hypothesised that her 
underlying anxiety was responsible for feeding into her depression. As such, Estelle 
thought her treatment needed to focus upon her anxiety rather than her depression:  
“I notice that it’s been easier to get out of my low mood and that. I 
normally only get it when I’m anxious, so I need to sort my anxiousness 
out and then I think lower mood will go” 
The treatment of complex young people suffering multiple difficulties presents a 
challenge for individual, clinicians and services. 
Memory / Intelligence 
Some staff members questioned whether successful engagement in treatment might 
be dependent upon intellectual ability:  
“I don’t know if this is about intellectual ability. I found [BA] worked 
really well with the young person who was intellectually very bright, less 
well with the one that wasn’t, really” [Geoff S1] 
“I think were some difficulties, just thinking back about some other BA 
work I’ve seen, there were some difficulties around understanding the 
model. And I think from my experience of therapeutic models BA is one 
of the most simple, which I think is why it’s really good for service users. 
But I think you kind of still need to rely on that cognitive level that a 
young person is able to understand. And not just that cognitive level, I 
suppose, but also that meta-cognitive level. If they can’t be reflective 
about it then this is why this is happening, this is how I feel, they don’t 
have the skills necessary to do that. In the same way as CBT you need to 
acknowledge that they can reflect on their own mood. If you can’t do 
that then BA is not going to work” [Shane] 
This was evidenced in the ability of young people to complete homework tasks that 
were set, indicating perhaps that a young person’s ability or capacity, as well as 
  253 
motivation to engage in treatment, is an important element in the subsequent 
success of therapy. In most cases where homework tasks were not completed, this 
was linked to difficulties remembering to complete the task.  
Other staff members and young people suggested it may be difficulties in 
retaining the session content that caused problems. Two young people reported 
difficulties remembering the content of sessions or recalling the details of their 
assigned between-session tasks, such as completing a mood diary. Jennifer’s parent 
(P1) felt this was due to their child not reading the materials that were provided. 
Frankie (P2) found it hard to remember to complete the tasks:  
“I feel like maybe that mood diary thing that she wanted me to do might 
have been helpful if I’d actually done it, but I kept forgetting” 
The young person’s carer challenged this by pointing out that, since treatment 
finished, Frankie had bought and completed a regular mood diary. The parent 
thought the mood diary was a good idea as it allowed the young person to revisit 
past events and this was viewed as an important tool for Frankie to maintain a 
positive mood. A staff member found memory was also a challenge for another 
client:  
“We were finding session by session they could rarely remember any of 
the BA that we’d gone through using the manual; however, yeah they’d 
activated really well. They weren’t doing any of the between-session 
tasks. So what we ended up doing in sessions was almost abandoning the 
manual…. and just referenced the activation that this service user was 
doing in the context of their BA formulation and thinking about it more, I 
suppose more as a process than as an individual instance of something 
that they’d done. And I think that’s probably the thing that’s going to 
help in the long-term with that service user [Alicia]”. [Shane] 
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The clinician did not attribute this activation to the BA treatment, rather to ‘extra 
therapeutic factors’ such as concurrent efforts to return to education. Such 
serendipitous events will be considered as a facilitator under external barriers. 
External barriers or facilitators 
External barriers were generally outside of the control of the young person and were 
often of a practical nature (see Figure 24). They related to the support network 
surrounding the young person, environmental events or resource limitations that 
may influence treatment and factors specific to the BA treatment.  For parents, their 
own mental health represented a barrier to offering support during treatment and 
for clinicians, their lack of faith in the BA treatment acted as a barrier to delivery of 
the treatment.  
One staff member reflected how there may be insurmountable barriers during 
the course of BA treatment, and questioned whether this was adequately addressed 
in the manual: 
“I think one of the biggest problems I found with [BA] is the dependency 
on the ability to overcome barriers. And I think like all behavioural and 
cognitive behavioural interventions, it’s very heavily designed around 
overcoming internal barriers, navigating around external barriers. 
Throughout the training that we’ve had and throughout my experience 
delivering it, we’ve had very little guidance on when external barriers are 
not ‘overcomeable’ – if that’s a word” [Shane S3] 
Shane went on to discuss how many young people may face recurrent “physical, real 
[or] concrete barriers”, separate to BA, that are also unfeasible to overcome. He felt 
that BA was perhaps not able sufficiently to address such situations. 
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Figure 24: Pictorial representation of identified external barriers to successful BA treatment by young people, their parents and clinicians 
 
Support Network 
- Unsupportive Friends or Family 
- Friends or family with poor mental health 
- Friends with a lack of freedom 
 
Environmental Restraints 
- Summer Holidays 
- Lack of facilities or opportunities in local area 
- Exams 
Resource Limitations 
- Lack of money 
- Lack of transport 
 
Treatment Specific Factors 
- Manual too paper-heavy 
- Manual has poor graphics 
- Manual repetitive 
- Therapist Alliance/Equipoise 
 
External Barriers / Facilitators 
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Support Network 
As alluded to in previous sections, the external environment that young people live 
in acts as a facilitator or barrier during BA treatment. One aspect of this is the social 
support network of friends and family that they have around them. For David (P3), 
his desire for no parental involvement in his treatment was at odds with his parent 
and clinician who both believed increased parental involvement would have resulted 
in improved treatment outcomes. When the reasons for his parent’s lack of 
attendance were explored, David’s parent reported they had their own internal 
challenges to overcome and cited these as a reason for not attending David’s (P3) 
treatment sessions:  
“I’m going to admit it…I was going to go towards the end but, and I’m 
going to say this and it’s really stupid and you’ll think I’m ridiculous, but 
where the place is situated it’s opposite the police station. And my 
husband, soon to be ex-husband and his girlfriend work there, and I lost 
my nerve of going” [David’s parent]  
Again, this is indicative of parental issues being revealed as a barrier to attendance at 
their child’s therapy sessions. This is analogous to the reports of parents bringing 
their own issues into therapy sessions. 
Frankie (P2), who received three sessions of BA, identified that their external 
environment was making it difficult to complete the tasks and goals that had been 
set by their therapist Sharon (S5):  
“She [Sharon] had a few goals that I still need to try and sort out, like 
taking the bus by myself, going out more. But the problem is all of my 
friends are really introverted and depressed and indoorsy and I hate 
them. I really want to fix this whole slump I’ve forced myself into for the 
past three years and, like, none of my other friends give a shit. They all 
just want to rot there and, like, die” 
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Frankie’s friends were not a positive source of support. Sharon identified that a 
young person’s friendship group also had an impact on David, another of her clients: 
“If he [David] actually had more friends, that might have helped. If he’d 
had interests in this country that might have helped.” [Sharon S5] 
Sharon refers to David’s only hobby, a niche international interest that was not easily 
accessible in the UK. Patient Frankie also reflected upon how external stimuli such as 
their friend’s poor mental health, had impacted upon their own mood.  
“Oh yeah, [my friend], his mum found out that he’d been self-harming 
and she wouldn’t let him leave the house alone. So I couldn’t hang out 
with him at all. And he’s not in my college anymore so I don’t really see 
him now. So I just talk to him on Facebook. And [another friend], she has, 
she’s got something. Like, despite being in therapy for the majority of her 
life she’s never had it officially diagnosed, and that’s really fucked up I 
think. But she shows quite a lot of signs of some kind of autism and 
various other things. But like her parents are really weird with it. She 
even claims that they’re not overprotective but I know that they are – 
like it’s really just easy to spot” [Frankie]  
Frankie’s parent agreed “There wasn’t really friends available either. I think that was 
the big thing wasn’t it?” These quotes highlight the impact of significant others in 
young people’s lives which is an issue that is very difficult for therapy and therapists 
to address: however, it should be noted that, there may be a link back to the 
comorbid conditions/individual differences theme, as both Frankie and David 
suffered from an ASD, which is linked to social difficulties.  
As discussed earlier, other young people and staff members felt parents were 
a vital source of a support. Shane reflected on whether parental involvement was a 
hindrance or facilitator in the context of BA treatment: 
“I think if parents are quite encouraging that can be a good thing. But I 
think parents can be over-encouraging, particularly when it’s around 
activity diaries, mood diaries that can be quite personal for the young 
person. Do I think this behaviour was helpful, did it lift my mood? So I 
think parents have a beneficial effect” 
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Environmental Restraints 
External events and the physical environment in which young people live impacts 
upon the success of BA treatment. Frankie continued discussing the impact of 
outside influences in relation to their BA treatment by detailing the lack of places to 
visit in their local area and restrictions due to their friend’s preferences. These 
outside influences had an impact on completing between-session tasks:  
“But the problem is there’s nowhere really for us to go other than 
[nearest city], and I’m only really friends with people at my college now 
who are all from [local town] so they don’t really give a shit about [the 
city]. I do have this one friend …but he never wants to go to [the city], 
because he goes to [the city] all the time basically. And whenever I want 
to go suddenly it’s too much of a hassle for him. I think he is feeling 
depressed lately but he’s like just not, he’s just like completely repressing 
his feelings and not talking to his parents about it. And he’s like gone off 
his therapy counsels and that, and I’m like you are, that’s a really bad 
idea” 
Again, echoing the impact of the support network theme on young people’s lives and 
opportunities. 
A staff member similarly felt that where the young person lives could represent 
a barrier to their successful engagement in treatment: 
“And sometimes being able to say well what is it you’d get out of doing 
this, can we find another way into it, is not feasible. For example if the 
service user has no means, if they live in the middle of nowhere, which a 
lot of people in [the area] do, and they’ve got no means of getting out of 
the house into a social hub, if their goal is to be more socially active and 
if they’re feeling low because they’re socially isolated, there may not be a 
way to overcome that” [Shane] 
Shane particularly comments on how this environmental restraint limits the 
opportunities for coming into contact with differing sources of positive 
reinforcement (i.e. hobbies, friends). This is a key aspect of ‘activation’ during BA 
treatment. 
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Resource Limitations 
David (P3) found a lack of money hampered completion of certain activation tasks, 
such as days out:  
“Money, travel, I can’t really travel to many places because you have to 
get a bus…because I like going to museums and art galleries, [but] there’s 
not many in reach of buses and it takes too long to get there” 
David’s parent found this particularly frustrating, stating, “Well, you see, if you’d 
asked me I would have given you some money – I didn’t know that”, again 
highlighting a potential benefit of parental participation in treatment. Of course, on 
the contrary, it could represent an excuse on David’s part, as to why he could not 
complete his between session task. This would link back to the internal barrier of 
motivation. David’s parent felt that the summer holidays had disadvantaged 
progress in treatment “…and of course it’s the summer holidays so he doesn’t have 
to go to wherever, you know”. This is in line with the effect of his therapist Sharon 
also taking time off during the summer months. 
Treatment Specific Limitations 
Treatment Manual  
Staff identified the manual materials may have hampered delivery of the BA model. 
Paul (S4) suggested moving the concept of goal-setting to earlier in the course of 
treatment. Paul found the manual itself was too paper-heavy, required slimming 
down so that it was not overwhelming to the clinician, and that the graphics could be 
improved for the young people (i.e. it was perceived to be “a little bit clipart heavy”). 
Although, interestingly, the graphics were not mentioned by other young 
interviewees in this current study. Geoff (S1) seconded this sentiment related to the 
manual graphics, but also commented that the prescriptive format of the manual 
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aided the continuity and management of the therapy delivery, helping the clinician 
keep up with where they were with the work. Nicola (S2) felt:  
“…the layout of it is fine. A bit cluttered I found. The ones [worksheets] 
that stand out are the ones that make visually more sense” 
“…one of the packs was very long” 
“…some of it was too wordy” 
“[Some worksheets were too] busy for me. If they had more space, just a 
bit busy maybe” 
Nicola reported young people did not like the homework, “but the ones that do it, 
again that’s motivation to do that, they really didn’t like. She [Estelle P5] wasn’t too 
bad actually but in general they’re not fond of homework, so you’re only as good as 
the homework you do”. Sharon (S5) felt that that there was a lot she did not like “a 
lot of it that would have trimmed down and just put into my ordinary way of 
therapy, which would be counselling/psychotherapy. I thought it was repetitive. I 
understand why they want it to be repetitive in some way but I still thought it was 
repetitive”. Like Paul, Sharon felt the materials were helpful but “initially a little bit 
clunky”. In particular she felt young people struggled with the activity sheets and 
identifying how they felt at a particular time, as it proved too complicated for them 
due to their other commitments and finding the time to record this information. It 
was suggested an electronic format may be a better way to record this information, 
such as a phone app.  
Therapist Alliance 
Shane (S3) suggested the biggest barrier to successful BA treatment was poor 
therapeutic alliance between therapist and client:  
“I think the biggest barrier for service user engagement in BA, in any 
therapy, in any intervention, in any service, is that therapeutic alliance, 
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and I think young people need to be listened to, and I think they need it 
acknowledged that they’re being listened to. One of the advantages I had 
was that the service user I was working with identified me as not being 
one of those old therapists. Which put us more, I suppose more 
comfortable around each other, and that instant rapport building was 
much easier. So I think one of the barriers is just how well you get on 
with your therapist. And I think the other difficulty with this [BA] 
intervention, of course, is thinking about collaborative care and shared 
decision-making. We actively promote [as a service], if a service user 
doesn’t feel that they get on with their therapist they tell someone and 
they get a new one. Now if you’re midway through a manual that’s not 
going to be practical on the therapist or on the service user. Well, a new 
therapist or the service user, that is. I suppose that’s the main 
engagement with the model is around that therapeutic alliance” [Shane] 
He proposed this wasn’t specific to BA, but to any psychotherapy delivered through 
CAMHS.  
The therapeutic relationship between the young person and their therapist 
was highlighted as a facilitator by a parent who described their young person’s 
(Frankie P2) positive experience “I just think talking to [Sharon S5] really, and having 
her saying why don’t you try this or you’re doing really well…You know, I think 
somebody else telling you that you’re doing well is a good thing, isn’t it?”. 
“Well I think it’s effective and it helped us” [Frankie] 
“I think it’s helped a lot. The lady that I did it with was really nice, and she 
gave me goals. And I think they were good because I actually tried to do 
them and stuff. And then she gave me sheets of paper that you had to 
write down what you did, and I found them good because I felt as if I 
could write what was happening and what my triggers were” [Estelle P5] 
It was the goal-setting that Estelle felt made the biggest difference. Both Estelle and 
her carer identified having a clinician (Nicola S2) that they liked impacted upon their 
treatment experience; “We’ve enjoyed it. Got to know the clinician, didn’t we, and 
she was really nice”. Estelle said that “she listened”, and that “it was nice to have 
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help”. Her parent said, “…they’ve got to show empathy haven’t they, and she did”. In 
return, their clinician Nicola recalled that: 
“On the surface the girl was very much a people pleaser, very much. But I 
could tell that the biggest barrier again was avoidance. So the avoidance, 
there were a couple of times where she was teary and defensive. But 
when we went for the final session she admitted that defensiveness was 
part and parcel of it all, and she overcame them. So you’re not going to 
nicely overcome your fears. So I’d say it was very understandable, run of 
the mill relationship between the person doing the treatment, the 
therapeutic relationship was as expected and avoidance is part and 
parcel, you know, there’s no magic wand” 
Lucy (P6) valued the comfortable relationship with her therapist Geoff (S1), assessing 
it as helpful; “Yeah I think so. I think if it was someone that I didn’t, not necessarily 
see eye to eye with, but someone that didn’t fully understand or listen to what it 
was, or assumed it was to do with something when it hadn’t been fully explained”. 
Lucy’s parent said “I think you felt quite comfortable didn’t you, talking to 
[Geoff]…He was very good”. In turn, Geoff felt the therapeutic relationship between 
patient and clinician had been strengthened by the weekly format of sessions making 
it “much more positive, much more engaged”, even in cases where treatment was 
viewed to be less successful. In the same way that young people felt the staff 
member they had been assigned impacted upon their treatment experience, staff 
felt that the young person they were allocated also impacted upon the success of the 
subsequent treatment delivery. When reflecting upon a “less successful” experience 
of delivering BA, Geoff felt “I think that was about the profile of the young person in 
lots of ways”. He also attributed a successful case (Lucy) to the intrinsic abilities of 
the young person;  
“[Q]uite articulate, a high achiever at school, very much quite precise in 
terms of what she did and how she approached work. So a BA model 
suited her great. It really fitted well with her” [Geoff] 
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David (P3) felt that his therapeutic relationship with Sharon did not make a 
difference to his treatment. However, therapist Sharon though that “it might be 
difficult for him because of his ASD, because of his diagnosis. And, I mean, I do think 
that the most important part of therapy is the relationship, which is acknowledged 
as the most important part in most circles, and BA isn’t really about the 
relationship”. 
Therapist Equipoise 
Some clinicians did not value BA in the same way as other therapies, such as CBT. 
One clinician, Sharon (S5), stated she did not like the therapy and would not chose to 
use it as a stand-alone treatment. However, she did concede that she found the 
component BA parts useful and would deliver them alongside other approaches. 
Understanding why this might be the case is vitally important, as without clinical 
equipoise, it would be inadvisable to attempt to implement the treatment in 
practice. Shane reported that he held a lack of faith that the BA treatment would 
help Alicia in the long-term. Instead, Shane chose to rely upon his own clinical 
judgement in relation to the aspects of the BA treatment he felt would be most 
helpful to improve Alicia’s symptoms. These adaptions were not in-keeping with the 
suggested model of delivery and would require further monitoring and exploration in 
a future trial. Similarly, Nicola (S2) reported:  
“I had a very amenable young person [Estelle] and I think that made a big 
difference. Well she was amenable on the surface… underneath she was 
very resistant” 
 “[The family were] a very straightforward family to work with on the 
surface. The difficulties the girl [Estelle] faced were very ingrained 
though I think for BA” 
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Again, this implies a lack of confidence that the BA treatment would suitably address 
this young person’s symptoms, suggesting there may not be therapist equipoise. 
Staff felt there were limitations to a BA approach for depression: 
“I think behavioural activation, I just think it’s got those clear limitations 
around sometimes you do need to go further” [Shane S3] 
“I didn’t feel that I could address in this type of therapy what I wanted to 
address” [Sharon S5] 
“I find that using, having to use pure BA I feel very constrained and it 
hampers me. It hampers my intuitiveness and my kind of natural, the 
natural flow of therapy. And I don’t like it” [Sharon S5] 
For Sharon (S5), it was her own internal challenges that were most difficult to 
overcome, in order to deliver the treatment.  
Sharon (S5) also felt the BA approach was particularly suited to “practitioners 
who are very logical and like to follow procedures without having to think a lot for 
themselves”. This contrasted with feedback from other members of staff, who felt 
the approach suited them and some of the young people they were delivering 
treatment to. Nicola (S2) went on to report how her confidence in delivering therapy 
meant she did not struggle with delivery; “I think in general I quite like chatting to 
people anyway so for me just part and parcel. Because it’s your confidence in 
yourself isn’t it, so I didn’t struggle with delivery”. In contrast, Sharon (S5) felt the 
prescriptive manual and the acronyms were unhelpful; “Well, as I say, I felt 
constrained and I felt limited and I kept having to interrupt my train of thought to 
look at what various abbreviations meant and things. I felt that I wasn’t really 
listening to the client; I was more thinking about what I was supposed to do next in a 
procedural way”. Nicola agreed and felt some acronyms, such as TRAP and TRAC, 
were not easy to get across to young people, even if the theory behind them was 
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good. In contrast, other clinicians, such as Paul (S4), felt a BA manualised approach 
(with worksheets) sat well with his previous background delivering youth work 
interventions. He reflected on the fact that he had not been trained in any other 
therapeutic interventions. As discussed in the earlier ethnography (Chapter 3), this 
would again suggest that there cannot be a “one size fits all” approach to training or 
to staff recruitment to trials in this setting, and that such contextual factors need to 
be carefully considered. 
Helpful and unhelpful aspects of treatment 
Multifaceted change was reported for most of the young people interviewed and 
this varied from small one-off instances to large sustained improvements. Progress 
reported by young people was not necessarily related to aspects of their life targeted 
for ‘measurement’ using quantitative outcome measures. Instead, young people 
spoke about how their motivation had improved rather than concepts such as self-
esteem or specific depressive symptomology. In general, staff reported that the 
content was understandable and acceptable to the young people they delivered it 
to. Most staff also reported liking the treatment and found it useful to improve 
symptoms of depression. There were, however, some caveats. 
 Estelle (P5) found that BA treatment “definitely helped with my low mood” 
and particularly liked the goal-setting elements of treatment. This was in contrast to 
her therapist, Nicola (S2) who felt that young people did not enjoy the between-
session tasks, although she acknowledged that this may be a gendered issue, as 
some participating girls did like the between-session tasks. This was seconded by 
Frankie, who found that they were nowhere near as reluctant to go out following 
treatment as they had been previously.  
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Most staff and young people highlighted the goal-setting as a key part of 
treatment, and valued the progress made throughout this process of breaking larger 
tasks into smaller ones. Staff found that they were able to report improvements in 
young people, particularly in relation to achieving the goals they had set: 
“So the BA in fact for her was very good. It got her to do things, eat 
sandwiches in front of people [a goal]. It sounds really minor but if you’re 
eating in the dinnertime you’re probably feeling better later on in the 
day. Your physical and your mental health is very important, if you’re not 
eating you are worried later aren’t you?” [Nicola S2] 
 As previously mentioned some staff felt it was not in fact the treatment that 
was responsible for the reported improvements, rather it was external serendipitous 
factors: 
“Avoidance was the big thing. And because of generalised anxiety she 
actually believed in the reasons she avoided things. She really did 
struggle with [using] the bus. And it didn’t matter how you unpicked it, as 
I said there was a bit of serendipity, she did do it. Whether that’s got her 
back on the bus or not is another matter” [Nicola S2] 
Despite Sharon previously expressing her dislike for the treatment approach, she 
concluded:  
“I think BA is a good little eclectic technique, but I don’t really think it’s 
effective on its own unless it’s a very simple client that already has lots of 
resiliencies and resources” 
This raises questions relating to the impact of how a clinician’s belief in the efficacy 
of an intervention could impact upon its application in clinical services. 
The actual contents of the BA manual and BA model were felt to be 
important by families and staff. While the manual materials were highlighted as an 
external barrier earlier, the manualised format was viewed by some participants as a 
facilitator. Estelle (P5) felt that she learnt “the right things I needed to learn” during 
her BA sessions. She went on to say “I liked the homework; it didn’t really bother 
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me” and her parent confirmed she always completed the tasks she was set by the 
therapist. Shane (S3) described the success of between-session tasks: “I found the 
between-session tasks weren’t very accessible for [Alicia] … The other service user 
I’m seeing at the moment [outside of the study], is massively engaged with it. Is 
doing every between-session task, is feeding them back, is reflecting on them before 
feeding back”. When another young person was asked what happened during their 
BA sessions, Frankie (P2) responded “Basically I’d whine for a few minutes about 
shit, and then the lady would just actually tell us some good ideas as to how, I like, 
sort stuff out. And that’s it”. The practical nature of the treatment was a facilitator 
noted by some young people and staff delivering it. Lucy described how “it started 
with, it followed the booklet pretty precisely, because obviously it’s a test, and it was 
pretty good talking about things and having the sheets to go back and work on 
myself. So it wasn’t just someone talking and telling me what I could do, it was 
putting it into practice as well”. They went on to say “I think the most important 
parts was not just talking about it and what I could do, it’s making me put it into 
practice with the worksheets, and not with anybody else, like, by myself, so I could 
do it.”. 
Aspects of delivery 
Staff were motivated and engaged in the study. Geoff (S1) felt that the “action 
orientated” part of the programme was the most beneficial part. Another member of 
staff (Paul S4) felt BA “…seems to make sense. The whole approach is something I 
feel young people can grasp rather than some kind of detailed knowledge of 
psychology or their brain. You know, it’s how they’re living their life which is causing 
low mood”. Neither Paul nor Geoff could think of any parts of the BA concept that 
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they didn’t like. Nicola (S2) thought some of the handouts were “fantastic” and 
particularly liked the ones on:  
“Mood directed behaviour, goal directed behaviour. I think that 
absolutely is fantastic. And they really get that, because you can’t explain 
why you have to do things, not because you want to but because you 
have to, and it really nails avoidance really well- because avoidance is 
very powerful with depression and anxiety, so that made a lot of sense. I 
think once we’d done that it just slips into the language quite easily and 
yeah that made a lot of difference”  
Sharon went on to say “I liked the first, I definitely liked the first session. I thought 
that was brilliant”; and the relapse prevention at the end of treatment because it 
was helpful to review how far Estelle (P5) had come during treatment. Nicola felt the 
key thing was:  
“the motivation at the start of BA is far more, it’s not the BA package or 
anything, it’s how motivated the family are to change. And for me that’s 
the outcome of therapy, that’s my strongest feeling about it, and that’s 
one thing BA has really nailed home to me, I think, the family have to be 
motivated to change, not just the child. And there’s no point in family 
being motivated to change if the child is a bit ambivalent, but they’re 
very young” 
This echoes Geoff’s (S1) earlier observations. Although Sharon (S5) did not like the 
BA treatment as a whole, she did like some aspects of the BA model: 
“So what I liked about it is the model of what has led to somebody 
feeling the way they did and what maintains them in that state. I thought 
that was a good little explanation that could give someone kind of, oh 
what am I trying to say, a reason why they’re feeling the way they’re 
feeling. And I thought that was quite interesting and the clients found it 
quite interesting. I mean I know a lot of models can use their own way to 
explain behaviour, but as a model that bit was ok” 
Sharon said “The other thing I did like, because I liked bits of it, I liked kind of the 
diary bit, although I wouldn’t have made it as long. And the goal-setting, but I 
wouldn’t have made it as long and done it in that format”. David (P3) found BA 
treatment “quite easy to follow”, with the most useful part of treatment being 
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“doing the things you’d talk about doing” such as the between-session tasks. These 
tasks comprised of David cooking more meals for himself, for example. Sharon, 
David’s therapist reported his attendance was excellent and “he did complete the 
tasks that were set. Like he arranged and met a friend and went to [a shopping 
centre]. You know, he seemed to complete what was set”. However, a conversation 
between parent and child illustrated that the family had reservations about whether 
the positive benefits would continue now that treatment had stopped.  
Lucy (P6) found the start of therapy particularly difficult because they found it 
hard to explain how they felt. “I think the start was the most difficult bit, like, just 
understanding…with not really understanding how I felt in the first place”. They felt 
that “at first it was a little weird, because I didn’t really know anything about it. But 
after a while it was helpful”. Their parent commented “I think it was good, because I 
could tell [Lucy] understood what was going on and why they were trying to do it 
that way. And she realised that it would be helpful”. Lucy particularly liked that the 
fact that it was about her and focuses upon what she could do personally rather than 
being about what other people around her could do.  
Staff indicated practice and familiarity with materials improved after their 
initial patient. Furthermore, supervision was seen by two members of staff (Paul and 
Geoff) as a facilitator for staying on track when difficulties were encountered. Geoff 
described how they had encountered problems with delivering treatment according 
to the manual and so had accessed supervision, during which they were advised to 
be more flexible and to treat the manual materials as a reference point. This “freed” 
them to not “tie yourself up with the paperwork”. It appeared useful if the BA 
approach appealed to practitioners like Nicola, Shane and Paul “I really enjoyed it. It 
  270 
made a lot of sense to me”. Nicola said “I use aspects of it all the time. The whole 
ethos of it I used a lot”. Geoff agreed “So I think that certainly from my positive 
experience it is a model that can be applied to clinical practice and it does have a 
good outcome”. He went on to say “I think my view is that it felt satisfying in terms 
of my own clinical practice. I felt more in control. I felt that it had more of a 
structure. I felt more confident and competent in terms of what I was doing. So 
actually delivering it felt good, worthwhile”. Shane said “my experience of the BA 
model was I suppose positive from a clinician point of view”. He went on to say 
“Personally I found the model really engaging and really positive. I think it’s got a lot 
of really good things about it. And I think, yeah, being able to demonstrate how the 
model applies is really good; however, I think the manuals that we ended up using 
have far too much information. For the session constraints we have, you would need 
a massively engaged positive service user, and realistically if you’ve got a massively 
engaged positive service user, they’re (a) not going to have low mood or (b) they’re 
going to last eight weeks before they’re ready for discharge”.  
“It’s a tricky one. I’m very hesitant to comment on the effectiveness of an 
intervention without first seeing an evidence base. And I know the 
evidence base for BA is currently not great, particularly in children. 
However I think as a model, and this might just be me being a lazy 
therapist, I think it’s a very simple model which I think makes it very 
appealing to therapists, and also very appealing to service users. And if 
they can fit themselves into that, I think they get on really well with it. 
One of the other things that I’ve really liked about it is the very 
immediate nature of it, in a sense. So, service users that present with 
massive complex previous trauma, previous negative experience, if they 
don’t want to focus on that, they don’t need to. And I think that’s really 
good. You can say yes you’ve had all this, it’s horrible, I’m not going to 
dredge it up if you don’t want to, what we’re going to do is we’re going 
to be able to talk through what the situation is now and how we’re going 
to change that. That fits in really well with my ethos of that kind of 
mindful approach, which is why I think BA needs more mindfulness 
integrated, but that’s a different story. What I’d like to see is I’d like to 
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see how well it works alongside other interventions. Well, I’m just 
thinking when you’ve got people who have had massive histories of 
trauma, of abuse, it would be really interesting to see how well BA works 
for the short term where psychodynamic or EMDR interventions work for 
that long term. I’ve got no understanding of how they’d integrate. 
Currently I’m doing some work integrating BA alongside some systemic 
family work, which is quite interesting really because it almost bridges 
that gap between what are the barriers, how do we think we can address 
them, take them to the systemic session, talk it through with the family, 
and I find that’s really useful. So yeah, I think it’s really interesting to see 
how the cognitive component from CBT isn’t massively missed, but I 
think it would be very naïve of us to say even with an evidence base, if 
that cognitive component is not there and we’re getting positive results, 
that we couldn’t improve upon those results with additional integrated 
therapies ” [Shane S3] 
Finally, four young people and their parents couldn’t identify anything unhelpful 
about treatment, with David stating that “… it was just, I can’t really think of 
anything bad to say, it was just sort of all right”. 
Mechanisms of change 
Geoff (S1) commented that it had been around six months since the first contact 
with the young people they had treated. He felt that the young person who engaged 
with BA (Lucy P6), where there was evidence of an impact upon behaviour and 
beliefs, had not regressed. In contrast, the young people who did not engage well 
(Connor P9 and Neive P10) and for whom there was less evidence of impact, have 
been re-referred to CAMHS for further input in terms of their care. The reason 
articulated for this, and the point that Geoff considered the most important in terms 
of patient care, was that:  
“…young people get engaged with things which help their mood improve, 
rather than them having to try and think of it in a different way, in terms 
of changing [your] thoughts before you change [your] actions” 
Nicola (S2) reported that since the end of her BA sessions, Estelle (P5) had returned 
to CAMHS for treatment for her generalised anxiety. Nicola reflected that in this case 
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she felt Estelle’s low mood was a symptom of her anxiety rather than vice versa and 
that BA may be best suited to “separation anxiety, low mood and some low level 
anxieties…And I very much think for school refusal it’s brilliant. Anything to do with 
getting up and doing something, and having the tools to know that depression and 
anxiety is not just the way you feel, it’s what you do, how you think”.  
Summary of BUDDY trial qualitative results 
The feedback from both staff and participants overwhelmingly supports the weekly 
mode of delivery. Young people were generally found the length of treatment 
sessions acceptable .One young person would have preferred longer sessions, but he 
only received sessions that were on average half the maximum allocated length. 
Staff felt there was too much information to cover within the one-hour session 
length and also within the eight session limit. This led to difficulties delivering the 
manual content as intended. Although it is likely that young people were unaware of 
the content, staff were unable to deliver within the time/session restrictions. There 
was a mixed response in terms of the ideal number of treatment sessions; generally, 
participants felt the amount was sufficient to treat depressive symptoms, but some 
staff and families were concerned that the treatment did not address comorbid 
anxiety symptoms. Greater flexibility in the number of treatment sessions may 
address staff and family concerns that comorbid anxiety could not be addressed, and 
enable additional time to cover manual content. However, this needs to be 
considered in the context of the described service pressures. 
Most families enjoyed BA treatment, perceived it as acceptable and noted 
improvements to their low mood as a result of treatment. However young people 
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and their families noted significant barriers to many aspects of BA that should be 
explored further. The feedback from clinicians was more mixed; few practitioners 
reported great problems delivering the treatment, but they did raise a number of 
important feasibility questions in relation to the delivery of the treatment and its 
utility.  
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Stage II Discussion and Conclusions 
The BUDDY feasibility study is the first UK-based randomised trial in secondary care, 
of BA for young people with depression. This gap in the research was identified by 
the scoping review conducted in Chapter 1 and a recent systematic review of BA 
interventions for young people with depression (Tindall et al., 2017). This feasibility 
study shows that the BA intervention was potentially suitable to be disseminated 
and delivered in Child and Adolescent Mental Health Services (CAMHS) via the CYP 
IAPT service transformation initiative. This thesis brings together findings from the 
qualitative and quantitative outcomes relating to the BA intervention, across a broad 
range of domains. Primary findings relate to the acceptability of the BA intervention 
and the feasibility of the trial design in this context, which will be discussed below. 
Recruitment 
Staff 
It was important that CAMHS sites were willing to participate in the research study 
and that they could also be retained throughout the trial. In this respect, the BUDDY 
study was a success; all the services that were asked, agreed to take part and 
continued participation until the end of the study. It was equally important that staff 
members from each site were willing (and enabled) to be trained in and to deliver 
the BA intervention. We found a small number of staff were unwilling to attend the 
study training due to other commitments, such as CYP IAPT training or their 
workload. Despite this, we were able to train the desired number of staff for the 
trial. There were no instances reported where the CAMHS service would not allow 
staff to attend the training, which is unsurprising due to the study sites being self-
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selected. Furthermore, the findings of the Stage I ethnography meant that the 
training was designed to fit around the demands of the service by being delivered in 
two parts over two different weeks. This appeared to be broadly successful as the 
vast majority of those provided with information agreed to be considered (for 
training in the intervention), and most of those invited, attended.  
One challenge of this recruitment approach is selection bias. Staff 
volunteered personally to be put forward for the training. More motivated staff may 
have been more likely to volunteer, whilst those unwilling to try new approaches or 
to take on additional work may not. This situation may overinflate treatment effect. 
This could present difficulties if the intervention were to be implemented into clinical 
practice as staff may not be representative of the CAMHS team as a whole. This 
feasibility study also demonstrated that most of those trained continued to 
participate in the study until completion. Those who were trained in BA but did not 
provide treatment during the study period remained motivated to participate but 
were restricted by various external barriers, such as changes to their job roles or no 
suitable young people being recruited at their site. Training for the BUDDY study was 
delivered across three days plus supervision; other applications of BA have used 
even shorter durations of training, for example one (McCauley et al., 2016) or two 
days (Weersing et al., 2008). Staff recruitment and retention exceeded the 
expectations formulated in Stage I of the research and proved to be feasible in this 
context. 
Participants 
Another central objective of the feasibility study was to assess the most acceptable, 
feasible and effective ways to approach patients to participate. Three different 
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approaches to this were explored. Both clinician-led and patient-led recruitment 
approaches were deemed acceptable to young people and their parents/carers. In 
line with previous reports from CAMHS services in the County Durham area (Affleck 
and Seed, 2015), we found that approaches where there had been prior contact (i.e. 
with a clinician) were the most successful. The case note review was time-
consuming, unsuccessful (yielding few provisionally eligible patients) and ultimately 
unfeasible. The poster-approach involved minimum resources and although it did 
not yield large numbers of eligible participants, it proved the most reliable at 
identifying young people who met the provisional inclusion criteria. Conversely, due 
to the low numbers who contacted the study team after viewing the poster, it may 
be that it was unappealing to young people and/or their families. The clinician-led 
approach required more resources to implement than the poster (and less than the 
case note review) but provided a good recruitment rate and accounted for the 
recruitment of most subsequent participants. The high rate of suitable young people 
identified by their clinicians suggests that despite a lack of confidence initially, 
CAMHS staff understood and were able to apply the eligibility criteria effectively in 
order to screen patients. This indicates that the study information was appropriate, 
effective and was suitably disseminated around the CAMHS team. In a future study, 
it may be possible for clinicians to screen their own caseloads for eligible patients to 
boost study recruitment where necessary. The success of the poster and clinician 
based approaches suggest that a dual self- and clinician-led recruitment procedure 
would be the best choice for a future trial.  
Rather than the mode of the initial approach for recruitment, it was the 
subsequent interactions that patients and their families chose to focus upon in 
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interview, commenting on the speed or content of the way they were approached. 
Although one family expressed dissatisfaction with the study name, the young 
person (David) themselves questioned whether their diagnosis of Autism Spectrum 
Disorder (ASD) meant that they offered a unique viewpoint to the study materials. It 
should be noted that another young person in the study (Frankie) also had the same 
comorbidity and did not comment that they found the study name to be unsuitable. 
Whilst one family expressed dissatisfaction about the way they were approached, 
the lack of other comments or criticism relating to the recruitment study materials 
would suggest that the PPI input prior to the start of the trial was effective, which is 
in line with previous research (Mawn et al., 2016). 
Interestingly, at various points during the recruitment phase CAMHS 
clinicians excluded participants from the study for various reasons. Allowing 
clinicians the opportunity to assess patient eligibility for the trial in this way 
introduces another source of potential bias (selection bias), as staff’s beliefs - for 
example, those surrounding the utility of the BA treatment - may have led them to 
exclude participants with a particular profile, yielding the sample unrepresentative of 
the study population to which the results would be applied. This would need to be 
explored, and potentially addressed if the same procedure were to be used in a 
larger study. As an alternative procedure, if researchers took on this role, robust risk 
management procedures would need to be put in place and it raises difficult ethical 
dilemmas relating to the shift in clinical decision-making from clinicians to 
researchers.  
Poor recruitment is a common reason for unsuccessful trials (Lancaster et al., 
2004). Although the recruitment period went beyond the intended 12 months, this 
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was mainly due to service restructuring, which led to increased internal waiting lists 
in CAMHS throughout the duration of the study, rather than difficulties in identifying 
appropriate patients. During the study there were a high number of patients 
screened but this converted into a low inclusion rate for both those provisionally and 
subsequently eligible for the study. The overall recruitment rate of 18% in the 
BUDDY study was much lower than that reported in large psychotherapy trials in 
similar populations where the reported rates were between 27-40% (Goodyer et al., 
2017). If the BUDDY study had not used the case note review, and instead relied 
upon clinician and poster recruitment alone, the recruitment rate could be vastly 
improved (without impacting upon the numbers of young people identified) to 
approximately 67%. Greater resources (i.e. a research assistant onsite) to screen 
young people more quickly would improve researcher responsiveness, by recruiting 
more young people before their first treatment session. Extra resources would mean 
young people could be contacted earlier (reducing the time lag between contact and 
action) and this would mean patients would be less likely to have received a 
treatment session. More flexible inclusion criteria would also enable inclusion of 
participants who may have only had one ‘treatment’ session. This must be carefully 
weighed against the potential therapeutic contamination this may introduce into the 
study. A key aspect of this feasibility trial was to determine what the consent rate 
would likely be in a larger trial. The study was successful in obtaining this 
information.  
The consent procedure worked well; parents attended all initial assessment 
sessions for young people aged 15 and under and there were no occasions where a 
parent and child disagreed on the young person’s participation in the research. This 
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approach is in line with the National Institute for Health and Clinical Excellence 
(NICE) guidance (Guideline 28) recommending that family or carers of young people 
aged under 16 should be given information or support to help young people make 
decisions about their treatment (National Institute for Health and Clinical Excellence, 
2005). Again this demonstrated the feasibility of the consent process for a larger 
trial. 
A higher than expected proportion of those assessed using the Kiddie-SADS-
Present and Lifetime Version (K-SADS-PL) met the criteria for Major Depressive 
Disorder (MDD). This could indicate that the study procedures for screening 
participants prior to this stage were effective at screening out patients who would be 
ineligible for the study. The complexity of participants at baseline may also indicate 
that these procedures were too effective and may have actually screened out 
potential participants with milder degrees of depression. All randomised participants 
screened positive for an anxiety comorbidity and had a high number of other 
comorbidities. Furthermore in our study, several participants and/or their families or 
clinicians highlighted these complexities as a barrier to engaging in BA treatment. 
This indicates that the advice provided to staff screening young people for study 
entry and the criteria on the participant study poster should be reviewed to attract 
referrals with a milder depressive symptomology. The additional referrals that would 
be created as a consequence of this, must also be considered. 
Design 
Trial design is a key factor when assessing study outcomes, as if there are 
weaknesses in the design one is unable to ascertain whether the intervention has 
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been ineffective or whether the results reflect implementation failure (Craig et al., 
2008). Differing aspects of the BUDDY study trial design are discussed below. 
Patient and Public Involvement 
Previous research has highlighted the beneficial impact Patient and Public 
Involvement (PPI) can have upon research. One aspect of this is through involvement 
of stakeholders who raise issues not previously considered (Wilson et al., 2015). The 
PPI elements of the study, alongside the innovative focused ethnography to inform 
the trial from a staff and service perspective were beneficial in ensuring the trial was 
well adapted to the intended setting. In this study, when PPI input was obtained 
prior to the start of the trial, some suggestions (such as the amendments to the 
young person information sheets) challenged usual research practice and raised 
important ethical issues to be considered. Key messages from cumulative reviews of 
PPI in research suggest it is important to be sensitive to context and processes when 
designing studies (Wilson et al., 2015). The suggestions raised via PPI served to 
improve the materials and design, with the resulting trial recruiting the desired 
number of participants.  
Risk of Bias 
In addition to the potential bias in staff self-selection for the BA training, the 
distribution of staff (in terms of their pay grade and levels of experience) were 
unequal in the two arms of the study. In a future trial, using inferential statistics this 
is a source of potential bias in favour of Treatment As Usual (TAU). Firstly, staff in the 
BA arm were employed on a grade 7 or below due to the rationale that BA is easily 
disseminated to lower grade staff and those in the higher grades are already highly 
trained (i.e. Psychiatrists, Nurses, Clinical Psychologists). This means that the staff in 
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the TAU arm were skewed to be more highly skilled/experienced. However, the 
seniority of staff in the TAU arm combined with the less severe profiles of the young 
people (i.e. we excluded those requiring urgent care), may explain the lack of 
treatment seen in the TAU arm. It could be that senior staff held more complex or 
severe cases on their caseloads, which they prioritised over those young people in 
our study. This seems plausible in light of the difficult choices by staff navigating a 
lack of treatment resources, observed in the Stage I ethnography.  
If it was found to be the case that senior staff held more complex caseloads, 
with a greater number of clients at risk of suicide for example, it could explain why 
clinicians did not prioritise the care of young people in the BUDDY study. The 
updates to the clinical guidelines for treatment of MDD in the DSM-V reflect the 
clinical needs relating to risk of suicide. A new specifier is available which aims to 
shed light on suicidal factors in patients who are depressed. These factors include 
suicidal thinking, plans, and the presence of other risk factors, in order to make a 
determination of the prominence of suicide prevention in treatment planning for a 
given individual (American Psychiatric Association, 2013). However, these 
developments are unlikely to have an impact on practice in current UK settings, due 
to CAMHS generally working outside of a diagnostic framework. There was no 
suggestion from qualitative interviews with staff in the BA arm that this may have 
been an explanation for the low rates of treatment in the TAU arm for their TAU 
colleagues.  
One limitation of the trial design was that the qualitative exploration was 
limited to the BA arm so no staff or young people from the TAU arm were 
interviewed. Due to the way patients were allocated in the service it was not 
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possible to restrict staff in TAU to only those of a grade 7 and below; however, one 
way this could be achieved in future studies is by limiting the study intake to staff 
from Tier 2 of the service. 
Similarly, the study design did not control for the number of treatment 
sessions in the two treatment arms. In the BA arm families were offered 8 BA 
sessions plus any additional care their practitioner deemed necessary, whereas in 
the TAU arm they were offered only the care their clinician deemed necessary. In 
almost all cases, this resulted in TAU participants receiving fewer treatment sessions 
than their BA counterparts, which is a source of bias as young people may be 
responding to the increased contact time provided rather than the intervention 
itself. Guidance on the reporting of trial results, recommends reporting the precise 
details of the intended treatments participants in each treatment arm will receive 
(Thabane et al., 2010, Eldridge et al., 2016a); although intended, this was not 
achieved in the BUDDY study. Standardising the content and delivering of a complex 
intervention in a RCT is a major challenge (Stephenson and Imrie, 1998). Treatment 
pathways recorded in the TAU arm demonstrate a lack of detail and inconsistencies 
in the patient records completed by clinicians. This makes it very difficult to ascertain 
the exact treatments patients have received and to follow their care through the 
service. One way to overcome these shortcomings would be to have clinicians record 
the exact treatment provided at each session in a standardised log for research 
purposes. This needs to be weighed up against ethical issues relating to storing this 
data and an additional burden on already overburdened workforce. 
Pass and colleagues (2017) highlight the rationale for integrating Routine 
Outcome Measures (ROMs) into BA therapy in a UK CAMHS setting, as they allow the 
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clinician to track progress and monitor risk. In the BUDDY study, ROMs were rarely 
deployed by clinicians in either arm of the trial, which meant we were unable to use 
this information to assess whether young people who dropped out of treatment had 
done so due to an improvement in their symptoms. The reasons for this low 
deployment of ROMs are unclear. This contrasts with the aims of the CYP IAPT 
programme, which focuses on moving towards evidence-based delivery with clear 
monitoring of outcomes (using ROMs). 
The study endpoint was specified before the data were collected and was not 
sufficiently long enough for all BA participants to have completed treatment. This 
meant that, for some participants, additional appointments were required to 
complete the qualitative interviews, increasing study burden on participants. It also 
may damage the integrity of the study in that some participants had not completed 
the intended course of therapy in some cases. This demonstrates the need for a 
larger trial to extend the duration of follow-up, possibly at six-months for the 
primary outcome measure, to ensure all participants have completed treatment.  
Finally, the fact that qualitative interviews were offered prior to the main 
study endpoint at three-month follow-up could be a source of bias as it represents 
additional contact time for those in the BA arm. Qualitative interviews are usually 
experienced positively by participants and have been purported to have a 
therapeutic effect (O’Cathain et al., 2015), so this may have led to participants 
reporting more positive outcomes as a result. This needs to be weighed against the 
impact of interviewing participants several months following treatment, as this may 
impact upon the quality of data as they may have forgotten about certain aspects of 
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their treatment experiences but a benefit may be the ability to reflect upon the 
longer term outcomes of treatment. 
Randomisation 
The validity of a Randomised Controlled Trial (RCT) relies greatly upon the 
randomisation process (Akobeng, 2005b). As discussed in the methods section, 
randomisation is vital in a powered trial, as without a control treatment it is 
impossible to be sure that any response is due solely to the effect of the treatment 
and/or the importance of the new treatment in this population could be overstated 
(Akobeng, 2005b). It is difficult for a feasibility or pilot trial to effectively inform a 
larger RCT without introducing randomisation; using standard treatment as a control 
we took the first step towards a fully powered trial to investigate the effectiveness of 
the intervention in this novel population. However, the key purpose of 
randomisation in this feasibility study was to assess the acceptability of the two 
treatment options and observe the flow of patients through the study in order to 
inform a larger trial. Participants appeared to tolerate randomisation well (with only 
one young person declining participation explicitly due to the fact that they had to 
be randomised). This is a critical aspect of the future trial design.  
Randomisation eliminates selection bias and minimises confounding 
variables, which are factors associated with both the outcome of interest and with 
the intervention (Kendall, 2003). A strength of the BUDDY study design was that the 
randomisation list was designed and implemented outside of the assessor’s control. 
The randomisation process itself was not conducted satisfactorily due to errors 
allocating participants using distance randomisation. Although, there was no 
statistically significant differences found between the participants in two treatment 
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groups at baseline on depressive symptoms, self-esteem and functioning. This 
indicates these known confounding variables were equally distributed between the 
two treatment arms, this would be particularly important in a fully powered trial.  
Excluding participant choice by allocating patients randomly to one or 
another treatment has been criticised in behavioural trials (Stephenson and Imrie, 
1998). However, our findings from the qualitative interviews indicate that most 
young people in the BA arm did not report a preference for one treatment option 
over the other.  In contrast, the end of treatment survey for the same participants 
suggests the majority would not have preferred TAU. This might suggest that young 
people chose a different answer on a self-report measure to the in-person 
qualitative interview. However it more likely highlights the benefit in qualitative 
interviews of being able to explore young people’s responses in detail rather than 
restricting their responses. Those in the TAU arm expressed views in line with the 
qualitative findings in the BA arm, in that they did not have a preference towards 
either treatment option. If the findings of the interviews are most representative of 
the views of the participants, this suggests the study materials did not emphasise 
one treatment option over the other and both treatments were deemed acceptable 
treatment options to participants. This would suggest TAU, or combined treatment 
as it was referred to in the study materials, is an appropriate comparator for a larger 
trial. No disappointment was reported by young people being allocated to either the 
control or intervention arm, as has been reported in other research (Toye et al., 
2016). According to MRC guidance, if this were the case it would need to be 
addressed in the subsequent trial design. If trial participants have strong treatment 
preferences they may refuse to take part or drop-out if they did not get their desired 
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treatment. This undermines the advantage of randomisation (Craig et al., 2008). If 
they remain in the study it could impact upon their compliance with treatment. Lack 
of acceptability of the intervention may lead to failure of RCTs due to poor 
recruitment if patients are not willing to be randomised to both treatment options 
(Lancaster et al., 2004). The importance of an appropriate comparator can be seen in 
a recent US trial of BA for young people, they recruited only one young person (aged 
13 to 17) in 14 months to a trial of BA or Fluoxetine (medication) (Craighead, 2017).  
There are learning points from the BUDDY study that could be utilised to 
inform a larger trial:  
Firstly, the use of secretaries to staff the remote telephone randomisation 
was a pragmatic choice but using staff inexperienced in research can, and does, lead 
to errors which impact upon the quality of the trial. In a future study, a remote 
randomisation service would still be beneficial but the use of a professional clinical 
trials unit for remote randomisation would be superior.  
Secondly, the blocked randomisation resulted in equal groups but the 
stratification increased the complexity of the allocation process, which may increase 
the chances of technical error (as occurred) and was also inflexible to changes within 
the trial once the randomisation list had been finalised. This inflexibility could have 
been disruptive when a service restructure occurred during the recruitment period 
where two of the sites were restructured (Tier 2 and 3 were amalgamated), however 
in this case as the teams were still identifiable in their old format (i.e. the original 
staff were retained except for a manager) we were able to continue using the same 
randomisation lists. This could be minimised by the use of a professional trial service 
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(and statistician) to oversee the randomisation process and by not stratifying by Tier, 
instead, this could be controlled for in a larger trial in the statistical analysis. 
Thirdly, another difficulty that arose during the trial was the timing of the 
randomisation. In some cases this occurred too early in the study and may have led 
to increased rates of drop-out (i.e. the time lag between randomisation and start of 
treatment meant those who dropped out or were discharged prior to treatment 
were already randomised into the trial). It was difficult to identify the point at which 
patients would start treatment as they may have been allocated to a clinician but 
would remain on their caseload often for many months without active treatment. 
Potentially randomisation could be completed at a later point rather than as soon 
after the diagnostic assessment as possible, however this needs to be weighed up 
against the risk of causing treatment delay. One aspect that was not adequately 
accounted for in this study is that the block size did not vary, it is recommended in 
unblinded studies that mixed block sized are used to prevent the last allocation in 
each block becoming predictable (Kendall, 2003). 
Another learning point to reflect on, related to the format of the 
randomisation used. The BUDDY study utilised 1:1 randomisation. With the benefit 
of hindsight, an unequal randomisation of 2:1 in favour of the BA intervention would 
have been preferable for this feasibility stage. Doing this would have enabled each 
clinician in the BA arm to have been allocated a greater number of participants 
within the trial. As it was, clinicians only treated on average 1.8 randomised patients 
during the trial. As the BA intervention is not well-established in this population, this 
amendment would have provided important additional experience to staff delivering 
the intervention and a greater variety of cases for them to reflect on during the 
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qualitative interviews, whilst still allowing the study methods to have been 
adequately tested. That said, 1:1 randomisation remains the best choice for the 
subsequent fully-powered pilot trial because it provides the greatest power for 
testing effectiveness (Eldridge et al., 2016a).  
The importance of prior experience and expectations has been an enduring 
aspect to both Stage I and Stage II of this study. The qualitative interviews suggest 
that most of the young people did not have a full understanding of the treatments 
being presented to them, despite being provided with comprehensive written study 
materials. This suggests that other more novel approaches for educating young 
people about their care options may need to be considered. One option, suggested 
by NICE, is the use of more computer technology (National Institute for Health and 
Clinical Excellence, 2005). It may be that these technologies could be utilised to 
make accessible descriptions of the treatment options in the form of videos for 
example. Most young people had no prior expectations of what their treatment 
would consist of. As expected, with more life experience, the parents generally had 
different expectations to their young people. While outside the remit of this study, 
future studies might explore whether these prior expectations of treatment exert 
any influence upon patient outcomes.  
One unanticipated finding from the qualitative interviews related to the 
power of decision-making; young people were happy to remain open-minded to 
different treatment approaches perhaps expressing a trust in the CAMHS service and 
a reliance upon their professional or parent to make the right decision for them. This 
seems to be at odds with the mainstream push to have more patient-directed care in 
the National Health Service (NHS) as a whole. This move towards user-led research 
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(Mawn et al., 2016) may not have been successful in this environment where the 
traditional authority of the clinician still predominates. Wilson (2015) documents the 
history of the unquestioned authority of medicine and a sense of disillusionment 
from service user groups over health care decisions that are made without input 
from service users. This passivity was also evident in the preference by at least one 
parent for hypnotherapy and a family who requested medication (rather than 
psychotherapy), which may mean that treatments that do not involve active 
participation could be more attractive. 
As discussed earlier, this population were vulnerable in terms of their age. 
The findings from the BUDDY study suggest this is perhaps an area where more 
attention should be paid. Age may be an important inhibitor to psychological 
therapies that rely upon patient participation, which could be explored in further 
detail. This again emphasises the importance of seeking PPI input from both young 
people and parent/carer representatives. Despite a growing recognition of the 
importance of experiential knowledge being addressed alongside scientific 
understanding, there is also a clearly often an intrinsic resistance to acknowledging 
lay knowledge in relation to PPI (Wilson et al., 2015). 
Blinding 
Blinding to treatment allocation in clinical trials is intended to prevent the 
expectations of patients or researchers from influencing the outcome (Stephenson 
and Imrie, 1998). Blinding is seen as one of the most effective ways to reduce the 
chance of a biased result (Eldridge et al., 2016b, Eldridge et al., 2016a). A major 
limitation to the design of this study was the risk of assessment bias when the 
patients, parents, clinicians and the assessor were all aware of the treatment 
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allocation, which may influence the recording of signs and symptoms (Petrie and 
Sabin, 2009). The BUDDY study results suggest this may be the case, as the trends on 
the Children’s Global Assessment Scale (CGAS; judged by the assessor) were the only 
measure where an opposite trend was shown for participants in the TAU. One 
control to prevent this was to use a combination of self-report and assessor-
administered assessments, as well as structured tools that are less dependent upon 
the assessor’s subjectivity. The use of self-report may have reduced the risk of 
assessor bias; however there is an increased chance of performance bias (where 
participants give an answer they believe the assessor is looking for).   
In the BUDDY study, ideally as a minimum, the assessor would have been 
blinded to treatment allocation to avoid this source of bias but as the sole researcher 
responsible for all aspects of trial implementation concealment was not possible 
within the resource restraints inherent in a PhD project. In other large 
psychotherapy trials in both adults (Richards et al., 2016, Gilbody et al., 2017) and 
young people (Goodyer et al., 2017) it is accepted convention that participants and 
clinicians remain unblinded. A double-blind trial would not have been possible 
because it would have been unethical to blind patients and their parents to the 
treatment they were receiving. These limitations were offset to some degree by the 
fact the assessor was masked to the randomisation list so it was not possible to 
influence randomisation or treatment allocation. A key recommendation from this 
feasibility work is that in a future study, the assessor should be blinded to treatment 
allocation and a trial statistician should conduct analyses blinded to treatment 
outcome to reduce these sources of bias. Tindall and colleagues (2017) found all 
three of the RCTs conducted in the area to date did not blind participants or 
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personnel to treatment allocation meaning they all have a high risk of bias when 
evaluated using the Cochrane risk of bias tool. However in all included trials, the 
assessors were blinded to the outcome assessment demonstrating a low risk of bias 
in this respect, whereas in the BUDDY study it would be high. Without effective 
blinding of the assessor responsible for completing the outcome measures bias may 
be introduced into one arm not present in the other (i.e. because assessor may 
intentionally or unintentionally provide extra attention to those in the treatment 
arm (Kendall, 2003).  
Clinician’s beliefs in relation to the two treatment options being offered are 
important. Clinical and personal equipoise (Cook and Sheets, 2011) exists when a 
clinician has no good basis for a choice between care options. A lack of equipoise 
(O’Cathain et al., 2015) can lead to a lack of utility of the evidence in the real-world 
of clinical practice. It can be addressed by researchers through education or by 
increasing awareness and enabling open discussion. In this case, the qualitative 
findings demonstrate a lack of equipoise for some staff members. This may lead to 
bias, and could account for a proportion of the ‘effect’ that would traditionally been 
assigned to the intervention (Cook and Sheets, 2011). This also highlights a potential 
impact of the lack of blinding in this study, as the clinicians may have over 
compensated for their lack of faith in BA by providing ‘extra’ care, again leading to 
bias (Akobeng, 2005b). This is of crucial importance in a larger effectiveness study 
because it could lead to the overestimation of the treatment effect, if additional care 
over and above what is recommended in the manual or what has been declared is 
provided by clinicians. It was evident from the reasons clinicians provided for 
withdrawing patients that had been referred to the trial, as well as feedback from 
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some clinicians in the qualitative interviews, that CAMHS staff had preconceived 
personal preferences relating to the ability of TAU to provide better outcomes than 
BA treatment. Although this may be an unconscious bias, it is an ethical issue in trial 
design. 
Research paradigm 
Mason (2006) has suggested that viewing social phenomena and lived realities along 
only one continuum (i.e. positivist, trials-based knowledge) may lead to researchers 
experiencing an ‘impoverished’ understanding, while mixed methods allows access 
to multiple viewpoints and dimensions. This highlights the parallel insights gained 
through mixing methods (Cresswell, 2009), in this case through the experience of 
different stakeholders; the clinicians, patients and their caregivers. One illustration 
of this was when different families had very different perspectives on the level of 
involvement that parents should have in their young person’s treatment. This is 
where the qualitative and quantitative mixed methodology enabled an in-depth 
exploration of these differing viewpoints that would not have been achieved by 
using either approach in isolation. Some parents and young people were in 
agreement, whilst others had vastly differing opinions on the subject. This raises the 
question for clinical services and research studies; whose viewpoint should be given 
greater weight to when families disagree about the level of parental involvement? 
Several families mentioned the difficulties of working through issues during therapy 
with some discussing the benefits to their families as a result of this and others 
reflecting on an ability to tackle these difficulties. It is interesting that the clinician 
perspectives differ markedly from the young people’s comments relating to parental 
participation. One young person suggested how helpful parental involvement was, 
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even if it was initially undesirable, as an aid to “getting back to … normal things”. 
Furthermore, as discussed earlier, the survey data demonstrated that a sizable 
majority of participants made simplistic responses that, in later qualitative 
interviews, were shown to be complex issues. If solely survey outcome data had 
been collected, this would have been at worst misleading or, at best, represented a 
missed opportunity.  
Upon reflection, Stage I of this thesis (the focused ethnography) helped to 
determine my approach to the qualitative components of the trial; I found myself 
wanting to collect contextual information that I was exposed to during the trial, 
rather than in the post-hoc qualitative follow-up interviews with participants or 
clinicians. One example of this was watching young people attempting to complete 
the BADS measure; in almost all cases young people asked me or a parent how they 
should complete the tool or asked for help understanding the language used in the 
questionnaire. Not only has this shaped my desire not to use this measure in a future 
trial, but it would have been useful to systematically record this ethnographic 
information to inform the selection of a more appropriate tool. 
Treatment Uptake 
The numbers starting therapy were similar (at 82%) to those reported in a large-scale 
psychotherapy trial of adolescent depression, the IMPACT study (87-93%; Goodyer, 
et al., 2017). The young people who started BA treatment received a high number of 
the intended BA sessions. This contrasts with the IMPACT study, where participants 
received fewer treatment sessions than anticipated. Most young people attended 
the number of session assigned by their practitioner (i.e. completed the full 8 session 
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course of BA), as in previous research in young people (March et al., 2007, Ritschel et 
al., 2016). 
Treatment delivery 
Setting 
The CAMHS as a setting was successful but one family commented on a lack of 
flexibility as their clinician did not work after school hours. This was the primary 
reason for selecting CAMHS over the school setting used in the BODY and mind study 
(Arnott, et al., 2012) but in this families case it appeared to be the result of this 
particular clinicians working hours. In other respects, the setting of the BUDDY study 
seemed appropriate to deliver the BA intervention. 
Treatment as usual 
Most young people allocated to the TAU arm, remained in the service for six months 
and received little treatment for their significant mood difficulties. This is in keeping 
with previous nationally representative research in Britain, which reported low 
numbers of treatment sessions for those in contact with services (Ford et al., 2003). 
This reflects the findings of the focused ethnography and previous literature where 
commentators have reported concerns over the content of therapy sessions 
(Olubokun, 2017). This is further justification for a manualised approach across both 
treatment arms. 
Behavioural Activation  
Materials 
Several clinicians liked the manual materials but most felt there were too many 
worksheets. As McCauley and colleagues (2011) found, less is more in terms of a BA 
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manual and that the key component of BA, its simplicity, easily gets lost. This was 
less of a concern for the young people involved in the BUDDY study and may reflect 
some clinicians’ usual procedure of providing care without worksheets. From a 
clinician perspective, there was a need for more ‘practice’ time to focus on goal 
setting and activity scheduling and a less structured, more flexible format for 
therapy.  
Previous research has noted that therapists often rely upon an eclectic 
mixture of therapeutic approaches in order to treat young people (Ford et al., 2003). 
Staff made their own adaptions to the manual to fit the manual material into 8 
sessions. The rigid structure of the manual was felt to be too restrictive for more 
experienced clinicians who usually provided care using an eclectic style of mixed 
therapeutic approaches. Commentators note full treatment protocols may not be 
appealing to clinicians in clinical practice who may wish to blend newly acquired 
skills with existing skill sets (e.g. Rutter, 2008). Some clinicians in the BUDDY study 
reported the BA manual hampered their treatment delivery style and restricted 
them from following their intuition. And, as found in previous iterations of the 
manual (McCauley et al., 2011), this emphasis on early structure may have 
encouraged some clinicians to overlook or delay work on key treatment targets. In 
contrast, this structured format was felt to be helpful to guide sessions by less 
experienced clinicians. Future iterations of the manual should focus on better 
utilising the existing skills of CAMHS practitioners and allow delivery with flexibility 
and individualisation. Previous research (Davidson et al., 2014) utilised a speak-aloud 
technique to inform the design of a computerised BA depression module for 
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adolescents. This approach may be useful in identifying the relevant part of the 
manual that require updating.  
Riley et al (2005) suggest privileging the view of the people administering the 
intervention over those of university researchers, as they infer clinician’s views are 
likely to be closer to ‘reality’. This suggests, as utilised in the focused ethnography, 
that this “captured wisdom” (Webber, 2014) from clincians, will be useful in 
improving the relevance of the manual to the CAMHS setting. As the MRC guidance 
states, ensuring strict fidelity to a protocol may be inappropriate if there is 
knowledge that the intervention may work better if adapted to the local setting 
(Craig et al., 2008). This suggests that future iterations of the manual may need to be 
flexible enough to adapt to the specific local context. Considerations such as these 
are important, because a manual is of no use if it conflicts with deeply entrenched 
values in the setting (Craig et al., 2008). Our research suggests clinicians’ views 
relating to manualised treatment should be explored further.  
Staff Training 
The qualitative findings have provided rich data illuminating aspects of treatment 
experience and delivery that otherwise would have been inaccessible. We found 
staff below grade 7 across Tiers 2 and 3 were able to deliver the intervention and 
most of them found the training and delivery acceptable. This is particularly 
important for the rationale of choosing BA over other more specialised 
psychotherapy options such as Cognitive Behavioural Therapy (CBT). However, there 
were some training related concerns. Treatment pathways were interrupted for a 
variety of reasons. Improvement in the young person’s condition was given as a 
reason for not embarking on or continuing with treatment, whereas suspected 
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cognitive impairment was a reason for suspending the progression of sessions. In 
two of these cases there were suggestions that treatment was not delivered as per 
protocol and termination appeared premature. This was explored with one staff 
member but the other team member was unable to schedule time for a follow-up 
qualitative interview. It was not clear from our results, whether this was related to 
inadequate training or other difficulties. It may be that service pressures led to 
pressure from outside of the study for clinicians to discharge patients that they did 
not deem ‘risky’. This was supported by evidence from another staff member (Geoff) 
who cited their difficulty with the eight-session format, was it being suitable for the 
young people but not feasible within the CAMHS service due to external pressures. 
This suggestion is particularly concerning for trials that rely upon training existing 
NHS staff to deliver interventions in a pragmatic trial design such as this, and is an 
issue that could have been explored further if the ethnography from Stage I had 
been extended for the whole trial duration. 
Supervision 
Clinical supervision was found to be important to staff in this study, reflecting 
previous work in specialist CAMHS (Edwards et al., 2008). Team supervision was 
utilised in the BUDDY study, as others have done whilst applying BA to adolescents 
(Ritschel et al., 2016, McCauley et al., 2016), as recommended in Stage I of this 
research. This approach was well received and supervision was well attended. 
Delivery Format 
As in our study, other intervention trials found families reported it difficult to fit BA 
sessions in around school and existing commitments (Toye et al., 2016). Although 
context specific, our findings highlight young people experienced barriers to care, 
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which may be transferable to other treatments delivered in this setting. As in 
previous work, young people valued regular, pre-organised appointments (Affleck 
and Seed, 2015). Interestingly, greater gains have been observed in the first 9 weeks 
of treatment in other BA research (Ritschel et al., 2016), supporting the 8-session 
format. The weekly format was popular, however both clinicians and young people 
felt the tapering of treatment sessions towards the end of the programme would 
facilitate greater autonomy whilst retaining a level of support. Families were 
overwhelmingly in support of delivery on a weekly basis and were generally happy 
with the length of sessions. Again, the only opposing voice was David, one of the 
young people with an ASD; this may mean that BA treatment needs to be adapted 
for people with additional needs. Previous adaptations to BA treatment have 
included a period where young people can opt to focus the BA sessions on any 
outstanding issues (Ritschel et al., 2016). In other studies, additional flexibility has 
been offered via top-up sessions (such as in Richards et al., 2016). Gaynor and Harris 
(2008) suggest a stepped approach to BA care where more complex participants who 
do not respond to basic BA (i.e. activity monitoring/scheduling and values-focused 
work). Our findings also support a modular approach, which may have the added 
benefit of allaying clinician’s fears that BA “is not enough”. This may have been 
redressed by adding follow-up sessions at a later date or delivering the final sessions 
over a longer time period. NICE recommend that patients in remission from 
depression should be reviewed regularly for 12 months (24 months if it is recurrent 
depression) by an experienced CAMHS clinician; if remission is maintained, then they 
can be discharged into primary care (National Institute for Health and Clinical 
Excellence, 2005). The guidelines suggest this should take the form of follow-up 
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psychological therapy sessions to reduce the likelihood of, or at least detect a 
recurrence in, depression in those at high risk of relapse. Ritschel, Ramirez, Cooley 
and Craighead (2016) note that this flexibility is a pragmatic approach that is more 
reflective of clinical practice.  
Parental Involvement 
As in previous research (McCauley et al., 2011), parental involvement was key to 
avoiding barriers to treatment. This was particularly the case for external barriers, 
such as financial or transport provision. This led to problems for young people 
desiring autonomy but encountering parents as the gatekeepers to the required 
resources. This echoes the report of a previous, unsuccessful case study where 
manualised BA was delivered to a young people with depression in the USA 
(McCauley et al., 2011. One barrier identified was restricted access to a family car by 
parents, which acted as a barrier to the goals set by the therapist. Interestingly 
McCauley and colleagues (2011) also observed conflict between the clinician 
maintaining the therapeutic relationship with the participant and the need for 
parental involvement. In fact, a lack of contextual information about the 
adolescent’s home life hampered clinician effectiveness (McCauley et al., 2016). As 
in the BUDDY study, this meant clinicians missed vital information about obstacles 
and barriers to activation. In the BUDDY study, some clinicians felt parents needed to 
be more involved in their young person’s treatment, a view not always shared by the 
young people they were working with. We observed pairings of young people and 
their parents where caregivers understood the BA rationale; as such, they were able 
to observe the impact of their young person’s depression and support their 
activation. In contrast, however, in one case the young person’s parents themselves 
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were the barrier to treatment and refused involvement when invited by their 
clinician. As in previous reports (Affleck and Seed, 2015), young people reported that 
they valued the option of involving their parents in their treatment sessions. 
Emphasising the need for an individual plan for parental involvement in BA 
treatment. 
Previous adaptions to BA treatment for adolescents added in parental 
involvement at the beginning, middle and end (Ritschel et al., 2016). Our findings 
suggest the need for a more flexible approach, utilising the experience of the 
clinician in order to tailor the treatment to each individual. In adults, BA has been 
successfully adapted for patients with intellectual disabilities and depressive 
symptoms with the most notable adaption being the inclusion of a significant other 
during treatment (Jahoda et al., 2015): in this study, of the two participating young 
people with an ASD, one had a parent present and one did not. Further illustrating 
the need for an individualised approach. 
Parents mentioned their own mental health and the impact it had upon their 
young person’s care. NICE guideline 28 (National Institute for Health and Clinical 
Excellence, 2005) suggests parent’s own psychiatric problems should be treated in 
tandem if the young person’s mental health was to improve. This was not possible 
within the restrictions of this study but could be an important and interesting avenue 
to explore in future research. 
Individual Factors 
One thing that stood out in the young people’s descriptions of their journeys through 
treatment was the role of individual or family motivation. A parent of one young 
person who did not complete treatment stated they would have preferred their 
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young person not to be an active participant in treatment, whilst their young person 
said they were too tired to engage. Another young person, who completed 
treatment, suggested they knew they needed help but that it had taken them two 
years prior to treatment to get to a point of acceptance that they needed assistance 
to move forward. They went on to say some other young people may not yet be in 
the right place to accept the help offered or to accept that they can’t be “fixed”. 
Turner-Halliday (2014) described a similar concept in CAMHS which they termed 
‘readiness’: that is, that young people must be in the right place to embark upon 
therapy. This was evident from some young participants in the BUDDY study. The 
authors extend this concept to parents (Turner-Halliday et al., 2014), in the sense of 
whether they are ready to support their young person through therapy. In some 
cases, parents did not provide an optimal environment for their young people to 
undertake treatment whether this was due to their own mental health problems or 
through acting as a gate keeper for needed resources. 
The BUDDY study sample displayed higher rates of anxiety comorbidity (all 
young people screened positive for generalised anxiety disorder) than reported 
elsewhere where rates ranged between 30-80% (Birmaher et al., 1996), but this 
most likely represents our use of an anxiety screening rather than diagnosis tool. 
Rates of anxiety in the sample are relevant, as higher anxiety levels may be related 
to increased likelihood of disengaging from therapy; in a previous RCT of BA in the 
USA; anxiety was reported to be a contributing factor to treatment drop-out 
(McCauley et al., 2016). Future trials could use an additional measure of anxiety.  
The BA therapeutic approach was viewed by clinicians and some young 
people and their families, as unable to meet the needs of patients with multifaceted 
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symptom profiles. Some clinicians felt CBT may be better placed to address thinking 
errors. One young person also reported that BA may have helped their low mood but 
left other comorbidities such as their anxiety untreated. This may illustrate the 
difficulties of implementing a treatment focused upon one diagnosis in a clinical 
population with multiple complex symptoms. As Kessler and Glasgow (2011) also 
found, there were difficulties working with young people with multiple needs, those 
who were disruptive or stressful, or had unsupportive home lives. Similarly, some 
clinicians felt BA didn’t provide enough “tools” to deal with young people’s comorbid 
anxiety. This echoes NICE Guideline 28 for depression (National Institute for Health 
and Clinical Excellence, 2005), which states comorbid diagnoses should be assessed 
and treated in sequence or parallel with depression. It may be that, due to the high 
levels of anxiety seen in this population and, with all young people entering the trial 
suffering comorbid anxiety symptoms, the manual needs to incorporate a greater 
focus on treatment of these symptoms. Previous feasibility work has looked at this in 
a group therapy context in the USA (Chu et al., 2009) and BA in collaboration with 
exposure therapy to specifically target anxiety symptoms in individual therapy 
(Weersing et al., 2008, Weersing et al., 2017).  
Therapist Factors 
As previously mentioned, some staff did not have confidence in the BA approach, 
with some stating that BA was insufficient as a stand-alone treatment or that 
cognitive skills were required to bring about improvement. In a previous case study 
of BA, researchers found it was important that the clinician had faith in the ability of 
BA to bring about change (Pass et al., 2017). In the BUDDY study it was unclear how 
widespread these concerns were in the broader CAMHS team. In the staff interviews, 
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one staff member had strong feelings relating to the limitations of BA treatment. 
However, for most staff, concerns were related to specific aspects of care in certain 
cases rather than a broader lack of faith in the treatment. In fact, most staff 
expressed the value of the approach for treating depression.  
As in previous research (Affleck and Seed, 2015), young people valued 
working with CAMHS staff. In the context of therapy, NICE recommend therapists 
should develop a treatment alliance with the family (National Institute for Health 
and Clinical Excellence, 2005). Therapeutic alliance refers to how well client and 
therapist work together (Rutter et al., 2008). A meta-analysis of studies of 
therapeutic alliance over a range of treatment childhood modalities found an effect 
size of 0.21 for the effect of alliance (Shirk and Karver, 2003). This was raised as a 
concern by some therapists in the BA arm as they felt a manualised approach may 
damage this delicate relationship. Feedback from young people did not provide any 
accounts where this was the case. On the contrary, young people and their families 
highlighted the therapeutic relationship as a key facilitator in their engagement with 
the BA treatment.  
Impact of Treatment 
As discussed previously, there was some evidence that young people lacked control 
over their lives and experienced restricted autonomy; this is an important 
consideration, as lack of control has been indicated as a cause of youth suicides 
(Patel et al., 2007). Experiencing comorbidities alongside their depression made it 
difficult for some young people to complete, participate in or excel during BA 
treatment; however, a key facilitator appeared to be the practicality of the 
treatment approach. As one young person articulated it, “doing the things you talked 
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about doing”. Furthermore, young people and their parents highlighted how 
important the role of the therapist was, both in terms of the therapeutic relationship 
but also in simply having someone available to listen to what the young person had 
to say. The downside to this security was that when it was taken away (at the end of 
the manualised treatment sessions) some young people felt lost and lacked 
confidence that they could keep up changes that had been made or make suitable 
improvements in the future. One reasons suggested for this (Pass et al., 2017) is that 
clinicians become a source of positive reinforcement, which is then lost at the 
termination of sessions. Participants offered some suggestions for improvement, 
such as additional review or relapse prevention sessions following treatment.  
Young people also had some interesting reflections to offer on the barriers to 
treatment. One young person reflected upon their friendships and the links this may 
have had in maintaining their own depression. Most striking was how these insights 
echoed the focus of the BA treatment manual in identifying relevant internal and 
external barriers to increasing activation to improve mood.  
Overall, most young people and their young people reported positive 
outcomes in the qualitative interview, such as improved family relationship, 
increased variety of interests and activities, increased self-esteem and motivation, 
and decreased depressive symptoms. These positive impacts were supported by the 
quantitative data, which generally showed improvements across mood, self-esteem 
and functioning outcomes in both treatment arms. Although greater improvements 
were seen in those in the BA arm. Young people and their parents also reported high 
treatment satisfaction ratings on the end of treatment survey, finding BA was helpful 
and enjoyable. In this study young people found BA treatment had a wider impact on 
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their family relationships and valued the improvements observed. However, young 
people’s relationships with the outside world were a barrier to treatment, and BA 
did not enable all problems observed to be addressed. Furthermore, where they 
might have been expected to take ownership of these difficulties, young people 
found it difficult to do so and often placed the blame on others, such as 
friends/family. 
Behavioural Activation Techniques 
There are outstanding feasibility questions relating to the feasibility of delivering 
manualised BA in this context, as there was evidence that staff were adapting the 
manual to suit their own needs and expertise. In two cases in particular, there were 
suggestions that BA was not being delivered in the prescribed format and staff held 
diverse views on treatment delivery. Two staff members reflected upon the impact 
of their previous background in terms of therapy provision, with one finding BA 
matched well and the other finding the opposite. This is reminiscent of the individual 
differences dependent upon staff background, observed in the ethnography in Stage 
I. Similarly, Wells and colleagues (2012) found interventions were delivered 
differently depending upon the staff member. Generally, staff in the BUDDY study 
were positive about the BA approach and found it acceptable. Clinicians have 
previously been found to reject complex interventions because they do not fit with 
their normal practice (Wells et al., 2012). This may lead to clinicians acting as gate-
keepers deterring young people from receiving the treatment in practice; there were 
suggestions that this may have been the case if BA was to be implemented in its 
current form at this CAMHS site. This is building a strong argument when added to 
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the findings from Stage I about the individual differences between staff and how 
they relate to providing a manualised treatment.  
Another criticism of the use of manuals in psychotherapy is that it 
undermines the therapist patient relationship and restricts staff drawing on range 
treatment models (Goldfried and Wolfe, 1998). Although one staff member felt this, 
the young people working with this clinician did not agree. Generally, the 
participating young people and their carers reported building positive therapeutic 
relationships with their therapists and vice versa. This positive therapeutic 
relationship was viewed as crucial to the success of therapy and families did not feel 
it was hampered by manualised delivery of treatment.  
Some staff found it difficult working with difference (such as young people 
with ASD), and although surprising, this has implications for service delivery. It did 
appear that one young person with ASD in the study encountered their comorbidity 
represented a barrier to treatment whereas another young person with ASD did not. 
In the case of David, it was his rigid devotion to a niche interest that presented a 
barrier to activation. As this interest had been identified during the values based 
activities during the initial BA sessions, it was natural that the clinician and the young 
person attempted to schedule activities relating to this hobby. However, when these 
were deemed to be unrealistic, treatment stalled. It may be that for some young 
people with ASDs, that such a rigid mind-set might be incompatible with such a 
treatment. In contrast, however David reported on other activities that he was able 
to schedule effectively (such as cooking for himself).  
Activity monitoring serves to provide information on activity levels and 
related mood to inform activity scheduling and to demonstrate meaningful links 
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between activity and mood to client (Gaynor and Harris, 2008). Activity scheduling 
targets a variety of activities in a client’s life related to pleasure, mastery, goals and 
values, problems to be solved, areas of avoidance etc. determined with the therapist 
collaboratively (Gaynor and Harris, 2008). It was goal-setting and activity monitoring 
that most young people, their parents and clinicians chose to focus on as the most 
important part of BA therapy. There was evidence this technique had been deployed 
successfully for many participants. 
Outcomes 
It is not appropriate to place undue significance on the quantitative results as no 
formal power calculations have been undertaken (Lancaster et al., 2004). The reason 
for this is that the Confidence Interval (CIs) are likely to be imprecise even when 
there are significant differences. We have treated the quantitative results as 
preliminary for this reason and emphasised the descriptive findings. In this study, all 
participants who attended follow-up completed outcome measures fully, with only 
one instance of missing data. This was due to the way in which the questionnaires 
were administered, which provided an opportunity for the assessor to check the data 
whilst patients and their families were still present.  
Attendance at follow-up appointments, however, was low. Barlow (1981) 
cautioned that since some people always get better no matter what one does, there 
is ample opportunity for clinicians or researchers to attribute their success to their 
particular intervention. Both BA and TAU were associated with improvements on a 
variety of outcome measures (apart from on the CGAS measure for those in the TAU 
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arm). There was an absence of adverse events and decreases in symptoms in both 
treatment conditions, which is encouraging for reduction of morbidity.  
As this was a clinical trial we were interested in measuring the impact of BA 
treatment on a variety of outcomes, however without the study being powered, we 
cannot draw meaningful conclusions from these findings. According to the 
exploratory analysis, when the small sample size was controlled for, the result 
reached borderline statistical significance indicating remission from MDD in BA at 
three-month follow-up may be more likely in the BA treatment group compared to 
TAU. Moderate to large effect sizes were seen at three-months in Mood and Feelings 
Questionnaire- Child (MFQ-C) scores in the BA arm. Very small to small 
improvements in self-esteem were seen in BA compared to TAU. Functioning effect 
sizes at follow-up in the BA arm were moderate to large. The descriptive statistics 
indicate trends towards improvement in the numbers meeting the diagnostic criteria 
for MDD, the severity of those who still met MDD criteria, numbers of comorbidities, 
child and parent-reported depression at three-months and self-esteem across both 
arms of the study. There was a tendency to observe greater improvements in the BA 
arm. There was also a trend towards improvement in functioning in the BA arm but 
not TAU. This may reflect bias on the research rated measure, as discussed 
previously. However, translating these research findings into clinical practice 
requires more targeted research. The analysis was post-hoc, in a future trial a 
statistical analysis plan in advance to avoid ‘mining’ the data. 
Tindall and colleagues (2017) note that seven of the 10 studies in their 
systematic review used the Children’s CDRS-R (Poznanski and Mokros, 1996). A 
measure which demonstrates good inter-rater reliability in an adolescent population. 
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This may be an alternative to the lengthy K-SADS-PL. Half of the studies included in 
the systematic review included a measure of anxiety. Although we measured anxiety 
as a comorbidity, we didn’t measure it using the full K-SADS-PL anxiety diagnosis, 
which may offer more accurate insights to comorbidities but would add to an already 
lengthy assessment procedure. 
As in previous research (Ritschel et al., 2016) where 32% of the sample 
sought ongoing treatment, some young people were provided with further 
treatment following BA therapy. In a future trial, the content of this treatment 
should be closely monitored. 
Previous commentators have highlighted conducting underpowered trials as 
unethical, but they are acceptable in the context of a feasibility/pilot study as long as 
participants are informed of this (Thabane et al., 2010). To date, BA interventions 
have mainly been evaluated using uncontrolled before and after comparisons. 
Dissatisfaction with these comparisons is partly related to the statistical law known 
as regression to the mean (Stephenson and Imrie, 1998). If extreme values are 
singled out from a distribution, they are likely (for purely statistical reasons), to fall 
closer to the usual level if measurement is repeated. In the absence of a control 
group, lower ratings at follow-up may merely reflect the law of statistics (Stephenson 
and Imrie, 1998) but be wrongly attributed to the effect of an intervention. As such, 
progression to a pilot and future definitive RCT would add greatly to the literature. 
Attrition 
 
The number of participants dropping-out from treatment is an important element in 
trial design. Missing data were anticipated and treatment drop-out was in line with 
  310 
previous research; dropout from active psychotherapies such as BA is commonly 
high (Clarke et al., 2009). Similar numbers dropped out in both treatment arms and 
no differences were observed between completers and drop-outs. This suggests 
there is no evidence of attrition bias. The greater the drop-out, the less reliable the 
results of the study in a definitive trial (Everitt and Wessely, 2008), so it is useful to 
assess whether any changes to the protocol could be made to encourage 
participants to engage with the study follow-up.  
A greater rate of follow-up was achieved when the assessments were 
conducted in-person at three months, compared to the telephone follow-ups at six 
months. This may be because the telephone follow-up occurred later than the in-
person one at three months. Another reason for this may be that some families did 
not have a telephone so I had to call other family members, which complicated the 
process. The higher rate of follow-ups at three-months could be due to the fact that 
many young people were still receiving treatment at that point (so were engaged 
with the CAMHS service and used to attending the site) or the fact that they 
preferred face-to-face assessments to telephone ones. It might have been useful to 
trial alternative settings (rather than CAMHS) for the follow-up sessions, such as 
home visits or One Point centres because participants, who were no longer receiving 
treatment (particularly if they had been discharged), may have felt unwilling to re-
visit CAMHS (especially if they had not had a positive experience). Previous reports 
have highlighted home visits as an acceptable environment for young people (Affleck 
and Seed, 2015).  
  311 
Strengths 
The results of this feasibility trial are generalisable in the sense that they can be used 
to inform a larger trial of the BA intervention in this setting or similar trials with a 
similar population. We recruited from a clinically referred sample and used limited 
exclusion criteria, so the results should be relatively representative of the CAMHS 
population from which they were recruited. Weisz et al. (2005) highlight the 
importance of clinical representativeness in psychotherapy studies. They note three 
criteria in particular that indicate whether a study is likely to demonstrate good 
clinical relevance; clinical representativeness of young people sampled, therapists 
who provided the treatment and the delivery setting. On all three fronts, the BUDDY 
study was successful with high external validity; the young people were help seeking, 
recruited via usual referral routes with minimal exclusion criteria, and therapy was 
delivered by clinicians from the setting, in the intended setting. In Weisz and 
colleagues’ (2005) quantitative methodological review of youth psychotherapy 
studies, only 1% of the 236 studies from between the years 1962 to 2002 met all 
three criteria.  
Generalisability is the extent to which aspects of a study can be applied to 
other circumstances (Eldridge et al., 2016a). The small size of the study restricts our 
ability to comment on the implications of this study for routine clinical practice. We 
used a broad inclusion criteria to enhance the generalisability of our results; 
however the results are from three CAMHS teams in the North-East of England and 
may not be representative of other areas of the UK or the world. Our results 
represent the activities of one feasibility trial, but may reflect some of the challenges 
other researchers may face in conducting research in similar settings. 
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We analysed participants in the group to which they were randomised (ITT) 
(Kendall, 2003), which is important to avoid bias. Although the interpretations of the 
results have been limited by the study design and introduction of bias, many of the 
study objectives have been achieved. We were able to effectively recruit and retain 
staff and participants in a complex clinical setting. We were able to assess which 
recruitment methods were robust and which need to be adapted in future work in 
this setting. Behavioural Activation appears to be acceptable to the majority of 
lower-grade clinicians, young people and their parents. The pragmatic approach to 
trial design led to a comparison of viable, clinically relevant alternative treatments, in 
a study with good external validity.  This highlights a major strength of this study 
which was it was conducted in the reality of a busy CAHMS service by staff from the 
team, rather than a controlled research setting. This setting provides insight into the 
realities of implementing a treatment such as BA into clinical practice. Clinicians from 
the NHS were trained to administer the BA in this study. This is particularly pertinent 
when compared to some of the US literature where potential participants are 
recruited through advertisements, so were not help-seeking and may have been 
offered free treatment.  
We evaluated BA against a strong treatment comparison in which skilled 
therapists predominated. The BA given was standardised to some extent by a 
structured session-by-session treatment manual, although treatment fidelity was not 
assessed. The BUDDY trial builds on the previous work in the field; being the first 
study to introduce randomisation in a UK secondary care setting and to qualitatively 
explore (using a formal methodology) the experiences of staff delivering the 
intervention alongside those of the participants and their parents. Without this 
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qualitative element, the trial would have been at risk of editing out the complexity of 
young people’s, their parent’s and staff’s experiences of the novel treatment, in 
search of the general picture provided by the collation of quantitative outcome 
measures. This qualitative aspect to the trial has yielded the most insightful findings 
and can be used to refine the future intervention and trial design to inform a larger 
trial.  
A standardised validated diagnostic interview was used to assess depression 
status, addressing previous criticisms of UK-based literature. Remote randomisation 
was used to remove the researcher from the process of participant allocation to 
treatment, which removed a potential source of bias.  Selection bias was controlled 
for so there was a low risk of bias due to independent random sequence generation 
and allocation concealment.  
Limitations 
A major weakness is the number of confounding variables that may have influenced 
the data. This pragmatic trial, conducted in a busy CAMHS team, means that it is not 
possible to quantify or control for the contribution of antidepressant medication to 
outcome, although all participants were on a stable dose (of medication) at the 
outset of the trial, we did not monitor medication during the trial. This is important 
as we did not restrict clinicians from prescribing during the trial so it is possible that 
young people may have initiated new medication regimes during the trial. This 
represents a confounding variable. The number of BA sessions was controlled but 
not in the TAU arm; so therefore, any positive results could be due to the effects of 
meeting with a therapist rather than the BA treatment itself. Young people in the BA 
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arm received more treatment sessions than those in the TAU arm, which may 
account for the positive findings. The qualitative interview may have added to this 
inequity. Equally, due to the absence of measures for the quality of BA treatment 
(fidelity was unable to be assessed) there may have been contamination (for 
example, some BA therapists had previous CBT training). Contamination has the 
potential to impact upon the results and could lead to the misrepresentation of the 
treatment effect in a larger trial. This would be particularly important in light of the 
indications from staff and participant interviews, which could indicate weak or 
erratically implemented treatment. Not all clinician referrers or practitioners 
delivering BA, adopted a position of clinical equipoise, which is integral to conducting 
a high quality trial. Blinding was not feasible in the study, which means there was the 
added potential for contamination at clinician and patient level. Clinicians had a low 
number of participants to treat each, making it hard for them to generalise their 
experiences. No ethnicity data was collected. All three study sites were in the North-
East of England in areas with high levels of deprivation and may not be 
representative of other areas of the UK. Attempts to minimise loss to follow-up were 
ineffective. 
According to the Cochrane Collaboration’s tool for assessing risk of bias 
(Higgins et al., 2011), this study risks reporting bias (as there was no pre-published 
protocol) and an unplanned analysis was conducted for the purposes of this thesis. 
Attrition bias was present due to incomplete outcome data although we have 
attempted to account for this in the exploratory analyses using multiple imputation 
and LOCF within an ITT analysis. However all exclusions and attrition were reported 
and all randomised participants were accounted for. There was also a high risk in 
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relation to no blinding of outcome assessment, which could lead to detection bias 
and no blinding of participants or personnel could lead to performance bias.  
Conclusions 
This study adds to the literature on BA treatment in the UK. A BA manualised 
intervention for the treatment of young people in CAMHS with depression has the 
potential to represent an effective and acceptable solution to address the significant 
unmet need in provision of psychological support. If a larger fully powered trial were 
to show BA was comparable or non-inferior to CBT, as has been shown in adults 
(Richards et al., 2016), it would have substantial implications for practice. 
As in all treatments, and as observed in previous pilot studies of the 
application of BA to young people (Ritschel et al., 2016), we did not find BA was 
suitable for all participants. The key learning is the need for flexibility in delivering 
this novel treatment whilst considering the restrictions imposed by the service. The 
qualitative interviews enabled understanding on how staff adapted the manualised 
treatment into practice, sometimes in unanticipated ways, in order to deliver it in 
their local context.  
We were able to successfully recruit staff from, and adolescents attending, 
routine CAMHS. Broadly speaking, the qualitative results were encouraging from 
young people and their families but the feedback from staff about their participation 
in the study suggests caution. The findings are limited by attrition (particularly at 6-
months) and inherent biases, as a result of the study design. The BUDDY study 
suggests that a trial of BA for young people with depression may be feasible in an 
adolescent mental health setting. Moreover, there are at least tentative suggestions 
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that, compared to TAU, the BA approach may be more effective. Therefore, BA as a 
potential evidence-based treatment for young people with depression warrants 
further research in order to adequately address some of the outstanding feasibility 
questions.  
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Chapter 5 Thesis Summary 
Two intricate studies have been undertaken to address the aim of exploring the 
feasibility of conducting a trial of a Behavioural Activation (BA) intervention in a UK 
Child and Adolescent Mental Health Service (CAMHS) setting. The final chapter starts 
by detailing the main findings of this body of work, followed by a discussion of the 
implications of the research, the dissemination plan and proposed future research 
directions. 
Main Highlighted Findings 
• The focused ethnographic methodology was flexible and sensitive to the 
social context of the study site. This rigorous approach to data generation 
led to Stage I of the research successfully informing the design of the 
subsequent trial in Stage II. 
• Recruitment of participants to the feasibility trial in Stage II was 
successful, but could be further refined by removing researcher-led 
recruitment methods. 
• Trial participants were complex and multi-morbid, reflecting the setting, 
which increases the relevance of the findings for clinical services and 
policy makers. 
• Recruitment and retention of staff to Stage II of the research was 
successful. The BA treatment was disseminated to lower-grade CAMHS 
staff, who were able to deliver the brief intervention after receiving four 
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days training. Although, fidelity to the BA model was unable to be 
assessed. 
• The study procedures in Stage II of the research were acceptable to the 
adolescents and their families. Usual care was viewed as an appropriate 
comparator and young people tolerated randomisation well. 
• Most staff reported a variety of positive aspects of BA treatment and 
highlighted its utility in reducing symptoms of depression. However, one 
staff member found that BA treatment was incompatible with her usual 
eclectic practice. For others, there were caveats in relation to delivering 
the BA treatment using a structured manual and a lack of consensus over 
whether BA should be delivered as a ‘stand-alone’ therapy or deployed 
alongside other evidence-based treatments. These outstanding feasibility 
questions should be explored in future research. 
• The BA intervention format and content was acceptable to the involved 
young people and their families. Most young people experienced positive 
outcomes in terms of their depression, low mood and self-esteem. Young 
people particularly valued working collaboratively with their therapist and 
goal-setting activities. However, some young people and their parents 
experienced barriers to fully engaging in BA treatment. The key message 
was ensuring treatment is adapted to the individual. 
• The findings of this research add further to support the developmental 
approach to research data generation as advised by the Medical Research 
Council (MRC), as without the preparatory work undertaken, resources 
within the trial would have been wasted. 
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• The trial completed in Stage II of this thesis represents the first UK-based 
randomised study of a BA intervention for young people with depression 
in secondary care. As such, the Behavioural Activation for Major 
Depressive Disorder in Youth (BUDDY) study offers important insights into 
conducting a trial of a brief BA intervention in a UK CAMHS setting. A 
further strength was the use of a formal qualitative methodology to 
explore the experiences of adolescents, their parents and clinicians in 
relation to the BA intervention, which has advanced the international 
literature.  
Implications of the Findings 
A recent systematic review (Tindall et al., 2017) identified ten studies of BA 
treatment for depression in young people; none were UK-based and only three were 
Randomised Controlled Trials (RCTs). Since then, there has been one further RCT, in 
the USA, published in the area. All published UK-based evidence to date is based 
upon case study designs (Pass et al., 2015, Pass et al., 2016, Pass et al., 2017) and 
although this simple observational approach can be useful, as discussed in the 
background literature chapter, it is prone to bias. Internationally, few of these 
studies employ randomisation, which is an important control to reduce bias. As such, 
the BUDDY study will add to the growing international literature for the utility of a 
BA approach to treating depression in an adolescent population. Although the 
studies included in this thesis provide new and interesting knowledge about 
delivering complex interventions in a CAMHS setting, the results only provide 
provisional and early indications that BA may be a plausible treatment. The most 
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central findings relate to the learning gained around integrating a RCT of this 
intervention into a complex setting. This data will inform future research in this area, 
specifically by highlighting valuable areas for future studies to focus upon.  
The novel focused ethnography stretched the paradigm to inform the 
planned trial. Uniquely, the BUDDY study contained both randomisation and a 
significant qualitative arm, which explored the utility of the approach with both 
young people, their families and their clinicians. These qualitative findings in 
particular, potentially challenge the feasibility of BA delivery in a UK CAMHS context. 
It would be pertinent to explore the impact of staff’s clinical backgrounds on the 
delivery of psychotherapy, in light of the findings of the BUDDY study, as this may 
limit the clinical utility and generalisability of the BA approach in CAMHS teams. 
Other clinicians questioned the rigid and prescriptive nature of the manual and the 
impact this has on therapeutic alliance. Staff noted lacking the flexibility to respond 
to emerging issues during treatment may hamper patient care. This is a crucial 
question when services are attempting to cut costs and standardise treatments. 
The results from the BUDDY study are consistent with the majority of 
available studies in the area, in that we have found provisionally positive indications 
for BA as a treatment for depression in young people. The one case study that 
reported less favourable results was an early investigation using the ‘Adolescents 
Taking Action’ (ATA) manual (McCauley et al., 2011). However, following the 
adaptions made to the manual following delivery to this individual a large RCT using 
the manual did not report further difficulties. The results of the BUDDY study will 
inform the direction of future research and support existing calls for further research 
in this area. The focus of future directions will be discussed in more detail below.  
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Implications for Policy and Practice 
Child and adolescent mental health sits at the centre of the NHS Five Year Forward 
View (Ham and Murray, 2015, Department of Health, 2014). Currently in CAMHS, the 
demand for specialist mental health treatment outstrips the services’ capacity to 
provide it. The Department of Health states the need for early and effective 
evidence-based treatment available to those young people who need it (Department 
of Health, 2013a). As detailed in the background literature chapter, current 
evidence-based treatments for depression are costly to train staff in and resource 
intense to deliver, both in terms of the number of sessions required and the level of 
staff experience to deliver existing treatments. Successful delivery of such 
treatments requires extensive staff training and intensive, resource heavy packages 
of care, typically requiring a large number of treatment sessions. This may be 
incongruous with the NHS climate of austerity where difficult comprises have to be 
made.  In Stage I of this thesis, the difficult compromises the service had to make in 
light of this lack of capacity were alluded to. Encouragingly, my work has the 
potential to inform the future provision of equitable and effective care for 
adolescents.  
As discussed above, there is a lack of research evaluating BA in a UK-setting. 
Conducting research in a UK setting was particularly important because of the 
differences in the way healthcare is funded in the UK and the primarily insurance-
driven US. The Child and Young Person’s Improving Access to Psychological Therapies 
(CYP IAPT) programme aims to provide evidence-based therapy to young people and 
BA represents a plausible alternative to more costly, timely and complicated 
alternatives, such as Cognitive Behavioural Therapy (CBT). As National Institute for 
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Health and Care Excellence (NICE) guidance currently does not recommend BA as a 
standalone treatment for youth depression (National Institute for Health and Clinical 
Excellence, 2005), understanding how BA can be applied in a UK setting offers the 
opportunity to influence policy and practice, and inform future guidelines. The 
research detailed in this thesis and the proposed future research directions 
discussed below have been designed to be sensitive to policy maker’s requirements 
for high quality evidence to support clinical decision-making. In the BUDDY study and 
planned future trial, clinically relevant alternative interventions have been selected, 
the trials include a diverse population of participants recruited from clinical practice 
(and relatively representative of a CAMHS population), and data are collected on a 
wide range of health outcomes. Reliable evidence is required to support efficient use 
of limited resources and this is particularly the case in a CAMHS setting (Tunis et al., 
2003) and in times of economic constraint.  
One unanticipated outcome of this research was a greater understanding of 
the pathways participants took through CAMHS services’ Treatment As Usual (TAU). 
Although there were positive journeys these were in the minority, with most young 
people receiving little active treatment in the control arm of the study. This extends 
the debate and has wider resonance in conveying a message to commissioners and 
practitioners alike that new approaches to providing treatment within overburdened 
services is essential and timely. One hope in conducting and completing this research 
was, in some small way, to help to improve CAMHS services. There are many 
learning points from this research, although few offer solutions or positive messages. 
Within the qualitative strand of the BUDDY study, staff reported that a manualised 
approach to treatment may affect their therapeutic relationships; in contrast, 
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families were positive about this aspect of their BA treatment. These disparities need 
to be explored further before the findings would give credence to the suggestion 
that a manualised treatment could be a way forward to address the identified 
shortfalls in CAMHS care.  
Dissemination 
According to the MRC, dissemination is a central part of the research process (Craig 
et al., 2008) and is also an ethical obligation for researchers. Consequently, writing 
publications from my PhD research is a key priority. Stage I of this research (the 
focused ethnography) has already been published in Trials, an open-access journal, 
as a case study for the innovative approach taken to sequencing mixed methods in 
the context of trial design (Kitchen et al., 2017). The next planned publication is a 
short report to provide an overview of the RCT results of Stage II of the research, 
which will be submitted for publication in an academic peer-reviewed journal. 
Although underpowered tests have been performed for the purposes of the thesis, 
these will not be reported when seeking publication. Following this, a mixed 
methods paper will explore the RCT findings in more depth. It is anticipated that this 
will present challenges in conveying the complex findings in a meaningful format 
within the limitations of an academic journal.  
 A lay summary of the study results was sent to participants and their families 
in November 2017 (see Appendix 13). The next priority is further dissemination 
activities to academic and non-academic audiences. The results will be presented at 
academic conferences and via local University and Trust presentations during 
2018/19. This will include presentations to the participating CAMHS teams. The 
  325 
research will also be written in an accessible format for ‘The Conversation’, a blog-
site featuring academic and research news, which reaches monthly audiences of 5 
million readers. In addition, funding has been sought for further innovative, youth-
led dissemination activities.  
Future research directions 
The research conducted as part of this thesis identified many prospective avenues 
for further research. In the section below, two of these key domains are discussed, 
including a description of each overlapping area and why they may be worthy of 
further investigation.  
Clinician characteristics and the delivery of psychotherapies 
My PhD research raised some challenging questions about the way in which 
psychotherapies are delivered to young people in a CAMHS context. The first 
proposed area for future investigation relates to an issue identified in both stages of 
my research, related to the professional backgrounds and skillsets of staff who are 
trained via the CYP IAPT Programme and the individual factors that may impact upon 
the delivery of psychotherapy in this context. Findings of unexplained variability in 
clinical practice, high rates of inappropriate care and increased care costs have led to 
an increased demand for evidence of clinical effectiveness (Tunis et al., 2003). It may 
be that clinical effectiveness needs to be considered more broadly, rather than with 
a narrow focus on the effectiveness of the intervention of interest. Future research 
could investigate the feasibility of using existing CYP IAPT data from the national 
Mental Health Services Data Set, to explore the individual qualities that result in 
mental health professionals being more effective at engaging young people in 
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psychotherapies delivered in CAMHS and how these factors may relate to patient 
outcomes. Understanding these features is important in ensuring that CYP IAPT is 
effectively delivering evidence-based training and enabling practitioners to provide 
evidence-based treatment. It is also vital to understand what type of professionals 
may be best suited to delivering certain interventions because it would assist 
researchers and policy makers in recognising how best to generalise the results of 
the BUDDY study and future research more widely (to youth workers for example) to 
help improve wellbeing.  
Future trial of behavioural activation for young people with 
depression 
The promising findings relayed in this thesis have provided evidence that BA 
warrants further investigation as a treatment for depression for young people in 
CAMHS. The next step, based on these preliminary findings, is to plan a larger phase 
II (pilot) randomised trial to examine methodological and procedural uncertainties in 
a more rigorous manner (Craig et al., 2008). Pilot studies are miniature versions of 
the main study (O’Cathain et al., 2014). Subsequent progression of this research 
programme would then lead to a possible future definitive (phase III) RCT (informed 
by the results from the piloting phase). A fully-powered (phase III), well-designed 
RCT evaluating an intervention provides strong evidence of a cause-effect 
relationship if one exists (Kendall, 2003, Thabane et al., 2010). As such, a large, well-
designed RCT would contribute much needed quality evidence to the field of BA as 
an intervention for depression in young people. However, due to the outstanding 
feasibility issues identified during the BUDDY study, the next logical step would be to 
conduct a pilot, rather than a definitive trial. As per the MRC guidance for complex 
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interventions (Craig et al., 2008), an intervention should not progress beyond the 
piloting or feasibility stage if questions relating to feasibility have not yet been 
answered. Based on the BUDDY study results, we cannot yet be confident that the 
intervention can be delivered as intended due to outstanding questions that remain 
about fidelity, the manualised format of the treatment and the mode of delivery 
within the service. This is in keeping with MRC guidance that suggests depending 
upon the results, a series of pilot studies may be required to progressively refine the 
trial design before embarking on the definitive trial itself (Craig et al., 2008). The 
purpose of a pilot trial is to conduct a definitive trial in miniature (National Institute 
for Health and Clinical Excellence, 2017). There are two commonly touted 
alternatives when designing a pilot trial; an internal or an external pilot. An external 
pilot study is where the pilot trial is conducted independently of the definitive trial 
and, if the results are promising, further funding is sought for the fully-powered trial 
at a later date. The benefit of this approach is that resources are not wasted 
planning a larger trial that may have to change following the results of the pilot or 
may not be feasible at all. However, although according to the MRC, piloting and 
feasibility are viewed as integrated activities (Craig et al., 2008), the NIHR Research 
for Patient Benefit funding stream does not fund independent pilot studies as they 
are viewed as part of a phased development of a full trial (National Institute for 
Health Research, 2017). In contrast, as the name suggests, an internal pilot is 
situated within a planned definitive trial (Lancaster et al., 2004). Criteria are pre-
determined to progress from the pilot phase into the definitive trial, but this 
approach has been criticised for restricting the opportunity for significant changes in 
the trial design and it can lead to an increased risk of type I errors if the pilot data is 
  328 
included in the final analysis, as the two trials are being treated as unrelated in the 
sample size calculations (Lancaster et al., 2004). In light of the scope of the 
aforementioned outstanding feasibility questions from the BUDDY study, which may 
require significant changes to the protocol, an external pilot may be the most 
appropriate future study design.  
Key considerations are outlined below, in relation to deciding upon the 
methods to be used in a future pilot study to address the feasibility trial limitations. 
Sources of potential bias and remaining uncertainty about the feasibility of BA as a 
treatment for depression in CAMHS are discussed. 
Consent and recruitment procedures 
The consent procedure involving young people aged 16-17 providing informed 
consent or parents/carers (of patients under 16) providing informed consent, 
alongside their young person’s informed assent worked well in the BUDDY study. The 
age-appropriate materials informed by Patient and Public Involvement (PPI) were 
also acceptable to families. A similar procedure could be utilised in future trials. 
However, one concern was the lack of knowledge the young people in the BUDDY 
study had about the treatment options they were being offered. This suggests the 
need for more innovative strategies to adequately inform young people and their 
families about their care options. This is particularly challenging in trials that use a 
pragmatic comparator condition, such as usual care, because it is not possible to 
describe the exact treatment these participants will be offered. 
Trial design, randomisation and blinding 
In the BUDDY study, the BA staff at each site may have been a source of 
contamination as they regularly encountered other members of the team and 
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discussed the treatment of their patients. The findings from the focused 
ethnography of the CAMHS site, observed informal learning between team members 
rather than this being restricted to formal training or supervision sessions. The 
planned fidelity assessment may have provided an indication of whether therapeutic 
contamination was the case, whether this was from BA into the TAU arm or vice 
versa. However, this was unable to be commented upon in the BUDDY study due to a 
failure to collect audio recordings. The reasons why recordings were not made by 
clinicians as planned should be explored at an early stage of a future trial, in order to 
overcome these obstacles. If contamination was found to be occurring in a future 
pilot study, the trial design may need to be altered to account for this. One option 
would be a ‘cluster’ trial where groups of individuals or sites (such as a CAMHS team) 
are randomised to treatment as a whole. However, cluster randomised trials are 
inefficient, in a statistical sense, due to a lack of independence and therefore a large 
sample size is required to account for this (Everitt and Wessely, 2008). In terms of 
the pilot trial, a conventional individually-randomised parallel group design would be 
preferable and could be reconsidered if treatment contamination was observed. 
In the BUDDY study we utilised blocked randomisation, which was conducted 
by an otherwise uninvolved statistician. An independent statistician is an important 
control against bias; however, in a future trial the block sizes should be larger and 
randomly mixed in size to reduce the possibility of being predicted. This is important 
as predictability conflicts with the principle of randomisation (Kim and Skin, 2014). 
Although we used remote telephone randomisation in the BUDDY study, we used 
non-specialists to staff the service who did not have access to specialist 
randomisation software. Due to this, it was possible for the secretary to see the next 
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allocation on the randomisation list, which is a potential source of bias. It is therefore 
advisable to delegate specialist tasks to those who have appropriate expertise and 
resources (Kendall, 2003). In future trials, a professional remote randomisation 
service should be used where staff are blinded to the next allocation.  
A double blind study is the recommended design for RCTs whereby both 
investigators and patients are blinded to the treatment allocation, where this is not 
feasible it is advised that a blinded third party should be responsible for the 
collection of outcome measures (Kendall, 2003). It is also important to note anyone 
who is unmasked to treatment allocation during the trial.  
Treatment Manual 
During the BUDDY study, the ATA BA manual and associated materials represented a 
barrier to engagement in treatment for both young people and their clinicians. As 
discussed in the previous chapter, changes to the format and delivery of the manual 
have been suggested. Clinicians were vocal about their difficulties with the number 
of worksheets for each session, which made it difficult to deliver the treatment 
within the prescribed timescale. This suggests the manual requires further 
refinement prior to a pilot study. One method for investigating this further would be 
a formal usability method such as a ‘think aloud’ technique, which has been utilised 
in other studies of BA. In America, researchers video-recorded 24 adolescents 
undergoing a BA computerised module whilst voicing their thoughts on the BA 
programme (Davidson et al., 2014). The purpose of this additional qualitative 
research would be to assess the satisfaction of young people, their families and 
clinicians with any changes that would be made to the ATA manual. This would be a 
way to capture practice wisdom from clinicians and purview from young people’s 
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experiences using the materials in the context in which they are to be deployed. 
Webber (2014) discusses how involving clinicians in the creation of such materials 
provides external validity and ‘currency’ with practitioners due to the materials 
resonating with staff.  
Manualised treatments have become attractive to commissioners and 
services with reduced budgets who are required to deliver evidence-based 
treatments (Olubokun, 2017). The theoretical advantage of a manualised approach is 
consistency across treatment sessions and facilitation of the internal validity of the 
data by minimising the impact of the therapist on outcomes (Olubokun, 2017). Poor 
adherence to the protocol and feedback on therapist effects from the BUDDY study 
would suggest that a manual may not be feasible in this setting or that it requires 
further adaptation. In Rutter’s opinion, however, rather than fidelity or adherence, it 
is in fact the skill or competence of the practitioner in deploying the manual that is 
more relevant. Olubokun (2017) reported manuals can be criticised for being too 
rigid, regimented and inflexible, taking the approach that “one cap fits all” or not 
reflecting the real world of clinical practice. This was stated explicitly by one clinician 
in the BUDDY study, and other staff made reference to this when reflecting upon the 
manual use.  
There were suggestions that the ATA manual was not flexible enough to 
address young people’s comorbid mental health difficulties, such as anxiety. Some 
staff also felt the manual did not enable them to adequately tailor the BA treatment 
to each individual. Although the current ATA manual ensures all topics are covered in 
a logical order, greater emphasis needs to be on the flexibility for the practitioner to 
adapt the manual delivery to aid patient learning and engagement. In the pragmatic 
  332 
ADAPT trial of CBT in adolescents with depression, the manual content was used 
only as a guide to ensure the principles of treatment could easily be incorporated 
into NHS practice rather than rigid session by session instructions (Goodyer et al., 
2008). Another option to address this is to have optional modules within the manual 
itself. There is some debate about the utility of a ‘modular’ or ‘linear’ approach to 
manualised treatment, and which approach is most useful (Rutter et al., 2008) 
(Rutter et al., 2008). In a linear sequenced manual, all sessions have to be covered 
before treatment is complete, whereas in a modular manual there is more flexible in 
terms of the number and order of treatment sessions (Rutter et al., 2008). A modular 
manual may meet clinician’s desire for greater flexibility during BA treatment. 
However, previous research suggests that a modular approach may not be a good fit 
for a BA manual (Weersing et al., 2008) as a modular manual indicates a 
comprehensive approach is being taken to treatment whereas in BA there is a higher 
value placed upon parsimony. The concept of modular verses linear manual design 
could be explored via PPI with stakeholders in advance of a planned pilot study and 
could then be evaluated during the trial.  
Further to this, some staff members reported that delivery with a manual per 
say was incompatible with their usual delivery of care for depression. This is a 
potentially insurmountable feasibility issue in terms of the current BA delivery 
format that needs to be explored in further detail prior to or during any proposed 
pilot trial. A qualitative methodology is most likely to be useful to further illuminate 
practitioner’s experiences of using manuals to deliver psychotherapy in CAMHS. 
Wells et al. (2012) also found that staff developed their own ideas and preferences in 
relation to implementing treatment using a manual, but was unable to adequately 
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capture this knowledge due to the limitations of a traditional RCT design. It may be, 
in line with previous research (McCauley et al., 2016), that once BA strategies have 
been more thoroughly evaluated in young people they may be most useful as a first 
option in a stepped model of care or as components in a modular approach to the 
treatment of depression, allowing the therapist to follow an eclectic mix of evidence 
based therapies.  
In line with participant and parental feedback during the qualitative interview 
in the BUDDY study, another suggestion for a future trial would be the inclusion of 
‘top-up’ sessions or staggered delivery in the final BA sessions. The advantage of a 
top-up session is that it allows the young person to focus upon a topic of their choice 
and grants practitioners greater flexibility. This approach has been used in later 
iterations of the ATA manual when delivering BA to young people (McCauley et al., 
2016). 
Mixed Methods 
Although the information gleaned from the qualitative interviews was informative, 
young people, their parents and clinicians had to condense many months learning 
and experiences into a one hour interview. This may have meant vital information 
was lost. Multiple interviews over the course of treatment, reflexive diaries or 
recordings may be useful to counter this limitation during the trial. This is in keeping 
with a review by Lewin (2009) that suggested current RCT designs are not optimising 
the integration of qualitative research and that this is vital  to better understand the 
effects of interventions and how they are experienced by those participating in the 
trial. The continuation of a mixed methods approach, particularly the extension of 
the qualitative element of the feasibility study into the external pilot to explore 
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participant’s views on the changes to the intervention and data collection methods 
would be valuable. This would be in line with the MRC Guidance that recommends 
implementing a process evaluation to help to explain discrepancies between 
expected and observed outcomes (Craig et al., 2008). The impact of this design 
decision needs to be considered, as it can have broad consequences for the trial 
research team as a whole. O’Cathain et al (2015) describe three models of the 
relationship between qualitative research and a trial, based upon a qualitative study 
of researchers. The first is the ‘peripheral’ where the intention of qualitative 
research is not to add value to the trial but for another purpose (i.e. as an 
opportunity to obtain a higher degree). The second is the ‘add on’ where the 
qualitative researcher believes in the value of qualitative research but this belief is 
not shared by the lead investigator or key team members and third where qualitative 
research is viewed as ‘integral’ essential to evaluation. The resources required to 
undertake a qualitative evaluation should only be expended if it is integral to the 
study as a whole, or else the qualitative research risks becoming tokenistic. 
In the pilot trial design, I would argue for continuation of the ethnography 
throughout the trial stage of the study. The rationale for this is that it enables 
observation of the implementation of the research and the intervention in context; 
viewing the trial findings in a holistic way. However, the very recognition of context 
may challenge the central tenants of RCTs (Wells et al., 2012). The MRC recommends 
that a mixture of qualitative and quantitative methods are needed, for example to 
understand barriers to participation and to estimate response rates (Craig et al., 
2008). Previous research has utilised ethnography alongside RCTs (Ananthpur et al., 
2014), this approach will aid balancing a robust qualitative approach with a 
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pragmatic stance. Ethnography can indicate why an intervention did or did not work, 
enabling amendments to the trial protocol to be made (Savage, 2000). Document 
analysis may be a useful tool in order to place the BA intervention within a broader 
policy context using local and national policy documents. For example, relating to 
the observed Tier 2 eight-session treatment limit. Observational fieldwork would 
also inform the subsequent intervention; offering a staff viewpoint from the wider 
team that would be otherwise inaccessible. These methods will be particularly 
informative in respect to how the trial may be perceived in an organisational 
context. A significant limitation is the cost of completing an ethnography; although 
these are reduced using a focused approach, they may still be prohibitive. Traditional 
ethnographies may also encounter difficulties repeatedly securing access to the site 
(Reeves et al., 2008), especially when difficult findings are uncovered. As suggested 
in Stage I, engagement with gatekeepers is crucial in this respect. Another avenue to 
explore would be the use of ‘combinative’ fieldwork, where fieldwork is conducted 
simultaneously in different sites (Webber, 2014), accounting for different practice 
contexts with the aim of facilitating smooth implementation of the trial or 
intervention. However, the benefits of increased qualitative components of a trial 
need to be weighed against the potential for them to become an intervention 
themselves (O’Cathain et al., 2015). In the BUDDY study, the qualitative interview 
was conducted prior to the main outcome measures, which may influence the later 
outcomes taken and could represent a source of bias. This was particularly so in the 
BUDDY study where the qualitative interview was only offered to those in the BA 
arm. In future trials this could be countered by completing the interview following 
the follow-up assessment and offering the interview to participants in both arms of 
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the trial. As recommended by the MRC, a process evaluation marries well alongside a 
pragmatic trial. The importance of trials including multiple methods, sources and 
perspectives has been highlighted as a way to ensure they adequately reflect the 
context of clinical practice (Wells et al., 2012).  
Data Collection and Treatment Delivery 
During the BUDDY study, patient characteristics and treatment data were not 
recorded on the patient electronic records system in a systematic way by staff, which 
meant information relating to ethnicity, diagnosis or treatment content was unable 
to be obtained. A standard template requesting this information at baseline and 
during treatment sessions could account for this in a future trial, as used in the 
ADAPT trial (Goodyer et al., 2008). Although this represents a source of additional 
staff study burden, this information is vital due to the known high placebo response 
rate in depressed populations. Therefore, placebo-controlled studies are essential to 
determine whether any changes are due to therapeutic effect rather than just the 
fact the participants have had more therapeutic contact (Merry and Stasiak, 2012). 
This represents a confounding variable that should be controlled for in future 
studies, as even when using an active control such as TAU, if the session content or 
length is not known, it is impossible to separate the impact from contact time with a 
clinician from other treatment effects. By accurately recording this information 
aspects, such as the number of treatment sessions, can be controlled for using 
statistical techniques in a larger future trial. 
Another related difficulty in the BUDDY study was that staff in the TAU arm 
were not asked to follow a standard treatment manual or given specific guidelines 
such that the quality, quantity and content of the intervention could not be assessed 
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or controlled for. A comprehensive treatment protocol should be used; this could be 
situated within the setting by developing this protocol with stakeholders via PPI prior 
to the start of the trial. This will need to be reappraised in light of the findings from 
staff in relation to the utility of the BA manual. In the Improving Mood with 
Psychoanalytic and Cognitive Therapies (IMPACT) study they justify the use of 
manualised treatment based upon three points (Goodyer et al., 2017): firstly, 
protocols aid dissemination of treatment methods into clinical practice and aid 
standardisation of the intervention between therapists and across sites. Finally, the 
protocol can be used as the basis of assessment for fidelity ratings during treatment 
delivery in both arms of the trial. This, they argue, ensures that the interventions 
have been given appropriately and perhaps most importantly, that therapists in the 
group do not give the other intervention.  
Outcome measures 
In the BUDDY study, not all deployed outcome measures were successful. The BADS 
was difficult for young people to complete, and is not validated in this population. As 
such, an alternative more youth-friendly measure of activation or activity should be 
trialled in future studies following PPI input. 
Continuous outcome variables have the benefit of increasing the power of 
the trial over dichotomous variables (such as a diagnosis of depression using the 
Kiddie-SADS-Present and Lifetime Version) with only two outcomes (depressed/not 
depressed), which in turn permits a smaller sample size (Kendall, 2003). Therefore, 
the primary outcome measure in a future pilot study should be the Mood and 
Feelings Questionnaire- Child Version.  
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One major threat to the validity of the BUDDY study was the low follow-up 
rate at three-months and the very low follow-up rate at six-months. One reason to 
account for this is the high rates of drop-out in the CAMHS service as a whole, 
though there were also some suggestions that the setting for follow-up 
appointments may not have been optimal for all participants.  One family fed back 
that due to dropping out of the service they did not want to return to the building 
and I did not have ethical approval to conduct follow-up interviews at home. Young 
people in a previous consultation suggested home visits would be appropriate to 
reduce anxiety (Affleck and Seed, 2015). To accommodate this, future research 
should offer more flexibility in terms of the location of follow-up appointments. 
Pilot Trial Summary 
Although this chapter did not provide an exhaustive list of issues to be considered 
when designing a future pilot trial, it intended to summarise the learning gained 
from the BUDDY study and how findings could be utilised when planning future 
research. To summarise, a future pilot trial should include an adapted manual, mixed 
methods, research assessors independent of the treatment team and blind to 
randomisation, analysis by ITT and treatment protocols in both arms. 
Personal learning 
I feel I have learnt an immense amount whilst researching for my PhD. The core of 
that learning consisted of the research, writing and management skills that I have 
gained but, in this section I also wanted to reflect upon the more personal impact of 
studying towards a PhD. As someone who has never considered themselves, nor was 
I considered to be, academic at school, a doctorate was never an aspiration. I think 
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this led me to view my PhD very much as a practical apprenticeship that represented 
a route in life that I expected I would follow. As such, I sought out practical 
opportunities to learn along the way. The chance to undertake a clinical psychology 
placement alongside my PhD allowed me to expand my interests (after studying 
psychology at undergraduate level) and offered insight into the clinical population 
that I was studying, a chance that would never usually be afforded in a purely 
research-based PhD. Initially I did not fully appreciate the importance of this, but 
over the course of the two-year placement, I realised how the exposure to the 
setting from my role as an Assistant Psychologist was shaping my approach to 
research, the staff on my placement, my participants and to life in general. I naively 
thought that the writing or the statistics would be the areas of my PhD that would 
stretch or challenge me the most. Of course, I was wrong. These quickly became 
insignificant whilst on my clinical placement and during the data collection for Stage 
II of the study. The harrowing stories that families shared with me, especially the 
articulate descriptions the young people gave of their struggles, gave me a strong 
dose of perspective. I found dealing with clinical risk particularly difficult. Those 
stories will stay with me forever and remind me that any stress encountered during 
the process of creating this thesis should be remembered in the context in which it 
was created.  
Another opportunity I sought during my PhD was to obtain funding from the 
British Psychological Society to undertake a three-month secondment to work in the 
Parliamentary Office of Science and Technology in the Houses of Parliament. This 
experience highlighted gaps in my knowledge in terms of policy and research impact. 
I was able to observe the process of how research feeds into policy, and ultimately 
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practice. These experiences have confirmed my desire to work in applied health 
research, rather than a theoretical area. 
 Entwined with the emotional struggle, I encountered other challenges such 
as finding my ‘authorial voice’ as mentioned previously. My friends and family would 
find this surprising for someone who doesn’t struggle to articulate their views in 
everyday life; I think in the context of my research it was a case of imposter 
syndrome and a lack of confidence in my own ability to draw something meaningful 
from my data. I particularly liked Mason’s (2002) advice of being an active participant 
in qualitative research enquiry, rather than a passive researcher following a recipe 
book. However, my natural affinity to follow instructions made this self-directed 
inquiry difficult for me initially. In this respect, my supervisors have had a profound 
influence on me. Like my Stage I participants, my supervisors came from a variety of 
backgrounds; a psychiatrist, a nurse and an anthropologist. As is often the case, 
varied backgrounds lead to varied viewpoints, which offered invaluable perspectives 
that became an amazing resource during my PhD; although, on occasion, it was 
difficult to find a balance between my own knowledge gained from the setting and 
my supervisors’ personal experiences. Dikotomis (2016) reflects on the ‘academic 
world view’ and the comfortable environment of working with others who share this 
view. My diverse supervisory team led to an ongoing dialogue about ethnographic 
writing. I hope that I used these varied influences as a platform to explore, 
investigate and inform my own opinions that are presented in this thesis. Although 
my background is in psychology, I found increasingly during the course of my PhD 
that my research sat on the intersection between psychology, health, medicine and 
anthropology. Alongside this, my mixed methods approach to trial design meant that 
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I also didn’t fit neatly into the primarily quantitative trials tradition. Working at the 
interface of different disciplines, departments within the university and different 
methods has led to challenges articulating where to situate myself and my research. 
The methodological expertise within my own supervisory team was disparate; a 
trialist, a qualitative researcher and a psychometrician; all of whom brought with 
them different expertise. This was never more so evident in discussions relating to 
theory and pragmatics reflecting the wider disciplinary disputes. Whilst providing a 
vital resource upon which I capitalised, these diverse sources of oversight sometimes 
made it difficult to form a path of my own making. I can’t help but reflect that this 
echoed the difficulties observed in the CAMHS team.  
The primary gain from the process of producing this thesis is the opportunity 
to reflect upon the learning and experience I have gained in mixing methods. The 
initial decision to mix methods was established due to a desire to capitalise on the 
advantages of both approaches. The results and experience of the trial has enabled 
me to evaluate these decisions more critically and has provided time to reflect upon 
both the combination of the different methods selected and the sequencing of those 
methods. This insight is not often obtained because in larger trials, experts in 
quantitative and qualitative methodologists are often asked to consult upon their 
own area of expertise, which leaves the trial without an overarching methodologist. 
This makes it difficult to fully appreciate the challenges of mixing methods and leads 
to what have been termed ‘paradigm warriors’ (Kelle, 2006), where researchers 
assign themselves to a particular approach and offer unhelpful critical appraisal of 
other approaches, making it difficult to adopt a constructively critical view of their 
own tradition. I argue towards a more unified approach that acknowledges the pros 
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and cons of each approach, with a particular attention towards the issues arising 
when these often disparate approaches are mixed. Barbour (2014) opts for not 
categorising specific types of mixing methods, in contrast to Creswell (2007), in order 
to encourage innovation and thoughtful mixing of methods. Typically, mixed 
methods occur, as in this study, at an exploratory stage of a trial. The results of this 
research suggest there could be many advantages to extending this approach 
throughout the trial phases. I hope to publish my findings in the mixed methods 
format that I intended. 
Conclusions 
The results of this research are complex and multi-faceted, much like the setting in 
which the research was situated. The previous preparatory work, the focused 
ethnography of the study site and the pragmatic trial design removed common 
obstacles to study and intervention implementation during Stage II of the research.  
As would be expected however, the implementation of a complex 
intervention has met barriers that need to be further be explored, particularly in 
relation to staff’s experiences of delivering the BA intervention in a manualised 
format and the integration of the treatment into usual clinical practice. Although it 
may seem that this research has generated as many questions as it has answered, it 
has furthered the research field in the UK, added to the growing literature 
internationally for the utility of a BA approach to treating depression in an 
adolescent population. Furthermore, it has facilitated the ongoing adaption of the 
intervention in order to prepare for a larger definitive trial of BA as a brief 
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intervention for depression in young people in CAMHS. The findings support the case 
for future studies evaluating BA in this setting. 
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Appendix 1 
BODY and Mind Study: CONSORT flowchart of participant recruitment 
and retention 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Screening- Invited (n=1126) 
Total Excluded (n=569) 
- Parental opt-out (n=114) 
- Young person did not consent or 
was absent from school (n=455) 
Total Excluded (n=524) 
- Did not meet both weight and 
mood criteria (n=140) 
- Did not meet either weight or 
mood criteria (n=384) 
Excluded (n=1) 
- Did not present with significant 
depressive symptoms on the K-
SADS-PL 
Intervention Group (n=4) Waiting list control Group (n=4) 
Session 4 (n=4) Session 4 (n=4) 
Session 8 (n=4) Session 8 (n=4) 
Final Session (n=4) Final Session (n=3) 
Exit interview (n=3) Exit interview (n=4) 
Screening- Consented (n=557) 
Diagnostic Interview- Invited (n=33) 
Diagnostic Interview- Consented (n=9) 
Intervention- Invited (n=8) 
Intervention- Consented (n=8) 
Allocation ratio 1:1 
Total Excluded (n=24) 
- Moved schools (n=1) 
- Did not wish to take part (n=6) 
- Could not be contacted (n=17) 
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BODY and Mind Study: Qualitative Themes 
 
Theme Description 
Pressure This theme was rooted in the screening element of 
the study where young people felt peer, school and 
parental pressure to participate. In some respects, 
participants felt under pressure to take part and in 
other ways, they felt pressured to withdraw. It also 
incorporated participant’s concerns that they may 
‘fail’ the screening tool. 
Stigma  This encapsulated families’ negative perceptions of 
treatments for mood disorders, stigma around being 
overweight and gender differences in this respect. 
This included the experience of being identified to 
participate in the study, which led to varied reactions 
ranging from feeling special to being nervous. 
Participants valued the confidentiality the sessions 
offered with a facilitator from outside of the school 
setting. However, the location for these sessions was 
not universally popular. 
Responsibility This aspect was key to families’ experiences 
throughout the study. Participants valued the 
opportunity for self-recognition of their mood/weight 
problems and they emphasised their role in 
maintaining these difficulties. Young people would 
have preferred more control over the level of 
parental involvement in their treatment. However, 
they appreciated the self-directed nature of 
treatment and working together with the therapist to 
achieve their goals. Those that reported longer-term 
improvements attributed this to their increased 
motivation to change their lifestyle. Those who did 
not experience any impact upon their life from the 
treatment blamed external barriers, such as their 
parents/carers. 
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Stage I: Ethical Approval from the School of Medicine, Pharmacy and 
Health Ethics Sub-Committee 
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Stage I: Health Research Authority Research Assessment- Not 
Research 
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Stage I: Approval of a Minor Ethical Amendment from the School of 
Medicine, Pharmacy and Health Ethics Sub-Committee 
 
 Staff Information Sheet (Observation): Version 1 (06/06/2014) 
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Appendix 3 
Stage I: Staff Information Sheet (Observation) 
 
 
 
                                                                    
 
Information Sheet 
A focused ethnography of a Child and Adolescent 
Mental Health Service to inform the design of a 
randomised controlled trial 
 
Introduction 
Hello, my name is Charlotte Kitchen and I work for the 
Mental Health Research Centre at Durham University. I 
am also working as a research assistant in the South 
Durham Child and Adolescent Mental Health Services 
(CAMHS) team. I am currently involved in the planning 
and design of a study to evaluate an intervention for depression in CAMHS. 
The purpose of my placement with the team is to learn and fully understand 
how the team operates and functions. 
This is where I need your help! In order, to learn as much as I can, I 
would like to observe the everyday life of the team for three months and to 
take notes. At this stage I would like to ask your permission to make these 
observations.  
Who is being asked to take part? 
The whole team is being asked whether they would be happy for me to 
observe their normal day-to-day practice if and when I encounter them on my 
placement. This might range from regular contact with some members of staff 
to other members of staff who I never come into contact with. 
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What does taking part involve? 
It involves you just conducting your everyday job roles and being your normal 
selves! Although I will be observing everyday practice, there will be no 
monitoring of individual performance. I will not be commenting on individual 
members of staff; the purpose of my project is to record practical barriers to a 
future depression intervention for young people. For example, I may comment 
upon normal intake procedures for the team. This should in no way be 
disruptive to your normal ways of working. 
Do you have to take part? 
No, participation is completely voluntary and you will not be asked to provide 
a reason if you do not want to take part. If you do not want to be involved 
please complete the “opt-out” form attached. However, if you do opt out due 
to the observational nature of the study I will still be on placement with the 
team and may be observing colleagues that you are interaction with but no 
comments will be recorded on your part in those interactions. If you do not 
complete the opt-out form it will be assumed that you are happy to take part.  
Even if you do decide to take part, you can change your mind at any 
time during the research without giving a reason. If you do decide to stop 
taking part we will be able to use any information up to that point but we will 
not collect any further information. We are hoping that as many members of 
the team as possible will allow me to make notes on them to provide a more 
accurate picture of the current service. 
What are the possible risks of taking part? 
We are not anticipating any risks associated with involvement but in the 
unlikely situation that any risks are identified, the normal Trust procedures 
would be followed.  
What are the benefits to taking part? 
The notes taken will help to tailor the planned behavioural activation 
intervention trial for depression to be better suited to this unique setting 
meaning a better experience for both staff and patients.  
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What will happen to the observational data? 
All data will be stored according to Trust and university procedures. All 
information will remain confidential (not shared with anyone outside the 
research team) and a de-identified version of the findings will be circulated to 
the team. No member of the team will be named in our findings. You will also 
be informed of the outcomes of these findings; in terms of what impact they 
have had on the design of the future trial, any publications or presentations. 
Who to contact if you require further information or have a 
complaint? 
If you have complaint or a concern please contact either myself or my 
supervisor; 
 
Charlotte Kitchen     Paul Tiffin 
E113a Wolfson Building,   E107 Wolfson Building, 
Durham University Queens Campus, Durham University Queen’s Campus, 
Thornaby,      Thornaby, 
Stockton-on-Tees    Stockton-on-Tees. 
TS17 6BH      TS17 6BH 
Telephone: 0191 33 40455  Telephone: 0191 33 40707 
charlotte.kitchen@dur.ac.uk   p.a.tiffin@dur.ac.uk 
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Stage I: Staff Opt-Out Form (Observation) 
 
A focused ethnography of a Child and Adolescent Mental Health Service to 
inform a randomised controlled trial 
Please complete this form if you do NOT want to be commented upon in the 
researcher’s observation study. Please return this form directly to the researcher or 
post it into the sealed box located in 
……………………………………..……………(location of confidential box). 
 
I (name)…………………………………………..do NOT  wish to participate in the study 
named above. 
Signature…………………………………… 
Today’s date………………………………………… 
 Staff Information Sheet (Interview): Version 1 (07/05/2014) 
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Appendix 4 
Stage I: Staff Information Sheet (Interview) 
 
                                                                    
 
Information Sheet 
A focused ethnography of a Child and Adolescent 
Mental Health Service to inform the design of a 
randomised controlled trial 
 
Introduction 
I have been conducting an observational project in the South Durham Child 
and Adolescent Mental Health Services (CAMHS) team over the past three 
months and I would like to follow up on some of my findings by interviewing 
key stakeholders from the service. You have been identified as one such key 
stakeholder. 
What does taking part involve? 
It involves an interview lasting a maximum of 40 minutes one-to-one with 
myself. You will be provided with a copy of the interview transcript to read and 
check that we have understood everything that was discussed. You will then 
have the opportunity to clarify any misunderstandings. 
Do you have to take part? 
No, participation is completely voluntary and you will not be asked to provide 
a reason if you do not want to take part. If you would like to take part you will 
need to finish reading the information sheet and complete the consent form 
provided. Even if you do decide to take part, you can change your mind at any 
time during the interview. If you do decide to stop taking part we will be able to 
use any information up until that point but we will not ask you for further 
information.  
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What are the possible risks of taking part? 
Although we are not anticipating any risks associated with involvement, due to 
the small numbers of staff involved it may not be possible to completely 
ensure anonymity. However, we will make sure no members of staff are 
named in our findings. 
What are the benefits to taking part? 
This research will enable us to tailor the planned behavioural activation 
intervention trial for depression specifically to this service which is a unique 
opportunity. Your feedback will help clarify and put into context the findings 
from the earlier observational work. All the data collected will be fed into the 
design of the planned future intervention study to ensure it is better suited to 
the setting meaning a better experience for both staff and patients.   
What will happen to your data? 
The information will be digitally recorded on a Trust approved device and then 
transcribed word for word. The digital recording will then be securely 
destroyed. The data will be coded for common themes. All data will be stored 
according to Trust and university procedures. All information will remain 
confidential (not shared with anyone outside the research team) and a de-
identified version of the findings will be circulated to the team. You will also be 
informed of the outcomes of these findings; in terms of what impact they have 
had on the design of the future trial, any publications or presentations. 
Who to contact if you require further information or have a 
complaint? 
If you have complaint or a concern please contact either myself or my 
supervisor; 
 
Charlotte Kitchen     Paul Tiffin 
E113a Wolfson Building,   E107 Wolfson Building, 
Durham University Queens Campus,  Durham University Queen’s 
Campus, 
Thornaby,      Thornaby, 
Stockton-on-Tees    Stockton-on-Tees. 
TS17 6BH      TS17 6BH 
Telephone: 0191 33 40455  Telephone: 0191 33 40707 
charlotte.kitchen@dur.ac.uk   p.a.tiffin@dur.ac.uk
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Stage I: Staff Consent Form (Interview)     
                                                                  
                                                                   
 
 
Participant Identification Number:  
 
CONSENT FORM (INTERVIEWS) 
 
Study Title: A focused ethnography of a Child and Adolescent Mental Health 
Service to inform the design of a randomised controlled trial. 
 
Please initial the boxes to confirm  
you agree with each statement   
 
 
1. I confirm that I have read and understand the 
information sheet dated 06/06/2014 (version 1) for the 
above study. I have had the opportunity to consider the 
information, ask questions and have had these answered 
satisfactorily.  
 
2. I understand that my participation is voluntary and that I 
am free to withdraw at any time without giving any reason, 
and without my legal rights being affected. I understand 
that any information collected up until the point of my 
withdrawal will be kept and used as part of the research. 
 
3. I understand that by taking part in this research I will be 
interviewed and I agree that the interview can be audio 
recorded. 
 
4. I agree to the use of my anonymised quotes when this 
research is published. 
 
5. I agree to take part in the above study.  
 
 
 
Name of Participant: 
 
Date  
 
Signature  
 
Name of Person taking consent (Researcher): 
 
Date: 
 
Signature:  
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Appendix 5 
Behavioural Activation Session Agendas 
 
Session 1: Getting Started 
 Welcome 
 Structure of BA therapy 
 Rational for BA 
 Introduction to the BA model- individual formulation 
 Values, important people and activities 
 Between-Session Tasks 
 
Session 2: Getting Started II 
 A guide for Parents/Carers 
 Introduction to Mood Monitoring  
 Introduction to Activity Charts 
 
Session 3: Getting Active 
 Mood vs. Goal Directed Behaviour 
 Introduction to Avoidance (TRAP/TRAC) 
 Goal-setting  
 Introduction to Activity Scheduling 
 
Session 4: Getting Active II 
 Parenting skills 
 Why we do what we do… payoff and cost: Situation-Action-Mood 
  “Improve your Mood” vs. “Bring you Down Activities” 
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Session 5: Problem Solving 
 Mini-Steps 
 Monitoring Parental Support Behaviours 
 Triggers 
 Using COPE to manage challenging situations 
 
Session 6: Goal-Setting 
 Values Clarification 
 Review Goal-setting 
 Mini-steps to reach goals and values 
 Active listening for parents/carers 
 Identifying Barriers- internal/external 
 
Session 7: Overcoming Barriers 
 Overcoming Avoidance 
 Avoidance Modification (TRAP/TRAC) 
 Parental Strategies for Communicating Support 
  
Session 8: Staying on Track 
 Relapse Prevention 
 Identification of Early Warning Signs 
 Formulation of Relapse Prevention Plan 
 Goodbye 
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Appendix 6 
Stage II: Favourable Opinion Letter from the School of Medicine, 
Pharmacy and Health Ethics Sub-Committee 
 
 
  372 
Stage II: Approval of Minor Ethical Amendments from the School of 
Medicine, Pharmacy and Health Ethics Sub-Committee 7 
 
 
 
                                                 
7
 Letters have been included where they were issued, other minor amendments were confirmed via 
email correspondence. No major amendments were submitted. 
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Stage II: Favourable Opinion Letter from NRES Committee North East- 
Newcastle and North Tyneside 1 
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Stage II: Approval of Minor Ethical Amendments from NRES 
Committee North East- Newcastle and North Tyneside 1 
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Stage II: Research and Development Approval Letters 8 
 
 
 
                                                 
8
 Letters have been included where they were issued, other minor amendments were confirmed via 
email correspondence.  
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Stage II: University Sponsor Letter and Insurance Cover 
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Appendix 7 
Stage II: Invitation Letter 
 
 
                                                                                                  
              
The BUDDY Study 
 
 
[Date] 
 
 
Dear [insert parent/carer’s name], 
 
 
The [insert team name] Child and Adolescent Mental Health Services (CAMHS) team 
are working with researchers at Durham University to look at how we treat low 
mood. We want to ask young people to provide feedback on the treatments we 
normally provide and a new option for treatment so we can find out what works 
best. 
 
[You/your young person is/are] being invited to take part in the study because 
during your first assessment [you/your young person] reported symptoms of low 
mood meaning [you/they] may be suitable to take part. Taking part in the study 
involves two assessments and a telephone call (and possibly an interview).  
 
We have enclosed an information sheet about the study but we know that you will 
need more information in order to decide whether [you/[and] your young person] 
would like to take part. We would like to invite you to meet with Charlotte so that 
she can explain the study further.  
 
Please indicate whether or not you would be happy to receive more information 
by completing the enclosed ‘Contact form’ and return it using the pre-paid 
envelope (just post directly into a post box- no stamp required). You will receive an 
appointment letter once we receive your contact form. [You/your young person] will 
receive £10 in vouchers just for attending this information meeting.  
 
In the meantime, if you have any questions or would like let the research team know 
by telephone please call Charlotte Kitchen, on 0191 33 40455 or email: 
charlotte.kitchen@durham.ac.uk 
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Many thanks for taking the time to read this letter. 
 
Kind Regards, 
 
 
 
 
[Insert team] Child and Adolescent Mental Health Services team 
 ‘Consent-to-Contact’ Form: Version 2 (21/11/2014) 400 
Stage II: ‘Consent-to-Contact’ Form 
 
 
         
 
 
The BUDDY Study 
Permission for Researcher to Contact 
You 
 
Name (of young person): 
……………………………………………………. 
 
 
I am happy to be contacted. 
If you tick this box the research team  
will send you an appointment letter  
to meet with Charlotte so you can  
receive more information. This does  
not mean you have to take part in  
the study- you are only agreeing to  
receive more information. 
 
 
I do not want to be contacted.  
If you tick this box the research team  
will not contact you again. 
 
Insert ID number 
 Parent/Carer Baseline Workbook: Version 3 (26/01/2015) 401 
Stage II: Parent/Carer Baseline Workbook (including Information Sheet, 
Consent Form and Self-Report Baseline Outcome Measures) 
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Stage II: Young Person (aged 16-17) Baseline Workbook (including 
Information Sheet, Consent Form and Self-Report Baseline Outcome 
Measures) 
 
 
 Young Person (aged 16-17) Baseline Workbook: Version 3 (26/01/2015) 411 
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Stage II: Young Person (aged 12-15) Baseline Workbook (including 
Information Sheet, Consent Form and Self-Report Baseline Outcome 
Measures) 
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Stage II: Patient Study Poster 
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Stage II: Staff Study Poster 
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Appendix 9 
Stage II: Severity Criteria  
(available at http://www.psnpaloalto.com/wp/wp-
content/uploads/2010/12/Depression-Diagnostic-Criteria-and-Severity-Rating.pdf) 
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Appendix 10 
Stage II: Parent/Carer Follow-Up Workbook (including Self-Report Follow-Up 
Outcome Measures) 
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Stage II: Young Person (aged 16-17) Follow-Up Workbook (including Self-
Report Follow-Up Outcome Measures) 
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Stage II: Young Person (aged 12-15) Follow-Up Workbook (including Self-
Report Follow-Up Outcome Measures) 
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Stage II: Interview Topic Guides 
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Appendix 12 
Stage II: Clinician Interview Information Sheet and Consent Form 
 
 
 Clinician Interview Information Sheet and Consent Form: Version 2 (26/01/2015) 
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Appendix 13 
Stage II: Participant Lay Results Summary 
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Appendix 14 
Stage II: Overview of the care provided to participants assigned to treatment as usual 
 
Pseudonym Gender Tier Service Contact at 3-month  
follow-up 
No. Treatment 
Sessions:  
3-months 
Service Contact at 6-month 
follow-up 
No. Treatment 
Sessions:  
6-months 
Joseph m 3 Discharged without further 
assessment or treatment. 
0 One-hour individual 
assessment session. 
0 
Rhiannon f 2 One assessment session. 0 One-hour individual 
assessment session and one 
treatment session. 
1 
Kristen f 2 None given. 0 None given. 0 
Caseigh f 3 Discharged without further 
assessment due to no response to 
a 14-day letter. 
0 Discharged. 0 
Amber f 3 One half an hour assessment 
session, two one-hour CBT 
sessions, one 50-minute CBT 
session, one CBT session of an 
unspecified length, one brief care-
coordination review with parent. 
4 Discharged due to no 
response to a 14-day letter. 
0 
Antonia f 2 One ‘CBT inspired’ appointment for 
an unspecified time, one one-hour 
‘skills training (psychological 
wellbeing)’/ ’CBT inspired’ session, 
9 Four one-hour and one 40-
minute ‘coping strategies 
(psychological wellbeing)’ 
sessions, one appointment 
6 
  464 
six one-hour ‘coping strategies 
(psychological wellbeing)’/CBT 
sessions, one 50-minute ‘coping 
strategies (psychological 
wellbeing)’ and one 15-minute 
care-coordination review with 
parent. 
with a medic for an 
unspecified time and one 
review meeting with a 
parent. 
Ben m 2 One half an hour information 
giving/assessment session. 
0 One-hour information 
giving/assessment session, 
one-hour EIP assessment 
session, one-hour ‘First 
Episode Pathway’ treatment 
session, 10-minute physical 
health appointment. 
1 
Alannah f 2 One-hour group therapy session. 1 None given. 0 
Laura f 2 Four 45-minute and one half an 
hour CBT appointments. 
5 Discharged. 0 
Isabel f 3 One 45-minute discharge meeting. 0 Discharged. 0 
Megan f 2 One 50-minute assessment 
session. 
0 None given. 0 
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Stage II: Overview of the care provided to participants assigned to Behavioural Activation treatment 
 
Pseudonym Gender Tier Service Contact at 3-month  
follow-up 
No. Treatment 
Sessions:  
3-months 
Service Contact at 6-month 
follow-up 
No. Treatment 
Sessions:  
6-months 
Jennifer f 3 Two BA sessions over four weeks 
(one 60 and one 55-minutes), one 
unspecified session. 
2 Cognitive Assessment, one 
45-minute family therapy 
(systemic) session, 10-minute 
care coordination meeting 
with social worker, one-hour 
CBT assessment, one-hour 
care review with family. 
Discharged due to non-
attendance at two anger 
management sessions. 
1 
Frankie f 3 Three BA sessions over six weeks 
(two 45 and one 50-minutes), one 
50-minute assessment and one 45-
minute medication monitoring 
appointment. 
4 One unspecified 45-minute 
treatment session and one 
30-minute medication 
monitoring appointment. 
Discharged to GP. 
1 
David m 3 Two 10-minute medication 
reviews, one medication review 
(unspecified time), one 40 and one 
35-minute medication monitoring 
8 None. 0 
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sessions, one one-hour assessment 
session, eight BA sessions over 13 
weeks (seven 30 and one 45 
minutes). 
Jessica f 2 No response to 14 day letter. 
Discharged. 
0 Discharged. 0 
Estelle f 2 One 50-minute assessment, eight 
BA sessions over 11 weeks (one 30, 
two 45, one 55 and three 60-
minutes). 
8 Discharged. Referred back 
into the service. 
0 
Lucy f 2 One-hour initial assessment, eight 
BA sessions over 8 weeks (one 45, 
three 60, two 65, one 70 and one 
75-minutes). Discharged with no 
review. 
8 Discharged. 0 
Sophie f 2 One 70-minute assessment 
session, one 45-minute BA session, 
one unidentified session (appeared 
to be CBT content) for one-hour. 
Deemed at this point unsuitable for 
BA treatment by clinician. 
2 Transferred to Tier 3 for 
treatment. 
Excluded from 
study. 
Victoria f 2 Seven BA sessions over 9 weeks 
(one 55, two 50, two 45 and two 
40-minutes), 80-minute school 
review, one 35-minute unspecified 
session, one 45-minute 
information giving session and a 35 
and a 45-minute review. After not 
11 Discharged. 0 
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attending the final review, she was 
discharged. 
Connor m 2 One 50-minute assessment, four 
BA sessions over 8 weeks (one 30, 
one 45 and one 60-minutes, one 
delivered over two sessions of 20 
and 60-minutes). Did not attend 
next appointment. Discharged. 
4 Discharged. Referral back 
into service from the Youth 
Offending Service. 
0 
Neive f 2 One one-hour assessment session, 
three BA sessions over six weeks 
(one 45, one 50-minutes and one 
delivered over a 30 and 15-minute 
session). Terminated treatment as 
family wished to focus on exam 
anxiety. 
3 One 30-minute review. 0 
Alicia f 3 Eight one-hour BA sessions over 8-
weeks and one BA feedback 
session to a parent. 
8 One 90-minute group 
therapy assessment, six 90-
minute sessions group 
therapy, one 60 and one 90-
minute BA review session. 
6 
  468 
 
 
